2018 American Transplant Congress » 2018 ATC Sessions

Date & Time:
None. Available on demand

Location: None listed

Session Type:

Meeting: 2018 American Transplant Congress

A Calculator for Kidney Transplant Waitlist Outcomes under the New Kidney Allocation System

A. Hart,^1,2 N. Salkowski,² A. Matas,³ B. Kasiske,² J. Snyder,² A. Israni.²
Ablation of Both mTOR and STAT3 in T Cells Induces Heart Transplant Acceptance in Donor Skin-Sensitized Mice

A. Xie,^1,2 W. Chen.^2,3
Alemtuzumab is Associated with Higher Rates of De Novo Donor Specific Antibody (DSA) in Patients with No Pre-Transplant DSA

N. Bath, S. Parajuli, G. Leverson, M. Jorgenson, J. Fose, T. Ellis, D. Kaufman, A. Djamali, R. Redfield.
An Effective Tolerance Approach for Porcine Islet Xenotransplantation in Humanized Mice

F. Lee,¹ A. Dangi,¹ M. Burnette,¹ X. Zhang,¹ B. Hering,² X. Luo.¹
Assessment and Outcomes of Medication Nonadherence in Pediatric Kidney Transplant Recipients: Results from the IMPACT Study

A. Dokras,¹ M. Pearl,¹ J. Peipert,¹ P. Grimm,⁴ B. Warshaw,² E. Chambers,³ A. Kirk,³ R. Ettenger.¹
Association of Health Literacy with Adverse Outcomes among Kidney Transplant Candidates and Recipients

F. Warsame, C. Haugen, J. Garonzik-Wang, N. Desai, D. Crews, T. Purnell, M. McAdams-DeMarco, D. Segev.
Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection – A Double-Blind Randomized Placebo-Controlled Trial (BORTEJECT Study)

F. Eskandary,¹ H. Regele,² G. Bond,¹ N. Kozakowski,² M. Wahrmann,¹ L. Hidalgo,³ H. Haslacher,⁴ C. Kaltenecker,¹ M-.B. Aretin,⁵ R. Oberbauer,¹ J. Reeve,⁶ P. Halloran,⁶ G. Böhmig.¹
CTLA4-Ig and Bortezomib Successfully Reverses Established DSA Responses in Allograft-Sensitized Recipients

D. Jain,¹ J. Young,¹ D. Yin,¹ R. Pelletier,² A. Chong.¹
Clinical Implications of Positive Crossmatch in Liver Retransplants

F. Paterno, S. Tremblay, K. Wima, M. Cuffy, T. Diwan, N. Anwar, E. Woodle, S. Shah.
Diagnostic Accuracy of Non-Invasive Test of Hepatic Fibrosis in Liver Transplant Recipients

D. Galvez,¹ C. Bhati,¹ M. Siddiqui,² C. Schmoyer,² T. Arshad,² A. Sharma,¹ A. Cotterell,¹ K. Yadav,¹ T. Reichman,¹ M. Levy.¹
Early Steroid Withdrawal and Kidney Transplant Outcomes for Recipients with Delayed Graft Function

S. Bae, A. Massie, X. Luo, J. Garonzik Wang, D. Segev.
Enrichment of Endogenous Donor-Reactive Tregs in the Spleen and Graft during Transplantation Tolerance is the Result of Treg Proliferation and Conversion from Tconv

J. Young, D. Yin, M-.L. Alegre, A. Chong.
Eplet Mismatches and De Novo Donor Surface Antibody Development in Pediatric Renal Transplant Recipients

E. Blanchette,¹ M. Bradford,¹ P. Warner,² C. Blosser,³ I. Gimferrer,² J. Smith.¹
Everolimus with Reduced-Dose Calcineurin Inhibitor versus Mycophenolate with Standard-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Renal Function Results from the TRANSFORM Study

F. Oppenheimer,¹ C. Legendre,¹ J. Cruzado,¹ G. Russ,¹ O. Viklicky,¹ R. Oberbauer,¹ V. Garcia,¹ O. Witzke,¹ D. Kuypers,¹ R. Danguilan,¹ P. Bernhardt,² C. Sommerer.¹
Hidden Risk of Liver Transplantation for Nonalcoholic Steatohepatitis: A Propensity Score Matched Study

S. Nagai,¹ R. Schilke,¹ M. Safwan,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ M. Abouljoud,¹ D. Moonka.²
Impact of Changes to the LAS Calculation

R. Lehman,¹ R. Carrico,¹ K. Uccellini,¹ K. Chan,² T. Whelan.³
Impact of Donor Hepatectomy Time during Organ Procurement in Donation after Circulatory Death Liver Transplantation; The United Kingdom Experience

S. Farid, A. Magdy, D. Vijayanand, V. Upasani, S. Willis, A. Barlow, H. Ernest, A. Niaz.
Impact of Pre-Transplant Dialysis on ESRD-Free and Patient Survival in Heart Transplant Alone and in Simultaneous Heart/Kidney Transplant Recipients: UNOS Data Analysis

S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.
Improving DCD Livers Graft Function Using CD47 Blockade in the Setting of Normothermic Liver Perfusion

S. Garcia-Aroz,¹ M. Xu,¹ X. Wang,¹ J. Hollingshead,¹ A. Khan,¹ B. Banan,¹ L. Kang,² Z. Zhang,¹ G. Upadhya,¹ Y. Lin,¹ P. Manning,³ W. Chapman.¹
Increased Pre-Transplant Rejection-Risk Measured with Allospecific T-Cells Predicts Delayed Immunosuppression Minimization in Children with Intestine Transplantation.

K. Soltys, C. Ashokkumar, G. Mazariegos, G. Bond, M. Ningappa, A. Khanna, A. Ganoza, Q. Sun, R. Sindhi.
Inflammatory Frailty Index and Mortality after Kidney Transplantation

C. Haugen, H. Ying, M. McAdams-DeMarco, D. Segev.
Introduction of Direct Acting Antivirals for HCV: Fewer Kidney Discards but a Long Way to Go

T. Alhamad,¹ R. Thakkar,¹ D. Brennan,² J. Lappin,³ B. Kaplan,³ A. Malone,¹ V. Hicks,¹ J. Wellen,¹ K. Lentine.⁴
Ischemia Reperfusion Injury & Risk for Antibody Mediated Rejection (ABMR) in HLA Sensitized Patients Treated with C1 Esterase Inhibitor (C1INH)

A. Vo,¹ O. Aubert,² J. Choi,¹ N. Ammerman,¹ H. Edmund,¹ A. Peng,¹ R. Najjar,¹ S. Supreet,¹ S. Jordan.¹
Liver Stiffness Measurement, but Not Controlled Attenuation Parameter, is Increased in Deceased Liver Donors at the Time of Transplant Procurement

A. Duarte-Rojo,¹ G. Barone,¹ D. Borja-Cacho,¹ W. Concepcion,² M. Shaheen,³ J. Heimbach,³ W. Kim.²
Molecular Analysis of Acute Cellular Rejection in Clinical Face Transplants

T. Win, B. Dyring-Andersen, J. Teague, N. Murakami, A. Chandraker, B. Pomahac, L. Riella, R. Clark.
Natural History and Determinants of Infectious Complications after Kidney Transplantation: A Nationwide Prospective Population Based Cohort

A. Scelma, M. Perrier, O. Lortholary, S. Girerd, C. Kerleau, V. Garrigues, F. Buron, N. Kamar, C. Legendre, Y. Bouatou, C. Lefaucheur, M. Giral, A. Loupy.
Nephrosclerosis beyond That Expected for Age is Predictive of Early New-Onset Hypertension (HTN) in Living Kidney Donors (LKD)

N. Issa,¹ L. Vaughan,¹ A. Denic,¹ V. Nagineni,¹ H. Chakkera,² J. Lieske,¹ L. Lerman,¹ S. Taler,¹ M. Stegall,¹ W. Kremers,¹ E. Poggio,³ A. Rule.¹
Non-Invasive Diagnostic of Renal Allograft Rejection via Urine Metabolites Using NMR-Spectroscopy

M. Banas,¹ S. Neumann,² P. Pagel,² D. Chittka,¹ V. Pfahlert,² B. Banas.¹
Outcomes of Organ Transplantation from Donors with Cancer History

Z. Guo,¹ X. He,¹ S. Huang.¹
Pancreas Transplant Recipients with End-Stage Renal Disease Benefit from Kidney Transplantation

Y. Tang, Z. Zhu, S. Huang, Z. Zhang, W. Ju, Z. Guo, X. He, G. Chen.
Parsing the 100% CPRA Kidney Transplant Candidates, Who Gets Transplanted?

D. Keith.
Potential Living Donors Identified through Social Media

S. Weeks, K. Kumar, J. Konel, E. King, M. Henderson, A. Cameron, J. Garonzik Wang.
Respiratory Viral Infections Induces Exosomes and Antibodies to Lung Self-Antigens, Kα1Tubulin and Collagen V, Following Human Lung Transplantation

M. Gunasekaran,¹ S. Bansal,¹ M. Sharma,¹ R. Walia,¹ R. Hachem,² A. Limaye,³ R. Bremner,¹ M. Smith,¹ T. Mohanakumar.¹
Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to a Standard Tacrolimus-MPA Regimen in De Novo Kidney Transplant Recipients: ATHENA 12 Months Data on Infections

A. Hauser,¹ C. Sommerer,¹ B. Suwelack,¹ D. Dragun,¹ O. Witzke,¹ C. Hugo,¹ N. Kamar,² P. Merville,² P. Schenker,¹ M. Junge,³ F. Thaiss,¹ B. Nashan.¹
T Cell Exhaustion in Kidney Transplant Patients

M. Fribourg,¹ C. Fischman,² L. Anderson,² B. Burrell,³ P. Heeger,² P. Cravedi.²
The First 9 Years of KPD through the National Kidney Registry: Characteristics of Donors and Recipients Compared to National Transplant Registries

S. Flechner,¹ A. Thomas,² M. Ronin,³ J. Veale,⁴ D. Leeser,⁵ S. Kapur,⁶ J. Piepert,⁴ D. Segev,² G. Hil,³ A. Waterman.⁴
The First Series of Ischemia-Free Liver Transplantation in Human

X. He,¹ Z. Guo,¹ S. Huang,¹ Q. Zhao,¹ Y. Tang,¹ Z. Zhang,¹ Z. Zhu,¹ W. Ju,¹ L. Yang,² G. Chen.¹
The Risk Factors of Acute Rejection in Patients with BK Nephropathy after the Reduction of Immunosuppression

C. Baek,¹ H. Kim,¹ W. Yang,¹ D. Han,² S-.K. Park.¹
The Role of CD46 in Early Islet Engraftment in a Dual Transplant Model

Q. Gao, K. Samy, R. Davis, M. Song, A. MacDonald, F. Leopardi, T. How, K. Williams, G. Devi, B. Collins, A. Kirk.
Transplant Surgeon Perspectives on General Surgery in Transplant Recipients

S. DiBrito, M. Bowring, S. Rasmussen, C. Haugen, C. Holscher, N. Zonnenberg, M. Henderson, D. Segev, J. Garonzik-Wang.
mTOR Inhibition with Everolimus in De Novo Living Donor Liver Transplantation – 24-Months Results from the H2307 Pivotal Trial

L. Jeng,¹ S. Lee,¹ A. Soin,¹ S. Uemoto,¹ D. Maluf,¹ J. Emond,¹ M. Meier,² J. Kochuparampil,² C. Sips,² S. Kaneko,³ G. Levy.¹
mTORC2 Deficiency in CD11c⁺dendritic Cells Promotes Acute Kidney Injury

H. Dai,^1,2 A. Watson,¹ D. Fantus,¹ L. Peng,² A. Thomson,¹ N. Rogers.¹
A Novel Nomogram-Based Approach for Defining the Effect of Transplantation on Cancer Recurrence Risk

N. Ejaz,¹ R. Alloway,¹ F. Paterno,¹ A. Singhal,¹ X. Ji,² M. Kattan,² E. Woodle.¹
Analyzing Geographic Disparity in the US Heart Allocation System

F. Karami,¹ M. Nayebpour,² M. Gentili,¹ N. Koizumi,² A. Rivard.³
Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection

C. Lefaucheur,¹ D. Viglietti,¹ O. Aubert,¹ A. Philippe,² P. Halloran,³ A. Loupy,¹ D. Dragun.²
Are Donation after Cardiac Death (DCD) Kidneys Unsuitable for Pediatric Recipients?

M. MacConmara,¹ S. Levea,² C. Hwang.¹
CD4 T Cells Require Both S1PR1 and S1PR4 for Afferent Lymphatic Migration

Y. Xiong,¹ W. Piao,¹ C. Brinkman,¹ L. Li,¹ J. Kulinski,² A. Olivera,² A. Cartier,³ T. Hla,³ S. Schwab,⁴ K. Hippen,⁵ B. Blazar,⁵ J. Bromberg.¹
CMV-Specific Cell-Mediated Immunity after Valgancyclovir Prophylaxis Predicts Late Onset CMV Infection in Kidney Transplant Patients

M. Jarque,¹ E. Crespo,¹ E. Melilli,² A. Manonelles,² N. Montero,² S. Luque,¹ J. Cruzado,^1,2 J. Grinyo,^1,2 O. Bestard.^1,2
Causes of Death among Deceased Donors

M. Skeans, D. Zaun, B. Kasiske.
Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Differential Effects of Inhibiting Glycolysis on Human Treg Subsets

N. Tanimine, B. Priyadharshini, S. Germana, L. Turka.
Donor-Specific B-Cell Tolerance after Successful ABO Blood Type Incompatible (ABOi) Living Donor Liver Transplantation (LDLT)

T-.J. Wu, Y-.C. Wang, C-.H. Cheng, T-.H. Wu, C-.F. Lee, H. Chou, K-.M. Chan, W-.C. Lee.
Early Blockade of Toll-Like Receptor 4 Reduces Ischemia-Reperfusion Injury and Improves Islet Transplantation Outcomes

C. Chang,¹ M. Lawrence,² R. Kane,¹ B. Naziruddin.³
Extra-Renal Effects of Estrogen Receptor-Alpha Mediate Protection from Renal Ischemia-Reperfusion Injury

D. Aufhauser, D. Murken,¹ S. Concors,¹ Z. Wang,¹ G. Ge,¹ T. Bhatti,² W. Hancock,^2,3 M. Levine.¹
Gut Microbiota Dysbiosis is an Independent Risk Factor for Development of Urinary Tract Infections in Kidney Transplantation

J. Lee,¹ A. Sholi,¹ C. Gong,¹ M. Magruder,¹ S. Albakry,¹ E. Edusei,¹ B. Botticelli,¹ D. Dadhania,¹ M. Lubetzky,¹ Y. Taur,² L. Ling,² E. Pamer,² M. Suthanthiran.¹
Histone Deacetylase Inhibition Mitigates Limb Ischemia Reperfusion Injury

S. Concors,¹ D. Aufhauser,¹ D. Murken,¹ Z. Wang,¹ G. Ge,¹ T. Bhatti,⁴ W. Hancock,^3,4 M. Levine.^1,2
IL-17 is Critical for Airway Epithelial Injury after Transplantation

R. Zhang,¹ H. Fang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
Impact of Direct Acting Antiviral Agents (DAAs) for Hepatitis C Virus (HCV)-Induced Liver Diseases on Registration and Outcome on Waiting List (WL) for Liver Transplant (LT)

C. Antoine,¹ C. Jasseron,¹ F. Conti,² S. Dharancy,³ C. Duvoux,⁴ A. Coilly.⁵
Impact of Rapid Discontinuation of Prednisone on Kidney Transplant Outcomes in At-Risk Subpopulations: An OPTN/SRTR Analysis

D. Vock,¹ A. Matas.²
Impact of the Kidney Allocation System on Young Pediatric Recipients

W. Parker,¹ L. Ross,¹ J. Thistlethwaite,¹ A. Gallo.²
Inferior Patient and Graft Survival in Highly Sensitized Adult Kidney Transplant Recipients with a Prior Transplant Compared to Pediatric Kidney Transplant Recipients: An Analysis of OPTN Data

P. Almond,¹ S. Al-Akash,¹ D. Stewart,² A. Robinson.²
Landscape of Living Donor Kidney Transplantation with International Donors in the United States

A. Thomas,¹ M. Henderson,¹ A. Shaffer,¹ A. Massie,¹ B. Koons,² K. Lentine,³ D. Segev,¹ F. Al Ammary.¹
Liver Transplant Survival Index for Recipients with High MELD Score: A Model for Post-Transplant Survival in Severely Ill Patients

J. Steggerda,¹ M. Bloom,¹ C. Bresee,² D. Malinoski,³ A. Klein,¹ K. Kim.¹
Medullary Tissue Sampling in Renal Allograft Biopsy is More Sensitive for Pathologic Diagnosis of PVN

D. Abdelwahab,¹ H. Khamash,¹ S. Kriegshauser,³ R. Heilman,¹ M. Smith.²
Molecular Phenotypes of Injury and Rejection in Lung Transplant Transbronchial Biopsies

M. Parkes, K. Halloran, K. Famulski, P. Halloran, The INTERLUNG Study Group.
Morphometric and Metabolic Correlates of Frailty in Pancreas Transplant Recipients

R. Parsons, J. Wolosyn, R. Lynch.
Mortality and Kidney Transplantation Outcomes among Chronic Dialysis Patients Who Are Seropositive for Hepatitis C Virus

D. Sawinski,¹ F. Kimberly,¹ L. Vincent,¹ S. Justine,¹ B. Colleen,¹ C. Jordana,¹ G. David,¹ L. Jayme,² W. Joe,³ R. Peter.¹
Myeloid-Derived Suppressor Cells Suppress with Enhanced Donor Specificity in Donor ECDI-SP Treated Recipients

L. Zhang, J. Wang, Z. Zhang, X. Luo.
Opiate Use Trends after Liver Transplantation and the Factors Associated with Post-Transplant Opiate Dependence

M. Siddiqui,¹ R. Kaur,¹ S. Dhoop,² N. Sulejmani,¹ R. Salgia.¹
Predicting Survival after Deceased-Donor Kidney Transplants by Donor-Recipient Match: Who Can Tolerate a High-KDPI Kidney?

S. Bae, J. Garonzik Wang, K. Jackson, A. Thomas, X. Luo, A. Massie, D. Segev.
Prevention and Reversal of Diabetes through Restoration of B and T Cell Regulation and Immune Homeostasis

K. Brayman,¹ P. Chhabra,¹ C. Wilson,² A. Marshall,² D. Moore.²
Prevention of an Adaptive Immune Response by FDA-Approved Immunosuppressive Agents in Baboons with Pig Artery Patch Xenografts

T. Yamamoto,¹ H. Hara,¹ L. Wang,¹ Q. Li,¹ J. Li,¹ H. Zhou,¹ D. Eckhoff,¹ A. Tector,¹ D. Ayares,² D. Cooper,¹ H. Iwase.¹
Prospective, Double Blind, Randomized Trial Comparing the Use of Ketorolac and Lyrica versus SOC+placebo during Live Donor Nephrectomy for Transplant

J. Campsen,¹ T. Call,² A. Rosales,¹ C. Allen,³ A. Presson,³ R. Kim.¹
QPI-1002, a siRNA Targeting p53: Improvement in Outcomes Following Acute Kidney Injury (AKI): Cardiac Surgery to AKI Donors

J. Tchervenkov,² E. Squiers,¹ R. Stratta,³ D. Odenheimer,² D. Rothenstein,² QPI-1002 DGF Study Group.
Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results

M. Spaggiari,¹ C. Di Bella,¹ P. Di Cocco,¹ F. Gheza,¹ E. Benedetti,¹ I. Tzvetanov,¹ J. Oberholzer.²
Single-Cell Analysis of Graft Infiltrating T-Cells in Cardiac Allograft Vasculopathy

M. Habal, A. Myung, H. Yan, S. Rao, S. Lin, P. Colombo, C. Marboe, S. Restaino, A. Han, M. Farr, E. Zorn.
Temporal Changes in the Characteristics and Sensitization of Kidney Paired Donation Registrants

C. Holscher,¹ K. Jackson,¹ A. Thomas,¹ C. Haugen,¹ S. DiBrito,¹ M. Ronin,² A. Waterman,^3,4 A. Massie,^1,5 J. Garonzik Wang,¹ D. Segev.^1,5
The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation

Q. Xu,¹ A. Skaro,² V. McAlister.²
The Protective Effect of Multivisceral Transplantation on Intestinal Allograft Rejection – Its Correlation with T-Cell Macrochimerism from a Long-Term Prospective Study

P. Liou,¹ M. Martinez,¹ J. Fu,² M. Velasco,¹ A. Griesemer,¹ S. Lobritto,¹ J. Vittorio,¹ S. Ravella,¹ B. Levin,³ J. Emond,¹ M. Sykes,² T. Kato.¹
The TRANSFORM Study: Infection Outcomes with Everolimus Plus Reduced Calcineurin Inhibitor and Mycophenolate Plus Standard Calcineurin Inhibitor Regimens in De Novo Kidney Transplant Recipients

F. Vincenti, J. Cruzado, S. Mulgaonkar, V. Garcia, D. Kuypers, M. Buchler, F. Citterio, U. Huynh-Do, W-.L. Luo, P. Bernhardt, C. Sommerer.
Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR)

S. Patel, S. Mohan, H. Fernandez, I. Batal, L. Ratner, J. Crew.
Unique Gene Expression Signatures in Urine Distinguish BK Virus Nephropathy from Acute Rejection in Kidney Transplant Patients with Graft Dysfunction

K. Keslar,¹ P. Gotwald,¹ W. Xu,² A. Zmijewska,³ J. Chen,³ K. Newell,⁴ P. Heeger,⁵ J. Bromberg,⁶ R. Mannon,³ R. Fairchild,¹ The CTOT Consortium.
Validation of a Transplant Knowledge Quiz and Its Impact on Outcomes in Kidney Transplant Recipients

H. Corbo, N. Patel, N. Pilch, V. Rohan, J. Fleming, T. Harrison, J. Hardcopf, B. O'Brien, C. Perez, P. Baliga, H. Meadows, D. Taber.
Variation in Cost of Death and Graft Failure across All Solid Organs

M. Schnitzler,^1,2 M. Skeans,² D. Axelrod,³ K. Lentine,¹ H. Randall.¹
Cell Free DNA Sequencing for Diagnosing Infections, Estimating Growth Rates, and Characterizing Antibiotic Resistomes in Urine Supernatants

J. Lee,¹ P. Burnham,² D. Dadhania,¹ M. Heyang,² F. Chen,² M. Suthanthiran,¹ I. De Vlaminck.²
Central Role of Mef2 Transcription Factors in Regulation of Foxp3 Expression and Treg Function

A. Samanta,¹ L. Wang,¹ R. Han,¹ W. Hancock.^1,2
Clinical Impact of Denovo or Recurrent Donor Specific Antibodies in the First Year Post Kidney Transplant in Patients on Early Steroid Withdrawal Immunosupression Regimen

O. Adebiyi, T. Taber, W. Goggins, D. Mishler, M. Yaqub, A. Sharfuddin.
Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era

M. Kadatz,¹ J. Gill,² J. Gill,² K. Scott.³
Dependency on CD4 T Cells, Foreign Protein, and CD22 for Generation of Antibody Response to Non-Self Blood Group A-Antigen in a Mouse Model

I. Adam, B. Motyka, K. Tao, L. West.
Donor Liver Apoptosis is Associated with Early Allograft Dysfunction and Short-Time Graft Survival after Liver Transplantation

Z. Guo, Z. Zhu, Y. Tang, S. Huang, Z. Zhang, X. He, G. Chen.
Donor Reactive Eomesdermin^hiCD8⁺ T Cells Are Significantly Upregulated Early after Transplant in Kidney Transplant Patients without Rejection

A. Perez-Gutierrez,^1,2 D. Metes,¹ S. Hariharan,¹ A. Thomson,¹ M. Ezzelarab.¹
EVLP on Donor Lungs: National Trends and Outcomes

R. Lehman,¹ R. Carrico,¹ K. Uccellini,¹ K. Chan,² T. Whelan.³
Effect of Everolimus with Reduced Calcineurin Inhibitor on Efficacy and Safety in De Novo Kidney Transplant Recipients: 12-Month Results from the US Cohort of TRANSFORM Study

S. Mulgaonkar,¹ Y. Qazi,¹ D. Kim,¹ V. Peddi,¹ K. McCague,² D. Patel,² A. Wiseman.¹
Epitope/Eplet Mismatch in Pediatric Renal Transplantation and Development of Donor Specific Antibody

R. George,¹ H. Sullivan,² R. Garro,¹ P. Winterberg,¹ B. Warshaw,¹ H. Gebel,² R. Bray.²
Extended Experience Using Tocilizumab (Anti-IL6R, TCZ) for the Treatment of Chronic Antibody Mediated Rejection (CABMR)

J. Choi,¹ O. Aubert,² S. Louie,¹ N. Ammerman,¹ A. Vo,¹ A. Peng,¹ E. Huang,¹ R. Najjar,¹ D. Puliyanda,¹ S. Sethi,¹ M. Haas,¹ K. Lim,¹ A. Loupy,² S. Jordan.¹
First Birth after Uterus Transplant in the US

L. Johannesson, R. Gunby, Jr., T. Anthony, G. McKenna, E. Koon, A. Warren, G. dePrisco, J. Mitchell, J. Putman, K. Wallis, G. Klintmalm, G. Testa.
Five-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study

E. Bailly,¹ G. Blancho,² S. Ville,² E. Morelon,³ J. Bamoulid,⁴ S. Caillard,⁵ V. Chatelet,⁶ P. Malvezzi,⁷ J. Tourret,⁸ V. Vuiblet,⁹ D. Anglicheau,¹⁰ D. Bertrand,¹¹ P. Grimbert,¹² F. Haidar,¹³ M. Hazzan,¹⁴ N. Kamar,¹⁵ P. Merville,¹⁶ C. Mousson,¹⁷ V. Pernin,¹⁸ C. Pouteil-Noble,¹⁹ R. Purgus,²⁰ J. Sayegh,²¹ P. Westeel,²² M. Büchler.¹
Geographic Variation in the Survival Benefit of Heart Transplantation

W. Parker,¹ R. Gibbons,¹ M. Churpek,¹ A. Anderson.²
Glycogen Synthase Kinase 3 beta Regulates Liver Inflammation Activation and Resolution by Controlling AMPK Activities

H. Wang,^1,2 M. Ni,^1,2 H. Zhou,² L. Lu,² R. Busuttil,¹ J. Kupiec-Weglinski,¹ Y. Zhai.¹
Glycolytic Bias in mTORC2-Deficient Dendritic Cells Potentiates Antigen-Specific Immunity and Accelerates Graft Rejection

A. Watson,¹ H. Dai,¹ J. Diaz-Perez,² A. Menk,³ M. Killeen,² G. Delgoffe,³ A. Mathers,² A. Thomson.¹
Higher Early Post-Liver Transplant Mortality in Recipients with Severe Alcoholic Hepatitis versus Alcoholic Cirrhosis

B. Lee, G. Im, J. Dodge, M. Voigt, J. Rice, M. Lucey, D. Foley, L. Platt, A. Gurakar, N. Mehta, G. Therapondos, H. Han, D. Victor, O. Fix, L. Dinges, D. Dronamraju, C. Hsu, M. Rinella, H. Maddur, S. Eswaran, J. Hause, R. Ghobrial, Z. Li, N. Terrault.
Human Thrombomodulin Expression on Genetically Modified Donor Pigs is Required to Maintain the Anti-Coagulation Profile

A. Singh, L. DiChiacchio, J. Chan, P. Corcoran, B. Lewis, M. Thomas, D. Ayares, K. Horvath, M. Mohiuddin.
Identification of Noninvasive and Mechanistically-Informative Biomarkers Predictive of Reversal of Acute Cellular Rejection (ACR) in Kidney Allografts

D. Luan,¹ J. Schwartz,² R. Ding,² T. Muthukumar,² D. Dadhania,² M. Suthanthiran.²
Impact of Direct Acting Antivirals of Hepatitis C Virus Therapy on Tacrolimus Dosing Post-Liver Transplant

A. Bixby, L. Fitzgerald, R. Leek, J. Mellinger, S. Tischer.
Impact of KDPI and CPRA on Outcomes in Kidney Transplant Recipients

S. Sethi, R. Najjar, A. Peng, A. Vo, S. Jordan, E. Huang.
Intentional Transplantation of Hepatitis C Positive Livers into Hepatitis Negative Recipients- Report of the First Case-Series in the World

P. Martins, B. Movahedi, A. Ahearn, A. Bozorgzadeh.
Intragraft Gene Expression Differentiates Polyomavirus Nephropathy from T-Cell Mediated Rejection

B. Adam,¹ S. Wagner,¹ J. Bräsen,² V. Bröcker,² V. D'Agati,³ C. Drachenberg,⁴ E. Farkash,⁵ A. Farris,⁶ L. Geldenhuys,⁷ A. Magil,⁸ V. Nickeleit,⁹ P. Randhawa,¹⁰ H. Regele,¹¹ M. Mengel.¹
Kidney Transplant Allocation with CMV Seromatching Reduces CMV Infection without Affecting Wait Times

A. Narra,¹ L. Strasfeld,² D. Basuli,¹ M. Stack,¹ E. Langewisch,³ A. Olyaei,¹ D. Norman,^1,4 J. Lockridge.^1,4
Low Kidney Supply to Demand Ratio and Multi-Organ Transplant Centers Are Negatively Associated with Pediatric Renal Transplant Rates Post Kidney Allocation System Implementation: An Analysis of OPTN Data

P. Almond,¹ S. Al-Akash,¹ D. Stewart,² A. Robinson.²
Modifiable Causes of Racial Disparities in Living Donor Kidney Transplant

J. Beaumont,¹ J. Peipert,^1,2 C. Anderson,² A. Paiva,³ M. Robbins,³ A. Waterman.^1,2
Normothermic Machine Perfusion (NMP) Preservation for Human Liver Transplantation in the Cleveland Clinic

Q. Liu, D. Pezzati, A. Hassan, B. Soliman, P. Grady, S. Maikhor, G. Iuppa, T. Diago Uso, K. Hashimoto, F. Aucejo, M. Fujiki, B. Eghtesad, J. Cywinski, S. Irefin, J. Fung, K. Abu-Elmagd, C. Miller, C. Quintini.
Organ Transplantation Associated with High Incidence of Anal Cancer and Pre-Cancer Lesions among HIV-Infected Women and Men

P. Chin-Hong,¹ B. Barin,² M. Berry,¹ M. DaCosta,¹ T. Darragh,¹ L. Rosenthal,³ S. Bartlett,⁴ D. Dieterich,⁵ F. Poordad,⁶ N. Nissen,⁶ M. Wong,⁷ P. Stock,¹ J. Palefsky.¹
Outcomes in Liver and Combined Liver-Kidney Retransplantation

D. Sonnier, D. Bruce, H. Bohorquez, E. Bugeaud, I. Carmody, A. Cohen, A. Mathur, J. Seal, G. Loss.
Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients

S. Parajuli, S. Alagusundaramoorthy, F. Aziz, N. Garg, R. Redfield, H. Sollinger, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot.
Prolonged Cold Ischemia Storage of Renal Allografts Shifts DSA Specificity and Enchances Glomerular Injury

V. Gorbacheva, R. Fan, W. Baldwin, A. Valujskikh.
Simultaneous versus Pretransplant Native Nephrectomy in Autosomal Dominant Polycystic Kidney Disease Patients

M. Eltemamy, A. Crane, M. Elmer-Dewitt, B. Frainey, A. Elshafei, A. Wee, D. Goldfarb, V. Krishnamurthi.
Temporal and Geographical Trends of Intestinal Transplantation in the USA

M. Segovia,¹ S. Jafri,³ B. Summers,³ T. Schiano,² T. Pietrowsky,³ A. Al-Osaimi,⁵ A. Mavis,¹ S. Horslen.⁴
The Advantage of Utilizing ABO and HLA Compatible Pairs in Kidney Paired Donation

A. Basu,¹ C. Kosberg,¹ H. Khamash,² M. Mai,³ M. Prieto,¹ C. Schinstock.¹
The Altruistic Living Kidney Donor Phenotype – From Inquiry to Donation

V. Kumar, P. MacLennan, M. Bonventre, M. Hanaway, R. Reed, J. Locke.
Thymoglobulin Induction in HIV Positive Kidney Transplant Recipients: Report on Transplant and HIV Outcomes

E. Gibney, T. Ommert, R. Cross, A. Ray, J. Lizcano.
Transplant Hospitals Increase Volumes and Acceptance Rates under the COIIN Project

D. Klassen, H. Haskell, K. Sisaithong, M. McBride, R. Carrico, M. Curry.
Treatment of Post Transplant Hepatitis C (HCV) with Direct-Acting Antiviral (DAA) Agents May Improve Liver Function but Does Not Lead to an Increase in Liver Rejection

P. Sheiner, N. Mello, G. Baixauli, M. Einstein, C. Rochon, Y. Kwon, M. Bejon.
Trends, Patterns, and Recipient Outcomes of Kidney Transplants from Older (>60) Living Donors. A UNOS Database Analysis

A. Riaz, O. Adebiyi, M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin.
Ultra Low Dose of IL-2 Produces Long-Term Drug-Free Survival of Cynomolgus Islets Allografts

M. Koulmanda,¹ V. Chipashivili,¹ L. Li,¹ M. Duggan,² T. Strom.¹
Upregulated IL-33 in Heart Transplants Modulates Local Myeloid Populations to Protect against Chronic Allograft Rejection

Z. Zhang,¹ Q. Liu,¹ G. Hussey,² J. Dziki,² L. Mathews,¹ H. Dai,¹ G. Dwyer,^1,3 A. Lucas,¹ M. Oberbarnscheidt,¹ S. Badylak,² H. Turnquist.^1,3
Use of Hepatitis-C Treatments after Kidney Transplantation: Impact of the Direct-Acting Antiviral Era

K. Lentine, D. Axelrod,² R. Bloom,³ H. Xiao,¹ D. Segev,⁴ T. Alhamad,⁵ H. Randall,¹ R. Ouseph,¹ V. Dharnidharka,⁵ D. Brennan,⁴ N. Lam,⁶ A. Naik,⁷ G. Hess,⁸ B. Kaiske,⁹ M. Schnitzler.¹
A Transcriptomic Signature in PBMC from Kidney Transplant Recipients at Baseline Predicts Early Acute Rejection

W. Zhang,¹ Z. Yi,¹ P. Cravedi,¹ L. Li,¹ K. Keung,² C. Wei,¹ M. Menon,¹ J. Dudley,¹ P. O'Connell,² B. Murphy.¹
An Individualized Strategy Using Virus and Immune-Based Markers to Prevent Cytomegalovirus Disease after Face Transplantation

R. Razonable, H. Amer, S. Mardini.
Are Deceased Donor Characteristics Associated with Liver Graft Failure among Low MELD Patients Receiving a Liver Transplant Changing

K. Atiemo,¹ A. Skaro,² R. Craig-Schapiro,¹ S. Montag,¹ L. VanWagner,¹ M. Abecassis,¹ J. Levitsky,¹ L. Zhao,¹ D. Ladner.¹
Assessment of a Discharge Transplant Knowledge Quiz and Its Impact on Outcomes in Liver Transplant Recipients

H. Corbo, N. Patel, N. Pilch, C. Perez, J. Fleming, T. Harrison, J. Hardcopf, H. Meadows, B. O'Brien, J. McGillicuddy, P. Baliga, D. Taber.
B Cell Immune Repertoire Sequencing Identifies Pre-Transplant Rejection Risk

S. Pineda,^1,2 T. Sigdel,¹ J. Liberto,¹ K. Roskin,³ S. Robin,³ M. Sirota,² M. Sarwal.¹
BK Polyomavirus (BKPyV)-Specific T Cells as a Diagnostic and Prognostic Marker for BKPyV-Infections after Pediatric Kidney Transplantation

T. Ahlenstiel-Grunow,¹ M. Sester,² U. Sester,³ L. Pape.¹
Broader Geographic Sharing and Impact on Lung Transplant Waitlist Time and Lung Allocation Score

W. Tsuang, M. Budev.
CD40 Signaling in Proximal Tubules Regulates Fibrosis in Both Hypertension and Chronic Allograft Rejection

V. Bletsos, J. Breidenbach, S. Haller, S. Stepkowski.
CD8⁺Tissue Resident Memory T Cells Are Key Effector Cells in Intestinal Transplantation Patients with GvHD

O. Aguirre, B. Houlihan, A. Karabala, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.
Circulating Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V, and Immune Regulatory Proteins in Lung Transplant Recipient with Primary Graft Dysfunction

M. Sharma, S. Biswas Roy, R. Walia, A. Omar, R. Bremner, M. Smith, T. Mohanakumar.
Class II Anti-HLA IgG2 and IgG3 DSAs Predict Poorer Outcomes in Chronic Antibody Mediated Rejection of Renal Allografts

A. Gueret-Wardle,¹ G. Lucisano,¹ S. Hassan,¹ P. Brookes,² E. Santos-Nunez,² D. Goodall,¹ C. Clarke,¹ J. Galliford,¹ M. Willicombe,¹ D. Taube.¹
Diagnostic Value and Confounding Factors of Urinary Biomarkers in the Non-Invasive Screening of Renal Allograft Inflammation

A. Vermorel,¹ A. Devresse,¹ C. Tinel,^1,2 V. Sauvaget,² L. Morin,² L. Amrouche,^1,2 M. Rabant,^2,3 D. Anglicheau.^1,2
Donor Hypothermia Outcomes in Living Kidney Transplantation

J. Buggs,¹ J. Wei,² E. Rogers,³ R. Liu,² V. Bowers.¹
Early Considerations for Deceased Donor Chains

A. Toll,¹ R. Leishman,¹ V. Casingal,² M. Aeder,³ T. Sandholm,⁴ N. Turgeon.⁵
Early Evolution and Pathologic Characteristics of Treg-Rich Organized Lymphoid Structures (TOLS) Associated with Immunological Tolerance in Accepted Mouse Kidney Allografts

C. Yang,¹ I. Rosales,² T. O'Shea,¹ D. Ndishabandi,² R. White,² P. Russell,¹ J. Madsen,¹ A. Alessandrini,¹ R. Colvin.²
Effect of Early Attainment of Everolimus Target Trough Levels on Efficacy-Safety Outcomes in De Novo Kidney Transplant Recipients: 12-Month Results from US92 and TRANSFORM Studies

F. Shihab,¹ Y. Qazi,^1,2 V. Peddi,¹ D. Shaffer,¹ D. Kim,^1,2 K. McCague,³ D. Patel,³ S. Mulgaonkar.^1,2
Effect of Induction Therapy on CD4 Cell Count Recovery Following Renal Transplantation in HIV Positive Recipients – A Single Center Experience

J. Chique Figueroa, M. Prendergast, H. Wadei, M. Mai, K. Oshel, D. Leonard.
Enteric Conversion after Bladder-Drained Pancreas Transplantation: The Wisconsin Experience

J. Adler, R. Redfield, D. Kaufman, J. Odorico, H. Sollinger.
Estimated Impact of the Number of Simultaneous Offers on Kidney Delay and Discard

M. Mankowski,¹ S. Raghavan,³ C. Holscher,² M. Kosztowski,² D. Segev,² S. Gentry.⁴
Increase in Potentially Resistant Non-Aspergillus Molds Isolated in Lung Transplant Recipients after Voriconazole and Posaconazole Prophylaxis

M. Fung,¹ J. Greenland,^2,3 S. Hays,² J. Singer,² J. Golden,² P. Chin-Hong.¹
Intestinal Microbiome Diversity is Associated with Liver Disease Etiology and Predicts Post-Liver Transplant Mortality

E. Verna, M. Annavajhala, M. Nenad, R. Brown, S. Sullivan, G. Korakani, M. Gidins, S. Khan, A. Gomez-Simmonds, A-.C. Uhlemann.
Is KDPI Valid for Hepatitis C Aviremic Kidneys?

L. Sibulesky,¹ C. Kling,¹ C. Blosser,² C. Johnson,² A. Limaye,² R. Bakthavatsalam,¹ N. Leca,² J. Perkins.¹
Livers from Donation after Circulatory Death Donors Can Be Safely Used for Retransplantation

O. van Leeuwen,¹ M. van Reeven,² J. Erdmann,³ H. Metselaar,⁴ A. van den Berg,⁵ B. van Hoek,⁶ W. Polak,² R. Porte.¹
Lymphatic Endothelium Requires S1PR2 for T Cell Transendothelial Migration

Y. Xiong,¹ W. Piao,¹ C. Brinkman,¹ L. Li,¹ J. Kulinski,² A. Olivera,² A. Cartier,³ T. Hla,³ S. Schwab,⁴ K. Hippen,⁵ B. Blazar,⁵ J. Bromberg.¹
NFkB Inhibitor Improves Glycemic Control after Syngeneic Islet Transplantation by Suppression of Proinflammatory and Apoptotic Gene Expression in a Cerulein-Induced Pancreatitis Model

G. Yoshimatsu,¹ C. Darden,² K. Kumano,² C. Chang,² P. Saravanan,² M. Lawrence,² B. Naziruddin.³
Non-Medical Factors Predict Receipt and Type of Kidney Transplant in Veterans

K. Kendall, X. Li, C.-C. Chang, J. Pleis, E. Croswell, M. Dew, G. Switzer, A. Langone, A. Mittal-Henkle, S. Saha, M. Ramkumar, J. Adams-Flohr, C. Thomas, L. Myaskovsky.
Origin and Traffic of Donor-Derived Extracellular Vesicles during Allo-Sensitization

F. Zeng,¹ W. Shufesky,¹ M. Yang,¹ Q. Liu,¹ A. Larregina,² A. Morelli.¹
Pharmacological Defatting of Steatotic Human Livers Using a Novel Perfusion Solution during Normothermic Machine Perfusion

Y. Boteon,^1,2 J. Attard,^1,2 R. Laing,^1,2 A. Boteon,¹ R. Bhogal,¹ G. Reynold,² D. Neil,¹ H. Mergental,¹ D. Mirza,¹ S. Afford.²
Prevalence and Impact of CYP3A5 Genomic Variances on Clinical Outcomes among African-American Kidney Transplant Recipients

A. Maldonado,¹ S. Hudson,² L. Rebellato,² T. Asempa.¹
Private Insurance is Associated with Reduce Access to HCV Therapy after Liver Transplantation

D. Axelrod,¹ M. Schnitzler,² B. Kasiske,³ G. Hess,⁴ R. Bloom,⁵ F. Gordon,¹ H. Randall,² K. Lentine.²
Prospective Analysis of EBV+ PTLD Incidence in Pediatric Transplant Recipients in the Modern Era

O. Martinez,¹ S. Krams,¹ M. Lapasaran,¹ S. Boyd,² D. Bernstein,² C. Twist,³ K. Weinberg,² D. Gratzinger,² B. Tan,² B. Armstrong,⁴ D. Ikle,⁴ M. Brown,⁵ M. Robien,⁵ C. Esquivel,¹ The CTOTC-06 Investigators.
Proton-Pump Inhibitor Utilization is Associated with Higher Rates of Clostridium difficile Infection and Hypomagnesemia after Kidney Transplant

G. Kipp,² K. Dancsecs,¹ A. Lapping.¹
Renal Function, Blood Pressure, and Histologic Changes in Living Kidney Transplant Recipients from Hypertensive Donors

T. Dienemann, J. Schellenberg, K. Amann, K. Heller, A. Weidemann.
Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Chronic Antibody Mediated Rejection (cABMR) in Pediatric Renal Transplant Recipients

D. Puliyanda, I. Kim, J. Choi, M. Haas, X. Zhang, A. Vo, H. Pizzo, S. Jordan.
The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration

A. Kraljevic, C. D'Agostino, C. Kane, K. Cunningham, A. Shetty, C. Richardson.
The Role of Donor-Derived Cell-Free DNA in Identification of Injury in Kidney Allografts with Antibody-Mediated Rejection and De Novo DSA

H. Zhang,¹ L. Liu,¹ C. Zheng,² X. Li,¹ Q. Fu,¹ J. Li,¹ Q. Su,¹ H. Huang,¹ M. Ye,² C. Wang.¹
Transplantation of Kidneys from Hepatitis C Virus (HCV) Antibody (Ab) Positive, NAT Negative Donors to HCV Negative Patients Results in Seroconversion but Not Viral Transmission

M. de Vera, M. Volk, Z. Ncube, A. Kore, M. Robinson, P. Wai, S. Blais, P. Baron, R. Villicana.
Unraveling the Neuroimmunological Pathways Surrounding Brain Death: Systematic Study of Clinically Relevant Serum Biomarker Changes during Donor Management from Admission to Procurement

K. Bera, M. LoFaro, H. Huang, S. Maslau, R. Ploeg.
Validating Molecular Microscope Readings and Estimating Agreement with Histology

P. Halloran, J. Reeve, The INTERCOMEX Study Group.
Variation in Post-Transplant Opiate Prescribing Patterns across Transplant Centers

A. Mathur, D. Ubl, J. Harbell, K. Croome, C. Taner, J. Heimbach, A. Moss, E. Habermann.
Waiting for the Optimal Donor for MCS Patients Awaiting Heart Transplant

J. Kobashigawa, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, E. Passano, L. Czer, J. Moriguchi, F. Arabia.
hEPCR.hTBM.hCD47.HO-1 Contributes to Increased Survival, Reduced Platelet Sequestration, and Modulation of Coagulation Activation in GalTKO.hCD46 Porcine Livers Perfused with Human Blood

A. Cimeno,¹ L. Burdorf,¹ D. Ayares,² A. Azimzadeh,¹ R. Pierson III,¹ R. Barth,¹ J. LaMattina.¹
400 Kidney Paired Donor Transplants at a Single Center; The Methodist San Antonio Experience

A. Bingaman,¹ M. Kapturczak,¹ I. Ashlagi,² C. Murphey.³
Ex Vivo Expanded Regulatory B Cells Promote Allograft Survival through IL-10-Dependent Pathway

K. Lee, K. Deng, L. Kojima, C. Dai, C. Rickert, H. Yeh, J. Markmann.
Pneumocystis jiroveci Pneumonia (PJP) in Kidney and Pancreas Transplant Recipients in the Present Era of Routine Post-Transplant Prophylaxis: Risk Factors and Outcomes

N. Garg, M. Jorgenson, M. Birschbach, J. Descourouez, S. Parajuli, B. Astor, A. Djamali, D. Mandelbrot.
A Novel Approach to Preserve Pancreatic Islet Grafts in Extrahepatic Space for Reversal of Diabetes Using Parathyroid Gland Co-Transplantation

C. Ward, G. Faleo, G. Nair, Q. Duh, M. Hebrok, W. Chang, P. Stock, Q. Tang.
Allogeneic T Follicular and T Conventional Responses Assessed by Proliferation, Cytokine Production, and TCR Clonality

C. Macedo,¹ M. Yamada,¹ X. Gu,¹ M. Suchoroski,² D. Hamm,² M. Kaplan,² D. Metes.¹
Antibody-Verified Eplet Mismatches as Determinants of Premature Kidney Transplant Loss

R. Sapir-Pichhadze,¹ X. Zhang,¹ A. Ferradji,¹ A. Madbouly,² S. Fingerson,² K. Tinckam,⁵ H. Gebel,³ H. Cardinal,⁴ B. Foster.¹
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for the Treatment of Medically Refractory Hepatic Encephalopathy (HE) in Patients with ESLD and Significant Portal-Venous Shunting

N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Comparison of BMI, Waist Circumference and Waist-to-Height Ratio for Identification of Cardiovascular Risk in Pediatric Kidney Transplant Recipients

K. Sgambat, S. Clauss, A. Moudgil.
Development of a Novel Assay System for Ex Vivo T-Cell Mediated Rejection Responses in Intestinal Grafts

S. Okano,^1,2 K. Abu-Elmagd,² D. Kish,¹ K. Keslar,¹ M. Fujiki,² G. Costa,² C. Miller,² W. Baldwin,¹ R. Fairchild,¹ K. Hashimoto.²
Direct-Acting Antiviral Therapy Immune-Mediated Graft Dysfunction in Liver Transplant Recipients with Hepatitis C

C. Chan,¹ E. Agudelo,² J. Haydek,³ M. Hoteit,⁴ M. Laurito,⁵ J. Norvell,³ T. Schiano,⁶ N. Terrault,² E. Verna,⁵ A. Yang,¹ J. Levitsky.¹
Donor Deficiency of RIP3 Phosphokinase Activity Shortens Cardiac Allograft Survival in the Setting of Costimulation Blockade

M. Zhu, K. Samy, L. Lin, J. Wang, L. Cendales, A. Kirk, A. Barbas, T. Brennan.
Early Microcirculation Inflammation Associated with TCMR Leads to Poor Graft Outcomes in Kidney Transplant Recipients (KTRs)

A. Cherukuri, D. Chittka, R. Mehta, A. Sharma, P. Sood, S. Hariharan.
Evolving Trends in Demographic and Medical Characteristics of Liver Transplant Recipients

R. Rosenblatt,¹ N. Shen,¹ Z. Tafesh,¹ B. Fortune,¹ K. Halazun,¹ A. Jesudian.¹
Examples of the Observer Effect in Transplantation- Unintended Consequences of Regulation and Selected Outcome Metrics

A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss.
Feasibility of a National Class II Matching Strategy for Pediatric Kidney Transplant Candidates

T. Blydt-Hansen,¹ W. Klement,² K. Tinckam,³ J. Gill.¹
Human Pancreatic ECM Scaffolds for Islet Culture and Transplantation

D. Tremmel, S. Sackett, A. Feeney, R. Maguire, J. Odorico.
Impact of the New Kidney Allocation System A2/A2B –> B Policy on Access to Transplantation among Minority Candidates

M. Mustian,¹ P. Martins,² P. MacLennan,¹ J. Ortiz,² J. Caicedo,² S. Gray,^1,2 B. Kelly,² C. Esquivel,² ASTS Diversity Affairs Commmittee,² J. Locke.^1,2
Incisional Hernia Repair after Abdominal Solid Organ Transplant and Living Kidney Donation: A Single Institution Experience

C. Kensinger,¹ S. Phillips,² D. Hale,² D. Shaffer,² B. Poulose,² R. Baucom.³
Islet Xenotransplantation: A Quest for Clinically Available Immunosuppression Regimens

Q. Gao, R. Davis, M. Mulvihill, M. Song, F. Leopardi, M. Ribeiro, T. How, G. Devi, B. Collins, A. Kirk.
Macrophage Depletion of RCMV-Latently Infected Allografts Ameliorates Accelerated Chronic Cardiac Rejection

J. Burg,¹ N. Haese,² T. Andoh,² C. Kreklywich,² I. Jones,² S. Orloff,¹ D. Streblow.²
Multi-Organ (M-O) Prioritization of Kidneys: ? Time for Policy Modification

M. Aeder, N. Turgeon.
One-Pump versus Two-Pump Normothermic Ex Vivo Perfusion Machines in Discarded Human Livers

A. Hassan, Q. Liu, D. Pezzati, A. Nassar, B. Soliman, M. Blum, P. Grady, G. Iuppa, T. Uso, J. Fung, K. Abu-Elmagd, C. Quintini.
Probability of Developing Chronic Kidney Disease 1 Year after Living Donor Nephrectomy Correlates with Baseline Kidney Volume and Function

I. Hall, A. Shaaban, S. Beddhu, F. Shihab.
Programmed Cell Death Ligand 1 (PD-L1) Expression is Associated with Subtypes of Post-Transplant Lymphoproliferative Disorders (PTLD)

N. Rodig,¹ G. Pinkus,² G. Ramos Gonzalez,³ T. Agur,¹ O. Weinberg.⁴
Prospective, Multi-Center Observational Study of Cell-Mediated Immunity for Cytomegalovirus Infection in Kidney Transplant Recipients

D. Kumar,¹ P. Chin-Hong,² L. Kayler,³ D. Wojciechowski,⁴ A. Limaye,⁵ O. Gaber,⁶ S. Ball,⁷ A. Mehta,⁸ T. Blanchard,⁹ C. Kotton.⁴
Providing Actual Echocardiographic Images to Centers Markedly Increases Transplantation of Deceased Donor Hearts

J. Trageser, C. Wainaia, L. Stocks, R. Steiner.
Quality of Social Support Network and Access to Transplant: What Matters?

A. Waterman,^1,2 J. Beaumont,² S. Kawakita,² M. Dunbar-Forest,¹ G. Danovitch,¹ I. Hong,¹ C. Anderson,¹ M. Everly,^1,2 J. Peipert.^1,2
Recipient IFNAR1 Signaling Supports Costimulation Independent Rejection by Promoting T Cell Activation

D. Mathews, A. Ghosh, Y. Dong, K. Polireddy, A. Stephenson, C. Breeden, Y. Liu, A. Adams.
Retransplantation after Living Donor Liver Transplantation: Analysis of Data from the A2ALL Study

H. Braun, J. Grab, J. Dodge, S. Syed, G. Roll, C. Freise, J. Roberts, N. Ascher.
SIRT1-Ikaros Axis Promotes Macrophage M2 Polarization and Protects Liver Graft from Ischemia-Reperfusion Injury

K. Nakamura,¹ S. Kageyama,¹ X. Li,² A. Aziz,¹ R. Sosa,³ E. Reed,³ F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Safety of Antithymocyte Globulin Use in Donation after Circulatory Death (DCD) Liver Transplantation

D. Felix,¹ B. Geiger,¹ J. Descourouez,¹ M. Jorgenson,¹ B. Hanlon,² G. Leverson,² D. Foley.²
Significant Alteration in Transplant Center Performance Assessment with Extended Patient Follow Up Time

J. Schold, D. Goldfarb, S. Flechner, A. Wee, E. Poggio.
Survival Rates of Patients with Previous Cardiac Surgery Undergoing Lung Transplant

H. Niikawa, T. Okamoto, K. Ayyat, Y. Itoda, K. McCurry.
The ATHENA Study: 12 Months Safety and Efficacy Data from Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in De Novo Kidney Transplant Patients

B. Suwelack,¹ C. Sommerer,¹ D. Dragun,¹ O. Witzke,¹ C. Hugo,¹ N. Kamar,² P. Merville,² A. Hauser,¹ P. Schenker,¹ M. Junge,³ B. Nashan,¹ F. Thaiss.¹
The Impact of Age-Matching on Graft Function and Graft Survival after Living Donor Kidney Transplantation

J. Lee,¹ D. Kim,¹ J. Lee,¹ J. Lee,¹ Y. Jung,¹ M. Ju,¹ S. Song,² J. Lee,³ K. Huh,¹ B. Kim,⁴ S. Kim,¹ Y. Kim,¹ M. Kim.¹
The Mark of Zorro: IL35-Coated Exosomes Cross-Dress and Exhaust Recipient T & B Cells during Transplant Tolerance

W. Burlingham,¹ J. Sullivan,¹ D. Lema,¹ Y. Tomita,² Y. Zhou,¹ D. Vignali.³
The THINKER Trial: Quality of Life Results at 6- and 12-Month Follow-Up among Hepatitis C-Negative Patients Who Received Kidney Transplants from Deceased Donors with Hepatitis C Infection

V. Potluri, D. Goldberg, A. Peter, B. Emily, B. Roy, S. Deirdre, M. Levine, J. Trofe-Clark, M. Bleicher, S. Goral, A. Sicilia, S. Nazarian, R. Reddy, P. Porrett, P. Reese.
Thymoglobulin Induction Decreases Risk of Death in HLA-Sensitized Kidney Recipients

C. Loheac, O. Aubert, M. Assayag, D. Viglietti, C. Lefaucheur, A. Loupy.
Time in Therapeutic Range Predicts DSA Development and Acute Rejection in Kidney Recipients with High Tacrolimus Coefficient of Variation

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.
Unsupervised Analysis of the Alloimmune Response in a Novel Model of Vascularized Composite Allotransplantation

J. Harden, A. Sang, X. Qu, C. Esquivel, O. Martinez, S. Krams.
Viral-Specific Cytotoxic T-Cell (Viral-Tc) Responses in Highly-HLA-Sensitized Patients (HS) Maintained on Tacrolimus and Everolimus Post-HLAi Kidney Transplant

S. Ge,¹ M. Chu,¹ A. Karasyov,¹ D. Lovato,¹ J. Kahwaji,² A. Vo,¹ J. Choi,¹ S. Louie,¹ S. Jordan,¹ M. Toyoda.¹
mRNA Transcript Profiles of 14 Genes in Plasma Exosome Predict Risk for Antibody-Mediated Rejection (ABMR) of Renal Allografts

H. Zhang,¹ E. Huang,² C. Nast,³ J. Kahwaji,² A. Vo,² S. Jordan,² M. Toyoda.¹
In Vivo Imaging and Function of Renal Tertiary Lymphoid Organs

K. Abou-Daya, D. Zhao, A. Williams, M. Oberbarnscheidt.
A Propensity Matched Survival Analysis: Do Simultaneous Liver-Lung Transplant Recipients Need a Liver?

K. Freischlag,¹ B. Ezekian,² P. Schroder,² M. Mulvihill,² S. Knechtle.²
Allograft Function after 12 Months with Everolimus Plus Either Tacrolimus or Cyclosporine Compared to a Standard Regimen of Tacrolimus with MPA in De Novo Renal Transplant Recipients: The ATHENA Study

B. Nashan,¹ C. Sommerer,¹ B. Suwelack,¹ D. Dragun,¹ O. Witzke,¹ C. Hugo,¹ N. Kamar,² P. Merville,² A. Hauser,¹ P. Schenker,¹ M. Junge,³ F. Thaiss.¹
C5aR Regulates Myeloid Derived Suppressor Cells (MDSCs) in Transplantation

I. Llaudo, J. Ochando, P. Heeger.
Clinical Application of Mesenchymal Stromal Cells with a Simplified Protocol for ABO Incompatible Liver Transplantation in Severe Hepatic Failure Patients

Y. Zhang,^1,2 J. Zheng,^1,2 J. Cai,^1,2 J. Zhang,^1,2 K. Zeng,^1,2 J. Yao,^1,2 Y. Yang.^1,2
Clinical and Pathological Findings in Hepatitis C Positive Renal Transplant Recipients Following Alemtuzumab Induction

S. Jonchhe, J. Husson, A. Haririan, B. Ravichandran.
Comparison of Recipients with Early and Late Presenting Polyomavirus Nephropathy (PVN) with Regard to Histological Findings and Graft Survival: What is the Influence of CD4/CD8 Ratio on the Presenting Time of PVN

B. Ozdemir,¹ S. Ayva,¹ A. Terzi,¹ A. Ok Atilgan,¹ E. Akcay,¹ E. Ayvazoglu Soy,² F. Ozdemir,³ M. Haberal.²
Complex Combined Thoracic/liver Transplant: A Seven Year Experience

N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Cytomegalovirus (CMV) Infection in Small Intestinal and Multivisceral Transplant Recipients: The Role of Donor Selection on CMV Incidence and Outcomes

H. Grewal, M. Czech, C. Matsumoto, M. Natarajan, J. Fraker, W. Fan, J. Timpone.
Detection of Different Gene Expression Profiles in CD8⁺ T Cells from Chronic High EBV Load Carriers after Pediatric Heart and Liver Transplantation

M. Yamada,^1,2 C. Macedo,² X. Gu,² M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 U. Chandran,³ B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.^1,2
Do Recent Heart Transplant Patients Need to Reside Close to the Transplanting Center? A Look at the Impact of Commuting Times on Clinical Outcomes

A. Velleca, E. Kransdorf, J. Patel, M. Kittleson, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Donation after Circulatory Death Donor Liver Transplantation without Ischemic Cholangiopathy: Is It Time to Expand DCD Liver Donor Pool?

C. Kubal,¹ P. Mihaylov,^1,2 B. Ekser,¹ A. Cabrales,¹ J. Fridell,¹ R. Mangus.¹
Donor-Derived Cell-Free DNA Identifies Antibody-Mediated Rejection with Graft Injury in DSA-Positive Kidney Transplant Recipients

S. Jordan,¹ S. Bunnapradist,² J. Bromberg,³ A. Langone,⁴ D. Hiller,⁵ J. Yee,⁵ J. Sninsky,⁵ R. Woodward,⁵ A. Matas.⁶
Early Graft Losses in National PKE Programs: Gone, but Lost Forever?

J. Verbesey,¹ A. Waterman,² J. Veale,² S. Flechner,³ B. Javaid,¹ M. Ronin,⁴ G. Hil,⁴ C. Matthew.¹
Effects of a Multimodal Pain Control Regimen in Living Donor Laparoscopic Nephrectomies

E. Thomas, J. Nelson, E. Diaz.
Efficacy of At-Home Transplant Education on Transplant Knowledge and Pursuit in Low-Income and Black Dialysis Patients with Varying Educational Characteristics

A. Waterman,^1,2 J. Peipert,^1,2 J. Beaumont.²
Endothelin-1 Type A Receptor Antibodies Are Associated with Elevated Il-8, Arteritis and Decline in Renal Function in Pediatric Renal Transplant Recipients

M. Pearl,¹ J. Grotts,¹ M. Rossetti,¹ Q. Zhang,¹ P. Weng,¹ E. Reed,¹ E. Tsai Chambers.²
Estimated GFR at Donor Screening and Achieved Measured GFR after Living Kidney Donation

M. van Londen, J. van der Weijden, S. Bakker, S. Berger, J. Sanders, G. Navis, M. de Borst.
Evaluating Center Performance beyond Patient and Graft Survival

S. Asrani, G. Saracino, R. Bahirwani, G. McKenna, G. Klintmalm, J. Trotter.
Extracellular Microvesicles from Liver Perfusate: microRNAs, Cellular Cross-Talk, and Early-Post Liver Transplant Outcomes

A. Fernandez,¹ O. Ingram,¹ S. Bontha,¹ U. Erdbruegger,² L. Musante,² V. Mas,¹ D. Maluf.¹
Genetically Modified Porcine Erythrocytes: A Cell Model for Studying Human Preformed Antibody-Dependent Xenoimmune Responses In Vitro

Z. Wang, G. Martens, J. Ladowski, M. Tector, A. Tector.
IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

J. Breidenbach, C. Baum, P. Schroder, S. Stepkowski.
Identification of Exosomal Isletokines Released by Pancreatic Islets in Response to Inflammatory Stress

P. Saravanan,¹ G. Yoshimatsu,¹ R. Bhattacharjee,¹ C. Chang,¹ C. Darden,¹ B. Naziruddin,² M. Lawrence.¹
Improved Renal Allograft Survival for Pre-Emptive Paediatric Renal Transplant Recipients in the United Kingdom

M. Marlais,¹ K. Martin,² S. Marks.¹
Incidence of Acute Cellular Rejection in Liver Transplant Patients Receiving Direct Acting Antivirals for Hepatitis C Treatment

D. Bley,¹ L. Sagardia,¹ R. Ford,² S. Todd.¹
Inflammation in Scarred Areas (i-IF/TA): Defining the Response to Standard Treatment of T Cell-Mediated Rejection in Kidney Recipients

D. Viglietti, O. Aubert, J-.P. Duong Van Huyen, A. Loupy, C. Lefaucheur.
Lymph Node Stromal Laminins Affect Graft Survival through Regulation of CD4 T Cell Proliferation and Migration

L. Li, T. Simon, W. Piao, Y. Xiong, V. Saxena, T. Zhang, C. Wagner, J. Bromberg.
Mechanisms of Vascularized Bone Marrow Graft Protection of Vascularized Composite Allografts

E. Buckingham, N. Shockcor, W. Hassanein, C. Drachenberg, A. Nam, S. Bartlett, R. Barth.
Mitochondrial Autophagy Proteins Bnip3 and Nix Maintain Memory B Cell Survival

S. Kodali,¹ H. Sandoval,¹ M. Chen,² J. Wang.¹
Optimizing Outcomes with a Collaborative Approach after Kidney Transplant in Hepatitis C-Positive Recipients Receiving Hepatitis C-Positive Grafts

A. Ray, R. Rubin, T. Ommert, R. Cross, C. Klein.
Outcomes of Pregnancies in Female Liver Transplant Recipients

L. Coscia,¹ D. Armenti,¹ P. Patel,² S. Constantinescu,^1,3 M. Moritz.^1,2,4
Post Reperfusion Portal Flow Rate Impacts Liver Allograft and Patient Survival in Patients with Pre Transplant Portal Vein Thrombosis

M. Rizzari, M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud.
Pro-Inflammatory B Cells Predict Progressive Minimal Early Renal Allograft Inflammation Which is Associated with Poor Graft Outcomes

A. Sharma, A. Cherukuri, D. Chittka, R. Mehta, S. Hariharan, D. Rothstein.
Recipient HO-1 Deficiency Decreases Post-Transplant Graft HO-1 Expression and Exacerbates Liver Transplant Damage

S. Kageyama,¹ K. Nakamura,¹ T. Ito,¹ A. Aziz,¹ B. Ke,¹ R. Sossa,² E. Reed,² F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Skeletons in the Closet? An Insight into Donor Liver Discards in the US

K. Halazun, A. Rana, G. Roll, P. Tabrizian, V. Agopian, B. Samstein, R. Brown, J. Emond.
T-Cell Depletion Does Not Increase the Risk of CMV Infection in Donor-Positive, Recipient-Negative Kidney Transplants Due to the Absence of Preformed CMV-Specific Cell-Mediated Immunity

M. Jarque,¹ H. Kaminski,² L. Couzi,² E. Crespo,¹ J. Déchanet-Merville,³ S. Luque,¹ N. Montero,⁴ M. Pascual,⁵ O. Manuel,^5,6 P. Merville,² O. Bestard.^1,4
Tacrolimus Metabolism in Subjects with Potentially Absent CYP3A Activity

A. Scheibner,¹ R. Remmel,² D. Schladt,³ W. Oetting,¹ W. Guan,⁴ B. Wu,⁴ C. Door,⁵ A. Israni,⁵ P. Jacobson.¹
Ten Year Follow-Up of Islet Recipients on Anti-LFA1 Therapy: Over-Immunosuppression Leads to Operational Tolerance?

J. Gardner,¹ A. Posselt,¹ S. Wisel,¹ U. Mashirani,² G. Szot,¹ V. Nguyen,¹ K. Johnson,¹ J. McElroy,¹ Q. Tang,¹ P. Stock.¹
The Etiologies and Impact of Hospitalization in Older Kidney Transplant Recipients

M. Posadas Salas, R. Rodriguez, P. Amaechi, V. Rao, D. Taber.
The Impact of Rituximab Dose on Hepatitis B Virus Reactivation in HBsAg-Negative/anti-HBc-Positive Kidney Transplant Recipients

J. Lee,¹ J. Park,² Y. Jung,¹ D. Kim,¹ J. Lee,¹ S. Song,³ J. Lee,⁴ J. Lee,¹ B. Kim,⁵ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
Treatment of Active Chronic Antibody-Mediated Rejection with Rituximab, IVIG and Plasma Exchange

G. Piñeiro,¹ J. Rovira,² E. De Sousa-Amorim,¹ J. Villarreal,¹ M. Sole,³ I. Revuelta,¹ M. Lozano,⁴ E. Palou,⁴ F. Oppenheimer,¹ J. Campistol,¹ F. Diekmann.^1,2
Two Years of the HOPE Act

A. Wilk,¹ C. Durand,² D. Segev,² D. Klassen.¹
APRIL/BLyS Blockade Improves Depletion of Antibody Secreting B Cells Compared to BLyS Blockade Alone in Sensitized Murine Kidney Transplant Model

N. Bath,¹ X. Ding,¹ N. Wilson,² B. Verhoven,¹ A. Sukhwal,¹ L. Coons,¹ S. Panzer,² A. Djamali,² R. Redfield.¹
Altered Function of Cytomegalovirus Specific T Cells in Transplant Recipients

L. Higdon,¹ J. Trofe-Clark,² S. Liu,¹ N. Saligrama,¹ K. Margulies,² M. Davis,¹ J. Maltzman.^1,3
CD4⁺ T Cells Are Key Barriers to Tolerance Resistance to Islet Allografts in Autoimmune NOD Mice

A. Burrack,¹ K. Beard,² M. Coulombe,² R. Gill.²
CMV Mismatch Still Negatively Affects Patient and Graft Survival in the Era of CMV Prophylactic and Preemptive Therapy: A Paired Kidney Analysis

N. Leeaphorn,¹ N. Garg,² N. Thamcharoen,¹ E. Khankin,¹ F. Cardarelli,¹ M. Pavlakis.¹
Characterization of Viral and Host Cell Genomic Alterations in EBV+ PTLD

Y. Balachandran,¹ M. McPherson,¹ S. Boyd,² C. Esquivel,¹ S. Krams,¹ O. Martinez.¹
Comparison of Induction and Maintenance Immunosuppression Regimens in Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Registry

S. Nagai,¹ M. Rizzari,¹ Y. Muszkat,² K. Collins,¹ A. Yoshida,¹ S-.M. Jafri,² M. Abouljoud.¹
Comparison of Three Approaches for Laparoscopic Donor Nephrectomy: Transvaginal, Transumbilical Single Site and Retroperitoneal

M. Miura, H. Higashiyama.
DAP12 and Its Triggering Co-Receptor TREM2 Play Key Roles in Regulation of Mouse and Human Liver DC Function and Control of Liver Ischemia-Reperfusion Injury

T. Nakao,¹ Y. Ono,¹ H. Dai,¹ A. Perez-Gutierrez,¹ G. Camirand,¹ H. Huang,¹ D. Geller,^1,2 A. Thomson.^1,3
Deceased Donor Urinary Biomarker Signature and the Effectiveness of Peritransplant Lymphocyte Depletion on Early Renal Allograft Function

S. Bernd,² P. Heeger,¹ T-.P. Heather,³ I. Hall,⁷ M. Doshi,⁴ F. Weng,⁵ P. Reese,⁶ C. Parikh.³
Development of Denovo DSA after One Year Post Kidney Transplant and Clinical Outcomes in Patient on Steroid Free Immunosupression

A. Sharfuddin, M. Yaqub, D. Mishler, W. Goggins, T. Taber, O. Adebiyi.
Donor-Specific Antibody Mediates Chronic, but Not Acute, Kidney Allograft Rejection in the Absence of Natural Killer Cells

T. Yagisawa, N. Dvorina, A. Valujskikh, W. Baldwin 3rd, R. Fairchild.
End Stage Renal Disease after Face Transplant

N. Shockcor,¹ B. Buckingham,¹ W. Hassanein,¹ A. Haririan,¹ S. Roberts,² A. Nam,¹ E. Rodriguez,³ S. Bartlett,¹ R. Barth.¹
Exercise Rehabilitation's Effect on Employment and School Rates in Kidney Transplant Patients

A. Kastelz,^1,2 C. Di Bella,¹ I. Tzvetanov,¹ B. Fernhall,² L. Gallon,³ G. Hachaj,⁴ E. Benedetti.¹
Factors Related to Suboptimal Recovery of Renal Function after Living Donor Nephrectomy

S. Nishida, K. Kinoshida, K. Tanaka, Y. Hidaka, S. Hamanoue, C. Kawabata, M. Toyoda, A. Inadome, S. Uekihara, S. Yamanaga.
Frailty is Predictive of Early Post-Transplant Infection in Older Renal Transplant Recipients

M. Malinis,¹ C. Ogbejesi,² J. Luo,³ Y. Zhang,³ W. Asch,⁴ R. Deshpande,⁵ S. Akhtar.⁵
Geographic Variation in Deceased Donor Kidney Waitlist Deaths after Declining an Organ Offer

F. Winterhalter,¹ S. Husain,¹ R. Patzer,² S. Pastan,² S. Mohan.¹
IL-6 Inhibition with Tocilizumab to Promote Tregs and Control Renal Graft Inflammation: A Prospective Randomized Controlled Trial

S. Chandran, J. Leung, Z. Laszik, Q. Tang, C. Hu, M. Sarwal, F. Vincenti.
Impacts of HBsAg Seropositive Status on Patient and Graft Survival after Kidney Transplantation in the Era of New Antiviral Therapy: A Meta-Analysis

N. Leeaphorn,¹ C. Thongprayoon,² K. Sharma,² A. Sakhuja,³ W. Cheungpasitporn.⁴
Improved Long-Term Outcomes of Pancreas Transplantation: Analysis of Allograft Half-Lives and Predictive Demographic Factors

A. Adamusiak, R. Kandaswamy, T. Dunn, S. Riad, E. Finger.
Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation by Induction Treatment of the Non-Hematopoetic Erytropoetin Analogue Cibinetide in a Mouse Model

M. Yao,¹ M. Watanabe,^1,2 S. Sun,¹ B. Ericzon,¹ T. Lundgren,¹ M. Kumagai-Braesch.¹
Increasing Use of Exceptions after Changes to Pediatric Heart Allocation

A. Robinson,¹ W. Mahle,² R. Davies.³
Inflammation in Scarred Areas (I-IFTA) is a Reflection of Parenchymal Injury (Response to Wounding) Not T Cell-Mediated Rejection

P. Halloran, J. Chang, K. Famulski.
Investigation of Lower Treatment Failure Rate Seen among Black Kidney Recipients on LCP-Tacrolimus vs. IR-Tacrolimus: Subgroup Analyses of Two Phase 3 Trials

T. Sparkes,¹ B. Masters,¹ C. Staino,² S. Patel,² M. Cooper.³
Isolated Pre-Transplant Angiotensin II Type I Receptor Antibodies (AT1R Ab) Are Not Associated with Reduced Graft Function or Hypertension (HTN) in Pediatric Kidney Transplant (Ped KTx) Patients (pts)

H. Pizzo, J. Choi, M. Haas, X. Zhang, E. Kamil, I. Kim, S. Jordan, D. Puliyanda.
Liver Transplantation Using Pediatric versus Adult Donor Grafts in Adult Recipients

Y. Tang, Q. Zhao, Z. Zhang, L. Wang, W. Ju, Z. Zhu, S. Huang, Z. Guo, X. He, G. Chen.
Long-Term Follow-Up of Patients with Primary Sclerosing Cholangitis Undergoing Liver Transplantation with Duct-to-Duct Biliary Reconstruction

L. Coromina Hernandez, B. Eghtesad, T. Diago, K. Hashimoto, M. Fujiki, C. Quintini, F. Aucejo, G. Iuppa, A. Hassan, N. Menon, C. Miller.
Making Sense of Hepatitis B Reactivation Risk in Anti-HBc Antibody (Ab) Positive Liver Transplant Recipients

S. Leistman,¹ J. Melaragno,¹ M. Dokus,² B. Al-Judaibi,² T. Babu.³
Molecular Assessment of Pre-Implantation Donor Biopsies: Effects of Prolonged Cold Ischemia Time and Development of Delayed Graft Function

E. Akalin,¹ Y. Bao,¹ V. Bontha,² M. e Silva,³ M. Ajaimy,¹ P. [Oacute] Broin,³ V. Mas.²
Molecular Profiling of the Injury-Repair Response in Early Subclinical Inflammation

M. Seifert, D. Della Manna, X. Liu, F. Rosenblum, M. Yanik, E. Yang, J. Pollock, R. Mannon.
No Kidney Left Behind: Are We Maximizing Utilization of Deceased Donors with AKI?

A. Bongu, R. Quillin, M. Chiles, S. Husain, M. Garcia, S. Mohan, L. Ratner.
Origin and Pattern of Human Polyomaviruses Replication after Kidney Transplantation: A Prospective Study

E. Favi,¹ S. Delbue,² C. Colico,¹ P. Ferrante,² S. Villani,² I. Perna,² N. Mondoni,² A. Giussani,¹ L. Clementoni,¹ P. Messa,³ M. Ferraresso.¹
Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants

S. Pineda,¹ T. Sigdel,¹ J. Chen,¹ A. Jackson,² M. Sirota,¹ M. Sarwal.¹
Program-Specific Survival from Listing: Variability and Association with Pretransplant and Posttransplant Metrics

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
Prospective Trial Using Pulmonary Rehabilitation to Treat Frailty

C. Kennedy,¹ P. Novotny,² E. Stevens,¹ J. Kirsch,³ J. Garrett,¹ N. LeBrasseur,⁴ R. Benzo.¹
Recombinant Relaxin Protects Liver Transplants from Ischemia-Reperfusion Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside

S. Kageyama,¹ K. Nakamura,¹ T. Ito,¹ A. Aziz,¹ B. Ke,¹ R. Sossa,² E. Reed,² F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Relationship between Living Kidney Donor Follow-Up GFR and Recipient Graft Loss

C. Holscher,¹ T. Ishaque,¹ C. Haugen,¹ S. DiBrito,¹ K. Jackson,¹ A. Muzaale,¹ A. Massie,^1,2 M. Henderson,¹ J. Garonzik Wang,¹ D. Segev.^1,2,3
Resuscitation and Viability Testing of Initially Declined Livers Using Sequential Hypo- and Normothermic Machine Perfusion with an Acellular Fluid

Y. de Vries,^1,2 A. Matton,^1,2 S. Karangwa,^1,2 M. Nijsten,³ R. de Kleine,² A. van den Berg,⁴ V. de Meijer,² P. Meyer,⁵ M. de Boer,² R. Porte.²
Selection and Stratification of Anti-HLA-A and HLA-B Sensitized Patients in Pig-to-Human Xenotransplantation

G. Martens,¹ J. Ladowski,¹ J. Butler,² L. Reyes,¹ M. Tector,¹ A. Tector.¹
Steroid Sparing Maintenance Immunosuppression is Associated with Decreased Mortality after Simultaneous Liver Kidney Transplantation

S. Weeks, X. Luo, C. Song, L. Pote, A. Gurakar, F. Navqi, B. Philosophe, A. Cameron, N. Desai, S. Ottmann, D. Segev, J. Garonzik Wang.
The Transplant-Death Index: A Novel Method to Identify Disenfranchised Liver Transplant Waitlist Candidates

M. Kueht, J. Goss, N. Galvan, A. Rana.
Trends in Liver Transplantation with Older Liver Donors in the United States

C. Haugen, X. Luo, A. Thomas, C. Holscher, J. Garonzik-Wang, M. McAdams-DeMarco, D. Segev.
What Deceased Donors Do KPD Candidates Accept?

A. Toll,¹ R. Leishman,¹ V. Casingal,² M. Aeder,³ T. Sandholm,⁴ N. Turgeon.⁵
A Follow-Up Report on the Use of IVIG+Rituximab to Reduce Donor Specific Antibodies and Improve Transplant Rates in Highly-Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

R. Najjar, E. Huang, A. Vo, J. Choi, K. Lim, S. Louie, A. Peng, S. Sethi, M. Toyoda, X. Zhang, S. Jordan.
Ablation of IRF4 Induces Transplant Tolerance by Driving Intrinsic T Cell Dysfunction

J. Wu,^1,2 H. Zhang,¹ X. Shi,¹ X. Xiao,¹ Y. Fan,¹ J. Xia,² R. Sciammas,^1,3 X. Li,^1,3 W. Chen.^1,3
Anti-TIRC7 Antibody Acts Synergistically with Tacrolimus in Promoting Graft Survival in a Rat Kidney Transplant Model

S. Tullius,¹ Y. Kumamoto,² U. Nalan.³
Anticoagulation in Pediatric Liver Transplantation; the Pros and Cons

M. Werner,¹ R. de Kleine,¹ M. de Boer,¹ V. de Meijer,¹ R. Scheenstra,² H-.J. Verkade,² F. Bodewes,² S. Bontemps,³ T. Lisman,¹ R. Porte.¹
Antihypertensive Medication Use after Kidney Transplant: Practice Variation and Clinical Outcomes

H. Yamout,^1,2 R. Ouseph,¹ M. Schnitzler,¹ H. Xiao,¹ V. Dharnidharka,³ A. Naik,⁴ N. Lam,⁵ F. Koraishy,^1,2 H. Randall,¹ D. Brennan,⁶ D. Segev,⁶ B. Kasiske,⁷ G. Hess,⁸ K. Lentine.¹
Apoptotic Exosome-Like Vesicles Induce Endothelial Cell Plasticity

F. Migneault,^1,2,4 M. Dieudé,^1,2,4 J. Turgeon,^1,4 D. Beillevaire,^1,2,4 M-.P. Hardy,^2,3,4 C. Perreault,^2,3,4 M-.J. Hébert.^1,2,4
Cannabis Dependence or Abuse before and after Kidney Transplantation: Implications for Post-Transplant Outcomes

K. Lentine,¹ T. Alhamad,² N. Lam,³ A. Naik,⁴ F. Koraishy,¹ H. Randall,¹ D. Segev,⁵ V. Dharnidharka,² D. Brennan,⁵ B. Kasiske,⁶ R. Ouseph,¹ M. Schnitzler.¹
Cognition and Self-Management in Liver Transplant Recipients

D. Ko,¹ L. Bratzke,² R. Muehrer.²
Comparing Outcomes between Induction Immunosuppressive Therapies in Simultaneous Heart/Kidney Transplantation

I. Moinuddin, J. Yu, L. Kang, C. Bhati, D. Bandyopadhyay, A. King, D. Kumar, L. Kamal, D. Tang, I. Yakubu, G. Gupta.
Consequences of Being Listed at a Small Pancreas Program

S. Niederhaus,¹ M. Curry,² A. Fox,² J. Fridell,³ J. Odorico.⁴
Containment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections at a Solid Organ Transplant Centre

A. Mularoni,¹ G. Martucci,¹ S. Gruttadauria,¹ M. Campanella,¹ F. Tuzzolino,¹ G. Arena,¹ A. Arcadipane,¹ U. Palazzo,¹ A. Luca,¹ B. Gridelli,¹ P. Grossi.²
Deceased Donor Initiated Kidney Transplant Exchanges and the Forgotten Incompatible Directed Donor Recipients

E. Molmenti,¹ C. Molmenti,² E. Grodstein,¹ H. Rilo,¹ L. Teperman.¹
Delayed Graft Function in Simultaneous Liver Kidney Transplantation

S. Weeks,¹ X. Luo,¹ S. Ottmann,¹ A. Gurakar,² F. Naqvi,² B. Philosophe,¹ A. Cameron,¹ N. Desai,¹ D. Segev,¹ J. Garonzik Wang.¹
Dialysis Modality, Inflammation, and Frailty in Kidney Transplant Candidates

P. Shrestha, H. Ying, M. McAdams DeMarco, D. Segev.
Discard and Post-Transplant Outcomes Associated with Organs Donated after Drug-Overdose Death

M. Bowring, C. Durand, L. Kucirka, A. Thomas, A. Massie, M. Sulkowski, A. Cameron, N. Desai, D. Segev.
Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection

J. Assaker,¹ A. Srivastava,¹ J. Hurley,² B. Al Doujailan,¹ S. Eskandari,¹ C. Coticchia,² M. Mohamed,¹ S. Bentink,² V. Tadigotla,² L. Riella,¹ A. Chandraker,¹ J. Skog,² J. Azzi.¹
Disparity in Access to Kidney Allograft Offers among HIV+ Transplant Candidates

J. Cohen,¹ J. Locke,² B. Shelton,² R. Reed,² P. MacLennan,² D. Sawinski.¹
Endoplasmic Reticulum Stress Sensor IRE1α Deficiency Promotes Infiltrating Macrophage Polarization and Induces Long-Term Renal Allograft Acceptance in Mice

L. Qiu,¹ J-.J. Wang,¹ X. Yeap,¹ D. Fang,² J. Zhang.¹
Evolving Etiologies for Readmissions and Their Impact on Graft Survival in Kidney Transplantation

D. Taber, N. Pilch, Z. Su, C. Mardis, J. Fleming, N. Patel, H. Meadows, P. Mauldin, V. Rao, D. Dubay.
Genome Wide Non-HLA Alloimmunity Contributes to Graft Loss after Kidney Transplantation

R. Reindl-Schwaighofer, A. Heinzel, A. Kainz, K. Jelencsics, O. Viklicky, G. Böhmig, G. Fischer, B. Keating, R. Oberbauer.
HIV, HBV, and HCV Screening with NAT and Serology in the OPO Setting

N. Theodoropoulos,¹ M. Ison.²
HO-1 Regulates SIRT1– Autophagy Pathway in Liver Transplantation: From Mouse-to-Human

K. Nakamura,¹ S. Kageyama,¹ S. Yue,¹ A. Aziz,¹ T. Ito,¹ D. Oncel,¹ B. Ke,¹ R. Sosa,² E. Reed,² F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Identifying the Specific Causes of Kidney Allograft Loss: A Population Based Study

C. Loheac, O. Aubert, D. VIglietti, N. Kamar, M. Delahousse, C. Lefaucheur, A. Loupy.
Immunophenotype of Cells Infiltrating the Graft Explains the Benefits of Belatacept

J. Furuzawa-Carballeda,¹ N. Uribe-Uribe,² G. Mondragon-Ramirez,⁴ J. Arreola-Guerra,⁵ R. Reyes-Acevedo,⁵ M. Vilatoba,³ R. Chavez-Fernandez,¹ F. Lopez-Verdugo,¹ A. Lopez-Toledo,⁴ G. Mondragon-Salgado,⁴ J. Alberu.³
Improving the Organ Donation Referral Process through Telemedicine

M. Groveman,¹ M. Perry,² I. Berman,² N. Benavides,¹ A. Friedman.¹
Inflammation in Fibrotic Areas (i-IF/TA) Identifies a T Cell-Mediated Rejection Component of IF/TA with Poor Kidney Allograft Outcome

D. Viglietti, O. Aubert, J-.P. Duong Van Huyen, A. Loupy, C. Lefaucheur.
Interferon-b Promotes Regulatory T Cell (Treg) Induction and Prolongs Allograft Survival

M. Fribourg,¹ M. McGinty,² A. Angeletti,² M. Demir,² S. Sealfon,¹ P. Heeger,² P. Cravedi.²
Kidney Transplant Rejection is Associated with Robust and Prolonged Bioenergetic Reprogramming and Metabolic Maladaptation

A. Zmijewska, J. Zmijewski, J. Chen, R. Mannon.
Liver Transplantation for Patients with Hepatocellular Carcinoma Presenting beyond Milan Criteria: Analysis of 789 Patients from the US Multicenter HCC Transplant Consortium

V. Agopian, United States Multicenter HCC Transplant Consortium.
Medical Crowdfunding for Organ Transplant Patients

W. Durand,¹ J. Peters,¹ A. Eltorai,¹ S. Kalagara,¹ A. Osband,² A. Daniels.³
Meeting OPTN Requirements for Living Kidney Donation Follow-Up: Findings from the KDOC Study

J. Rodrigue,¹ C. Sokas,¹ A. Fleishman,¹ J. Schold,² P. Morrissey,³ J. Whiting,⁴ J. Vella,⁴ L. Kayler,⁵ D. Katz,⁶ J. Jones,⁶ B. Kaplan,⁷ M. Pavlakis,¹ D. Mandelbrot.⁸
Morbidity Outcomes in Live Kidney Donors in the UK: 15 Year Compartive Cohort Study

N. Krishnan,¹ L. Mumford,³ G. Lipkin,⁴ S. Fletcher,¹ I. Dasgupta,⁵ P. Gill,⁶ R. Ryan,⁷ N. Raymond.⁸
Not All HLA Mismatches Are Equal: Determining the Relative De Novo DSA Induction Capacity of HLA Mismatches

V. Jucaud,¹ L. Rebellato,² K. Briley,² A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² M. Everly.¹
Recurrent FSGS Post-Transplantation: Prevalence and Risk Factors

R. Aguiar,¹ A. Gasparini,² P. Chowdhury,¹ D. Game,¹ D. Moutzouris.¹
Relationship between Mixed Chimerism and Acceptance of HLA-Matched and Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs

J. Scandling, S. Busque, R. Lowsky, J. Shizuru, K. Jensen, A. Shori, E. Engleman, E. Meyer, R. Hoppe, S. Strober.
Robotic Assisted Live Donor Kidney Transplantation – Technique and Outcomes

H. Pahari,¹ B. Waldman,² J. Stracke,¹ L. Malinzak,¹ J. Denny,¹ D. Kim,¹ W. Jeong,³ M. Menon,³ A. Yoshida.¹
Split/Reduced Liver Grafts in Adult Liver Transplantation, No Longer a Risk for Graft Loss

K. Sasaki, D. Firl, J. McVey, G. Iuppa, M. Fujiki, T. Diago Uso, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.
Tacrolimus Pharmacokinetics (PK) at Low, Medium, and High Trough Levels in Patients Converted from Twice-Daily Immediate-Release Tacrolimus (TacBID) to Once-Daily Extended-Release Tacrolimus (LCPT)

P. Malvezzi,¹ S. Bunnapradist,² D. Stevens,³ M. Moten,³ A. Loh,³ S. Patel,³ L. Rostaing.¹
The Predictive Power of MELD is Decreasing in the Era of Older, Sicker Patients

E. Godfrey,¹ J. Lai,² T. Miloh,³ N. Galvan,¹ R. Cotton,¹ C. O'Mahony,¹ J. Vierling,¹ N. Sussman,¹ A. Rana.¹
The Results of the PRISM (Prediction of Rejection In Sensitized Patient Blood SaMples) Trial with a Novel Bioassay

F. Vincenti, A. Schroeder, S.-C. Hseish, J. Liberto, P. Towfighi, C. Koh, T. Sigdel, M. Sarwal.
Transplanting Kidneys from HCV-Infected Donors into HCV-Negative Recipients: Longer-Term and Extended Results of the THINKER Trial

D. Goldberg,¹ E. Blumberg,¹ P. Abt,¹ M. Levine,¹ P. Porrett,¹ A. Naji,¹ S. Nazarian,¹ D. Sawinski,¹ J. Trofe-Clark,¹ V. Van Deerlin,¹ C. Gentile,¹ J. Smith,¹ M. Kaminski,¹ A. Sicilia,¹ R. Hasz,² L. Suplee,² R. Reddy,¹ R. Bloom,¹ P. Reese.¹
A 3C Approach Drives Epigenetic Fixation of Foxp3 Expression and Stabilizes Treg Cell Lineage and Therapeutic Function

X. Xiao, X. Zhang, J. Li, S. Chen, P. Lan, Y. Dou, W. Chen, X. Li.
A Medical Decision Analysis for the Use of Donation after Cardiac Death Donors for Simultaneous Liver-Kidney Transplant

A. Miller, K. Tennankore, B. Kiberd.
Accepting a DCD Liver May Improve Patient Survival Compared to Waiting for a Non-DCD Liver

A. Wey,¹ N. Salkowski,¹ J. Lake,² W. Kim,³ B. Kasiske,¹ A. Israni,¹ J. Snyder.¹
Alloreactive B Cells Acquire Cell-Intrinsic Hyporesponsiveness in Tolerant Recipients

S. Khiew,¹ D. Jain,¹ J. Young,¹ J. Chen,¹ J. Yang,¹ Q. Wang,¹ D. Yin,¹ R. Sciammas,² A. Chong.¹
As Clear as Mud: Volatility of the Five-Tier Quality Assessment of Kidney Transplant Centers in the United States

J. Schold,¹ K. Andreoni,² A. Chandraker,³ R. Gaston,⁴ J. Locke,⁴ A. Mathur,⁵ T. Pruett,⁶ A. Rana,⁷ L. Ratner,⁸ L. Buccini.¹
Combination Proteasome Inhibition and Anti-BAFF Therapy Permits Highly Sensitized Rhesus Kidney Transplantation

B. Ezekian, J. Kwun, M. Manook, P. Schroder, J. Yoon, M. Mulvihill, K. Freischlag, J. Park, J. Cochran, K. Kroning, J. Yi, S. Knechtle.
Donor Derived Transmissions in 2016-2017: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

C. Wolfe, S. Tlusty, G. Vece, R. Bag, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, P. Wood, N. Theodoropoulos, M. Michaels.
Early Results from USHER: A Pilot Trial of Transplanting HCV-Infected Hearts into HCV-Negative Recipients Followed by Anti-Viral Therapy

R. McLean, P. P. Reese, M. Acker, P. Abt, A. Sicilia, N. Hornsby, P. Atluri, K. R. Reddy, E. Blumberg, V. Van Deerlin, D. S. Goldberg.
Effects of IdeS on HLA-SAB, C1q-SAB and CDC-XM

S. Järnum,¹ A. Runström,¹ L. Winstedt,¹ T. Lorant,² C. Kjellman.¹
Endothelial Cell Heterogeneity Governs Basal and Inducible Inflammatory Responses Relevant to Allograft Injury

N. Valenzuela.
Engineering Regulatory T Cells with Interleukin (IL-)2 Nanogel for Improved Alloimmune Suppression

S. Eskandari,¹ M. Bandeira Melo,² J. Assaker,¹ A. Mansouri,¹ S. Cai,¹ B. Al Dulaijan,¹ M. Mohamed,¹ D. Irvine,² J. Azzi.¹
Familial Risk of End-Stage Renal Disease in Healthy Live Kidney Donors

A. Muzaale,¹ A. Massie,¹ F. Al Ammary,¹ K. Lentine,² D. Segev.¹
Follow Up of Patients Treated with the IgG Endopeptidase (IdeS) for Desensitization and HLA Incompatible (HLAi) Kidney Transplantation

S. Jordan,¹ J. Choi,¹ E. Huang,¹ R. Najjar,¹ A. Peng,¹ X. Zhang,¹ S. Louie,¹ M. Haas,² S. Sethi,¹ I. Kim,¹ A. Vo.¹
Hard-To-Place Kidney Offers: System- Level Predictors of Discard

L. Kayler,¹ J. Nie,² K. Noyes,² M. Leeman,³ R. Narvaez.¹
Hospital Readmissions Following ABO-Incompatible Live Donor Kidney Transplantation: A National Study

B. Orandi,¹ X. Luo,² S. Bae,² E. King,² J. Garonzik-Wang,² D. Segev.²
Impact of Infections on Patients with Left Ventricle Assist Devices(LVAD): Allo-Sensitization and Heart Transplantation

C. Buto-Colletti, P. Kimball, K. Shah, M. Quader.
Improving Prognostication amongst Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: An International, 16-Center Study to Validate and Recalibrate HALTHCC

D. Firl,¹ K. Sasaki,¹ S. Kimura,² W. Dumronggittigule,³ A. Gorgen,⁴ J. Lerut,⁵ M. Rossi,⁶ U. Cillo,⁷ A. Viveiros,⁸ E. Tsochatzis,⁹ G. Otto,¹⁰ G. Ettorre,¹¹ G. Tisone,¹² M. Vivarelli,¹³ S. Agnes,¹⁴ J. Markmann,² T. Ikegami,¹⁵ T. Kaido,¹⁶ G. Sapisochin,⁴ V. Agopian,³ Q. Lai,^5,6 F. Aucejo.¹
Kidney Allograft Vascular Disease Post-Transplant (KTX): Risk Factors and Implications

M. El Ters,¹ L. Cornell,² J. Grande,² F. Cosio.¹
Kidney Registration Volume vs. Expectation: Impact of ESRD Burden and Outreach

A. Wilk, R. Urban, R. Carrico.
Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

J. Leventhal,¹ J. Galvin,¹ J. Mathew,¹ L. Gallon,¹ D. Stare,¹ K. Kurtenbach,¹ K. Ravindra,³ M. Horwitz,³ J. Miller,¹ M. Abecassis,¹ S. Ildstad.²
Long-Term Medical, Financial, Psychosocial, and Overall Health-Related Quality of Life after Living Donation in Liver Transplantation

J. Emamaullee,¹ L. Sher,¹ T-.L. Fong,² K. Dhanireddy,¹ S. Zielsdorf,¹ C. Romero,¹ N. Wade,¹ Y. Genyk.¹
Marijuana Use Should Not Preclude Consideration for Kidney Transplantation

K. Fabbri, T. Anderson-Haag, A. Spenningsby, A. Israni, R. Nygaard, P. Stahler.
Multicentre Epidemiological Study on Prevalence of Recurrent Glomerular Disease Post-Transplantation in the United Kingdom

R. Aguiar.
National Study of Living Donor Program Protocols, Processes, and Resources within U.S. Transplant Centers

D. Moore,¹ M. Dietrich,¹ P. Buerhaus,² J. Rodrigue,³ A. Minnick.¹
Obesity is Not Associated with Worse Outcomes for Type 2 Diabetic Simultaneous Pancreas-Kidney (SPK) Transplant Recipients

R. Forbes, S. Niederhaus, A. Fox, J. Fridell, P. Abrams, O. Olaitan, F. Kandeel, R. Urban, M. Curry, J. Odorico.
Population-Based Modeling of Prototypes and Determinants of Allograft Function Trajectories after Kidney Transplantation: Implications for Patient Monitoring and Risk Stratification

M. Raynaud, O. Aubert, M. Naessens, E. Morelon, M. Giral, N. Kamar, E. Wong, S. Jordan, B. Orandi, D. Segev, M. Stegal, P. Reese, C. Lefaucheur, A. Loupy.
Presence of Donor Specific Antibodies is Associated with Accelerated Podocyte Detachment

A. Naik, J. Aqeel, D. Cibrik, M. Samaniego, S. Wang, M. Chowdhury, F. Afshinnia, R. Wiggins.
Prevention of New Onset Diabetes after Transplantation Using Bariatric Surgery

A. Bailey, Y. Kim, S. Woodle, S. Shah, F. Paterno, M. Cuffy, T. Diwan.
Prospective Multicenter Validation of Human Transitional B Cell Cytokines as a Predictive Biomarker in Renal Transplantation

A. Cherukuri,¹ D. Chittka,¹ A. Sharma,¹ A. Salama,² C. Magee,² D. Rothstein.¹
Risk Factors and Outcomes with Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Bloodstream Infections among Solid Organ Transplant Recipients

J. Anesi,¹ E. Blumberg,¹ E. Lautenbach,¹ P. Tamma,² K. Thom,³ K. Alby,¹ W. Bilker,¹ J. Omorogbe,¹ P. Tolomeo,¹ A. Werzen,³ K. Nemati,² J. Han.¹
Risk Factors for Chronic Opioid Use after Liver Transplantation

J. Fleming, D. Taber, B. O'Brien, N. Patel, N. Pilch, R. Gilbert, L. Wilson, Z. Elmaasarani, S. Ball, P. Mauldin, P. Baliga.
Survival Benefit of Partial Grafts in Pediatric Candidates with Acute Liver Failure Awaiting Liver Transplantation: SRTR Analysis over 26 Years

D. Firl, K. Sasaki, C. Quintini, B. Eghtesad, C. Miller, K. Hashimoto.
Targeted Donor Complement Blockade after Brain-Death Prevents Delayed Graft Function but Not Progression to Antibody-Mediated Rejection in a Non-Human Primate Model of Kidney Allo-Transplantation

J. Danobeitia,¹ T. Zens,¹ L. Zitur,¹ P. Chlebeck,¹ J. Torrealba,³ D. Burguete, E. Van Amersfoort,² A. Relan,² A. D'Alessandro,¹ L. Fernandez.¹
Th17 and NK Responses Are Differentially Induced in Renal Allografts According to Recipient Murine Cytomegalovirus Dose and Strain

M. Shimamura,¹ M. Li,² S. Boddeda,¹ B. Chen,² Q. Zeng,¹ T. Schoeb,² V. Velazquez.¹
The BEST Trial: A Prospective Randomized Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression

E. Woodle,¹ D. Kaufman,² A. Shields,¹ J. Leone,³ A. Wiseman,⁴ A. Matas,⁵ P. West-Thielke,⁶ E. King,¹ R. Alloway.¹
The Ethical Turmoil of Imminent Death Donation

N. Galvan, J. Geha, R. Ackah, M. Kueht, R. Cotton, C. O'Mahony, A. Rana, J. Goss.
The Impact of Aorto-Iliac Calcifications on Patient and Graft Survival in Renal Transplant Recipients Using the TASC II Classification

A. Rijkse,¹ M. van der Zijden,² J. Roodnat,² S. Ten Raa,³ D. Bijdevaate,⁴ K. Muller,¹ J. IJzermans,¹ H. Kimenai,¹ R. Minnee.¹
The Stunning Rise in Organ Donors Deceased from Drug Overdose

N. Agrawal,¹ S. Rhazouani,¹ D. Reino,¹ D. McMichael,² C. McClenney,³ D. Sears,¹ K. Al Khalloufi,¹ S. Gebreselassie,¹ S. Ebaid,¹ M. Berho,⁴ X. Zervos,¹ C. Sheffield,¹ A. Tzakis.¹
Urinary Tract Infections after Renal Transplantation: Is Male Gender a Risk Factor for Resistant Microorganisms?

G. Guneri, A. Velioglu, E. Asicioglu, H. Arikan, S. Tuglular, C. Ozener.
Use of HCV Ab+/NAT- Donors in HCV Naïve Renal Transplant Recipients

A. Dao,¹ M. Cuffy,¹ T. Kaiser,¹ A. Loethen,¹ J. Cafardi,² A. Shields,² M. Cardi,² R. Alloway,¹ A. Govil,¹ K. Sherman,¹ S. Shah,¹ E. Woodle.¹
Use of Proton-Pump Inhibitors is Associated with Lower Magnesium and Iron Status and Excess Mortality in Renal Transplant Recipients

A. Gomes-Neto,¹ R. Douwes,¹ M. Eisenga,¹ S. Berger,¹ R. Gans,¹ E. Berg,¹ G. Navis,¹ H. Blokzijl,² S. Bakker.¹
Vesicoureteral Reflux after Kidney Transplantation Influences Long-Term Graft Survival

T. Hirose,¹ K. Hotta,² N. Fukuzawa,³ A. Mitsuke,³ H. Harada.³
A Multi-Center Analysis of Risk Factors for Pneumocystis Pneumonia (PCP) in Solid Organ Transplant Recipients

S. Hosseini-Moghaddam, M. Shokoohi, G. Singh, S. Dufresne, A. Jevnikar, D. Kabbani, H. Cardinal, I. Houde, M-.J. Hebert, A. Shoker, G. Prasad, A. Humar, D. Kumar.
A Novel Dropout Risk Score in Hepatocellular Carcinoma (HCC) Patients Listed for Liver Transplant (LT) – Identifying a Threshold That Predicts Worse Post-LT Survival in Short Wait Regions

N. Mehta, J. Dodge, F. Yao.
Acquired Resistance to Transplantation Tolerance as a Result of Prior Pregnancy Requires B Cells

A. Suah,¹ S. Khiew,¹ J. Young,¹ D. Yin,¹ Q. Wang,¹ M. Alegre,² A. Chong.¹
Approaches to Prevention of Antibody Rebound after HLA Sensitization in a Mouse Model

I. Kim, G. Wu, N-.N. Chai, A. Klein, S. Jordan.
Center Variation in Six-Month Post-Donation Follow-Up of Obese Living Kidney Donors

R. Reed,¹ P. MacLennan,¹ B. Shelton,¹ M. Mustian,¹ D. McWilliams,¹ J. Blackburn,² D. Sawinski,³ J. Locke.¹
Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients

S. Sethi, J. Choi, A. Vo, A. Peng, K. Lim, R. Najjar, S. Jordan, E. Huang.
Clinical Outcomes of Patients with BK Viremia in ABO-Incompatible Kidney Transplantation and Comparison with ABO-Compatible Kidney Transplantation

J. Yoon, C. Baek, S-.K. Park, H. Kim.
Disparate Candidate Selection Practices and Substantial Use of Low KDPI Kidneys in Combined Heart-Kidney and Liver-Kidney Transplantation, 2012-2016

R. Steiner,¹ J. Halldorson.²
Donor Derived Renal Cell Carcinoma (RCC) Transmission Events 2008-2016: A Report of the OPTN Disease Transmission Advisory Committee (DTAC)

M. Pavlakis, M. Michaels, S. Tlusty, N. Turgeon, G. Vece, C. Wolfe, R. Wood, M. Nalesnik.
Efficacy and Safety of Bleselumab in Kidney Transplant Recipients: A Phase 2, Randomized, Open-Label Study

R. Harland,¹ G. Klintmalm,² S. Jensik,³ H. Yang,⁴ J. Bromberg,⁵ J. Holman,⁶ M. Anil Kumar,⁶ V. Santos,⁶ T. Larson,⁶ X. Wang.⁶
Frequency of Whole-Organ in Lieu of Split-Liver Transplantation over the Last Decade: Children Experienced Increased Wait Time and Death

P. Valentino,¹ S. Emre,² L. Li,³ Y. Deng,³ G. Gan,³ D. Mulligan,² U. Ekong,¹ M. Rodriguez-Davalos.⁴
Impact of Local Liver Supply on Liver Offer Acceptance

M. Bowring,¹ S. Zhou,¹ A. Massie,¹ S. Gentry,^1,2 D. Segev.¹
Influence of Initial Tumor Burden and Wait Times on Post-Transplant Outcomes after Down-Staging of Hepatocellular Carcinoma (HCC)

N. Mehta, J. Dodge, F. Yao.
Interim Results of the kSORT in the SAILOR Randomized Multicenter Trial

P. Lindner,¹ A. Shroeder,² J. Ekberg,¹ S. Hsieh,² P. Towfighi,² I. Damm,² T. Sigdel,² M. Sarwal.²
Kidney Transplantation and Progression of Peripheral Arterial Disease in the Ipsilateral Lower Extremity

A. Rasmussen,¹ R. Moore,¹ T. Schuler,¹ G. Todd,¹ K. Wen.²
Linking Donor Ischemia Reperfusion Injury (IRI) to Costimulatory Blockade Resistant Murine Heart Graft Rejection through Complement-Initiated Necroptosis

R. Ang, N. Chun, A. Ting, P. Heeger.
Living Liver Donor Follow-Up: Fewer Than Half of Centers Meet Follow-Up Requirements in the US

A. Thomas, C. Holscher, A. Shaffer, J. Garonzik-Wang, A. Massie, D. Segev, M. Henderson.
Lymphotoxin Beta Receptor Modulation in Lymphatic Endothelial Cells Alters Regulatory T Cell Dynamics

V. Saxena, W. Piao, Y. Xiong, L. Li, C. Wagner, J. Bromberg.
Major Adverse Cardiovascular Events Following Simultaneous Pancreas and Kidney Transplantation. A Study of the United Kingdom Transplant Registry

P. Yiannoullou,^1,2 A. Summers,^1,2 C. Fullwood,² Z. Moinuddin,^1,2 I. Shapey,^1,2 H. Khambalia,^1,2 T. Augustine,^1,2 M. Rutter,^1,2 D. van Dellen.^1,2
Medication Adherence: Does Where You Live Matter?

S. Wadhwani,¹ S. Taylor,¹ C. Brokamp,¹ W. Guo,¹ E. Shemesh,² J. Bucuvalas.¹
Metformin Use after Kidney Transplantation: A Safe Option in Carefully Selected Patients

F. Koraishy,¹ L. Vest,¹ Z. Zhang,¹ M. Schnitzler,¹ V. Dharnidharka,² D. Axelrod,³ R. Ouseph,¹ A. Naik,⁴ N. Lam,⁵ H. Randall,¹ T. Alhamad,² D. Segev,³ D. Brennan,³ B. Kasiske,⁶ G. Hess,⁷ K. Lentine.
Mortality and ESRD in Older Live Kidney Donors with Hypertension

F. Al Ammary,¹ X. Luo,¹ A. Muzaale,¹ A. Massie,¹ D. Brennan,¹ A. Wiseman,² J. Snyder,³ D. Segev.¹
Outcome Implications of Benzodiazepines and Opioid Co-Prescriptions before Kidney Transplantation

N. Lam,¹ M. Schnitzler,² D. Axelrod,³ V. Dharnidharka,⁴ D. Segev,⁵ A. Naik,⁶ H. Xiao,² R. Ouseph,² H. Randall,² G. Hess,⁷ B. Kasiske,⁸ D. Brennan,⁵ T. Alhamad,⁴ K. Lentine.²
PD-L1 May Serve as a Biomarker for Chimerism-Induced Tolerance in Kidney Transplant Recipients

A. Merchak,¹ A. Khalil,¹ A. Chhabra,¹ J. Leventhal,² S. Ildstad.¹
PGE2/Beta-Catenin/XBP1 Signaling Controls Mesenchymal Stem Cell-Mediated Immune Regulation in Liver Ischemia and Reperfusion Injury

C. Li, S. Yue, L. Jiang, Q. Zhu, D. Farmer, R. Busuttil, J. Kupiec-Weglinski, B. Ke.
Positive Relationship between Transplant Center Volume and Utilization of Hard to Place Liver Allografts after Late Declines

J. Knox,¹ H. Braun,¹ S. Syeed,¹ K. Halazun,² G. Roll.¹
Predictive Scores for Delayed Graft Function Based on Hypothermic Machine Perfusion Variables in Kidney Transplantation

C. Ding,^1,2 W. Xue,^1,2 P. Tian,^1,2 X. Ding,^1,2 X. Pan,^1,2 H. Xiang,^1,2 Y. Li,^1,2 X. Tian,^1,2 F. Han,^1,2 Q. Tai.^1,2
RNA-Seq Based Analysis of Renal Allograft Biopsies Reveals Key Mediators of Interstitial Fibrosis/Tubular Atrophy

C. McEvoy,^1,2,4 E. Brennan,^1,2 A. Dorman,^2,3 D. Sadlier,^1,2 A. Konvalinka,⁴ P. Conlon,^2,3 C. Godson.^1,2
Recurrence of Immunoglobulin A Nephropathy in Related Donor Kidney Transplant Recipients

M. Okumi,¹ D. Okada,¹ K. Unagami,² Y. Kakuta,¹ H. Shirakawa,³ T. Shimizu,⁴ K. Omoto,⁴ H. Ishida,¹ K. Tanabe.¹
Robotic Kidney Transplantation in Obese Recipients: The New Standard?

I. Tzvetanov, C. Di Bella, K. Tulla, M. Spaggiari, F. Gheza, P. Di Cocco, J. Oberholzer, E. Benedetti.
Role of C1q-Binding Donor-Specific Anti-HLA Antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis

K. Louis, D. Viglietti, O. Aubert, A. Loupy, C. Lefaucheur.
Shared HLA Specificities between the Blood and Transplant Donor Increases the Risk of De Novo DSA Development Following Blood Transfusion in Transplant Recipients

S. Hassan,¹ F. Regan,² C. Brown,³ A. Harmer,² N. Anderson,² E. Santos,⁴ P. Brookes,⁴ D. Taube,¹ M. Willicombe.¹
Temporal Trends, Predictive Factors, and Regional Differences in Discard of Increased-Risk Kidneys

J. Lipinska, D. Clark, J. Whiting.
The Feasibility of Laparoscopic Living Donor Right Hepatectomy Compared to Open Surgery Including 100 Laparoscopic Cases

J. Rhu, G. Choi, J. Kim, J. Joh, C. Kwon, S. Kim.
The Financial Impact of the Opioid Epidemic on Kidney Transplantation Readmissions

L. Wilson, D. Taber, N. Pilch, R. Gilbert, Z. Elmaasarani, B. O'Brien, N. Patel, P. Mauldin, S. Ball, P. Baliga, J. Fleming.
The Utility of a CD31/CD68 Dual Immunohistochemical Stain to Improve Accurate Diagnosis of Antibody Mediated Rejection in Cardiac Transplantation

C. Glass, Y. Butt, T. Gokaslan, J. Torrealba.
Type I NKT Cells Augment Humoral and Cellular Alloimmunity in Response to Hepatocyte Transplantation

S. Elzein, J. Zimmerer, B. Ringwald, C. Avila, G. Bumgardner.
Using the SRTR Expected Survival Worksheet to Estimate Expected Number of Events

J. Gregg,¹ K. Womer,¹ K. Andreoni.²
Validation of an Integrative and Dynamic Prognostic Score for Response to Therapy in Solid Organ Transplants

A. Loupy, O. Aubert, D. Viglietti, C. Legendre, D. Glotz, C. Lefaucheur.
Waitlist Outcomes and Access to Liver Transplantation for HIV+ Candidates

A. Shaffer,¹ A. Thomas,¹ A. Massie,¹ S. Gustafson,² J. Snyder,² B. Shelton,³ R. Reed,³ J. Locke,³ D. Segev,^1,2 C. Durand.¹
modified DFPP Can Eliminate Donor-Reactive IgG Antibody with Preserving Fibrinogen before Kidney Transplantation

D. Iwami,¹ T. Matsumoto,² K. Hotta,¹ M. Ota,² Y. Chiba,² H. Higuchi,¹ N. Shinohara.¹
p16^INK4a Deletion in Vascular Endothelium Improves Kidney Regeneration Post Ischemia Reperfusion Injury

A. Melk,¹ A. Baisantry,^1,2 S. Wang,¹ F. Kubaink,¹ R. Bhayadia,¹ R. Schmitt.²
Ex Vivo-Expanded Human CD19⁺CD73^–CD25⁺CD71⁺TIM-1⁺ B Regulatory Cells Can Prolong Allograft Survival in a Humanized Mouse Model of Skin Transplantation and Are Dependent on TIM-1-Mediated Regulation of STAT3 Signaling

S. Shankar,¹ J. Stolp,^1,2 S. Juvet,^1,3 J. Hester,¹ K. Wood.¹
A Low Level of De Novo DSA Sialylation is Associated with a Decreased of Allograft Survival in Non-Sensitized Kidney Transplant Recipients

M. Bonnet,^1,2 V. Pernin,^1,3 J-.E. Serre,¹ V. Georgescu,⁴ M. Le Quintrec,^1,2,3 G. Mourad,^1,2 J-.F. Eliaou,^2,5 C. Rene.^2,5
A Novel Peripheral Blood mRNA Biomarker Predicts Subclinical Rejection and Kidney Transplant Outcomes

J. Friedewald,¹ S. Kurian,² T. Whisenant,² R. Heilman,³ E. Poggio,⁴ C. Marsh,² P. Baliga,⁵ N. Bridges,⁶ J. Odim,⁶ M. Brown,⁶ D. Ikle,⁷ B. Armstrong,⁷ J. Charette,¹ S. Brietigam,¹ N. Sustento-Reodica,¹ L. Zhao,¹ M. Kandpal,¹ D. Salomon,² M. Abecassis.¹
A Phase-I Clinical Trial of Donor-Derived MIC Cell Infusion for the Induction of Donor-Specific Hyporesponsiveness after Living Donor Kidney Transplantation (TOL-1 Study)

C. Morath,¹ A. Schmitt,² C. Kleist,³ V. Daniel,³ G. Opelz,³ C. Süsal,³ F. Fälble,¹ C. Sommerer,¹ L. Wang,² M. Zeier,¹ M. Schmitt,² M. Schaier,¹ P. Terness.³
Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry

S. Sanoff,¹ K. Ravindra,¹ W. Irish.^1,2
Cost Impacts of Alternative Kidney Transplant Immunosuppression: A National Cohort Study

K. Lentine,¹ D. Axelrod,² V. Dharnidharka,³ H. Xiao,¹ D. Brennan,⁴ D. Segev,⁴ H. Randall,¹ R. Ouseph,¹ A. Naik,⁵ N. Lam,⁶ T. Alhamad,³ B. Kasiske,⁷ G. Hess,⁸ M. Schnitzler.¹
Digital-Enabled Refills and Medication Adherence among Transplant Recipients

S. Boghani, H. Kirkham, G. Pietradoni, N. Hira.
Donor Safety in Obese Patients: 1038 Consecutive Robotic Living Donor Nephrectomies

C. Di Bella,¹ M. Spaggiari,¹ K. Tulla,¹ P. Di Cocco,¹ J. Oberholzer,² I. Tzvetanov,¹ E. Benedetti.¹
Economic Evaluation of Contemporary Kidney Transplant Practice

D. Axelrod,¹ M. Schnitzler,² H. Xiao,² W. Irish,³ J. Tuttle-Newhall,³ S-.H. Chang,⁴ B. Kasiske,⁵ T. Alhamad,⁴ K. Lentine.²
Factor Analysis (FA) Identifies 5 Major Axes of Kidney Transplant Biopsy (KTxBx) Pathology

L. Hunsicker,¹ J. Grande,² J. Cecka,³ A. Matas,⁴ The DeKaf Consortium.
Geographic Disparity in Access to Deceased-Donor Liver Transplantation for Pediatric Candidates

M. Bowring,¹ D. Mogul,¹ D. Segev,¹ S. Gentry.^1,2
Gut Microbiota, Mycophenolate Mofetil, and Post-Transplant Diarrhea in Kidney Transplant Recipients

J. Lee,¹ M. Magruder,¹ L. Zhang,¹ D. Dadhania,¹ M. Satlin,¹ L. Westblade,¹ A. Robertson,¹ Y. Taur,² L. Ling,² E. Pamer,² M. Suthanthiran.¹
HLA-DR4 Matching and Hepatocellular Carcinoma Recurrence after Liver Transplantation

M. Xu, S. Garcia-Aroz, N. Vachharajani, Y. Lin, W. Chapman.
Health and Economic Disparities in Waitlist Access and Liver Distribution Policy

R. Lynch,¹ K. Ross,¹ T. Pearson,¹ D. Goldberg,² R. Patzer.¹
How Safe is Crossing the ABO Blood Group Barrier? A Meta-Analysis to Determine the Additive Risk of ABO-Incompatible Kidney Transplantation

A. de Weerd, M. Betjes.
Identification of Anti-Inflammatory and Pro-Inflammatory Gut Microbiota That Determine Graft Survival

Y. Xiong, C. Brinkman, L. Hittle, W. Fricke, E. Mongodin, J. Bromberg.
IgA Recurrence in a Single Center with a Protocol Biopsy Program

M. Merzkani, N. Lepori, M. El Ters, F. Cosio, H. Amer.
Impact of Center Volume on Kidney Transplant Outcomes in Contemporary U.S. Transplant Practice

T. Alhamad,¹ F. Abbas,¹ D. Brennan,² A. Malone,¹ J. Wellen,¹ R. Delos Santos,¹ A. Khan,¹ J. Li,¹ R. Rattanavich,¹ K. Lentine.³
Impact of the Differences between Body Mass Index of Recipient and Donor in a Population of Robotic Kidney Transplant

K. Tulla,¹ I. Tzvetanov,¹ C. Di Bella,¹ F. Gheza,¹ M. Spaggiari,¹ J. Oberholzer,² E. Benedetti.¹
Improving Prediction of Post-Transplant Death and Graft Loss with Expanded Clinical Data Collection

R. Sung,¹ J. Magee,¹ M. Schnitzler,² N. Dzebisashvili,³ K. Lentine,² L. Ly,¹ D. Axelrod.⁴
Ischemia Reperfusion Injury in Liver Transplantation is Associated with Acute Kidney Injury: Role of Inflammatory Mediators

P. Mihaylov,^1,2 P. Li,¹ J. Skill,¹ L. Timsina,¹ J. Fridell,¹ B. Ekser,¹ R. Mangus,¹ C. Kubal.¹
Kidney Transplant Patients with Polycystic Kidney Disease Have a Lower Risk of Post-Transplant BK Infection Compared to Other Causes of ESRD

S. Panzer, C. Plafkin, B. Astor, A. Djamali, T. Singh.
LDLT for High MELD Recipients: A Single Center Experience

S. Ganesh, M. Molinari, T. Amit, H. Christopher, H. Abhinav.
Legal Status, Criminal History, and Substance Use in Listing Decisions

G. Lee, A. Wall, J. Maldonado, D. Magnus.
Long Term Renal and Patient Risks for Living Kidney Donors

Y. Kim, M. Yu, Y. Kim, H. Lee.
MERTK Mediates Transplant Tolerance via IFN-a Regulation of MDSCs and Tregs

L. Zhang, M. DeBerge, E. Thorp, X. Luo.
Mechanisms of DEPTOR Function in CD4⁺ T Cell Subsets

J. Wedel,¹ K. Liu,¹ P. Sage,² M. Laplante,³ D. Briscoe.¹
New Onset Diabetes after Kidney Transplant: Comparisons of Risks Associated with Various Steroid-Containing Calcineurin Inhibitor and Sirolimus Regimens

A. Santos, Jr.,¹ M. Casey,¹ K. Alquadan,¹ X. Wen,² C. Chen,³ A. Gutierrez-Mena,¹ K. Womer.¹
Non-Myeloablative Conditioning with Low-Dose Total Body Irradiation in Place of Cyclophosphamide Induces Mixed Chimerism and Long-Term Immunosuppression Free Allograft Survival without Acute Kidney Injury in HLA Mismatched Kidney Transplantation

T. Kawai,¹ T. Spitzer,¹ T. Oura,¹ N. Torkoff-Rubin,¹ N. Elias,¹ M. Sykes,² R. Colvin,¹ D. Sachs,² A. Cosimi.¹
Novel Function of TIE2 in Immunoregulation

C. Ghosh, T. Agur, A-.L. Mak, S. Pal, J. Wedel, B. David.
Outcomes after HIV+ Liver Transplant: A HOPE in Action Study

C. Durand,¹ M. Bowring,¹ A. Tobian,^1,3 D. Brown,¹ A. Cameron,¹ S. Ottman,¹ K. Oshima,¹ D. Ostrander,¹ A. Redd,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² S. Chandran,⁶ A. Chao,⁶ V. Kirchner,⁷ T. Pruett,⁷ A. Massie,¹ D. Segev.¹
Outcomes of C4d+ Immunostaining in Heart Transplantation: Is All Immunologic AMR Bad?

M. Rafiei, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, S. Mersola, G. Esmailian, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Pancreas Transplant Alone (PTA) Outcome is Best in Brittle Diabetic Patients without Advanced Nephropathy

M. Laftavi,¹ A. Gruessner,² O. Pankewycz,¹ B. Kaylene,² S. Sidharth,² R. Gruessner.
Prolonged Graft Survival in Old Recipients is Abrogated by Immunosuppressive Treatment with CTLA4-Ig

T. Heinbokel,¹ M. Quante,^1,2 K. Edtinger,¹ K. Minami,¹ Y. Nian,¹ A. Lau,¹ A. Elkhal,¹ S. Tullius.¹
Reducing No-Show Rate and Filling Cancelled Appointments: Multi-Faceted Interventions Markedly Reduced Time to Kidney Transplant Evaluation

E. Gibney, K. Payne, C. Fowler.
Risk Factors for Chronic Opioid Use after Kidney Transplantation

J. Fleming, D. Taber, R. Gilbert, L. Wilson, Z. Elmaasarani, B. O'Brien, N. Patel, N. Pilch, S. Ball, P. Mauldin, P. Baliga.
Risk Factors for Invasive Fungal Infections among Lung Transplant Recipients

K. Whitaker, J. Anesi, E. Blumberg, L. Gardo, J. Lee, M. Crespo, C. Bermudez, L. Glaser, M. Wilck.
Senolytic Drug Treatment Attenuates mtDNA-Mediated Inflammatory Injury in Old Donors and Prolongs Cardiac Allograft Survival

K. Minami,¹ M. Seyda,¹ T. Heinbokel,¹ Y. Nian,¹ M. Quante,¹ G. Liu,¹ R. Abdi,² T. Tchkonia,³ J. Kirkland,³ A. Elkhal,¹ S. Tullius.¹
T cell Phenotypes Predict Infectious Risk in Transplanted Children

E. T. Chambers,¹ R. Ettenger,² H.-J. Lee,¹ C. Chan,¹ L. Stempora,¹ B. Warshaw,³ P. Grimm,⁴ E. F. Reed,² M. Sarwal,⁵ A. Kirk.¹
The Benefit of Higher KDPI Renal Transplantation over Waiting for a Better Offer

E. Grodstein,¹ J. Yang,² V. Nair,¹ E. Molmenti,¹ L. Teperman.¹
Waitlist Survival is Approaching Survival after Kidney Transplantation

A. Rana, B. Murthy, C. O'Mahony, J. Goss.
Worsening Racial/Ethnic Disparities in Pediatric Kidney Transplant Outcomes in the US

T. Purnell, X. Luo, L. Cooper, D. Crews, K. Covarrubias, A. Massie, D. Segev.
A Novel Score for Predicting Mortality and Graft Failure after Kidney Transplant

C. Parsons, F. Shamoun, S. Patel, S. Cha, R. Heilman, M. Keddis.
ACEI/ARB Use within One Year of Kidney Transplant is Associated with Less AKI and Graft Loss in Older Recipients

M. Posadas Salas, R. Rodriguez, P. Amaechi, V. Rao, D. Taber.
Assessment and Validation of Potential Predictors of Non-Adherence in Contemporary Kidney Transplant Recipients

T. Harrison, C. Perez, N. Patel, H. Meadows, J. Fleming, N. Pilch, B. O'Brien, H. Corbo, J. Hardcopf, P. Baliga, D. DuBay, D. Taber.
Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial

C. Leibler,¹ F. Canoui,² M. Matignon,¹ E. Rondeau,³ A. Zarour,² A. Durrbach,⁴ S. Malard,⁵ P. Grimbert.¹
Can Immunosuppression Maintenance after Renal Allograft Failure Prevent Further Sensitization?

A. Mena-Gutierrez, K. Alquadan, A. Santos, K. Womer, M. Casey.
Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial

S. Patel, S. Kuten, R. Knight, J. Nolte, D. Nguyen, E. Graviss, L. Moore, I. Agboli, C. Pham, A. Gaber.
Cold Pulsatile Machine Perfusion versus Static Cold Storage in Kidneys from Donation after Circulatory Death: A Multi-Centre Randomised Controlled Trial

D. Summers,^1,2 L. Randle,¹ A-.M. O'Sullivan,³ R. Johnson,² D. Collett,² M. Attia,⁴ N. Ahmad,⁴ M. Clancy,⁵ M. Akyol,⁶ A. Tavakoli,⁷ N. Jamieson,³ A. Bradley,¹ C. Watson.¹
Confirmation of the Feasibility of Ex Vivo Creation of a Novel Human Multi-Chimeric Cells Therapy for Tolerance Induction in Vascularized Composite Allotransplantation

J. Cwykiel, G. Rafidi, M. Siemionow.
Cost Effectiveness of Hepatitis C Positive Donor Kidney Transplantation for Hepatitis C Negative Recipients with Concomitant Direct-Acting Anti-Viral Therapy

G. Gupta, Y. Zhang, H. Kale, N. Carroll, R. Sterling.
Declining Number of Pancreas after Kidney Transplants Despite Significant Improvement in Outcome

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
Development and Validation of a Socioeconomic Kidney Transplant Derailers Index (KTDI)

J. Peipert,^1,2 J. Beaumont,² M. Robbins,³ A. Paiva,³ C. Anderson,¹ A. Waterman.^1,2
Development of an Individualized Online Shared Decision Making Tool for Kidney Transplant Candidates

A. Hart,^1,2,3 M. Bruin,¹ S. Chu,¹ M. Partin,¹ A. Matas,¹ C. John,¹ A. Israni.^1,2,3
Effect of Acute Vascular Inflammation (v) on Death Censored Graft Failure (DCGF) Following Kidney Transplant (KTx)

J. Grande,¹ L. Hunsicker,² R. LeDuc,³ A. Matas, The DeKAF Consortium.
Estimation of Mortality on the Wait List

S. Asrani, L. Jennings, J. Trotter, G. Klintmalm.
Graft Dendritic Cell p40 Homodimers Activate Donor-Reactive Endogenous Memory CD8 T Cells within Higher Risk Allografts

H. Tsuda, A. Valujskikh, R. Fairchild.
HLA Eplet Mismatch and Donor Specific Antibodies in Kidney Transplantation

S. Wan,^1,2 S. Angel de Wilde,² B. Rosales,² S. Chadban,^1,2 K. Wyburn.^1,2
Heart and Lung Transplantation Outcomes in HIV-Positive Recipients

C. Koval,¹ M. Malinis,² N. Mueller,³ J. Krisl,⁴ M. Hannan,⁵ P. Grossi,⁶ S. Huprikar.⁷
Immunity and Tolerance after Bilateral Orthotopic Lung Transplant (BOLT) in Tandem with a CD3+/CD19+ Depleted Vertebral Bone Marrow Transplant (BOLT+BMT) from 1 of 8 HLA-Matched Cadaveric Donors

P. Szabolcs,¹ X. Chen,¹ A. Donnenberg,² M. Hill,¹ J. Rowan,¹ S. Mcintyre,¹ G. Kurland,¹ J. Barnum,¹ J. McDyer.¹
Increasing the Donor Pool for Highly Sensitized Patients with Allele Specific Antibodies: Optimizing the Virtual Crossmatch (vXM)

A. Zhang,¹ Z. Zaky,² J. Africa,³ D. Good,¹ R. Bray,⁴ H. Gebel.⁴
Influence of Liver Allograft Steatosis on Postoperative Acute Kidney Injury

C. Jadlowiec,¹ S. Mao,² D. Abdelwahab,¹ A. Nehra,² T. Taner.²
Living Donor Liver Transplantation for Alcoholic Liver Disease: Data from the A2ALL Study

H. Braun, J. Dodge, J. Grab, S. Syed, G. Roll, C. Freise, J. Roberts, N. Ascher.
Living Kidney Donation: Impact of Transplant Center Labor, Organization, and Resources

D. Moore,¹ M. Dietrich,¹ P. Buerhaus,² J. Rodrigue,³ A. Minnick.¹
Long-Term Risk of Solid Organ De Novo Malignancies after Liver Transplantation: A French National Study on 11226 Patients

O. Seree, M. Altieri, J. Dumortier, GReF2.
Metabolic Therapy as a Platform for CTLA4Ig Costimulation Blockade in Preventing Allograft Rejection

C-.H. Cheng,^1,2 C-.F. Lee,^1,2 G. Furtmüller,³ B. Oh,³ C. Patel,¹ Y-.C. Lo,¹ M. Fryer,³ G. Brandacher,³ J. Powell.¹
OX40 Costimulation Prevents Induction of Foxp3⁺ Tregs through Upregulation of Novel Repressors of Foxp3 Gene Expression

X. Zhang,¹ X. Xiao,¹ P. Lan,¹ J. Li,¹ Y. Dou,¹ W. Chen,¹ N. Ishii,² S. Chen,¹ E. Taparowsky,³ X. Li.^1,4
Outcomes of DCD Renal Transplantation from Donors with Acute Kidney Injury

E. Grodstein, J. Yang, V. Nair, L. Teperman.
Outcomes of Pediatric Donor Liver Grafts for Adult Transplantation: A National Analysis

J. Yerxa, Q. Gao, U. Scheuermann, R. Davis, D. Vikraman, A. Barbas.
Pilot Study of Plasma Cell Niche-Targeted Therapy for Enhancement of Proteasome Inhibitor Effectiveness

S. Tremblay,¹ C. Castro-Rojas,² J. Driscoll,¹ S. Knechtle,³ A. Shields,¹ R. Alloway,¹ H. Singh,² D. Hildeman,² E. Woodle.¹
Pre-Donation Body Mass Index Associations with Outcomes in Living Kidney Donors: A Single Centre Experience

A. Kousios, K. Koutroutsos, R. Charif, J. Galliford, N. Stubbs, H. Dulku, H. Orr, M. Loucaidou.
RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance

R. Smith,¹ M. Matsunami,³ B. Adam,² A. Rosales,¹ T. Oura,³ A. Cosimi,³ T. Kawai,³ M. Mengel,² R. Colvin.¹
Racing to Activation: Using LEAN Principles to Effectively Manage Your Waitlist with Predicted Improved Outcomes

L. Curry, V. Rao, D. Cassidy, V. Rohan, D. Dubay, N. Pilch, S. Gray.
Recombinant Thrombomodulin alpha Attenuates Kidney Graft Damage after Long Cold Ischemia Time in a Rat Kidney Transplant Model

S. Tamaki,¹ K. Shinoda,¹ M. Shimoda,² S. Morita,¹ H. Asanuma,¹ M. Oya.¹
Serum Cytokines as Markers of Influenza Infection Outcomes after Transplantation

A. L'Huillier,¹ V. Ferreira,¹ C. Hirzel,¹ E. Cordero,² A. Limaye,³ G. Reid,⁴ J. Englund,³ E. Blumberg,⁵ A. Humar,¹ D. Kumar.¹
Superior Renal Function with CNI-Free Everolimus over Standard CNI-Based Regimen: 18 Months Data from the Randomized, Multi-Center MANDELA Trial in De Novo Heart Transplant Recipients

M. J. Barten,¹ S. W. Hirt,¹ J. Garbade,¹ C. Bara,¹ A. Doesch,¹ C. Knosalla,¹ C. Grinninger,¹ J. Stypmann,¹ C. Sieder,² M. Junge,² U. Schulz.¹
T Cell-Mediated Rejection Poses Greater Risk to Graft Survival Than Antibody-Mediated Rejection in Heart Transplants

M. Parkes, K. Famulski, P. Halloran, The INTERHEART Study Group.
T-Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell Generation and Regulatory-T-Cell-Dependent Cardiac Allograft Survival

N. Chun,¹ D. Verghese,¹ M. Demir,¹ M. Fribourg,³ I. Llaudo,¹ E. Medof,⁴ P. Heeger.¹
Transplant Community Perceptions of the Benefits and Drawbacks of Alternative Quality Metrics for Regulation

S. Rasmussen, S. Zhou, A. Thomas, D. Segev, L. Hersch Nicholas.
Transplantation Tolerance Prevents CMV Reactivation and Preserves Kidney Allograft Function in a D+/R- Transplant Setting

A. Dangi,¹ J-.J. Wang,² M. Burnette,¹ Z. Zhang,² X. Luo.^1,2
Treatment Outcomes of Recurrent Primary Focal Segmental Glomerulosclerosis (FSGS) after Kidney Transplantation

R. Aguiar,¹ F. Pereira,² A. Gasparini,³ P. Chowdhury,¹ D. Game,¹ D. Moutzouris.¹
Trends and Policy Influences on Multiple Listing Practices for Kidney Transplantation between 2000 and 2017

M. Decoteau,¹ D. Stewart,² A. Toll,² J. Case,¹ C. Marsh.¹
Unbiased Sequencing of Urine Cell-Free DNA (cfDNA) to Evaluation Urine Virome and Associated Renal Allograft Damage

D. Dadhania,¹ P. Burnham,² J. Lee,¹ C. Snopkowski,¹ C. Li,¹ S. Albakry,¹ H. Yang,¹ T. Muthukumar,¹ I. De Vlaminck,² M. Suthanthiran.¹
Use of Surgically Placed Transversus Abdominis Plane (TAP) Block Catheter with Local Anesthetic Infusion in Renal Transplantation

M. Dib,¹ S. Borden,² T. Schell,¹ P. Stahler,¹ T. Al-Qaoud,¹ E. Martinez,¹ E. Grodstein,¹ A. D'Alessandro,¹ J. Odorico,¹ L. Fernandez,¹ J. Mezrich,¹ R. Redfield,¹ D. Foley,¹ D. Al-Adra,¹ D. Kaufman.¹
Aggressive Immunosuppression Minimization Shortens BK Viremia, Does Not Improve Outcome, but Increases the Risk of De Novo Donor Specific Antibodies in Kidney Recipients

A. Devresse,^1,2 C. Tinel,¹ A. Vermorel,¹ R. Snanoudj,¹ L. Morin,¹ V. Avettand-Fenoel,³ L. Amrouche,¹ A. Scemla,¹ J. Zuber,¹ C. Legendre,¹ M. Rabant,⁴ D. Anglicheau.¹
B Cell Reconstitution: 36-Month Analysis of Patients Post-Alemtuzumab Induction Followed by Belatacept-Based Immunosuppression

Q. Gao,¹ A. Mehta,² A. Guasch,² A. Ghali,² A. Kirk,¹ H. Xu.¹
Deceased Pediatric Donor Livers: How Current Policy Drives Allocation and Transplantation

E. Hsu,² J. Ge,¹ J. Bucuvalas,³ J. Lai.¹
Effect of HLA Antibodies on Graft Survival in Adult Live Donor Liver Transplantation

M. Simpson,¹ M. Akoad,¹ F. Gordon,¹ Y-.L. Cheah,¹ C. Simon,¹ J. Pomposelli,² E. Pomfret.²
Elevated Serum Penteraxin in Cardiac Allograft Antibody Mediated Rejection: From Cytokine Arrays to Patients with ABMR

O. Moussa,³ M. Kavarana,² L. Klingman,¹ J. Felius,¹ S. Hall,¹ M. Askar.¹
Enhancement of Intrinsic Apoptosis via Bcl-2 Inhibition Promotes Induction of Robust Mixed Chimerism and Renal Allograft Tolerance without Myelosuppression in Nonhuman Primates

T. Oura,¹ A. Dehnadi,¹ I. Rosales,¹ H. Sasaki,¹ P. Cippa,² R. Fehr,² A. Cosimi,¹ T. Kawai.¹
Enhancing Coordination across Healthcare Settings through a Web-Based Transplant Referral Exchange (T-REX) Platform

L. McPherson,¹ R. Mutell,² P. Broughton,² M. Basu,¹ J. Gander,¹ S. Pastan,¹ R. Patzer.¹
Ex Vivo Expanded Regulatory T Cells Combined with Short-Term Costimulation Blockade Prevent Rejection of Vascularized Composite Allografts

B. Oh,¹ G. Furtmüller,¹ M. Grzelak,¹ L. Vuong,² M. Iglesias,¹ M. Fryer,¹ D. Cooney,¹ W. Lee,¹ G. Raimondi,¹ G. Brandacher.¹
Factor Analysis (FA) of Renal Transplant Biopsy (KTxBx) Data Enables Objective Assessment of Risk for Subsequent Death Censored Graft Failure (DCGF)

L. Hunsicker,¹ J. Grande,² J. Cecka,³ A. Matas,⁴ The DeKaf Consortium.
Factors Associated with the Development of Chronic Kidney Disease after Liver Transplantation

M. Kalisvaart, A. Schlegel, P. Trivedi, K. Roberts, D. Mirza, T. Perera, J. Isaac, J. Ferguson, P. Muiesan.
Few Gender Differences in Attitudes and Experiences after Live Kidney Donation, with Minor Changes over Time

J. Wadström,^1,2 B. von Zur-Mühlen,³ S. Yamamoto.³
Frailty Assessment Pilot Study in Older Kidney Transplant Recipients

B. Abdalla, B. Hale-Durbin, J. Schaenman, C. Lee, G. Danovitch.
HCV Ab+/NAT- Organ Donors, and the Challenges of 'Eclipse Windows': Analysis of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC)

C. Wolfe, S. Tlusty, G. Vece, R. Sawyer, R. Bag, G. Berry, J. Bucio, L. Danziger-Isakov, D. Goldberg, C. Ho, D. Florescu, D. Klassen, R. La Hoz, K. Lilly, A. Mehta, M. Malinis, M. Nalesnik, N. Theodoropoulos, P. Wood, M. Michaels.
Humoral Immune Response to Seasonal Influenza Infection in Transplant Recipients

C. Hirzel,¹ V. Ferreira,¹ A. L'Huillier,¹ K. Hoschler,² E. Cordero,³ G. Reid,⁴ J. Englund,⁵ A. Limaye,⁶ A. Humar,¹ D. Kumar.¹
Identification of Human SIRPa Diversity That Could Regulate Innate Allorecognition

A. Friday,¹ H. Dai,¹ A. Williams,¹ M. Oberbarnscheidt,¹ J. Danska,² F. Lakkis.¹
Impact of Ambulatory Transplant Pharmacy Services on Outcomes and Readmissions in Adult Abdominal Transplant Recipients

K. Joyal,¹ C. Rogers,² M. Cote,² M. Pavlakis,² A. Evenson,² V. Patwardhan,² K. Richards.²
Improved OPO Performance Drives Broader Organ Sharing in the United States

R. Carrico, B. Shepard, D. Klassen.
Information Needs of Adolescent Transplant Recipients Transitioning to Adult Care

B. Kosmach-Park,¹ D. Shellmer,² C. Nguyen,³ G. Mazariegos.²
Lab Turnaround Times: A Performance Improvement Project in Post Kidney/Pancreas Transplant Clinic

M. Farrell, S. Kapadia.
Liver Transplantation Outcomes after Share 35: Analysis of NASH Recipients from UNOS Database

Y. Zhang,¹ M. Boktour.²
Long Term Histologic Allograft Health is Preserved Despite Rejection during Protocolized Immunosuppression Withdrawal (ISW) in Stable Pediatric Liver Transplant Recipients

V. Venkat,¹ J. Bucuvalas,² M. Martinez,³ K. Spain,⁴ G. Mazariegos,¹ A. Demetris,⁵ S. Feng.⁶
Long-Term Kidney Transplant Survival after Deceased-Donor Acute Kidney Injury

I. Hall, E. Akalin, J. Bromberg, M. Doshi, M. Harhay, Y. Jia, S. Mansour, S. Mohan, T. Muthumkumar, P. Reese, B. Schröppel, P. Singh, H. Thiessen-Philbrook, F. Weng, C. Parikh.
Novel Vascular Inflow Offers Renal Transplantation to Recipients with Severe Central and Peripheral Vascular Disease

S. Mao,¹ E. Giorgakis,² A. Moss,² T. Taner.¹
Offspring Living Kidney Donors Should Not Be Ruled Out

X. Luo, A. Massie, C. Holscher, D. Segev.
Outcome of Second Kidney Transplantation According to Previous Pediatric Donor Type: A Retrospective Cohort Analysis

K. Phonphok, T. Duong, S. Panombualert, S. Bunnapradist.
Outcomes Analysis of Liver Transplantation Combined with Neoadjuvant Therapy in Patients with Unresectable Locally-Advanced Cholangiocarcinoma

M. Wong,¹ J. Kim,¹ C. Eriksen,¹ T. Pearson,¹ J. Robbins,² B. George,³ M. Zimmerman,¹ J. Hong.¹
Pancreas Transplant in the Elderly Patient – Should It Be Done?

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
Post‐Donation eGFR Levels Predicts New‐Onset Antihypertensive Medication Use after Living Kidney Donation

K. Lentine,¹ D. Segev,² N. Lam,³ A. Garg,⁴ A. Naik,⁵ D. Axelrod,⁶ H. Xiao,¹ M. Henderson,² A. Massie,² B. Kasiske,⁷ G. Hess,⁸ C. Hsu,⁹ D. Brennan,² M. Schnitzler.¹
Post-Transplant Outcomes under the New HCC Exception Policy

T. Ishaque, A. Massie, C. Haugen, D. Segev.
Preformed Donor-Reactive T-Cells That Persist after ABO Desensitization Independently Predict Severe Acute Cellular Rejection after Living Donor Kidney Transplantation

T. Schachtner,^1,2,3 M. Stein,² P. Reinke.^1,2
Prevalence of Frailty among Kidney Transplant Recipients in the United States

A. Thomas,¹ A. Shaffer,¹ H. Ying,¹ S. Norman,² D. Segev,¹ M. McAdams-DeMarco.¹
Race, Income, and Insurance Status Predict Migration for Liver Transplantation in the United States

A. Kwong, A. Mannalithara, W. Kim.
Rapamycin Impairs Human Endothelial Cell Alloimmunogenicity Independent of PD-1/PD-1 Ligand Inhibitory Signaling

Q. Gao, V. Bendersky, A. Kirk, H. Xu.
Redo Kidney Transplant in FSGS

J. Verbesey, A. Javaid, S. Yi, G. Vranic, A. Gilbert, P. Abrams, S. Ghasemian, J. Moore, B. Thomas, M. Cooper, B. Javaid.
Screening of RhoA/ROCK Inhibitors for the Ability to Prevent Chronic Rejection of Mouse Cardiac Allografts

W. Chen, W. Chen, X. Li, R. Ghobrial, M. Kloc.
Secular Trends in the Medical Complexity and Outcomes of Medicare-Insured Patients Undergoing Kidney Transplant

C. Lenihan,¹ S. Liu,¹ M. Montez-Rath,¹ W. Winkelmayer.²
Should More Donation after Cardiac Death Livers Be Used in Pediatric Transplantation?

C. Hwang,¹ S. Levea,² M. MacConmara.¹
TORC1 Inhibition Protects Activated Human Regulatory T Cells from Self-Inflicted Damage via Granzyme B

B. Al Dulaijan, S. Eskandari, J. Karnyski, J. Assaker, S. Cai, A. Mansouri, M. Mohamed, J. Azzi.
Tissue Talks: Graft´s Histological Findings 10 Years after Belatacept or CNI

G. Mondragon-Ramirez,¹ N. Uribe-Uribe,² J. Arreola-Guerra,⁵ R. Reyes-Acevedo,⁵ M. Vilatoba,³ J. Furuzawa-Carballeda,⁴ A. Lopez-Toledo,¹ G. Mondragon-Salgado,¹ J. Alberu.³
Two Trajectories of Post-DSA eGFR after Kidney Transplant

J. Beaumont,¹ K. Briley,² A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² L. Rebellato,² M. Everly.¹
Urinary C5b-9 is an Independent Predictor of Graft Failure in Renal Transplant Recipients

R. Lammerts, M. Eisenga, M. Alyami, M. Seelen, M. Daha, J. van den Born, S. Bakker, S. Berger, On behalf of the COMBAT Comsortium.
VLA-4 Blockade Inhibits Early Endogenous Memory CD8 T Cell Infiltration into Higher Risk Cardiac Allografts and Donor-Reactive T Cell Priming

S. Miyairi,¹ S. Iida,² H. Tsuda,¹ W. Baldwin III,¹ K. Tanabe,² R. Fairchild.¹
α-1 Antitrypsin Facilitate Apoptosis Donor Cells Inducing Donor Specific Protection to Mice Cardiac Allografts

G. Chen, X. Lai, L. Qiu, Y. Zhao, S. Yu, C. Wang, J. Zhang, F. Ning, L. Chen.
5-Year Serum Alkaline Phosphatase Levels after Kidney Transplantation is Associated with Long-Term Graft Survival and Mortality in Kidney Recipient

H. Choi,¹ D. Kim,^2,3 K. Huh,^2,3 Y. Kim,^2,3 B. Kim.^1,3
In Vivo and In Vitro PPAR-y Activation Decreases M1-Macrophage Polarization and Improves Liver Ischemia Reperfusion Injury

I. Linares,¹ A. Bartczak,¹ K. Farrokhi,¹ D. Kollmann,¹ M. Kaths,¹ M. Hamar,¹ P. Urbanellis,¹ S. Ganesh,¹ O. Adeyi,² P. Yip,³ M. Selzner,¹ N. Selzner.¹
A Novel Conditioning Approach to Establish Chimerism Using Manipulation of JAK-STAT Pathways

H. Xu, A. Merchak, L. Kahn, A. Chhabra, Y. Wen, Y. Huang, S. Ildstad.
A Novel Preservation Solution for Lung That Improves Cell Viability and Tissue Architecture

J. Friedman,¹ M. Samamrco,¹ L. Marrero,¹ B. Bunnell,¹ D. Spyropoulos.²
A Pre-Transplant Blood-Based Lipid Signature for Prediction of Antibody-Mediated Rejection in Kidney Transplant Patients

G. Gupta, S. Bobba, D. Contaifer, P. Kimball, A. King, D. Kumar, M. Levy, J. Stern, D. Wijesinghe.
A Single Center Transition of Care Model from Pediatric Heart Recipients to Adult Services Ongoing Study Model

S. Adams, M. Wigger.
A Study to Identify Marginal Factors for Donors of Pancreas Transplantation in Japan

T. Ito, T. Kenmochi, K. Kurihara, N. Aida.
A Substantial Fraction of Surveillance Transplant Biopsies Have Clinically Actionable Findings

A. Shammout,¹ A. Naik,² M. Samaniego,² E. Farkash.¹
ABO Tolerance after Treatment of Infant or Adult Mice with MHC-Matched A-Expressing Blood Cells

B. Motyka,¹ J. Fersovich,¹ B. Lamarche,¹ M. Sosniuk,¹ I. Adam,¹ J. Pearcey,¹ K. Tao,¹ C. Cairo,² P. Cowan,³ L. West.¹
ABO-Incompatibility Lower Incidence of DSA-Induced Antibody-Mediated Rejection

D. Lee,¹ B. Kim,¹ J. KIm,¹ I. KIm,¹ M. Jeon.¹
ADL and IADL Limitations Resolve but New Cognitive Impairments Develop in Liver Transplant Recipients

J. Corriveau, R. Chandrasekhar, S. Geevarghese.
AT1R Antibody Analysis: High Proportion of Non-Specific Reactivity?

A. Halpin,^1,3,4,5 S. Abou-Zeki,³ I. Larsen,^1,4 P. Campbell,^2,3,4,5 S. Urschel,^1,4,5 L. West.^1,3,4,5
Absolute Quantification of Plasma Graft-Derived Cell-Free DNA for Diagnosis of Kidney Transplant Rejection

J. Whitlam,¹ L. Ling,² F. Ierino,³ D. Bruno,² H. Slater,² D. Power.¹
Achieving Allograft Tolerance through Antigen-Specific Regulatory B Cells

C. Rickert,^1,2 S. Kimura,^1,2 L. Kojima,¹ K. Lee,¹ M. Aburawi,¹ F. Fontan,¹ K. Deng,¹ H. Yeh,^1,2 J. Markmann.^1,2
Acute Murine CMV Infection Results in Loss of Intragraft CD73^HIFR4^HIPD1⁺ CD4 T Cells and Graft Rejection in Previously Tolerant Recipients

A. Dangi,¹ L. Zhang,¹ X. Zhang,² X. Luo.^1,2
Acute Tubular and Glomerular Kidney Injury Markers Reflect Ischemia-Reperfusion and Rejection

Y. Shim, R. Fan, N. Dvorina, W. Baldwin.
Addressing the “Crisis” in Pancreas Transplant Volume Using a Multidisciplinary Approach

J. Scalea, S. Bartlett, R. Barth.
After Action Review of Emergency Preparedness for “Hurricane Harvey” for LifeGift Houston

R. Wood, K. Myer.
An Increase in Spot Urine Protein Excretion during the First Year after Kidney Transplantation Associates with Subclinical De-Novo Donor-Specific Antibodies and Microvascular Inflammation at 1-Year Surveillance Biopsies

M. Arnol,¹ G. Mlin[scaron]ek,¹ M. Oblak,¹ A. Kandus,¹ N. Kojc,² J. Buturović-Ponikvar.¹
An Integrative Approach for the Assessment of Peritubular Capillaritis Extent and Score in Microvascular Inflammation – Association with Transplant Glomerulopathy and Graft Loss

N. Kozakowski,¹ H. Herkner,² F. Eskandary,³ M. Eder,³ W. Winnicki,³ G. Bond,³ Ž. Kikić.³
Anti-IdeS Antibodies in IVIg and Its Effect on IdeS Activity

A. Runström,¹ S. Järnum,¹ S. Jordan,² L. Winstedt,¹ C. Kjellman.¹
Anti-Thymocyte Globulin Directly Binds and Functionally Inhibits Allo-Regulatory Myeloid Derived Suppressor Cells

Y. Lee, E. Davila, J. Bromberg, J. Scalea.
Antibody Mediated Kidney Transplant Rejection Treated with Bortezomib – Case Series from a Single Center

G. Piecha,¹ R. Król,² H. Karkoszka,¹ A. Wiecek.¹
Assessment of Hepatic Ischemia-Reperfusion Injuries by NRF2-Dependent Transcriptional Activities of Bile Transporters in Rats

J. Kim,¹ A. Martin,¹ J. Yee,¹ L. Fojut,¹ A. Geurts,² K. Oshima,³ M. Zimmerman,¹ J. Hong.¹
Assessment of Immune Cell Profiles in HLA-Sensitized (HS) & Non-HS Patients (Pts) with End Stage Renal Disease (ESRD)

S. Ge,¹ M. Chu,¹ E. Ortiz,¹ A. Vo,² D. Lovato,¹ S. Jordan,² M. Toyoda.¹
Association between Everolimus Trough Levels, Onset of Related Adverse Events, and Treatment Discontinuation after Liver Transplantation: 24-Month Results from the H2304 Study

J. Fung,¹ F. Saliba,¹ H. Schlitt,¹ G. Junge,² K. McCague,³ D. Patel,³ M. Charlton.¹
Association of Body Mass Index of Kidney Transplant Recipients with Graft Function Post-Transplant

A. Yaldo, I. Bajjoka, C. Crombez, M. Abouljoud.
Association of Leptin with Cystatin C in Kidney Allograft Dysfunction

A. Bera,¹ M. Watson,² N. Gana,¹ J. Karaian,¹ S. Radhakrishnan,¹ M. Subramanian,¹ D. Little,² R. Nee,² A. Chatterjee,¹ S. Rothwell,¹ H. Pollard,¹ R. Jindal,³ M. Srivastava.¹
Association of Tacrolimus Adherence and Discontinuation with Sepsis Risk among Kidney Transplant Recipients

J. Donnelly,¹ P. MacLennan,¹ R. Mannon,¹ R. Saran,² J. Baddley,¹ H. Wang,³ G. McGwin, Jr.,¹ P. Muntner.¹
Association of CYP3A5*3*6*7 Metabolic Composites to Tacrolimus Pharmacokinetics in African American and Caucasian Renal Transplant Recipients

K. Tornatore,^1,5 D. Brazeau,² C. Meaney,¹ K. Attwood,^3,4 G. Wilding,⁴ S. Chang,⁵ R. Venuto.⁵
Associations of Poor Physical and Cognitive Performance and Kidney Transplant Waiting List Denial

M. Harhay,¹ K. Ranganna,¹ F. Michie,¹ C. Selinski,¹ T. Bajakian,¹ L. Levin Mizrahi,¹ J. Lee,¹ G. Malat,¹ G. Xiao,¹ D. Reich,¹ S. Guy,¹ P. Reese.²
B-Cell Depletion with Rituximab Exacerbates Anti-Donor CD4⁺ T-Cell Responses in Patients with Donor-Specific Anti-Human Leukocyte Antigen Antibodies

A. Tanaka, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, S. Shimizu, H. Ohdan.
BETA-2 Score is an Excellent Tool for Monitoring of Islet Allograft Function and Early Detection of Transplant Dysfunction

P. Bachul,¹ J. Gołębiewska,² L. Basto,¹ M. Kijek,¹ N. Fillman,¹ K. Cieply,¹ K. Golab,¹ L-.J. Wang,¹ M. Tibudan,¹ C. Thomas,¹ A. Dębska-Ślizień,² J. Fung,¹ P. Witkowski.¹
BK Viremia in Simultaneous Kidney Pancreas Recipients: Single Center Experience

M. Alebrahim,¹ R. Pelletier,¹ A. Rajab,¹ G. Bumgardner,¹ R. Daloul,² C. Akateh,³ K. Washburn,¹ A. El-Hinnawi.¹
Bariatric Surgery before and after Kidney Transplantation: Long-Term Weight-Loss and Allograft Outcomes

J. Cohen, M. Lim, C. Tewksbury, S. Torres Landa, J. Trofe-Clark, P. Abt, N. Williams, K. Dumon, S. Goral.
Bioinformatics Approach to the Development of a Novel Molecular Biomarker for Sub-Clinical Acute Rejection (subAR) in the Peripheral Blood Following Kidney Transplant (KT)

T. Whisenant,¹ S. Kurian,¹ M. Kandpal,² L. Zhao,² D. Ikle,³ B. Armstrong,³ J. Friedewald,² R. Heilman,⁴ E. Poggio,⁵ C. Marsh,¹ P. Baliga,⁶ N. Bridges,⁷ J. Odim,⁷ M. Brown,⁷ J. Charette,² S. Brietigam,² N. Sustento-Reodica,² D. Salomon,¹ M. Abecassis.²
Biomaterial-Based Localized and Controlled Delivery of Tofacitinib to Actuate Enhanced Costimulation Blockade and Promote Long-Term Transplant Survival

G. Raimondi,¹ P. Majumder,² V. Ivanova,¹ X. Calderon-Colon,³ A. Mirdad,¹ M. Iglesias Lozano,¹ W. Lee,¹ G. Brandacher,¹ J. Schneider,² J. Patrone.³
Biopsy Correlates of DSA in Antibody-Mediated Rejection: C4d vs Microvascular Inflammation Scores

C. Harris, L. Anderson, R. Khaim, J. Choudhuri, R. Shapiro, S. Florman, F. Salem, M. Menon.
Brain Death Conditions Intensify Inflammation and Impair Metabolic Gene Expression

L. Zitur, P. Chlebeck, S. Odorico, T. Zens, J. Danobeitia, M. Eerhart, J. Reyes, A. D'Alessandro, K. Brunner, S. Capuano, L. Fernandez.
Brincidofovir for Disseminated Adenovirus in Kidney and Kidney-Pancreas Transplant Recipients: Report of a Case Series

L. Bowman, R. Baliga, C. Mayer.
Burden of Primary CMV Infections Remains High Despite Six Months Valganciclovir Prophylaxis in High-Risk Kidney Transplant Recipients

I. Helanterä,¹ F. Ortiz,² R. Loginov,³ L. Mannonen,³ M. Lempinen,¹ I. Lautenschlager.³
C1q-Binding Donor-Specific Anti-HLA Antibodies for Clinical Decision Making in Kidney Recipients with Antibody-Mediated Rejection Receiving Standard of Care Treatment

C. Lefaucheur,¹ D. Viglietti,¹ Y. Bouatou,¹ O. Aubert,¹ A. Zeevi,² A. Loupy.¹
C3a Receptor Regulates the CD8 T-Cell Alloresponse via Intrinsic and Extrinsic Mechanisms

J. Horwitz, D. Mathern, P. Heeger.
CCAAT-Enhancer-Binding Protein Homologous Protein Promotes Liver Ischemia and Reperfusion Injury by Inhibiting Beclin-1-Mediated Autophagy in Hepatocytes

H. Zhou,¹ Z. Rao,¹ Y. Xia,¹ R. Liu,¹ S. Zhou,¹ X. Wang,¹ Y. Zhai,¹ L. Lu.¹
CD19+ Cell Ratio as a Predictive Marker of Antibody Mediated Rejection in ABO Incompatible Kidney Transplantation

K. Unagami,¹ R. Maenosono,² M. Furusawa,² Y. Kakuta,² M. Okumi,² H. Ishida,² K. Tanabe,² K. Nitta.¹
CD4⁺CD25^bright Regulatory T Cells Prevent Acute Xenogeneic GVHD

Y. Huang, A. Merchak, H. Xu, A. Chhabra, A. Khalil, Y. Wen, M. Binion, M. Badder, L. Kahn, S. Ildstad.
CXCR4 Inhibition Improves Donor Leukocyte Depletion during Ex Vivo Lung Perfusion

R. Davis, Q. Gao, J. Yerxa, M. Daneshmand, J. Haney, J. Klapper, M. Hartwig, A. Barbas.
Calibration of Updated LSAM

J. Pyke,¹ T. Weaver,¹ D. Schladt,¹ N. Salkowski,¹ A. Wey,¹ J. Lake,² W. Kim,³ S. Gentry,⁴ A. Israni.¹
Can Delayed Abdominal Fascia Closure Modify the Short Term Outcome after Adult Liver Transplantation?

I. Vella,¹ M. Pellicciaro,¹ G. Ciancio,² T. Manzia,¹ R. Angelico,³ J. Gaynor,² G. Iaria,¹ G. Tisone,¹ R. Vianna.²
Can We Expect the “Unexpected”?

D. Pinelli, A. Tambur.
Cardiac Grafts from Insulin Resistant Donors Trigger a Heightened Immune Response via Excessive Induction of Autophagy

S. Cai,¹ J. Miao,² A. Chandraker.¹
Cause of ESRD is Not Associated with Risk of Post-Transplant CMV Infection

S. Panzer, S. Peery, B. Astor, A. Djamali, T. Singh.
Challenges in Cultural and Linguistic Discordance in Caring for Somali Kidney Transplant Recipients at a Large-Volume Transplant Center

K. Peterson,¹ O. Serrano,¹ M. Odegard,¹ S. Mongin,² D. Berglund,³ D. Vock,⁴ S. Chinnakotla,¹ T. Dunn,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas.¹
Changes in Carotid Arterial Inflammation in De Novo Renal Transplant Recipients as Assessed by ¹⁸F-FDG PET/CT

H. Yoon, Y. Kim, C. Yang, S. Shin.
Changes in Geographic Disparity Following Share 35

M. Bowring,¹ E. Chow,¹ A. Massie,¹ D. Segev,¹ S. Gentry.^1,2
Changes in Graft Gene Expression Contribute to Coagulopathy in UDCD Liver Transplantation

A. Hessheimer, M. Vendrell, D. Sabater, J. Muñoz, A. Blasi, J. García-Valdecasas, A. Ruíz, M. Navasa, C. Fondevila.
Changes in Phenotype, Immune Suppressive, Function, and Gene Expression of Myeloid Derived Suppressor Cells in Patients Given Combined Kidney and Hematopoietic Cell Transplants in a Tolerance Protocol

K. Jensen,¹ P. Zheng,² J. Xuhuai,² A. Saraswathula,¹ J. Scandling,³ S. Busque,⁴ J. Shizuru,⁵ R. Lowsky,⁵ A. Shori,⁴ H. Maecker,² E. Engleman,¹ E. Meyer,⁵ S. Strober.¹
Changes in Vitamin D Levels after Kidney Transplantation

E. Lum, K. Phonphok, N. Datta, S. Bunnapradist.
Characterization of Exosomal DNA from Human Lung Transplant Recipients

S. Bansal, M. Sharma, R. Walia, R. Bremner, M. Smith, T. Mohanakumar.
Characterization of Renal Allograft Tolerance Induction via Transient Mixed Chimerism in Non-Human Primates

H. Sasaki,¹ C. Thaiss,¹ T. Oura,¹ A. Rosales,² R. Smith,² R. Colvin,² B. Cosimi,¹ T. Kawai.¹
Circulating Follicular Helper T Cells (cTfh) in Renal Transplantation: Utility as Rejection Biomarker

R. Laguna-Goya,¹ A. Utrero-Rico,¹ F. Cano-Romero,¹ E. Gómez-Massa,² D. Arroyo,¹ P. Auñon-Rubio,³ A. Sevillano-Prieto,³ M. Castro-Panete,² A. Andrés,³ E. Paz-Artal.^1,2
Circulating Wnt Pathway Factors Are Non-Invasive Biomarkers of Transplant Vascular Injury

M. Seifert,¹ A. Malone,² L. Boohaker,¹ J. Gaut,² S. Jain,² D. Brennan,^2,3 R. Mannon.¹
Clinical Heterogeneity of Early Anamnestic Donor Specific Antibody Responses in Kidney Transplantation

A. Loethen,¹ A. Lichvar,¹ S. Tremblay,¹ A. Shields,^1,2 A. Dao,¹ M. Cardi,² P. Brailey,¹ A. Girnita,¹ B. Abu Jawdeh,¹ R. Alloway,¹ E. Woodle.¹
Clinical Outcomes of Kidney Transplant Recipients Infected with Hepatitis C Virus and Treated with Direct-Acting Antiviral Therapy

M. Alkadi,¹ E. Abuhelaiqa,¹ M. Derbala,² O. Fituri,¹ J. Mahmoud,³ M. Jarman,³ M. Asim,¹ A. Aziz,¹ A. Nauman,¹ A. Hamdi,¹ Y. Medhat,² S. Al Kaabi,² H. Al-Malki.¹
Clinical Response to Salvage Bortezomib Therapy for Antibody Mediated Rejection and Mixed Acute Rejection in a High Immunologic Risk Renal Transplant Population

A. Lichvar, J. Benken, E. Benedetti.
Clinical Significance and Therapeutic Potential of Orosomucoid 1 for Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

H. Higuchi,^1,2 K. Hotta,¹ D. Iwami,¹ J-.J. Jiang,² D. Kamimura,² Y. Arima,² T. Atsumi,² Y. Takada,^1,2 H. Harada,³ M. Murakami,² N. Shinohara.¹
Clinical Significance of BK Virus-Specific ELISPOT Assay in Kidney Transplant Recipients

J. Chang,^1,2 H. Bae,³ K. Park,³ H. Lee,³ B. Choi,^1,2 C. Park,^1,2 C. Yang,^1,2 Y. Kim,^1,2 E-.J. Oh,^1,4 B. Chung.^1,2
Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation

S. Parajuli, R. Redfield, F. Aziz, N. Garg, M. Mohamed, W. Zhong, T. Ellis, A. Djamali, D. Mandelbrot.
Clinical Validation of a Novel ELISpot-Based In Vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients

B. Banas,¹ D. Steubl,² L. Renders,² D. Chittka,¹ M. Banas,¹ T. Wekerle,³ M. Koch,⁴ O. Witzke,⁵ A. Muehlfeld,⁶ C. Sommerer,⁷ A. Habicht,⁸ C. Hugo,⁹ T. Huenig,¹⁰ M. Lindemann,⁵ T. Schmidt,¹¹ A. Rascle,¹¹ S. Barabas,¹¹ L. Deml,¹¹ R. Wagner,^1,11 B. Kraemer,¹² B. Krueger.¹²
Cold Ischemia Time is an Important Risk Factor for Post-Liver Transplant Prolonged Length of Stay

E. Pan, D. Yoeli, N. Galvan, M. Kueht, R. Cotton, C. O'Mahony, J. Goss, A. Rana.
Comparison of Bortezomib in Addition to Rituximab Based Treatment of Acute Antibody Mediated Rejection in Kidney Transplantation

A. Mattiazzi,^1,2 J. Pagan,^1,2 A. Arunachalam,¹ I. De la Cruz Alcantara,¹ J. Revollo,² A. Centeno,² A. Valdes,^1,2 G. Guerra.^1,2
Comparison of C1Q Binding and Flow Cytometric Crossmatch Results Provides an Accurate Evaluation of Hypersensitive Kidney Transplant Patients

E. Eksioğlu-Demiralp,¹ A. Türkmen,² B. Yelken,² S. Görçin,² O. Elbasi,¹ F. Yalçin,³ B. Koçak,² C. Karatas,⁴ M. Tuncer,⁴ M. Altinel.³
Comparison of Glycemic Control in Type 1 and Type 2 Diabetic Patients after Pancreas Transplantation

O. Andacoglu,¹ A. Murthy,² J. Ahn,³ J. Verbesey,¹ S. Ghasemian,¹ M. Cooper,¹ P. Abrams.¹
Comparison of Microvascular Inflammation in Renal Allograft Tissue between ABO Incompatible and ABO Compatible Kidney Transplantation

E. Ko,^1,2 B. Choi,^1,2 C. Park,^1,2 Y. Kim,^1,2 C. Yang,^1,2 B. Chung.^1,2
Compatible Donor and Recipient Pairs' Perspectives on Participation in Kidney Paired Donation Programs: The Emotional Implications of Indirect Donation and Transplantation

M. Fortin,¹ J. Gill,² F. Ballesteros,¹ J. Gill.²
Comprehensive Efficacy Analysis of Pancreas Transplantation Alone for Type 1 Diabetes Mellitus

Y. Kudva,¹ V. Dadlani,¹ B. Smith,³ K. Bebjakova,¹ P. Dean,² M. Stegall.²
Contemporary Desensitization with Low Dose Rituximab Ensures Kidney Transplant Outcome beyond ABO Blood Type Incompatibility:A Comparison between past Regimens in Single Institute

H. Harada, Y. Wada, A. Mitsuke, T. Hirose, N. Fukuzawa, T. Seki.
Contemporary Practice Patterns & Outcomes after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement: A Multicenter US Experience of 1,146 Patients

J. Boike,¹ J. Ge,⁵ M. German,³ N. Jest,² G. Morelli,² E. Spengler,³ A. Said,³ A. Lee,³ A. Hristov,³ K. Kolli,⁴ J. Lai,⁴ A. Desai,⁵ S. Junna,⁵ B. Pokhrel,⁵ T. Couri,⁶ S. Paul,⁶ N. Christian-Miller,⁷ C. Frenette,⁷ M. Laurito,⁸ E. Verna,⁸ U. Rahim,⁹ A. Goel,⁹ A. Das,¹ S. Pine,¹ D. Gregory,¹ L. VanWagner.¹
Cryptococcal Infections in Kidney Transplant Recipients. A Single Center Experience

M. Radisic,¹ N. Pujato,¹ A. Dotta,² R. Livia Franzini,² M. Bravo,¹ L. Rodriguez Rilo,¹ C. Giampieri,² L. Leon,¹ M. Rial,¹ D. Casadei.¹
Cumulative United States Experience in Domino Liver Transplants

K. Barrera, S. Sharma, A. Gruessner, R. Gruessner.
DCD Utilization in Cholestatic Liver Disease: Distinct Outcomes between PSC and PBC Recipients

J. Pasko, E. Maynard, E. Dewey, K. Roayaie, S. Orloff, D. Scott, W. Naugler, J. Ahn, C. Enestvedt.
DNA Methylation Age and Differential Patterns of DNA Methylation in Older Compared with Younger Kidney Transplant Recipients

J. Schaenman, X. Zhou, R. Guo, M. Rossetti, E. Liang, B. Abdalla, E. Lum, S. Bunnapradist, G. Danovitch, E. Reed, D. Elashoff.
DSA-Level Liver Availability and Liver Utilization

S. Zhou, M. Bowring, A. Massie, S. Gentry, D. Segev.
De Nove Malignancies after Liver Transplantation: Single Center Experience in Korea

Y. Yoon,¹ J. Lee,¹ Y. You,² D. Kim.²
Decline in Pancreas Transplantation Numbers is Accompanied with Lower Publication Rates

S. Benjamens,¹ C. Margreiter,² E. de Koning,³ H. Leuvenink,¹ R. Pol.¹
Decreased Clinical Significance of Isoagglutinin Titer with the Current Desensitization Protocol in ABO-Incompatible Kidney Transplantation

C. Baek, H. Kim, W. Yang, D. Han, S-.K. Park.
Defining Response to Standard of Care Treatment in Kidney Recipients with Antibody-Mediated Rejection: Role of C1q-Binding Donor-Specific Anti-HLA Antibodies

Y. Bouatou, D. Viglietti, O. Aubert, A. Loupy, C. Lefaucheur.
Delayed Graft Function in Live Donor HLA-Incompatible Kidney Transplant Recipients: A Multicenter Study

J. Motter,¹ A. Massie,¹ J. Garonzik Wang,¹ K. Jackson,¹ X. Luo,¹ A. Muzaale,¹ B. Orandi,² D. Segev.¹
Desensitization to Facilitate Matching in a Large, National Kidney Paired Exchange Clearinghouse

C. Holscher,¹ A. Thomas,¹ K. Jackson,¹ C. Haugen,¹ M. Ronin,² A. Waterman,^3,4 A. Massie,^1,5 J. Garonzik Wang,¹ D. Segev.^1,5
Determinants of Delays and Reduced Rates of Waitlisting and Kidney Transplant among American Indians

M. Keddis, M. Ilyas, N. Zhang, H. Khamash, S. Leischow, A. Sharma, R. Heilman.
Development and Validation of Nomogram to Predict Primary Non Function in Liver Transplant Recipients Using Donation after Cardiac Death Donor Graft

Z. Guo, J. Zeng, Q. Zhao, B. Chen, Z. Zhang, L. Wang, X. He.
Development of a Predictive Model for Deceased Donor Organ Yield

W. Marrero Colon,¹ M. Lavieri,¹ S. Guikema,¹ D. Hutton,² N. Parikh.³
Diabetic Nephropathy after Kidney Transplantation in Patients with Pre-Transplantation Type II Diabetes May Occur Later and Be Less Common Than Previously Thought

A. Cimeno, J. Munley, S. Sultan, M. Weir, S. Bartlett, C. Drachenberg, A. Hararian, J. Bromberg, J. Scalea.
Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation by Blood Expression of Genes Involved in IFN Signaling

M. Matz,¹ Q. Zhang,¹ F. Heinrich,² C. Lorkowski,¹ K. Wu,³ P. Durek,² N. Lachmann,⁴ M-.F. Mashreghi,² K. Budde.¹
Diagnostic Usefulness of Medullary C4d Staining in Renal Allografts

J. Von Visger,¹ C. Von Visger, A. Satoskar,² T. Nadasdy,² J. Hemminger,² S. Brodsky.²
Differences in Liver Waitlist Mortality Due to Geographic Disparity in Organ Availability

A. Massie,¹ S. DiBrito,¹ J. Motter,¹ M. Henderson,¹ S. Zhou,¹ K. Jackson,¹ D. Segev,¹ S. Gentry.²
Different Expression Patterns of Exosomal miRNAs under Cyclosporin A and Rapamycin Treatment in Distinct Aggressiveness Colorectal Carcinomas

V. Tubita,¹ M. Ramírez-Bajo,¹ J. Lozano,² D. Moya-Rull,¹ J. Rovira,³ J. Campistol,^4,5,6 F. Diekmann,^1,4,5,6 I. Revuelta.^1,4,5,6
Diffuse Optical Non-Invasive Organ Risk (DONOR) Indexing Using Diffuse Reflectance Spectroscopy for Pre-Transplant Evaluation

H. Borron,¹ D. Piao,² A. Hawxby,³ H. Wright,³ E. Rubin.⁴
Direct Oral Anticoagulation Use in Kidney Transplant Recipients

S. Shaikh,¹ M. Samaniego,² J. Park.²
Do High-Risk Categories Convey the Wrong Message to Waitlisted Patients – Is It Time to Reconsider the Absolute Risk of Graft Loss?

A. Zarinsefat, H. Braun, S. Syed, B. Orandi, G. Roll.
Do Protocol Biopsies in the Highly Sensitized Improve Renal Allograft Survival? A Single Center Evaluation of 2 Year Graft Function

S. Kuppachi, R. Kalil, M. Fraer, M. Sanders, M. Swee, Z. Stewart, C. Thomas.
Do We Need to Worry about EBV DNAemia in the Late Post-Transplant Period?

M. Morton,¹ K. Daga,² P. Klapper,² M. Picton,¹ P. Vallely.²
Does Biliary Duct Reconstruction Technique Impact Liver Transplantation Outcomes?

R. Shahbazov,¹ M. Kessel,² K. Knapp,² F. Azari,² S. Tsutsui,³ A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹
Donor TM6SF2 rs58542926 Genotype is a Risk Factor for Liver Graft Steatosis

I. Mikova,¹ M. Neroldova,² J. Hubacek,² D. Dlouha,² L. Kolesar,³ M. Jirsa,² E. Honsova,⁴ E. Sticova,⁴ V. Lanska,⁵ J. Spicak,¹ P. Trunecka.¹
Donor Hepatectomy Time in Donation after Circulatory Death Donors is an Independent Risk Factor for the Development of Biliary Strictures and Early Graft Loss after Transplantation

O. van Leeuwen,¹ M. van Reeven,² M. Fujiyoshi,¹ V. de Meijer,¹ R. de Kleine,¹ M. de Boer,¹ J. de Jonge,² J. Ijzermans,² W. Polak,² R. Porte.¹
Donor T Cells Undermine the Graft-Protective Effect of DST Plus Anti-CD154

M. Iglesias, M. Chicco, W. Lee, G. Brandacher, G. Raimondi.
Donor and Procedural Variability in DCD Liver Transplant: Is It Time to Come to a Consensus?

L. Ruffolo, M. Balceniuk, R. Hernandez Alejandro.
Donor-Derived Cell-Free DNA Outperforms Serum Creatinine Changes for Identifying Kidney Transplant Rejection

M. Weir,¹ D. Hiller,² J. Yee,² A. Matas.³
Double Deficiency of Gelatinase-A and Gelatinase-B Does Not Protect against Hepatic Ischemia Reperfusion Injury

S. Duarte, P. Matian, S. Ma, R. Busuttil, A. Coito.
Dunbar Syndrome in Liver Transplantation: Results of a Single Center Matched-Pair Analysis and a European Survey Study

D. Morales-Santana,¹ Z. Czigany,¹ J. Böcker,¹ A. Andert,¹ W. Schöning,¹ T. Ulmer,¹ J. Bednarsch,¹ I. Amygdalos,¹ F. Meister,¹ P. Isfort,³ M. Liebl,³ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
Dynamics of CD25-Positive Myeloid Suppressor Cells in Solid Organ Transplanted Patients and Relationship with Rejection

A. Utrero-Rico,¹ R. Laguna-Goya,¹ F. Cano-Romero,¹ E. Gómez-Massa,² M. Fernandez-Ruiz,³ J. Aguado,³ E. Mancebo-Sierra,² M. Castro-Panete,² E. Paz-Artal.^1,2
Early Biliary Complications after Orthotopic Liver Transplantation – Non-Randomised Comparison of 3 Methods of Biliary Tract Drainage

A. Jóźwik,¹ M. Kosieradzki,¹ B. Łągiewska,¹ W. Lisik,¹ E. Karpeta,¹ J. Bednarek,² M. Zaborska,² J. Trzebicki,³ M. Pacholczyk.¹
Early Experience Using Donor-Derived Cell-Free DNA for Detection of Rejection in Kidney Transplantation

E. Huang, A. Vo, J. Choi, A. Peng, S. Sethi, R. Najjar, S. Jordan.
Early Infectious Complications Post Total Pancreatectomy with Islet Autotransplantation

J. Gołębiewska,¹ P. Bachul,² L. Basto,² M. Kijek,² N. Fillman,² K. Cieply,² K. Golab,² L. Wang,² M. Tibudan,² C. Thomas,³ A. Dębska-Ślizień,¹ J. Fung,² P. Witkowski.²
Early Infectious Outcomes of Older Adults Undergoing Kidney Transplantation (KT). A Case Control Study

M. Hemmersbach-Miller,^1,2 K. Schmader.³
Early Predictors of Metabolic Outcomes in TPIAT

M. Kanak,¹ Y. Shindo,¹ M. Levy.^1,2
Eculizumab for the Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients: A Single Center Experience

A. Chi, J. Phillips, D. Quan.
Effect of Donor-Recipient Gender-Mismatch on Long Term Function after Pancreas Transplantation

F. Messner,¹ C. Bösmüller,¹ M. Maglione,¹ M. Riedmann,² R. Oberhuber,¹ B. Cardini,¹ T. Resch,¹ S. Schneeberger,¹ C. Margreiter.¹
Effect of Erythropoietin on Cardiac Allograft Survival in Non-Human Primates

J. O.,¹ K. Robinson,¹ W. Sommer,¹ K. Pruner,¹ J. Paster,¹ M. Hanekamp,¹ A. Dehnadi,¹ I. Rosales,¹ R. Smith,¹ P. Cravedi,² P. Heeger,² G. Benichou,¹ J. Madsen.¹
Effect of Ethnicity on Recipient Characteristics, Kidney Transplant Provision and Outcomes in a High-Volume National Health Service Hospital

E. Favi,¹ C. Puliatti,² M. Ferraresso,¹ R. Cacciola.²
Effect of Everolimus on Body Composition; 1-Year after Kidney Transplantation

M. Yoshikawa,¹ T. Ishimura,² S. Nishi.¹
Effect of Influenza Vaccine in Patients with Kidney Transplant

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²
Effects of Sarcopenia on Patients Undergoing Liver Re-Transplantation

J. Stracke, M. Ilias, S. Nagai.
Efficacy and Safety of Tocilizumab in Treatment of Acute Antibody Mediated Rejection

K. Venkatachalam, D. Reem, M. Andrew, R. Delos Santos, T. Alhamad.
Efficacy of IVIG + Rituximab Desensitization Therapy on HLA Antibodies is Independent of HLA Loci

X. Zhang,¹ S. Jordan.²
Elevated Levels of CD19⁺ B Cells before or after Rituximab Administration is a Risk Factor for the Early Rejection of a Living Kidney Transplant

M. Kono,¹ H. Shirakawa,² S. Wakai.¹
Eluates from Fine-Needle Allograft Biopsy Increase Donor-Specific Antibody Identification in Antibody Mediated Rejection

A. Girnita,^1,2 E. Portwood,² P. Brailey,² M. Cuffy,¹ M. Cardi,¹ F. Paterno,¹ T. Diwan,¹ S. Shah,¹ A. Govil,¹ R. Alloway,¹ E. Woodle.¹
Elucidating Novel Signatures of Allograft Rejection through Cytometry by Time of Flight (CyTOF) in Kidney Transplant Recipients

S. Eskandari,¹ B. Al Dulaijan,¹ J. Assaker,¹ L. Riella,¹ A. Kurdi,² J. Azzi.¹
Endothelial Progenitor Cell-Derived Extracellular Vesicles Inhibit Kidney Ischemia-Reperfusion Injury through the Transfer of Specific microRNA and mRNA Coding for the Complement Inhibitors CD55, CD59, Factor H and for the Transcription Factor NRF2: Relevance for Delayed Kidney Graft Function

V. Cantaluppi,¹ D. Medica,¹ S. Dellepiane,¹ G. Merlotti,¹ A. Airoldi,¹ M. Quaglia,¹ G. Castellano,² L. Gesualdo,² G. Camussi.³
Enteric Conversion of Bladder Drained Pancreas as a Time Dependent Predictor of Outcomes in over 900 Recipients

S. Riad,¹ D. Keys,¹ V. Vakil,¹ S. Jackson,² D. Berglund,² A. Matas,³ R. Kandaswamy.³
Estimation of Beta Cell Function after Total Pancreatectomy with Islet Autotransplantation Using Single Fasting Blood Sample Based Indices and Modified Igls Score.

J. Gołębiewska,¹ P. Bachul,² L. Basto,² M. Kijek,² N. Fillman,² K. Cieply,² K. Golab,² L. Wang,² M. Tibudan,² C. Thomas,³ A. Dębska-Ślizień,¹ J. Fung,² P. Witkowski.²
Evaluating Transplant Quality Staffing Models via a National Survey

M. Cook, I. Feurer, L. Smith, S. Rega, E. Zavala.
Evaluation of Allergy to Tacrolimus in Kidney Transplant Candidates and Recipients with a History of Macrolide Antibiotic Allergy

J. Trofe-Clark,^1,2 M. Doshi,³ O. Fadugba,⁴ M. Lim.²
Evaluation of Efficiency and Patient Perception of Solid Organ Transplant Medication Education after Pharmacist-Created Video Education

Y. Mitchell, J. Volpendesta, J. Vongspanich-Dray.
Evaluation of FlowDSA Crossmatch for Detection of Donor-Specific HLA Antibodies

J. Lee, J. Ryu, A. Choi, E-.J. Oh.
Evaluation of KPD: Does It Improve Overall Transplant Center Performance?

M. Rees,³ E. Michelin,¹ N. Koizumi,² J. Ortiz.³
Evaluation of MPA Dose on Development of DSA Following Pancreas Transplant

J. Descourouez,¹ M. Jorgenson,¹ A. Twigg,¹ G. Leverson,² J. Odorico,³ R. Redfield.³
Evaluation of Salt Intake by 24-h Urinary Sodium Excretion in Kidney Transplant Patients

T. Abe,¹ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ R. Imamura,¹ N. Ichimaru,² S. Takahara,² N. Nonomura.¹
Evaluation the Outcomes of Liver Transplant Recipients Underwent Splenectomy: A Meta-Analysis

M. Chen, X. Lin, B. Huang, X. He.
Evolutive Analysis of a 20-Year Pancreas Transplant Program

M. Perosa,¹ J. Branez,¹ L. Mota,¹ H. Noujaim,¹ B. Zeballos,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ F. Sergi,¹ M. Paredes,¹ T. Genzini-Miranda,² A. Silvestre,³ G. Martinho,⁴ T. Genzini.¹
Ex Vivo Lung Perfusion Using the Portable OCS Maintains Endothelial Integrity in the Context of Reduced Severe PGD Rates

B. Wiegmann,¹ R. BellmasSanz,² C. Neudörfl,² C. Kühn,¹ I. Tudorache,¹ M. Avsar,¹ A. Haverich,¹ G. Warnecke,¹ C. Falk.²
Ex-Vivo Generation of Alloantigen-Specific Immunomodulatory Cells: Elucidating the Mechanistical Synergy of Cell Components

M. Yao,¹ M. Kumagai-Braesch,¹ M. Watanabe,^1,2 K. Tokodai,¹ T. Lundgren,¹ M. Uhlin,¹ B. Ericzon.¹
Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage

D. Harriman, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Extended Criteria Donors Have Higher Expression of Inflammatory Genes Than Standard Donors

M. Abbud-Filho,^1,2,3 M. Fernandes-Charpiot,^1,2 M. Baptista,^1,2 H. Caldas,^1,2 G. Florim.¹
Factors Influencing Post-Transplant Mortality in Primary Biliary Cholangitis

V. Mendiratta, K. Alsafadi, D. Venkat.
False-Positive Flow-Cytometric T Cell Crossmatch Associated with Blood Type Antigen Expressed on Lymphocytes in ABO Incompatible Kidney Transplantation

D. Iwami,¹ M. Ito,² K. Hotta,¹ H. Higuchi,¹ N. Shinohara.¹
Financial Impact of Testing Standardization for Solid Organ Transplant Recipients

S. Ugolini,² L. Dranow,¹ P. Sadler,² M. Berry,² J. Stehlik,¹ S. Drakos,¹ J. Nativi,¹ E. Gilbert,¹ S. McKeller,¹ A. Koliopoulou,¹ M. Yin,¹ E. Davis,² C. Selzman,¹ O. Wever-Pinzon.¹
Fosfomycin vs Other Antibiotics for UTI after Kidney Transplant

O. Mgbako,¹ J-.E. Ha,¹ N. Topilow,² E. Min,¹ D. Taupin,¹ V. Tatapudi,¹ B. Gelb,¹ S. Hochman.¹
Four Eyes Are Better Than Two: Improving Laboratory Report Quality Control

S. Dionne,² K. Klama,² H. Rashid,² A. Niedzinski.²
Four Years Follow-Up in Kidney Transplant Patients with Vascular Calcifications

L. León,¹ A. Uriona,¹ J. Hidalgo,¹ L. Condori,¹ O. Guardia,¹ E. Chuluyan,² D. Casadei.¹
Functional Assessment of Kidney Transplant Candidates with the 6 Minute Walk Test and Hand Grip Strength

S. Anand,¹ S. Gilligan,² D. Morris,¹ T. Srinivas.
Gains from Joining Kidney Paired Donation with Several Incompatible Donors

M. Bray, W. Wang, P. Song, J. Kalbfleisch.
Galangin Promotes Treg Development and Function

F. Liang,¹ H. Fang,¹ R. Zhang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
Gender Disparities in Need for Dialysis, Access to the Renal Transplant Waitlist and Renal Transplant Survival

B. Schmidt,¹ J. Epping,² C. Falk,⁴ S. Geyer,² A. Melk.³
Gene Silencing with p53 si-RNA Downregulates Inflammatory Markers in the Liver: Potential Utilization during Normothermic Machine Preservation

C. Moore,¹ M. Thijssen,^1,2 X. Wang,³ P. Mandrekar,³ E. Xiaofei,³ R. Abdi,⁴ R. Porte,² A. Bozorgzadeh,¹ H. Leuvenink,² T. Kowalik,³ P. Martins.¹
Genome-Wide Association Study Assessing Risk of Rejection in Pediatric Transplant Recipients

T. Papaz,¹ S. Min,¹ O. Lee,¹ T. Blydt-Hansen,³ U. Allen,¹ Y. Avitzur,¹ P. Birk,² B. Foster,⁴ H. Grasemann,¹ L. Hamiwka,⁵ R. Parekh,¹ V. Phan,⁶ S. Urschel,⁷ S. Mital.¹
Genome-Wide Association Study of Tacrolimus Dose in Pediatric Solid Organ Transplant Recipients in the CNTRP POSITIVE Study

S. Min,¹ T. Papaz,¹ T. Blydt-Hansen,³ O. Lee,¹ U. Allen,¹ P. Birk,² H. Grasemann,¹ L. Hamiwka,⁴ C. Litalien,⁵ V. Ng,¹ R. Parekh,¹ K. Tinckam,⁶ S. Urschel,⁷ B. Foster,⁸ S. Mital.¹
Global Expression Profiles of miRNA and Expression Patterns and Localization of the miR-21 in One-Hour Biopsy Specimens of Human Kidney Tansplantation from Donors after Cardiac Death

M. Kusaka,¹ N. Fukami,¹ H. Sasaki,¹ A. Kawai,¹ T. Kenmochi,² T. Ito,² R. Shiroki,¹ K. Hoshinaga.¹
Glucocorticoid Receptor Polymorphism Affects Susceptibility of Dyslipidemia in Recipients One Year after Kidney Transplantation

K. Numakura,¹ H. Kagaya,² N. Komine,¹ R. Yamamoto,¹ N. Fujiyama,³ H. Tsuruta,¹ A. Maeno,¹ M. Saito,¹ S. Narita,⁴ T. Inoue,¹ T. Niioka,² M. Miura,² T. Habuchi,¹ S. Satoh.³
Gr1^– Macrophages Play Critical Roles in Liver Inflammation Resolution after IRI via Efferocytosis

M. Ni,^1,2 H. Wang,^1,2 R. Busuttil,¹ J. Kupiec-Weglinski,¹ X. Wang,² Y. Zhai.¹
Graft and Patient Outcomes after Kidney Transplant for American Indians

R. Seipp, N. Zhang, H. Khamash, S. Leischow, A. Sharma, R. Heilman, M. Keddis.
HLA Desensitization Using Rituximab/ Immunoadsorption before Kidney Transplantation

P. Malvezzi, T. Jouve, D. Masson, J. Maurizi, B. Bardy, P-.L. Carron, B. Janbon, N. Terrier, L. Rostaing.
Haematological Autoimmune Disorders Associated with Alemtuzumab Induction in Renal and Simultaneous Pancreas and Kidney Recipients

A. Kousios,¹ R. Charif,¹ M. Atta,² A. Luqmani,² N. Cooper,² D. Taube.¹
Heart En Bloc Thymus Cotransplantation in NHPs Controls Cellular but Not Humoral Alloreactivity

W. Sommer, J. O., K. Pruner, J. Paster, M. Hanekamp, A. Dehnadi, I. Rosales, R. Smith, R. Colvin, G. Benichou, J. Allan, J. Madsen.
Hepatic Artery Resistive Indices on Doppler Ultrasound at Long Term Follow Up in Liver Transplant Recipients: Importance and Implications

P. Serrano Rodriguez, L. Cramer, K. Jones, E. Lemmon, T. Masakadza, A. Milukas, R. Watkins, D. Gerber, C. Desai.
High Fibre Diet Induces Donor Specific Kidney Allograft Tolerance in Mice

H. Wu,^1,2 T. Kwan,² Y. Loh,² C. Wang,² L. Macia,² S. Alexander,^2,3 S. Chadban.^1,2
High Prevalence of New Onset Diabetes Mellitus in a Predominantly Minority Urban Cohort of Kidney Transplant Recipients and Clinical Outcomes

S. Aleksic, S. Zahedpour, E. Tsomos, M. Ajaimy, J. Zonszein, E. Akalin.
High Serum Resistin Levels Predict Future Acute Kidney Injury in Kidney Transplantation Patients

M-.C. Lee,^1,3 B-.G. Hsu.^2,3
Hispanics' Perceptions of a Culturally Targeted Transplant Program: A Mixed Methods Study

N. Alhalel,¹ N. Francone,¹ J. Caicedo,¹ R. Ruiz,² A. Salazar,² S. Primeaux,² E. Gordon.¹
Histone Deacetylase-6 Inhibition Mitigates Liver Ischemia-Reperfusion Injury and Acetaminophen Toxicity in Mice

S. Concors,¹ D. Murken,¹ D. Aufhauser,¹ Z. Wang,¹ G. Ge,¹ T. Bhatti,⁴ W. Hancock,^3,4 M. Levine.^1,2
Hospitality Houses and Transplant Patients: Assessing the Impact of a Hospitality House Dedicated to Transplant Patients and Their Families

T. Giordano,¹ J. Campbell,² J. Weinstock,³ H. Nathan.³
Hospitalization, Dialysis Center Type, and Disparities in ESRD Survival and Waitlist Access

R. Lynch, R. Zhang, A. Adams, R. Patzer.
How Should Pancreas Transplant Rejection Be Treated?

F. Aziz, S. Parajuli, S. Salahuddin, K. Harrold, A. Djamali, B. Astor, J. Odorico, D. Mandelbrot.
Hsp70 Inhibitor Could Induce Transplant Tolerance through mTORC2/Akt Pathway

G. Gu, T. Lu, N. Xu, Q. Xia.
Human CD8⁺CD28^– T Cells Driven In Vitro by IL-15 Suppress in Allo-Specific Manner Partially through PD-1:PD-L1 Pathway

F. Feng,^1,2 G. Liu,¹ P. Zhu,¹ M. Zhu,¹ X. Lu,¹ J. Liu,² X. Luo,³ Y. Liu,¹ Y. Yu.²
Human CD8⁺CD28^– Ts Cells Expanded by Common Gamma Chain (γc) Cytokines Keep Steady Allospecific Suppressive Capacity In Vivo

G. Liu,¹ F. Feng,¹ P. Zhu,¹ J. Liu,² Y. Liu,¹ Y. Yu.²
Hyaluronic Acid as Early Biomarker of Graft Loss after Liver Transplantation: A Prospective Study

A. Rostved,¹ S. Ostrowski,² L. Peters,³ J. Lundgren,³ C. Sørensen,¹ H-.C. Pommergaard,¹ J. Hillingsø,¹ A. Rasmussen.¹
Hyperglycemia Aggravates Hepatic Ischemia and Reperfusion Injury by Inhibiting Liver Resident Macrophage M2 Polarization via C/EBP-Homologous Protein-Mediated Endoplasmic Reticulum Stress

Z. Rao, J. Sun, X. Pan, Z. Chen, H. Sun, P. Zhang, M. Gao, Z. Ding, C. Liu.
Hyperglycemia-Triggered ATF6-CHOP Pathway Exacerbates Liver Ischemia/Reperfusion Injury: Immunomodulation by Regulating β-Catenin Signaling

J. Rao,^1,2 C. Yang,¹ Y. Hu,¹ S. Yang,¹ Y. Xia,¹ F. Zhang,¹ X. Wang,¹ Y. Zhai,² L. Lu.^1,2
Hyperglycemia-Triggered S1P/SIPR3signaling Exacerbates Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization

J. Rao,^1,2 Y. Hu,¹ C. Yang,¹ S. Yang,¹ F. Cheng,¹ F. Zhang,¹ X. Wang,¹ Y. Zhai,^1,2 L. Lu.^1,2
Hyperkalemia in the Early Post Renal Transplant Period

E. Christie, J. Okel, M. Gowrishankar.
Hypoxia Results in Endoplasmic Reticulum Stress and Activation of the Unfolded Protein Response in Isolated Human Islets and Human Donor Pancreases

B. Sandhu, M. Prendecki, N. Vallant, G. Rutter, C. Pusey, V. Papalois.
IL-10 Requirement in In Vitro Expanded Breg-Mediated Allograft Tolerance is Tissue Specific

C. Dai, K. Lee, L. Kojima, K. Deng, S. Kimura, C. Rickert, H. Yeh, J. Markmann.
IL23R is a Pathogenic Gene in Type 1 Regulatory T Cells during Mouse Cardiac Transplantation Models

G. Gu, T. Lu, N. Xu, Q. Xia.
Ideal Body Weight versus Actual Body Weight for Rabbit Antithymocyte Globulin Induction in Pancreas Transplantation

E. Martinez,¹ D. Felix,² J. Wiegel,² T. Al-Qaoud,¹ G. Leverson,¹ A. Condon,² R. Redfield,¹ J. Odorico.¹
Identification of Exosomal Proteins from Human Lung Transplant Recipients

S. Bansal,¹ P. Pirrotte,² M. Saltzman,² K. Garcia,² M. Sharma,¹ M. Gunasekaran,¹ M. Smith,¹ R. Bremner,¹ T. Mohanakumar.¹
Identifying Patients at Risk of Mortality and Major Adverse Cardiovascular Events Following Simultaneous Pancreas and Kidney Transplantation Using the Pre-Transplant QRISK2 Score

P. Yiannoullou,^1,2 S. Goh,² H. Khambalia,^1,2 Z. Moinuddin,^1,2 A. Summers,^1,2 I. Shapey,^1,2 C. Fullwood,² T. Augustine,^1,2 M. Rutter,^1,2 D. van Dellen.^1,2
IgM HLA DSAs Do Not Alter the Outcomes of Renal Allograft Rejection

A. Gueret-Wardle,¹ P. Dodd,¹ G. Lucisano,¹ S. Hassan,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² D. Goodall,¹ C. Roufosse,¹ M. Willicombe,¹ D. Taube.¹
Immune Phenotyping in a Pediatric Multicenter Transplant Study: Suitability of a Pre-Formulated Dry Antibody Panel System

S. Urschel,¹ L. Ionescu,¹ T. Blydt-Hansen,³ B. Foster,⁵ S. Mital,² U. Allan,² S. Iveson,³ L. Hamiwka,⁴ J. Yap,¹ V. Phan,⁵ P. Birk,⁶ L. West,¹ M. Levings.³
Immunologic Impact of Tocilizumab Treatment in Kidney Transplant Recipients with Allograft Inflammation

J. Leung, S. Chandran, F. Vincenti, Q. Tang.
Immunomodulation of Alloantibody Responses

C. Schuetz, M. Climov, A. Paril, Z. Wang, A. Andrews Roy, N. Navarro Alvarez, A. Matar, D. Sachs, R. Duran-Struuck, C. Huang.
Immuoadsorption-Based Desensitization in Highly Sensitized Patients Awaiting Deceased Donor Kidney Transplantation.

C. Bureau, P. Galichon, Y. Luque, N. Ouali, E. Rondeau, C. Rafat.
Impact of Balanced Solutions on Acid Base Disorders during and after Kidney Transplantation

N. Maillard,² H. Chraka,¹ G. Claisse,² E. Alamartine,² S. Molliex,¹ C. Mariat.²
Impact of Bw4 and Bw6 Epitope Mismatch on Clinical Outcomes after Renal Transplantation

C. Liu,¹ D. Brennan,² K. Lentine,³ R. Delos Santos,¹ J. Li,¹ A. Malone,¹ T. Alhamad.¹
Impact of De Novo DSA (DnDSA) on Outcomes in HLA-Sensitized (HS) Patients Transplanted after IVIG + Rituximab Desensitization (DES)

A. Vo,¹ O. Aubert,² H. Edmund,¹ A. Peng,¹ R. Najjar,¹ S. Supreet,¹ J. Choi,¹ K. Lim,¹ S. Jordan.¹
Impact of Donation after Cardiac Death Allografts on Outcome Following Liver Transplantation for Fulminant Hepatic Failure: An Analysis of the UNOS Database

S. Kumar,¹ S. Lin,² J. Schold.²
Impact of ELAD C3A Cell Conditioned Medium Enhanced Perfusate Fluid on Functional Recovery of Extended Criteria Donor Livers during Normothermic Machine Perfusion

S. Afford,² L. Wallace,² R. Laing,² Y. Botteon,² D. He,³ S. Soundararajan,⁴ D. Mirza,¹ R. Ashley,³ J. Brotherton,³ H. Mergental,¹ D. Reich.⁴
Impact of New Pancreas Transplant Allocation Policy on Pancreas Transplant Volume and Outcomes: A Single Center Study

N. Singh, A. Pulisetty, D. Aultman, R. McMillan, G. Zibari, H. Shokouh-Amiri.
Impact of On-Site Overestimation of Macrosteatosis on Donor Liver Biopsy

M. Wright, J. Seal, L. De Gregorio, H. Bohorquez, D. Bruce, E. Bugeaud, I. Carmody, A. Mathur, D. Sonnier, G. Galliano, I. Oliva, L. Bratton, G. Loss.
Impact of Pneumocystis Prophylaxis on Incidence of Treated Urinary Tract Infections Following Kidney Transplantation

S. Sanchez, M. Brokhof, N. Kenyon, C. Varughese, N. Alvey.
Impact of Postoperative Serum Chloride Changes on Graft Function and Acute Rejection in Recipients of Living Kidney Transplants

V. Vakil, D. Keys, M. Junghare, S. Jackson, D. Berglund, A. Matas, S. Riad.
Impact of Pretransplant Donor-Specific Antibodies on Kidney Allograft Recipients with Negative Flow Cytometry Crossmatches

H. Kwon, Y. Kim, J. Choi, S. Shin, J. Jung, M. Cho, J. Kim, D. Han.
Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes

L. De Gregorio,¹ E. Bugeaud,¹ G. Galliano,² H. Bohorquez,¹ D. Bruce,¹ I. Carmody,¹ A. Cohen,¹ J. Seal,¹ D. Sonnier,¹ A. Mathur,¹ G. Loss.¹
Impact of Vitamin D Status on Immune-Mediated Graft Function Following Kidney Transplantation

C. Pham,¹ B. Pierce,¹ S. Bapat,² S. Kuten,¹ L. Moore,³ A. Gaber.³
Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients

M. Cote,¹ C. Rogers,¹ K. Khwaja,² A. Evenson,² M. Pavlakis,² K. Richards.¹
Implementing Mobile Health Technology for Living Kidney Donor Follow-Up: Transplant Provider Perspectives

A. Eno,¹ J. Ruck,¹ S. Rasmussen,¹ D. Segev,^1,2 M. Henderson.¹
Improved Cardiac Risk Stratification Method in Kidney Transplant Candidates.

L. Punnoose, N. Fonseka, M. Lashner, G. Mythili, S. Rao.
Improving Organ Donation Rates through a Primary Care Physician Office-Based Intervention

R. Kashyap,¹ M. Dokus,¹ N. Ryan,³ A. James,³ R. Kochik,³ R. Hernandez,¹ J. Dolan,² P. Veazie,² M. Orloff,¹ S. McIntosh.²
Improving and Delivering Medical Education about Organ Donation and Transplantation to Medical Students Could Play a Fundamental Role in Organ Donation Expansion: Its Time to Get the Basics Right.

A. Ghazanfar, E. Vyra.
In Vitro α-Galactosylceramide Stimulation Expands CD4⁺CD25⁺Foxp3⁻ Regulatory T Cell Precursors in Murine Thymocytes

H. Katsumata,^1,2 M. Ikemiyagi,¹ T. Kanzawa,¹ H. Fukuda,¹ R. Ishii,¹ K. Saiga,^1,3 M. Okumi,¹ Y. Ishii,⁴ K. Tanabe.¹
In Vivo Allograft Exposure to Mitochondrial DAMPs Prior to Organ Procurement Increases Graft Rejection in Mice

L. Lin, J. Wang, L. Cendales, A. Kirk, T. Brennan.
In-Situ Tissue-Based Gene Expression Profiling is a Reliable Method to Detect Gene Transcripts in Human Kidney Transplant Biopsies

D. Dobi,¹ J. Henrik,² T. Sigdel,² A. Chen,¹ Z. Laszik.¹
Incidence Trends among Deceased Liver Transplant Recipients in the United States, 2011-2016: A Propensity Score-Matched Study

R. Schilke, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Increased BMI is a Predictor of Early Post-Transplant Cardiac Events and Mortality

A. Mahgoub, S. Jackson, J. Lake, N. Lim.
Increased Risk of Early Graft Loss in Pancreas Transplant: A Retrospective Review of the UNOS Database

E. Steen,¹ C. Liu,² E. Siskind,² J. Ortiz.¹
Influence of X-Ray Repair Cross-Complementing Group (XRCC) Genes Polymorphisms on the Development of Antibody-Mediated Rejection (ABMR) in Renal Transplant Recipients

Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.
Influence of mTOR Inhibitors on Metabolic Outcomes One Year after Kidney Transplantation: The Role of Pre-Transplantation Diabetes

D. Cucchiari,¹ S. Karam,² P. Ventura-Aguiar,¹ J. Torregrosa,¹ F. Diekmann.¹
Inhibition of Neutrophil Recruitment and Activation Protects Airway Epithelium after Transplantation

R. Zhang,¹ H. Fang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
Innovative Strategies to Accommodate Increased Patient Volume in an Outpatient Transplant Infusion Center

J. Estrada, M. Tyrell, J. Choi, J. Jagolino, S. Jordan.
Insulin Use after Pancreas Transplant: Implications for Post-Transplant Outcomes

R. Ouseph, K. Lentine,¹ Z. Zhang,¹ D. Axelrod,² H. Randall,¹ B. Kasiske,³ A. Israni,³ V. Dharnidharka,⁴ T. Alhamad,⁴ D. Brennan,⁵ D. Segev,⁵ G. Hess,⁶ M. Schnitzler.¹
Insulin Use on Intensive Care Units as a Marker of beta-Cell Death in Brain Dead Pancreas Donors

M. Shapey,^1,2 A. Summers,² J. O'Sullivan,² P. Yianoullou,^1,2 T. Augustine,² M. Rutter,¹ D. van Dellen.²
Integration of Blood Type Incompatibility Desensitization Protocols into Kidney Paired Donation (KPD) Programs

F. Karami,¹ M. Nayebpour,² M. Gentili,¹ N. Koizumi,² K. Melancon.³
Inter-Correlations between Psycho-Social Pre-Transplant Determinants of Post-Transplant Kidney Allograft Function

S. Shah, A. Gamilla-Crudo, B. Schreiber, C. Machner, O. Aleter, M. Mujtaba.
Interactive Software for Simulation and Management of a Kidney Paired Donation Program

M. Bray,¹ W. Wang,¹ M. Rees,² P. Song,¹ A. Leichtman,³ V. Ashby,¹ J. Kalbfleisch.¹
Interstitial Inflammation is Correlated with DQ Antibodies in Kidney Transplant Recipients

C. Harris, L. Anderson, R. Khaim, J. Choudhuri, R. Shapiro, S. Florman, F. Salem, M. Menon.
Intragraft MicroRNA Transcriptome of Acute Antibody Mediated Rejection of Human Kidney Allografts

H. Yang,¹ K. Akat,² C. Li,¹ C. Snopkowski,¹ Z. Khan,¹ D. Dadhania,¹ T. Tuschl,² M. Suthanthiran,¹ T. Muthukumar.¹
Intragraft MicroRNAs Foretell Fibrosis in Kidney Transplant Recipients

H. Yang,¹ L. Amrouche,² K. Akat,³ C. Li,¹ Z. Khan,¹ C. Tinel,² T. Tuschl,³ D. Anglicheau,² T. Muthukumar.¹
Involvement of Aldehyde Dehydrogenase 2 (ALDH2) in Fatty Liver Graft Protection Mechanisms against Cold Ischemic Injury

A. Panisello-Rosello,¹ A. Lopez,² C. Castro,² S. Bellogi,¹ E. Folch-Puy,¹ A. Rolo,³ C. Palmeira,³ R. Adam, J. Roselló-Catafau.
Is Percent Exception at Transplant a Driver of MELD Inflation?

D. Schladt,¹ J. Snyder,¹ A. Israni,¹ W. Kim,² J. Lake.³
Is the NETos Increased in Acute Antibody Mediated Rejection?

R. Villca-Gonzales,¹ J. Torres-Ruiz,² D. Gomez-Martin,² J. Alberu,³ L. Morales-Buenrostro.¹
Ischemia Reperfusion Injury Significantly Differs between Lung vs. Heart Transplantation with Respect to Lead Cytokines and Correlation to Clinical Outcome

B. Wiegmann,¹ N. Ledwoch,² J. ISke,² C. Neudörfl,² I. Tudorache,¹ C. Kühn,¹ T. Kaufeld,¹ F. Ius,¹ S. Rojas,¹ M. Avsar,¹ A. Haverich,¹ G. Warnwcke,¹ C. Falk.¹
Ischemic Preconditioning Ameliorates Renal Ischemia-Reperfusion Injury in Mice via Heme Oxygenase-1-Mediated Autophagy

J. Hwang,² H. Choi,¹ M. Kim,² K. Jun,² K. Kown,² S. Park,² J. Kim,² I. Moon.²
Isolated Pancreas Transplantation: Does Rank List Position Matter for Imported Grafts?

J. Adler, R. Redfield, D. Kaufman, J. Odorico.
Isolated Right Hepatic Vein (RHV) Obstruction after Piggyback Liver Transplantation, an Infrahepatic Terminolateral Cavo-Cavostomy as a Rescue Technique to Save the Graft

K. Pineda-Solis, C. Florez-Zorrilla, A. Sanchez-Cedillo, L. Ladrón de Guevara-Cetrina.
Isolation and Profiling of miRNAs from Formalin Fixed Paraffin Embedded Endomyocardial Tissues from Human Heart Transplant Recipients

R. Nog,^1,2 C. Gupta,^1,2 J. Fallon,^1,2 J. Panza,^1,2 N. Haque.²
Kidney Allografts Confer Tolerance upon Co-Transplanted Heart Allografts by Promoting Tregs

C. Yang,¹ T. Ashry,¹ I. Rosales,² J. Ge,¹ T. O'Shea,¹ R. White,² P. Russell,¹ J. Madsen,¹ R. Colvin,² A. Alessandrini.¹
Kidney Donor Profile Index (KDPI) is Not Inferior to Liver Donor Risk Index (LDRI) in Predicting Long-Term Liver Graft Survival

U. Scheuermann, K. Freischlag, Q. Gao, J. Yerxa, B. Ezekian, R. Davis, P. Schroder, A. Barbas.
Kidney Transplantation in ESKD Patients with a History of Sickle Cell Disease/Trait

A. Lee, G. Malat, M. Harhay, L. Levin, G. Xiao, S. Guy, D. Reich, K. Ranganna.
Kidney Transplantation is Associated with Decreasing Native T1 Time: A Cardiac Magnetic Resonance Study

M. Contti,¹ L. de Andrade,¹ H. Nga,¹ M. Valiatti,¹ H. Takase,¹ A. Bravin,¹ A. Mauricio,² M. Barbosa.³
LAG-3 Deletion Upregulates Memory in a Dendritic Cell-Dependent Process

S. Gibney,¹ M. Efre,¹ T. Ashry,¹ C. Yang,¹ T. O'Shea,^1,2 R. White,² P. Russell,¹ J. Madsen,¹ R. Colvin,² A. Alessandrini.^1,2
Lactate/platelet Ratio after Liver Transplantation; a Novel Predictor for Short-Term Graft Failure

K. Takahashi,¹ S. Nagai,² M. Safwan,² K. Collins,² M. Rizzari,² A. Yoshida,² N. Ohkohchi,¹ M. Abouljoud.²
Large Decrease in Liver Waiting List Dropout Rate for MELD > 14

D. Schladt,¹ J. Pyke,¹ A. Israni,¹ W. Kim,² J. Lake,³ J. Snyder.¹
Leukocytes from Recipients with Severe Primary Graft Dysfunction after Lung Transplant Adoptively Transfer Alloreactivity to Vessel Grafts Trans Vivo

A-.K. Knoefel,¹ T. Siemeni,¹ N. Madrahimov,¹ W. Sommer,¹ M. Avsar,¹ L. Ahrens,¹ I. Tudorache,¹ A. Haverich,¹ C. Falk,² G. Warnecke.¹
Liver Allocation: One OPO's Experience with Expedited versus Non-Expedited Placement

C. Muse, R. Squires, C. Trahan, J. Whaley, J. Orlowski.
Liver Retransplantation and Renal Failure: The Benefit of Simultaneous Kidney Transplant

J. Berumen,¹ V. Irine,² S. Mita,² S. Gabriel,¹ M. Kristin.¹
Liver Transplant Patients with MELD>50 at Listing Have Poor Waitlist Outcomes and Similar Post Transplant Survival to Status 1A Patients

M. Safwan, R. Schilke, U. Nwagu, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Liver Transplantation in Patients with Spontaneous Spleno-Renal Shunt

M. Gastaca,¹ M. Bruno,² P. Ruiz,¹ A. Ventoso,¹ I. Palomares,¹ M. Prieto,¹ A. Valdivieso.¹
Living Donor Renal Transplantation in Adult Renal Transplant Recipients Varies Markedly across UNOS Networks

A. Brar,¹ A. Gruessner,¹ M. Salifu,¹ R. Gruessner,² N. Sumrani,² D. John,² F. Tedla.¹
Long Noncoding RNA NEAT1 Induces Tolerogenic Dendritic Cells in Heart Transplantation

J. Wu,^1,2 Y. Zheng,^1,2 S. Li,^1,2 M. Zhang,^1,2 H. Zhang,^1,2 X. Zheng,^1,2 Y. Sun,^1,2 B. Yu.^1,2
Long-Term HIF-1α Stabilization is Associated with Fibrosis in Rat Lung Allografts

K. Freischlag,¹ B. Ezekian,¹ P. Schroder,¹ J. Everitt,¹ J. Yoon,¹ M. Swiderska-Syn,³ W. Parker,¹ A. Diehl,¹ J. Kwun,¹ S. Knechtle.¹
Long-Term Nonhuman Primate Renal Allograft Survival without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation

K. Hotta, T. Oura, A. Dehnadi, M. Matsunami, I. Rosales, R. Smith, R. Colvin, A. Cosimi, T. Kawai.
Long-Term Outcome of Kidney Transplant Recipient with HTLV-1 Infection

N. Goto,¹ M. Minami,¹ K. Futamura,² M. Okada,¹ M. Tsujita,¹ T. Hiramitsu,² S. Narumi,² Y. Watarai.²
Long-Term Outcomes and Predictors of Survival after Liver Transplantation for Wilson Disease (WD)

P. Jalal, S. May, A. Rana.
Longitudinal Molecular Assessment of Renal Allograft and Short-Term Outcome: Markers of Injury and Recovery

S. Bontha,¹ A. Fernandez,¹ E. Bardhi,¹ L. Gallon,² V. Mas,¹ D. Maluf.¹
Loss of HIF-1α in CD4 T Cell Improve Outcome of Mouse Vascularized Osteomyocutaneous Allotransplantation under Costimulation Blockade

C-.H. Lin,^1,2 M. Anggelia,^1,2 H. Yang,³ W. Chuang,⁴ H. Cheng,¹ F-.C. Wei,^1,2 G. Brandacher.⁵
Low Intensity Conditioning Protocol for Inducing Chimerism-Based Tolerance in Non-Obese Diabetic Mice

A. Chhabra, Y. Huang, H. Xu, A. Merchak, S. Ildstad.
Low Serum 3-Methyl Histidine Level is Associated with Peripheral Arterial Stiffness in Renal Transplant Recipients

B-.G. Hsu,^1,4 Y-.H. Lai,¹ J. Hou,¹ C-.H. Liu,³ M-.C. Lee.^2,4
Lower Uric Acid Level after Kidney Transplantation Impact on Better Long-Term Allograft Outcomes

D. Kim,¹ H. Choi,² Y. Jung,¹ J. Lee,¹ J. Lee,¹ J. Lee,¹ K. Huh,¹ M. Kim,¹ B. Kim,² Y. Kim.¹
Lymph Node Reprogramming: Microparticle Delivery of Immune Signals to Induce Tolerance and Prolong Allograft Survival

Y. Xiong,¹ L. Tostanoski,² C. Jewell,² J. Bromberg.¹
M-CSF and TNF-α Induce Human MDSCs That Attenuate GVHD

F. Han, C. Ding, Y. Zhao, P. Tian.
MELD Based Allocation Deteriorates Patient Survival without Improving Waiting List Mortality in a Low Donor Area

P. Ritschl, L. Wiering, F. Aigner, M. Biebl, D. Eurich, M. Schmelzle, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
MELD-Na Score Based Liver Allocation: Hyponatremia is No Longer a Risk Factor for Waitlist Mortality

S. Nagai,¹ L. Chau,¹ M. Safwan,¹ R. Schilke,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ M. Abouljoud,¹ D. Moonka.²
Magnitude of Pre-Biopsy Decline in Renal Function and Its Association with Allograft Rejection

S. Voora,¹ P. Ahearn,¹ M. Tavakol,² K. Johansen,^1,3 E. Ku.¹
Malignancy Complications after Kidney Transplantation, the Role of Immunosuppression

M. Molina,¹ J. Cabrera,² E. Gonzalez,¹ A. Hernández,¹ N. Polanco,¹ A. Andres.¹
Measures of Physical Frailty, Cardiac Function and Cardiac Biomarkers among Kidney Transplant Candidates

S. Gilligan,¹ S. Anand,² D. Morris,² M. Minder,¹ T. Srinivas.²
Measuring and Monitoring Equity in Access to Deceased Donor Liver Transplants

D. Stewart, A. Robinson, A. Harper, D. Klassen.
Metabolic Complications 10-Years after Kidney Transplant

E. Lorenz, F. Cosio, M. Stegall.
Mid-Term Outcome of Donor Specific Antibody Positive Deceased Donor Kidney Transplantation with Peri-Transplant Desensitization

K. Osickova,¹ P. Hruba,² J. Slatinska,¹ A. Slavcev,² J. Fronek,² E. Honsova,² O. Viklicky.¹
Mitochondrial Membrane Permeability Plays a Critical Role for Endothelial Cell Necroptosis and Cardiac Allograft Rejection

I. Gan, J. Jiang, D. Lian, X. Huang, W. Liu, A. Haig, A. Jevnikar, Z. Zhang.
Molecular Classifiers Can Outperform the Flawed Histologic “Gold Standard” on Which They Are Trained

J. Reeve, P. Halloran.
Molecular Monitoring for Kidney Allograft Injury Following HLA Incompatible Transplantation

A. Jackson,¹ B. Iglehart,¹ S. Bagnasco,³ N. Desai.²
Most Pediatric Transplant Centers Are Underperforming and in Proximity to Higher Volume Centers

T. Nichols, A. Rana, J. Goss.
Multidisciplinary Approach to Prevention of Cytomegalovirus (CMV) Complications in Kidney and Liver Transplant Recipients

S. Shoham,¹ S. Anderson,² R. Avery,¹ M. Belden,³ L. Boyer,³ W. Cochran,³ N. Desai,¹ M. Holechek,³ E. Kraus,¹ J. Langlee,³ P. Spitz,² K. Marr.¹
Multidisciplinary Transplant Rounds: A Step to Improved Team and Patient Satisfaction

K. Sigafus,¹ E. LaMura,¹ M. Massimiani,¹ C. Chiang,² K. Nicoll,² M. Yoho,³ M. Bleicher,² S. Nazarian.²
Multiple Factors Contribute to an Expanded Immune Risk Profile in Pre Renal Transplant Candidates

D. DeWolfe,¹ K. McGann,¹ J. Ghofrani,¹ E. Geiger,¹ C. Helzer,¹ S. Kleiboeker,² S. Jost,¹ C. Tan.¹
Myeloid Derived Suppressor Cells Are Induced after Transplantation and Home to the Transplanted Kidney

Y. Lee, E. Davila, J. Bromberg, J. Scalea.
NK Cells in Allograft Kidney Biopsies during Rejection: Detection, Quantification, and Precise Localization Using Multiplex Immunofluorescence

M. Terada,¹ J. Duong Van Huyen,² F. Drieux,⁴ C. Legendre,³ P. Bruneval,¹ M. Rabant.²
NK Cells with a Lung-Resident Phenotype Represent the Most Prominent Donor Passenger Leukocyte Subset after Clinical Lung Transplantation

C. Falk,¹ R. BellmasSanz,¹ B. Wiegmann,² A-.M. Hitz,¹ K. Bläsing,¹ C. Neudörfl,¹ I. Tudorache,² C. Kühn,² M. Avsar,² A. Haverich,² G. Warnecke.²
NOS2 Deficiency Limits Long Term Survival of Murine Kidney Allografts

I. Aljabban,^1,2 B. Jiang,¹ C. Yang,¹ T. O'Shea,¹ D. Ndishabandi,¹ R. White,¹ P. Russell,¹ R. Colvin,¹ J. Madsen,¹ A. Alessandrini.¹
Neuropeptide PACAP Protects Hepatocyte against Liver Ischemia/Reperfusion Injury by Promoting Yes-Associated Protein (YAP) Function

Z. Xue, Y. Liu, C. Zhang, R. Busuttil, J. Kupiec-Weglinski, H. Ji.
Neutrophil-Lymphocyte Ratio(NLR) is Significantly Decreased in Kidney Transplant Patients: Is NLR a Novel Predictor of Cardiovascular Disease in Kidney Transplant Patients?

H. Shirakawa,¹ J. Hasegawa,² A. Ishiwatari,² M. Kono,² S. Wakai.²
No Correlation between US News "Best Hospitals" Rank and Outcome of Liver or Kidney Transplantation

J. Shreve,¹ S. Markowiak,² M. Nazzal,² J. Ortiz.²
Non Active Desensitization Protocol: Improving Access to Kidney Transplant for Hyperimmunized Patients

S. Le Bot,¹ F. Delbos,² C. Garandeau,¹ S. Malard Castagnet,² A. Cesbron,² M. Hourmant.¹
Non-Invasive Imaging Modalities for Immune Monitoring of Vascularized Composite Allografts Using a Translational Large Animal Model

J. Etra,¹ K. Cilwa,² G. Furtmueller,¹ A. Leto Barone,¹ K. Kolegraff,¹ E. Elster,¹ W. Lee,¹ G. Brandacher.¹
Non-Invasive Proteomics to Detect Biomarkers for Kidney Allograft Dysfunction

M. Watson,¹ M. Srivastava,³ D. Little,¹ O. Eidelman,³ R. Nee,¹ A. Bera,³ J. Karaian,³ D. Oliver,¹ H. Pollard,³ R. Jindal.²
Non-US Citizen Liver Transplant Recipients (LTR) Have Superior Outcomes Compared to US Citizen LTR: A Retrospective Study of 50,422 Subjects Using the Organ Procurement and Transplant Network (OPTN) from 1992-2015

T. Butler,¹ A. Rana,² M. Garfinkel.¹
Noninvasive Detection of Infection and Rejection in Renal Transplant Patients

Y. Zhou,¹ Y. Cheng,¹ T. Chiang,² G. Yang,² X. Li,² F. Zeng,² X. Wang,¹ J. Ge,² X. Hu,² H. Shi,¹ T. Wang,² L. Liu.³
Obese Patients Show Resistance to Narcotics Reduction after TPIAT for Chronic Pancreatitis

G. Yoshimatsu,¹ B. Naziruddin,³ K. Kumano,² H. Fernandez,³ E. Beecherl,³ N. Onaca.³
Objective Measures of Nutrition in Pre-Pancreas Transplant Patients with Type I Diabetes

S. Nagaraju, R. Mangus, T. Salisbury, W. Bush, J. Davis, J. Powelson, J. Fridell.
Offer Acceptance Practices and Geographic Variability in Allocation MELD at Transplant

A. Wey,¹ S. Gentry,² J. Pyke,¹ D. Schladt,¹ T. Weaver,¹ N. Salkowski,¹ B. Kasiske,¹ A. Israni,¹ J. Snyder.¹
Opportunistic Infections after Kidney Transplantation Are Independent Risk Factor of Kidney Allograft Loss: A Retrospective Cohort Study

P. Attias,¹ G. Melica,² E. Audureau,³ D. Boutboul,⁵ N. De Castro,⁴ S. Gallien,² P. Grimbert,¹ M. Matignon.¹
Organ-Specific Differences in a Thymoglobulin and Belatacept-Based Protocol for Tolerance Induction in Non-Human Primates

W. Sommer, J. O., K. Robinson, A. Dehnadi, M. Hanekamp, I. Rosales, K. Pruner, R. Smith, R. Colvin, T. Kawai, G. Benichou, J. Madsen, J. Allan.
Outcomes from Brain Death Donors with Cardiac Arrest Accepted for Pancreas Transplantation

P. Ventura-Aguiar,¹ J. Ferrer,² D. Paredes,³ C. Rodriguez,³ C. Fontdevilla,² E. Esmatjes,⁴ J. Garcia-Valdecasas,² F. Oppenheimer,¹ F. Diekmann,¹ M. Ricart.¹
Outcomes of ABO Non-Identical Pancreas Transplant

S. Nagaraju, R. Mangus, J. Fridell.
Outcomes of Enteric Conversion of Bladder Drained Pancreas; over a Decade of Experience at a Single Center

S. Riad,¹ D. Keys,¹ V. Vakil,¹ S. Jackson,² D. Berglund,² A. Matas,³ R. Kandaswamy.³
Outcomes of Kidney Transplantation from HBsAg Positive Donors to HBsAb Positive Recipients

G. Chen, C. Wang, Z. Wu, X. Liu, C. Wang, L. Chen.
Outcomes of Livers Allocated to High UNOS Match Sequence Number Recipients at a High Volume Transplant Center

M. Park, L. De Gregorio, H. Bohorquez, D. Bruce, E. Bugeaud, I. Carmody, A. Cohen, A. Mathur, D. Sonnier, J. Seal, G. Loss.
Outcomes of Moderately Macrosteatotic Liver Allografts

J. Alvikas, A-.P. Deeb, K. Lemon, X. Chen, S. Malik, G. Zeng, C. Hughes, A. Humar, A. Tevar.
Outcomes of Second Opinion Kidney Transplant Evaluations

M. Harhay, T. Bajakian, K. Ranganna, G. Malat, S. Guy, G. Xiao, L. Levin Mizrahi, D. Reich.
Outcomes of Transplant Patients with Encapsulating Peritoneal Sclerosis(EPS) Treated with Tamoxifen and Steroids

R. Parthasarathy,¹ T. Fairhead,^1,2 B. McCormick,^1,2 G. Knoll,^1,2 S. Hoar.^1,2
Outpatient Prophylactic Valganciclovir Dose Optimization Post-Renal Transplant

M. Spinner,¹ V. Athans,¹ C. Koval.²
Overexpression of BAX, NOL3, and XIAP Apoptotic Genes Participates in Calcineurin Inhibitors Nephrotoxicity: New Insights into Chronic Allograft Dysfunction

L. Garcia-Covarrubias,¹ G. Queipo,² M. Fonseca,² D. Alcantara,¹ P. Prieto,¹ H. Diliz,¹ A. Garcia,¹ H. Hinojosa,¹ A. Cicero,¹ G. Melendez,³ M. Alamilla,³ R. Lascurain,⁴ V. Soto.⁵
Pancreas Outcomes between Living and Deceased Kidney Donor Recipients in Pancreas after Kidney Transplantation

P. Ventura-Aguiar,¹ J. Ferrer,² I. Revuelta,¹ D. Paredes,³ E. De-Sousa,¹ J. Rovira,⁴ E. Esmatjes,⁵ J. Garcia-Valdecasas,² F. Oppenheimer,¹ F. Diekmann,¹ M. Ricart.¹
Pancreas Retransplantation: Outcomes of This Technical and Immunological Challenge over 38 Patients

F. Paret,¹ D. Cantarovich,² G. Karam,³ T. Batard,⁴ M. Nedelec,⁵ J. Branchereau.⁶
Pancreas Transplant for Type 2 Diabetes is Associated with Preserved Function, but Impaired Glucose Tolerance: A Comparative Analysis

S. Doshi, C. Pulitano, D. Al-Adra, A. Norgate, G. Sapisochin, M. Selzner, I. McGilvray, J. Schiff, M. Cattral.
Pancreas and Kidney Co-Transplantation in Type II Diabetes: A Single Center Experience

J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.
Pancreatic Graft Loss after Simultaneous Pancreas Kidney (SPK) Transplant within First 90 Days. Predictors beyond the Surgical Cause. A UNOS/OPTN Data Analysis

H. Sharma, M. Abraham, J. Chen, D. Mikhail, S. Aquil, S. Patel, A. Skaro, V. McAlister, A. Sener, P. Luke.
Parathyroidectomy Outcomes in Renal Transplant Recipients: Subtotal vs. Total

R. Rathore,^1,2 A. Sharma,² A. Halawa.²
Patient Attitudes and Perceptions of Using Mobile Health Technology for Living Kidney Donor Follow-Up and Care Management

A. Eno,¹ A. Thomas,¹ J. Ruck,¹ S. Rasmussen,¹ S. Halpern,¹ D. Segev,^1,2,3 M. Henderson.^1,3
Patient Change in Residence and Risk of Readmission after Renal Transplant in the US

J. Hogan, M. Anderson, Y. Zhang, J. Kim, G. Karadkhele, X. Zhang, A. Adams, R. Patzer.
Patients Converted to Belatacept Show Different Immunophenotyping Compared with De Novo Belatacept-Treated Patients

M. Rial,¹ F. Caro,² A. Nella,² D. Guerrieri,² L. León,¹ P. Uva,¹ E. Chuluyan,² D. Casadei.¹
Peptides Encoded by EBV Latent Cycle Proteins Affect NK Cell Reactivity

B. Mbiribindi, C. Romero Moreno, C. Esquivel, O. Martinez, S. Krams.
Peri-Transplant Glycaemic Control as a Predictor of Pancreas Transplant Survival

M. Shapey,^1,2 R. Tan,¹ H. Khambalia,² C. Fullwood,² P. Yianoullou,^1,2 A. Summers,² T. Augustine,² M. Rutter,¹ D. van Dellen.²
Peripheral Blood Immune Response-Related Gene Analysis for Evaluating the Development of Subclinical Antibody-Mediated Rejection

T. Yamamoto,¹ K. Iwasaki,² K. Murotani,³ A. Takeda,⁴ M. Tsujita,⁴ T. Hiramitsu,⁴ N. Goto,⁴ S. Narumi,⁴ Y. Watarai,⁴ K. Uchida,² T. Kobayashi.⁵
Platelet Counts as Predictors of Short- and Long-Term Outcomes in Liver Transplantation: Cassandras or Just Rats on a Sinking Ship?

I. Amygdalos,¹ Z. Czigany,¹ J. Böcker,¹ F. Meister,¹ M. Krebbers,¹ D. Morales Santana,¹ J. Bednarsch,¹ W. Schöning,¹ F. Ulmer,¹ G. Koek,³ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
Portal Vein Thrombosis (PVT) in Liver Transplantation – Recent Experience

D. Bruce, H. Bohorquez, J. Seal, A. Cohen, E. Bugeaud, I. Carmody, D. Sonnier, A. Mathur, L. De Gregorio, H. Sharma, G. Loss.
Post-Hoc Analysis of Everolimus Trough Levels around the Onset of Related Adverse Events and Treatment Discontinuation in De Novo Kidney Transplant Recipients from the US92 Study

F. Shihab,¹ Y. Qazi,¹ V. Peddi,¹ D. Shaffer,¹ K. McCague,² D. Patel,² S. Mulgaonkar.¹
Post-Transplant High Dose Cyclophosphamide Treatment Induces Thymus-Independent Immune Tolerance of Vascularized Composite Allografts via Complete Depletion of the Alloreactive TCR Repertoire.

G. Furtmüller,¹ B. Oh,¹ J. Sidhom,² M. Fryer,¹ V. Malek,¹ X. Zhou,¹ D. Cooney,¹ C. Brayton,³ J. Dodd-o,⁴ S. Ganguly,² G. Raimondi,¹ W. Lee,¹ L. Luznik,² G. Brandacher.¹
Pre-Emptive Rituximab and Intravenous Immunoglobulin (IVIg) Fail to Prevent Rejection in Kidney Transplant Recipients (KTx) with Donor Specific Antibodies (DSA)

J. Crew, R. Vasilescu, E. Campenot, S. Mohan, S. Patel.
Pre-Operative Predictors of Health-Related Quality of Life for Pancreas Transplant Recipients

I. Mosca,³ S. Mittal,¹ J. Smith,² P. Friend.^1,3
Pre-Transplant Duration of Dialysis, N-Terminal Pro-Brain Natriuretic Peptide and Post-Transplant Mortality in Renal Transplant Recipients

M. Yeung, M. Van Londen, U. Nakshbandi, Y. Said, M. Eisenga, B. Hepkema, M. Nolte, S. Berger, M. De Borst, S. Bakker.
Predicting Liver Allograft Discard: The Discard Risk Index

A. Rana, M. Kueht, N. Galvan, R. Cotton, T. Miloh, C. O'Mahony, J. Goss.
Predictors of Early Graft Loss in Older Kidney Transplant Recipients

P. Amaechi, R. Rodriguez, V. Rao, D. Taber, M. Posadas Salas.
Predictors of Graft Survival amongst Recipients of Liver Allografts with Prolonged Cold Ischemic Time (CIT)

J. Steggerda,¹ K. Kim,¹ D. Malinoski,² M. Bloom.¹
Predictors of Immunosuppressive Medication Adherence in Chinese Renal Transplant Recipients: Marital Status and Immunosuppressive Medication Beliefs

J. Liu,¹ S. Liu,² J. Xie,¹ J. Yan.¹
Preemptive Chest Tube in Liver Transplantation – An Unconventional Way to Reduce Morbidity

P. Ritschl, L. Wiering, F. Sponholz, A. Brandl, F. Aigner, M. Biebl, M. Schmelzle, D. Eurich, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
Pregnancies in Female Pancreas Transplant Alone Recipients

P. Patel,¹ D. Kliniewski,² L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^1,2,4
Preoperative Patient Education to Improve the Inpatient Experience for Living Donors

K. Ventura, K. Sigafus.
Prevention of Hepatitis B Virus Reactivation in HBsAg-Positive Renal Transplant Recipients with Rituximab Treatment

J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.
Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients is Associated with Prolonged Cold Ischemic Time of Seropositive Donor Organs

C. Falk,^1,7 F. Schlott,^2,7 K. Katsrintaki,^1,7 D. Steubl,³ W. Puppe,⁴ C. Blume,⁵ H. Haller,⁶ L. Renders,³ U. Heemann,³ D. Busch,² M. Neuenhahn.^2,7
Progression of Vertebral Bone Disease among Kidney Allograft Recipients on Steroid Maintenance

E. Abuhelaiqa,¹ M. Alkadi,¹ M. Jarman,² J. Mahmoud,² A. Hamdi,¹ A. Ashor,¹ A. Nauman,¹ M. Asim,¹ O. Fituri,¹ H. Al-Malki.¹
Prolongation of Skin Allograft Survival through Dietary Supplementation of Ayrl Hydrocarbon Receptor Ligands

A. Afrazi, L. Owens, J. Fechner, C. O'Driscoll, J. Mezrich.
Proteinuria is Associated with Increased Risk for Cardiovascular Disease after Kidney Transplantation

R. Rahamimov,^1,2,3 M. Molcho,³ I. Vahav,³ A. Chagnac,^1,3 E. Mor,^2,3 B. Rozen-Zvi.^1,3
Protocolar Biopsies in Patients with Subclinical De Novo DSA in Kidney Transplantation

D. Bertrand,¹ M. Jaureguy,² C. Garrouste,³ J. Sayegh,⁴ N. Bouvier,⁵ S. Caillard,⁶ L. Lanfranco,⁷ A. Galinier,⁸ A. François,⁹ F. Hau,¹⁰ I. Etienne,¹ P. Gatault.¹¹
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation

T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
Qualitative Analysis of Facebook Posts Created via the Donor Application

J. Konel, S. Weeks, K. Kumar, D. Helfer, D. Segev, J. Garonzik Wang, M. Henderson, A. Cameron.
Race/Ethnicity and Hypertension Self-Care Behaviors among US Living Kidney Donors

M. Johnson, T. Purnell, X. Luo, L. Cooper, M. Waldram, D. Crews, M. Henderson, A. Massie, D. Segev.
Racial Differences in Patient-Perceived Barriers to Starting the Kidney Transplant Evaluation

R. Hamoda, L. McPherson, K. Lipford, J. Gander, S. Pastan, R. Patzer.
Racial Differences in Rates of Malignant and Infectious Cutaneous Genital Disease after Solid Organ Transplantation

M. Larijani,¹ K. Nadhan,¹ J. Abbott,¹ A. Doyle,² C. Chung.¹
Racial Disparities in Post-Liver Transplant Survival before and after Share 35 Implementation

K. Ross,¹ R. Lynch,² R. Patzer.^1,2
Racial and Socioeconomic Influences on Kidney Transplantation. A 10 Year Retrospective Study

A. Arvelakis, S. Lerner, V. Wadhera, V. Delaney, S. Ames, V. Shegal, R. Kent, G. DeBoccardo, N. Singh, S. Florman, R. Shapiro.
Rates of Posttransplant Cutaneous Disease Differ between Black and White Solid Organ Transplant Recipients

R. Allawh,¹ K. Nadhan,¹ A. Doyle,² M. Harhay,³ C. Chung.¹
Re-Transplantation for Hepatic Artery Thrombosis: A National Perspective

C. Garcia, X. Mei, F. Marti, M. Shah, J. Berger, M. Daily, M. Gupta, R. Gedaly.
Real-Time Expert Evaluation of Liver Biopsy for Transplant: The Significance of Smartphone and Microscope Adapter in Telepathology

N. Bath,¹ X. Wang,² J. Bledsoe,² M. Thijssen,¹ A. Ahearn,¹ B. Movahedi,¹ A. Bozorgzadeh,¹ P. Martins.¹
Recent Exposure to Four-Factor Prothrombin Complex Concentrate (4F-PCC) is Associated with Intracardiac Thrombus during Liver Transplantation

M. Misel,^1,2 G. Schnickel,¹ J. Berumen,¹ R. Sanchez,³ K. Mekeel.¹
Recipient Conditioning Results in IL-33 Support of Potent Th1 Alloimmune Responses after CD4⁺ T Cells Upregulate ST2 during Lymphopenia Induced Proliferation

G. Dwyer,¹ L. Mathews,¹ A. Lucas,¹ B. Blazar,² H. Turnquist.¹
Recovery of Wild-Type Genotype after Documented Ganciclovir-Resistance in Transplant Recipients with Recurrent CMV Viremia

J. Fose, M. Jorgenson, Z. Degrave, R. Redfield, J. Smith, D. Mandelbrot.
Reducing Hospital Readmissions: Referral of High Risk Liver Transplant Patients to a Transitional Care Coordination(TCC) Program

A. Masoumi,¹ R. Barth,² T. Stern,¹ D. Bruno,² J. LaMattina,² S. Hanish.²
Reduction in Circulating CD19⁺CD24⁺CD27⁺ Regulatory B Cell Frequency Predicts Acute Rejection in Liver Transplant Patients

H. Zhou, Z. Rao, Y. Lu, J. Rao, J. Gu, L. Lu, Y. Xia.
Regional Variation in the Outcomes of MELD-Na Based Liver Allocation

L. Chau,¹ D. Moonka,² K. Collins,¹ M. Rizzari,¹ A. Yoshida,¹ M. Abouljoud,¹ S. Nagai.¹
Regression of Left Atrial Diameter after Kidney Transplantation is Associated with Prolonged Survival: An Observational Study

A. Kainz,¹ F. Regele,¹ M. Kammer,² A. Beer,³ R. Steringer-Mascherbauer,⁴ T. Binder,⁵ R. Oberbauer.¹
Rejection and Graft Loss in Patients with BK Viremia after Simultaneous Pancreas and Kidney Transplant

D. Keys, S. Riad, V. Vakil, S. Jackson, D. Berglund, A. Matas, R. Kandaswamy.
Relation between Seroprevalence of Cytomegalovirus and Graft Survival in Japanese Kidney Transplant Recipients: The Japan Academic Consortium of Kidney Transplantation Study

K. Miyake,^1,2 M. Okumi,¹ K. Unagami,³ Y. Kakuta,¹ H. Shirakawa,⁴ K. Omoto,⁵ H. Ishida,¹ K. Tanabe.¹
Renal Allograft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation

L. Gallon,¹ J. Mathew,¹ S. Bontha,² C. Dumur,² P. Dalal,¹ L. Nadimpalli,¹ D. Maluf,² A. Shetty,¹ S. Ildstad,³ J. Leventhal,¹ V. Mas.²
Repeat Kidney Transplant Patients with Active Rejection Have Elevated Donor-Derived Cell-Free DNA

S. Mehta,¹ J. Chang,² T. Hailey,¹ D. Hiller,³ M. Grskovic,³ J. Yee,³ R. Mannon.¹
Resident Perceptions and Evaluations of a Fellow-Led Transplant Service versus Resident-Led Surgical Services

A. Williams, M. Barrett, N. Matusko, S. Dennahy, R. Sung, G. Sandhu, K. Woodside.
Retrospective Study of Cryptococcosis in Kidney Transplant Recipients from a Single Center

R. Wang, M. Cen, J. Lin, H. Huang, W. Peng, J. Wu.
Rictor mTORC2 Signaling Protects Ischemic Liver Injury by Targeting Both Liver Parenchymal and Non-Parenchymal Cells

H. Zhou,¹ Z. Rao,¹ R. Liu,¹ S. Zhou,¹ J. Rao,¹ J. Gu,¹ H. Lu,¹ Y. Xia,¹ X. Wang,¹ Y. Zhai,² L. Lu.¹
Risk Factors for Graft Failure in Kidney Transplant Recipients with Polycystic Kidney Disease

G. Bhutani, B. Astor, A. Djamali.
SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes

M. Guthoff,¹ M. Mahling,¹ S. Nadalin,² N. Heyne.¹
Sensing T Cell Killing Activity with Granzyme B Activity Probes

Q. Mac,¹ D. Mathews,² J. Kahla,¹ C. Stoffers,¹ O. Delmas,¹ B. Holt,¹ A. Adams,² G. Kwong.¹
Serial Monitoring of Resolution of Sub-Clinical Acute Rejection (subAR) in Kidney Transplant Recipients (KTR) Using a Gene Expression Profile (GEP)

L. Zhao,¹ B. Armstrong,² J. Friedewald,¹ T. Whisenant,³ S. Kurian,³ R. Heilman,⁴ E. Poggio,⁵ C. Marsh,³ P. Baliga,⁶ N. Bridges,⁷ J. Odim,⁷ M. Brown,⁷ D. Ikle,² J. Charette,¹ S. Brietigam,¹ N. Sustento-Reodica,¹ M. Kandpal,¹ D. Salomon,³ M. Abecassis.¹
Serum Treatment with Fetal Bovine Serum Significantly Increases Luminex-Based HLA Antibody Assay Specificity by Reducing Heterophile Antibody Interference

A. Jaramillo,¹ J. House,¹ L. Nelson,¹ S. Stoll,¹ R. Ridgley,¹ H. Khamash.²
Significance of Antibody-Mediated Vascular Rejection (AMVR) on Graft Survival: Correlation with Pure Antibody-Mediated Rejection (AMR)

B. Ozdemir,¹ F. Ozdemir,² A. Terzi,² G. Ozdemir,¹ A. Ok Atilgan,¹ E. Ayvazoglu Soy,³ A. Akdur,³ G. Moray,³ M. Haberal.³
Significant Difference between Proteasome and Immunoproteasome Inhibition in Acute Kidney Injury

F. Han, C. Ding, Y. Zhao, P. Tian.
Single Center Experience in Use of Check Point Inhibitors and Outcomes in Kidney Transplant Recipients

K. Venkatachalam, R. Delos Santos, T. Alhamad.
Single-Center Experience with Sofosbuvir-Based HCV Treatment after Kidney Transplantation

V. Garcia, G. Meinerz, C. da Silva, R. Bruno, E. Keitel.
Soluble Fibrinogen-Like Protein 2 Regulates Myeloid-Derived Suppressor Cells Differentiation and Enhances Its Immunosuppressive Function of in Allograft Immunity

C. Yang, T. Zhu.
Staged Biliary Reconstruction after Liver Transplantation Reduces Post-Transplant Biliary Complications in High-Acuity Patients

T. Pearson, M. Zimmerman, J. Kim, P. Palines, M. Wong, C. Erickson, J. Hong.
Standard Induction Immunosuppression Interferes with the Role of Vascularized Bone Marrow in Vascularized Composite Allograft Protection

N. Shockcor, E. Buckingham, W. Hassanein, A. Nam, S. Bartlett, R. Barth.
Standard- versus Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Kidney Transplant Recipients

N. Wilson, N. Sulejmani, A. Jantz, A. Patel, B. Summers.
Stress-Related Exosomal MicroRNA Biomarkers Released by Human Islets during Transplantation

P. Saravanan,¹ P. Nguyen,¹ G. Yoshimatsu,¹ C. Chang,¹ C. Darden,¹ R. Bhattacharjee,¹ X. Wang,¹ J. Gu,¹ M. Lawrence,¹ B. Naziruddin.²
Subclass Distribution of DSA Analyzed by Mass Spectrometry Predicts the Risk of Humoral Rejection

V. Pernin,^1,2 N. Bec,³ C. Larroque,³ C. Duperray,² G. Mourad,¹ M. Lequintrec.^1,2
Sufficient Hepatic Artery Flow Redeems Poor Portal Vein Flow after Liver Transplantation in Patients with Porta Vein Thrombosis

L. Coromina Hernandez, K. Sasaki, D. Firl, J. McVey, M. Fujiki, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.
Survival Advantage from Accepting a Circulatory Death Liver Transplant

J. Richards,¹ R. Taylor,² E. Allen,² A. Goh,¹ J. Neuberger,³ D. Collett,² G. Pettigrew.¹
T Cell Immunomonitoring Including Donor Specific Treg Expansion Prospectively Predicts Renal Allograft Tolerance Induced by Transient Mixed Chimerism

K. Hotta, T. Oura, A. Dehnadi, K. Huh, M. Matsunami, H. Sasaki, G. Benichou, J. Madsen, A. Cosimi, T. Kawai.
TGF-b Plus Rapamycin Induce Foxp3 and Promote iTreg Development and Suppressive Function, Leading to Long-Term Allograft Survival

L. Wang, A. Samanta, R. Han, N. Zhou, W. Hancock.
TGR5-Mediated AMPK/mTOR Signaling Regulates Macrophage Migration and Polarization in Liver Ischemia Reperfusion

S. Zhou, H. Zhou, R. Liu, F. Zhang, X. Wang, L. Lu.
Tacrolimus Exposure in Human Proximal Tubule Cells Results in Differentially Increased CTGF Expression in Relation to Pharmacogenetic Variants of CYP3A5 and ABCB1

N. Knops,¹ Y. Ramazani,² B. Van den Heuvel,² R. Goldschmeding,³ T. Nguyen,³ E. Levtchenko,¹ D. Kuypers.⁴
Tax1bp3 is Upregulated in the Ischemia/Reperfusion Injury of Kidney

W. Qiu, J. Lin, Y. Tian.
Telehealth Evaluations to Screen Kidney Transplant Candidates Does Not Adversely Affect Time to or Rate of Transplant

R. Forbes,^1,2 D. Rybacki,¹ T. Johnson,¹ D. Shaffer,^1,2 D. Hale.^1,2
Telemedicine Implementation in Organ Transplantation at a Metropolitan Academic Medical Center

D. Tsapepas, H. Li, D. Kohlberg, B. Watts, J. Monteiro, A. Monteiro, N. Jandovitz.
Temporal Variability of IgG Subclasses

D. Pinelli, M. Gopalakrishnan, A. Joong, P. Thrush, A. Tambur.
The Clinical Significance of Pretransplant C1q Assay Status in Positive Crossmatch Kidney Transplantation

J. Lee,¹ D. Kim,¹ B. Park,² S. Song,³ J. Lee,⁴ Y. Jung,¹ J. Lee,¹ J. Lee,¹ B. Kim,⁵ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
The Complexity of HLA-DQ

D. Pinelli, A. Tambur.
The Effect of Steroid Maintenance in Recipients with Pancreas Transplant Alone: A Single Center Experience

J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.
The Effects of Pre-Transplant Pyuria of the Deceased Donor on Post-Transplant Urinary Tract Infections in the Case of Gender Mismatch Transplantation

Y. Kim,¹ S. Park.²
The Fate of Older Candidates Referred for Kidney Transplantation

M. Shwetar, K. Abdel-Kader, B. Concepcion.
The Impact of Anticoagulation Therapy Modifications during the Index Hospitalization on Clinical Outcomes in Kidney Transplant Recipients

J. Hardcopf, H. Meadows, N. Pilch, C. Perez, N. Patel, J. Fleming, H. Corbo, T. Harrison, B. O'Brien, D. DuBay, P. Baliga, D. Taber.
The Impact of Childhood Solid Organ Transplantation on B-Cell Maturation

L. Ionescu,¹ T. Blydt-Hansen,² B. Foster,⁷ S. Mital,³ L. Hamiwka,⁵ U. Allan,³ V. Phan,⁴ P. Birk,⁶ C. Morgan,¹ S. Urschel.¹
The Impact of Immunosuppression on Mineral Metabolism One Year after Kidney Transplantation: Differences between a Mycophenolate-Based Regimen versus an mTOR-Inhibitor-Based One

D. Cucchiari,¹ S. Karam,² P. Ventura-Aguiar,¹ F. Diekmann,¹ J. Torregrosa.¹
The Impact of Obesity on Incidence of Vascular Complications after Liver Transplantation: A Meta-Analysis

R. Deng, Y. Shi, B. Huang, Y. Ma.
The Impact of Pre-Transplant Donor Specific Antibodies (DSA) on AMR Rates in HIV-Infected Kidney Transplant Recipients Inducted with IL-2 RA

S. Farouk, B. Rollins, V. Delaney, N. Singh, V. Sehgal, R. Kent, M. Menon, R. Shapiro, S. Florman, G. DeBoccardo.
The Implications of Impaired Glucose Tolerance after Kidney Transplantation

F. Tinney, Jr.,¹ S. Norman,² A. Naik,² D. Cibrik,² R. Sung,² D. Frietze,³ M. Stegall,⁴ M. Samaniego,² C. Jay.³
The Incidence and Outcome of Isolated Distal Deep Vein Thrombosis in Kidney Transplant Recipient

M. Kim, J. Hwang, S. Kim, S. Park, I. Moon, J. Kim.
The Inhibitory Effect of Plasma on Activation of Lymphocytes from Kidney Transplants is Significantly More Severe in Tacrolimus Based Regimen: What Implications for Plasma Exchange Role in Anti-Rejection Therapy?

A. Assounga,^1,2 S. Omarjee.¹
The Initial Hepatic Artery Reperfusion versus Initial Portal Reperfusion in Liver Transplantation: Where Do We Stand?

R. Shahbazov,¹ F. Azari,³ J. Alejo,² M. Talanian,² M. Fox,² K. Kennedy,² S. Kessel,² A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹
The Likelihood of Re-Transplantation in Patients Undergoing Allograft Nephrectomy

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹
The LncRNA MALAT1 Induces Tolerogenic DCs and Antigen Specific Tregs Subsequently Mediating Cardiac Allograft Tolerance in Mice via MiR-155/DC-SIGN/IL10 Axis

M. Zhang,^1,2 J. Wu,^1,2 H. Zhang,^1,2 M. Liu,^1,2 Y. Zheng,^1,2 X. Jin,^1,2 S. Li,^1,2 Q. Zhao,^1,2 X. Liu,^1,2 Y. Sun,^1,2 B. Yu.^1,2
The Neutrophil to Lymphocyte Ratio is Confounded by MELD in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation

J. McVey, K. Sasaki, F. Dan, Q. Cristiano, H. Koji, M. Charles, A. Federico.
The Opioid Strikes Back: Pre-Transplant Opioid Exposure is Associated with Increased Readmissions after Renal Transplant

B. O'Brien, N. Patel, L. Wilson, P. Mauldin, S. Ball, R. Gilbert, Z. Elmaasarani, P. Baliga, N. Pilch, D. Taber, J. Fleming.
The Price of Diabetes Medication Management in Kidney Transplantation: Similar Rates of Readmissions, but More Healthcare Utilization

J. Hardcopf, H. Meadows, N. Pilch, C. Perez, N. Patel, J. Fleming, H. Corbo, T. Harrison, B. O'Brien, D. DuBay, D. Taber.
The Promising Approach in Difficult Atypical Hemolytic Uremic Syndrome Series in Renal Transplantation

B. Yelken,¹ S. Gorcin,¹ E. Demir,² C. Karatas,³ E. Arpali,⁴ B. Akyollu,³ B. Kocak,⁴ O. Elbasi,⁵ E. Eksioğlu,⁵ A. Turkmen.²
The Providers Can't Let Go! An Analysis of an RN Driven Tacrolimus Dose Adjustment Protocol

Z. Elmaasarani, C. Mardis, L. Gylten, J. Fleming, H. Meadows, N. Patel, C. Perez, D. Taber, V. Rao, V. Rohan, P. Baliga, D. Dubay, N. Pilch.
The Regulatory Role of Plasma Cells (as Bregs) is Counterbalanced by a NOVEL Inflammatory Role in Murine Transplant and Autoimmune Models

Z. Song,^1,2 Y. Zhou,² Q. Ding,¹ D. Rothstein.¹
The Relative Immunogenicity of HLA Mismatches in Adult Liver Transplant Recipients

V. Jucaud,¹ A. Shaked,² M. DesMarais,³ P. Sayre,³ M. Everly.¹
The Results of Plasmapheresis and Anti-CD20 Based Desensitization without Intravenous Immunoglobulin in Positive Crossmatch Kidney Transplants

H. Kwon, Y. KIm, J. Choi, S. Shin, J. Jung, M. Cho, J. Kim, D. Han.
The Role of NKT Cell /IL-17 Axis in the Autoimmune Lupus Nephritis

J. An,¹ Y. Kim,² M. Yu,² J. Lee,¹ C. Lee,³ Y. Kim,² S. Yang.⁴
The Role of pDCs in Formation of Treg-Rich Organized Lymphoid Structures in Spontaneously Accepted Murine Kidney Allografts is Dependent on Mismatching of MHC Class II Molecules at the H2-I-A^b Locus

T. O'Shea,^1,2 C. Yang,¹ I. Rosales,² N. Oh,¹ D. Ndishibandi,^1,2 T. Ashry,¹ P. Russell,¹ J. Madsen,¹ R. Colvin,² A. Alessandrini.^1,2
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis

S. Wan,^1,2 T. Ying,^1,2 K. Wyburn,^1,2 D. Roberts,^3,4 M. Wyld,^1,2 S. Chadban.^1,2
The Use of LiMAx for Evaluating Donor Livers on Normothermic Machine Perfusion

J. Schurink,¹ J. de Haan,² M. Verstegen,¹ H. Metselaar,³ J. Ijzermans,¹ J. de Jonge.¹
The Utility and Futility of Extra-Corporeal Membrane Oxygenation in Liver Transplant Recipients

B. Nguyen, K. Dhanireddy, Y. Genyk, N. Kaur.
The Utility of an Online Survival Calculator in Selecting Older Candidates for Kidney Transplantation

M. Shwetar, K. Abdel-Kader, B. Concepcion.
Three-Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas-Kidney Transplantation in Type 2 Diabetes

T. Alhamad,¹ R. Kunjal,¹ A. Malone,¹ D. Brennan,² A. Wiseman,³ J. Wellen,¹ V. Hicks,¹ K. Lentine.⁴
Thymus Co-Transplantation Promotes Donor-Specific Tolerance in Allogeneic Heart Transplantation

J. Kwun,¹ J. Li,² C. Rouse,³ J. Park,¹ A. Kirk,¹ L. Markert.²
Time and Perfusate Dependent Molecular Response in Ex Vivo Lung Perfusion

P. Dromparis,¹ N. Aboelnazar,² S. Wagner,¹ S. Himmat,² C. White,² J. Luc,² D. Freed,² J. Nagendran,² M. Mengel,¹ B. Adam.¹
Tipping the “Immune Balance” towards Tolerance by Specific and Systematic Depletion of Donor and Host Effector Cells

R. Bascom, K. Tao, L. West.
Title: Donor-Derived Cell Free DNA Predicts Development of Clinically Significant Changes in Donor Specific Antibody Following Kidney Transplant

A. Brubaker,¹ D. Stoltz,¹ M. Grskovic,² R. Woodward,² A. Gallo.¹
To Score a Pancreas, Stars Must Be Aligned

A. Friedman, P. Bagavan, K. Delli Carpini.
Tomotherapy and Donor Hematopoietic Cells for Tolerance to Kidney Transplants in Rhesus Macaques

D. Kaufman,¹ L. Haynes,¹ P. Hematti,¹ W. Burlingham,¹ L. Forest,² J. Post,¹ R. Redfield,¹ L. Fernandez,¹ A. D'Alessandro,¹ J. Haynes,¹ K. Jensen,³ S. Strober.³
Transplant Candidates and Potential Living Kidney Donors Are Supportive of Reciprocity for Transplant Candidates Who Participate in Kidney Paired Donation with a Compatible Donor

J. Gill,¹ J. Gill,¹ F. Ballesteros,² M. Fortin.²
Transplant Hepatectomy with Portacaval Shunt and Molecular Adsorbent Recirculating System (MARS) Therapy for Perioperative Catastrophe

A. Cimeno, S. Sultan, J. Alvarez-Casas, S. Hanish, D. Bruno, W. Hutson, D. Stein, T. Scalea, R. Barth, J. LaMattina.
Transplant Outcomes in Female African American Recipients

A. Patel,¹ R. Prashar,¹ D. Lim.²
Transplant Tourism and Invasive Fungal Infection

F. Al Ismaili,¹ A. Metry,³ M. Al Riyami,⁵ F. Khamis,⁶ F. Shaheen,⁷ A. Hola,⁴ I. Al Salmi.²
Trends in Safety Reporting to UNOS Related to Non-Recovery, Discard, or Delay

A. Doyle,¹ R. Urban,² S. Tlusty,² M. Marvin,³ E. Hollinger,⁴ D. Marshman,⁵ M. Green.⁶
Trends in Safety Reporting to UNOS by Event Type

A. Doyle,¹ S. Tlusty,² R. Urban,² M. Marvin,³ E. Hollinger,⁵ D. Marshman,⁴ M. Green.⁵
Tuberculosis among Kidney Transplant Patients Compared to Dialysis and Non-Dialysis CKD Patients over a Decade Period

A. Metry, I. Al Salmi, F. Al Ismaili, A. Hola, F. Shaheen, I. Al Salmi.
Type-1 Interferon Impairs the Immunoregulatory Activity of IL-10: Understanding the Mechanisms of Abrogation of Transplant Tolerance

M. Iglesias, A. Arun, M. Chicco, B. Lam, V. Ivanova, W. Lee, G. Brandacher, G. Raimondi.
Umbilical Cords-Derived Mesenchymal Stem Cells Ameliorates Hepatic Ischemia-Reperfusion Injury via Activating the AMPK-mTOR/ULK1 Signaling Pathway Enhanced Autophagy

J. Zheng,^1,2 J. Cai,^1,2 L. Chen,^1,2 J. Yao,^1,2 K. Zeng,^1,2 H. Li,^1,2 Y. Zhang,^1,2 Y. Yang.^1,2
Unique Recipient Benefits with Paired Kidney Donation

J. Buggs,¹ E. Rogers,² V. Bowers.¹
Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

D. Chen, J. Chen.
Urinary Chemokine CXCL-10 in Long Term Renal Transplant Patients Associates with Urinary Tract Infections and Microvascular Damage

G. Irish,^1,2 M. Hockley,^1,2 S. Kireta,^1,2 J. Johnson,^1,2 R. Carroll.^1,2
Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in DCD Kidney Transplant Recipients

J. Bank,¹ R. Ruhaak,² D. Soonawala,¹ F. Romijn,² C. van Kooten,¹ C. Cobbaert,² H. de Fijter.¹
Urine AngiotensinII Signature Proteins as Biomarkers of Fibrosis in Kidney Transplant Recipients

Z. Mohammed-Ali,¹ S. Reid,^1,3 T. Tokar,¹ A. Tavares,² P. Yip,¹ H. Cardinal,² Y. Li,¹ S. Kim,^1,3 I. Jurisica,^1,3 R. John,¹ A. Konvalinka.^1,3
Using Machine Learning and Simulation to Compare High Risk Kidney Transplant Survival to Waiting for a Non High Risk Organ

E. Mark, D. Goldsman, P. Keskinocak, B. Gurbaxani.
Utility of Preoperative CT to Guide Perioperative Management for Kidney Transplantation

E. Werlin,¹ J. Walker,² J. Freise,¹ P. Stock,¹ J. Hiramoto.²
Utilization of Older Donor after Cardiac Death Allografts in Liver Transplantation: An Opportunity to Increase the Donor Pool

F. Paterno, K. Wima, T. Diwan, M. Cuffy, N. Anwar, E. Woodle, S. Shah.
Validation Study of Gene Expression Signatures Associated with Antibody-Mediated Rejection (ABMR) and Cell-Mediated Rejection (CMR) in Renal Allograft Biopsies (Bx) Suggests Complexity of Molecular Diagnosis for ABMR Compared to CMR

H. Zhang,¹ C. Nast,² J. Doldron,² M. Cheung,² A. Vo,³ S. Jordan,³ M. Toyoda.¹
Validation Study of Operational Tolerance Signatures in Korean Kidney Transplantation Recipients

J. Seo,¹ Y. Lee,¹ Y. Kim,¹ J. Moon,¹ K-.H. Jeong,¹ C-.D. Kim,² J. Park,³ B. Jeong,⁴ S-.H. Lee.¹
Vendor-Specific Differences in Identical Strains of Mice Yield Dichotomous Result in Lung Allograft Rejection

Y. Guo, Q. Wang, O. Onyema, A. Gelman, D. Kreisel, A. Krupnick.
Virtual Encounters: Robust Methods to Manage Your Active Waitlist

K. Curry, S. Zimmerman, D. Cassidy, S. Gray, V. Rao, V. Rohan, N. Pilch, A. Milling, L. Curry.
Waiting List Outcomes for Patients Registered for Simultaneous Pancreas and Kidney Transplantation

V. Surendrakumar,^1,2 J. Richards,^1,2 M. Hossain,² G. Pettigrew.^1,2
Waitlist Candidates Who Travel for Liver Transplantation and the Donor Organs They Receive

J. Ge, J. Lai.
Waning Enthusiasm for a Once Promising Test: C1q Testing Does Not Provide Prognostic Information for DSA Screening Protocols

A. Gilbert, D. Li, M. Awwad, S. Rosen-Bronson, P. Abrams, J. Verbesey, G. Vranic, M. Cooper.
What's Normal? An Evaluation of Pediatric T Cell Markers in Healthy Controls

M. Sosniuk,¹ A. Halpin,^1,2,5,6,7 J. Wizniak,⁷ A. Szkotak,^6,7 S. Urschel,^1,2,5 L. Ionescu,^1,2,5 L. West.^1,2,3,4,5,6
When Does Donor Age Matter? A Review of over 70,000 Liver Transplants

D. Yoeli, E. Pan, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss, A. Rana.
Whole-Transcriptome Sequencing to Identify Macaque Immune Gene Variants

A. Haj,¹ J. Karl,¹ R. Wiseman,¹ D. O'Connor.^1,2
All DQ DSA May Not Be Equal: Comparing Outcomes between De Novo DQ DSA Specificities

M. Everly,¹ K. Briley,² A. Nguyen,¹ V. Jucaud,¹ A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² L. Rebellato.²
Alveolar Macrophages Derived from MCMV Latently Infected Donors Drives the Viral Reactivation and Dissemination Following the Orthotopic Left Lung Transplantation in Mice

S. Han, Z. Zheng, M. He, J-.J. Wang, S. Yan, M. Abecassis, Z. Zhang.
Antiviral Therapy for Donor-Derived Hepatitis C Virus Infection after Solid Organ Transplantation

A. Kwong,¹ A. Wall,² M. Melcher,² U. Wang,³ A. Ahmed,¹ K. Khush,³ A. Subramanian,³ J. Tan,³ P. Kwo.¹
Brincidofovir Was Used to Successfully Treat Adenovirus Infections in Solid Organ Transplant Recipients and Other Immunocompromised Patients

D. Florescu,¹ M. Grimley,² G. Papanicolaou,³ V. Prasad,⁴ E. Vainorius,⁵ G. Chittick,⁵ T. Brundage,⁵ G. Nichols.⁵
Curative Correction of FAH Deficiency by Chimeric Stem Cells Transplantation

D. Joo,^1,2 E. Nelson,¹ Y. Zhang,¹ B. Amiot,¹ S. Ho,³ C. Lancto,⁴ D. Carlson,⁴ L. Queiroz,⁵ S. Nyberg.¹
DSA with TCMR Identifies High Risk Renal Transplant Recipients That Can Be Predicted by Proinflammatory Transitional B Cells

D. Chittka, A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015

K. Ross,¹ R. Lynch,² D. Goldberg,³ R. Patzer.^1,2
Determining the Relative Immunogenicity of HLA Mismatches with Calcineurin Inhibitor Immunosuppression: An Analysis of the BENEFIT and BENEFIT-EXT Renal Transplant Cohort

V. Jucaud,¹ M. Roberts,² H. Gebel,³ R. Bray,³ M. Everly.¹
Development and Validation of FLF-Transplant Score to Predict Mortality of Status 1A Candidates

Z. Guo, B. Chen, Q. Zhao, E. Xin, Z. Zhang, L. Wang, X. He, G. Chen.
Development of Post-Transplant DSA Following Immunosuppression Minimization/Withdrawal in Liver Transplant Recipients

V. Jucaud,¹ A. Shaked,² M. DesMarais,³ P. Sayre,³ M. Everly.¹
Do Reconstruction Techniques for Two Renal Arteries Affect Long-Term Graft Survival after Living Donor Renal Transplantation?

S. Yamanaga, P. Stock, M. Tavkol, S-.M. Kang.
Dual Inhibition of PI3K and mTORC2 Causes ERK Hyperactivation Induced by HLA-II Antibody in Human Endothelium

Y-.P. Jin, E. Reed.
Emergence of a Costimulation-Susceptible T Cell Repertoire Post-Alemtuzumab Induction

Q. Gao,¹ A. Mehta,² A. Guasch,² L. Stempora,¹ A. Kirk,¹ H. Xu.¹
Expression of the Senescence Marker P16/INK4A in Kidney Implantation Biopsies is Uniquely Associated with Poor Late Graft Function

K. Famulski, P. Halloran.
Financial Burden of Liver Transplant vs Resection for HCC

J. Butler, N. Skill, C. Kubal, D. O'Brien, J. Kays, J. Fridell, M. Maluccio.
Hematopoietic Cell Kinase (Hck) Regulates Effector and Regulatory T Cell (Treg) Function

S. Farouk,¹ C. Wei,¹ B. Das,² P. Cravedi,¹ B. Murphy.¹
High Frequency of HLA-DQ De Novo Donor Specific Antibodies is Independent of the Number of Mismatches in Heart Transplant

X. Zhang,¹ E. Kransdorf,² J. Patel,² J. Kobashigawa.²
Impact of Elevated PSA, and Prostate Cancer in ESRD on Time to Transplant, and Survival

N. Sarabu,¹ N. Schiltz,² D. Hricik.¹
Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients after Desenstization (DES): 3yrs Post Implementation

A. Vo, E. Huang, N. Ammerman, S. Williamson, C. Myers, A. Peng, R. Najjar, S. Sethi, K. Lim, S. Jordan.
In-Vivo Visualization of Regulatory B Cells Reveals Ag-Dependent T Cell Interactions That Suppress Subsequent T Cell:DC Interactions

K. Mohib, A. Cherukuri, Y. Zhou, R. David.
Is Age a Potential Barrier to Pursuing Living Donor Kidney Transplant (LDKT)?

A. Raissi, N. Edwards, Y. Liao, D. Belenko, N. Singh, M. Khalid, D. Toews, I. Mucsi.
Kidney Quality Influences Patient and Graft Survival in Liver Transplant Recipients with End Stage Renal Disease

J. Reyes, M. Eerhart, J. Danobeita, P. Chlebeck, L. Zitur, L. Fernandez.
Longitudinal Analysis of Community Respiratory Virus Infection in Kidney Transplant Recipients

O. Beaird, K. Phonphok, S. Chandrasekaran, O. Garner, S. Bunnapradist, J. Schaenman.
Medication Reconciliation in Abdominal Transplantation

S. Todd,¹ J. Perryman,² R. Subramanian,² A. Patel,² M. Hawthorne,² R. Buenvenida,² K. Lee,² W. Allison,² D. Lo,² P. Reshamwala.²
Pancreas Graft Function >10 Years: The Cumulative US Experience

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
Pre-Donation eGFR, Early Post-Donation eGFR, and Subsequent ESRD Risk in Living Kidney Donors

A. Massie,¹ L. Fahmy,¹ M. Henderson,¹ A. Thomas,¹ J. Snyder,² D. Segev.¹
Precision Medicine for Determining the Efficacy of a Novel Belatacept Regimen

J. Shoji, J. Leung, E. Tavares, Q. Tang, F. Vincenti.
Predictors of Graft Survival at the Time of a Kidney Transplant Indication Biopsy

G. Einecke,¹ J. Reeve,^2,3 P. Halloran.^2,4
Results of LITMUS (NCT 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

A. Chruscinski,¹ V. Rojas-Luengas,¹ A. Issacher,¹ J. Luo,⁴ H. Yowanto,⁴ N. Selzner,¹ L. Lilly,¹ R. Smith,¹ E. Renner,¹ J. Zhang,¹ D. Grant,¹ O. Adeyi,¹ H. Atkins,² P. Juni,³ G. Levy.¹
Rituximab Interference in B-Cell Crossmatch: A Problem Solved

P. Malvezzi,¹ O. Senoussi,² T. Jouve,¹ C. De Palma,² L. Rostaing,¹ B. Bardy,² D. Masson.²
Robust Hematopoietic Mixed Chimerism and Donor-Specific Skin Allograft Tolerance after Non-Genotoxic Anti-CD117 Immunotoxin Conditioning and Donor Bone Marrow Allotransplantation

Z. Li,¹ A. Czechowicz,^2,3,4,5,6,7 A. Scheck,^2,3,4,5,6 D. Rossi,^3,4,5,6 P. Murphy.¹
Serelaxin-Notch1 Signaling Promotes Macrophage M2 Differentiation and Alleviates Hepatocellular Damage in Orthotopic Liver Transplantation: From Mouse-to-Human

S. Kageyama,¹ K. Nakamura,¹ B. Ke,¹ R. Sosa,² E. Reed,² F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Short- and Long-Term Outcomes of Interventional Radiology Treatment for Vascular Complications Following Living Donor Liver Transplantation: The Efficacy of Stent Placement

S. Mizuno,¹ A. Nakatsuka,² A. Hayasaki,¹ U. Iizawa,¹ H. Kato,¹ Y. Murata,¹ A. Tanemura,¹ N. Kuriyama,¹ Y. Azumi,¹ M. Kishiwada,¹ M. Usui,¹ H. Sakurai,¹ H. Sakuma,² S. Isaji.¹
T Cell Exhaustion Contributes to Operational Tolerance of Liver Allografts in Pediatric Liver Transplant Recipients

B. Ramaswami,¹ M. Marrari,² O. Yoshida,⁵ X. Guo,³ W. Hoffman,³ C. Bentlejewski,² D. Metes,¹ A. Demetris,^1,2 A. Zeevi,² A. Thomson,¹ G. Mazariegos,⁴ G. Chalasani.^1,3
Taking Your Center's Temperature: Using a Heat Map to Target Your Transplant-Specific Education for Regulatory Compliance

J. Anderson, D. Cassidy, D. Dubay, P. Hart, A. Hauser, N. Pilch.
The Cost Savings of Preemptive Kidney Transplantation

P. Dean,¹ H. Heien,² K. Swanson,² B. Borah,² L. Sangaralingham,² J. Naessens,² M. Stegall.¹
The Effect of Perioperative Antiplatelet/Anticoagulant Therapy on the Incidence of Early Postoperative Thromboembolic Complications and Bleeding in Kidney Transplantation – A Dual Center Retrospective Cohort Study of 2000 Kidney Transplant Recipients

T. van den Berg,¹ R. Minnee,² G. Nieuwenhuijs-Moeke,³ S. Bakker,⁴ R. Pol.¹
The Impact of Early versus Late Clinical Outcomes on Disparities in African-American Kidney Transplant Recipients

D. Taber, J. Fleming, Z. Su, P. Mauldin, J. McGillicuddy, S. Nadig, V. Rohan, P. Baliga, D. Dubay.
The Living Donor Lost Wages Trial: Study Rationale, Protocol, and Update

J. Rodrigue,¹ M. Pavlakis,¹ A. Evenson,¹ A. Fleishman,¹ M. Carroll,¹ D. Mandelbrot,² P. Baliga,³ D. Howard,⁴ J. Schold.⁵
Thirty-Six Consecutive Kidney Transplants in Recipients with Atypical Hemolytic Uremic Syndrome: A Single-Centre Experience

E. Favi,¹ G. Ardissino,² D. Cresseri,³ J. Brocca,¹ S. Testa,⁴ F. Tel,⁴ A. Giussani,¹ C. Colico,¹ C. Beretta,¹ M. Ferraresso.¹
Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors

K. Dessaix,¹ C. Bontoux,² O. Aubert,¹ J. Zuber,¹ R. Sberro Soussan,¹ V. Frémeaux-Bacchi,³ M. Le Quintrec,⁴ C. Legendre,¹ M. Rabant.²
Using the Explore Transplant Ontario Program to Increase Transplant Knowledge and Readiness among Patients on Maintenance Dialysis

D. Belenko,¹ C. Richardson,¹ V. Gupta,¹ T. Ahmed, N. Edwards, M. Novak,² J. Peipert,³ A. Waterman, I. Mucsi.
β-Glucuronidase Gene Expression in Stool Samples Associated with Chronic Allograft Dysfunction in Kidney Transplants

A. Israni,^1,2 D. Knights,³ G. Al-Ghalith,³ A. Muthusamy,² B. Wu,⁴ W. Oetting,⁵ D. Schaldt,² R. Remmel,⁵ P. Jacobson,⁵ For DeKAF Genomics & GEN03 Investigators.¹
“I'll Be Back”: Increasing Readmission Rates in the Era of the New Kidney Allocation System

N. Pilch, C. Mardis, H. Meadows, J. Fleming, N. Patel, C. Perez, P. Baliga, D. Dubay, V. Rohan, V. Rao, D. Taber.
“Majority Rules”: A Method to Reduce Variability in Diagnosing Antibody Mediated Rejection in Renal Allograft Biopsies Using Banff 2013

B. Smith,¹ L. Cornell,¹ M. Smith,² C. Cortese,³ X. Geiger,³ C. Schinstock,¹ W. Kremers,¹ M. Stegall.¹
10-Year Outcomes of Renal Transplantation from Circulatory Death Donors with Increased Terminal Creatinine

Y. Tomita, K. Iwadoh, I. Nakajima, S. Fuchinoue.
12-Months Evolution of Anti-HLA Antibodies Donor Specific Antibodies after Rescue Switch from CNi-Based Immunosuppressive Regimen to Belatacept in Kidney Allograft Recipients

M. Matignon,¹ C. Dudreuilh,¹ P. Rémy,¹ J-.L. Taupin,² P. Grimbert.¹
28-Year Cumulative US Experience with Pediatric Living Donor Liver Transplant – How Far Have We Come?

S. Sharma, K. Barrera, A. Gruessner, R. Gruessner.
Clostridium difficile Recurrence in Abdominal Organ Transplant Recipients: Metronidazole versus Oral Vancomycin

A. Moorman,¹ S. Todd,¹ G. Lyon III,² H. Triemer.¹
Ex Vivo Bloodless Oxygen Carrier for Perfusion of DCD Kidneys during Subnormothermic Storage

P. Luke,^1,2 M. Richard-Mohamed,² A. Haig,³ R. Mayer,² S. Aquil,² A. Sener,² A. Jevnikar,^1,2 R. Bhattacharjee.^1,2
In Vitro Evaluation of Antibiotic Persistence in Pseudomonas aeruginosa and Staphylococcus aureus Isolates from Cystic Fibrosis Patients

J. Fose, D. Bruckbauer, M. Jorgenson, W. Rose.
In Vivo Administration of Plerixafor and Bortezomib Results in Bone Marrow Plasma Cell Mobilization and Death While Inducing Biphasic Plasma Cell Apoptosis in Peripheral Blood

E. Woodle,¹ S. Tremblay,¹ C. Castro-Rojas,² S. Knechtle,³ A. Shields,¹ R. Alloway,¹ H. Singh,² J. Driscoll,¹ D. Hildeman.²
Mycoplasma hominis Infection in Lung Transplant Recipients: A Retrospective Case Series

J. Wright,^1,2 N. Law,⁴ M. Murray, S. Poutanen,^1,2 S. Husain,¹ S. Keshavjee,¹ L. Singer,¹ A. Humar,¹ D. Kumar.¹
A “Multi-Omic” Analysis of Proteome and Metabolome for Acute Rejection and PVAN in Kidney Transplantation

T. Sigdel, J. Yang, M. Sarwal.
A 5-Tier System for Categorizing Program-Specific Adjusted Transplant and Waitlist Mortality Rate Ratios

A. Wey, N. Salkowski, B. Kasiski, A. Israni, J. Snyder.
A Calculated Panel Reactive Antibody (CPRA) Calculator Supporting Both Allele-Level and Antigen-Level HLA Specificities

L. Gragert,^1,2 E. Kransdorf,³ N. Kaur,¹ M. Maiers,² J. Kobashigawa,³ M. Pando.⁴
A Comparison of Alemtuzumab versus Antithymocyte Globulin Induction in High-Risk, Non-Sensitized Renal Transplant Recipients

S. Patel, A. Lichvar, E. Benedetti, P. West-Thielke.
A Comparison of the Discard Rate in Hepatitis C Deceased Liver Donors between Two Eras, 2008-2013 and 2014-2017. A Single Organ Procurement Organization Experience

M. Nazzal,¹ G. Marklin,² O. Okoye,¹ Y. Kim,¹ R. Ouseph.¹
A Cost Analysis on Normothermic Machine Perfusion at a Single Center

D. Pezzati, Q. Liu, H. Hassan, G. Iuppa, L. Hernandez, G. D'Amico, T. Diago Uso, B. Heghtsad, C. Miller, C. Quintini.
A Decade of Dual Kidney Transplantation Reveals Excellent Patient Outcomes from Otherwise Discarded Organs

I. Rajput, S. Farid, A. Hakeem, M. Jameel, N. Ahmad, O. Masood.
A High Abdominal Aortic Calcification Score by Dual X-Ray Absorptiometry (DXA) is Associated with Cardiovascular Events after Kidney Transplantation

S. Benjamens,^1,2 R. A. Pol,¹ A. W. Glaudemans,² I. Wieringa,³ S. P. Berger,³ S. J. Bakker,³ R. H. Slart.²
A Long-Term Experience with Expansion of Milan Criteria for Liver Transplant Recipients

S. Commander,¹ B. Shaw,¹ L. Washburn,² D. Yoeli,² A. Rana,² J. Goss.²
A Machine Learning Approach for Prediction of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

S. Kawakita,¹ A. Waterman,^1,2 M. Everly.¹
A Meta-Analysis for Induction Therapy of Kidney Transplantation: Comparison of Antithymocyte Globulin and Interleukin 2 Receptor Antagonist

G. Chen, Z. Wu, C. Wang, X. Liu, C. Wang, L. Chen.
A Mobile App to Improve Medication Adherence in Kidney Transplant Recipients – Analysis of a Prospective Interventional Study

F. Halleck, S. Georgi, D. Khadzhynov, D. Schmidt, E. Schrezenmeier, L. Lehner, P. Glander, K. Budde, O. Staeck.
A National Survey of Valganciclovir Dosing Strategies in Pediatric Solid Organ Transplant Recipients

S. Shaikh, N. Panek, J. Park.
A Natural Herb Danshen Suppresses Allospecific Memory CD8+ T Cell Generation and Murine Allograft Rejection

Z. Dai, H. Liu, Y. Chen, C-.L. Liang, F. Qiu.
A New Reality: Virtual Crossmatch Can Be Used Successfully as Pre-Transplant Compatibility Testing for Most Deceased Donor Transplants at a High Volume Center

R. Rajalingam,¹ D. Gae,¹ Z. Laszik,² G. Roll,³ M. Tavakol,³ C. Freise,³ D. Adey,⁴ A. Webber,⁴ D. Dobi,² K. Cunniffe,¹ G. da Gente,¹ N. Ascher,³ P. Stock,³ J. Roberts.³
A Novel Combined Formula to Direct Optimal Immunosuppressive Drug Exposure in Renal Transplant Recipients

O. Pankewycz,¹ E. Onan,² M. Laftavi,¹ R. Gruessner,³ H. Smileuski,¹ E. Alissandrello,¹ A. Gruessner.³
A Novel Endothelial Cell Based Complement Dependent Cytotoxicity Test in Kidney Transplantation

R. Lammerts,¹ J. van den Born,¹ W. Dam,¹ M. Seelen,¹ B. Hepkema,² B. Kroesen,² M. Daha,¹ R. Pol,³ S. Berger,¹ On behalf of the COMBAT Consortium.¹
A Novel Protocol to Improve Kidney Transplant Outcomes in Patients with Renal Disease Due to Amyloidosis

A. Langone, B. Concepcion, D. Slosky, R. Cornell, S. Horst, S. Goodman.
A Novel, Dose-Adjusted Tacrolimus Intrapatient Variability Model Identifies High-Risk Kidney Transplant Recipients Better Than Existing Methodologies

J. Kim, S. Wilson, Y. Song, J. Schwartz.
A Phase I/II, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

S. Jordan,¹ J. Choi,¹ O. Aubert,² M. Haas,³ A. Loupy,² E. Huang,¹ A. Peng,¹ I. Kim,¹ S. Sethi,¹ S. Louie,¹ D. Puliyanda,¹ A. Vo.¹
A Population Based Study of Incidence of Post Kidney Transplant Malignancies

D. Sexton,¹ J. O'Neill,² P. O'Kelly,¹ S. Murray,¹ S. Deady,³ E. O'Leary,³ P. Morris,⁴ P. Conlon.¹
A Proteomic Analysis of Kidneys Subjected to Normothermic Ex Vivo Kidney Perfusion (NEVKP) Demonstrates That Metabolism is an Important Determinant of Kidney Function Following Warm Ischemia

A. Konvalinka,^1,4 T. Tokar,² S. Reid,⁴ P. Urbanellis,⁴ M. Hamar,⁴ M. Kaths,⁴ I. Jurisica,² L. Robinson,^4,3 M. Selzner.^4,5
A Protocol for the Management of Alemtuzumab Induced Leukopenia in Kidney Transplant Recipients

S. Hammad, B. Ravichandran, M. Crist, B. Masters.
A Research-Informed Framework for a Medication Adherence Intervention to Support Transition of Adolescent Kidney Recipients to Independent Medication-Taking

T. Irizarry,¹ A. DeVito Dabbs,¹ M. Dew,¹ B. Foster.²
A Retrospective Review of De Novo Coccidioidomycosis among Remote Solid Organ Transplant Recipients in Arizona

T. Zangeneh,¹ J. August,¹ N. Beatty,¹ K. Asbury,² L. Mi,² J. Blair.²
A Review of Pediatric Drug Development Programs and FDA Labeling for Immunosuppressive Drugs in Organ Transplant Patients

G. Burckart,¹ M. Cavaillé-Coll,² A. Duong,³ L. Hothem,⁴ R. Albrecht.²
A Single Center Outcomes Analysis of UNOS Defined "Hard to Place Kidneys"

Y. Qazi, K. Lee, A. Jones, L. Aguirre, M. Parma, M. Smogorzewski, T. T. Maw, L. Sher.
A Six-Month, Prospective, Single-Center, Pilot Study to Determine the Pharmacokinetics and Effectiveness of Immunosuppressant Regimens in Liver Transplantation Patients Receiving Twice-Daily Tacrolimus and Everolimus (TAC + EVR BID) Regimen Converted to Once-Daily Tacrolimus and Everolimus (TAC + EVR QD) Regimen – A Priliminary Report

T-.H. Wu, C-.H. Cheng, Y-.C. Wang, C-.F. Lee, T-.J. Wu, H. Chou, K-.M. Chan, W-.C. Lee.
A Theoretical Framework to Explain Factors That Impact Completion of the Medical Evaluation Process for African American (AA) End-Stage Renal Disease (ESRD) Patient

C. Nonterah,¹ H. Gardiner,² D. Vavra.¹
ABO Incompatible Deceased Donor Kidney Transplantation – Time to Remove the Barrier

J. Melancon,¹ M. Nayebpour,² K. Mahendran,¹ H. Spivak,¹ N. Koizumi.²
ABO‐incompatible Deceased Donor Liver Transplantation

X. Luo, C. Haugen, A. Thomas, J. Garonzik-Wang, D. Segev.
AMD3100 (Plerixafor) as a Single-Dose Stem Cell Mobilizing Agent in Vascularized Composite Tissue Allograft (VCA) Transplantation in a Canine Model

B. Swearingen,^1,2 S. Graves,^2,3 R. Storb,^2,3 D. Mathes.^1,2
APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO)

G. Guerra,¹ E. Poggio,² M. Ortigosa-Goggins,¹ M. Doshi,³ B. Freedman,⁴ D. Reboussin,⁴ P. Kimmel,⁵ APOLLO Investigators.
Absence of Rejection in a Facial Allograft Recipient with a Postive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20+ Monoclonal Antibody

B. Gelb,¹ J. Diaz-Siso,² N. Plana,² A. Jacoby,² W. Rifkin,² K. Khouri,² D. Ceradini,² E. Rodriguez.²
Accommodation and Antibody Mediated Rejection Are Associated with Distinct TACI Polymorphisms in Kidney Transplant Recipients

M. Cascalho, M. Barbosa,¹ E. Farkash,² J. Platt.¹
Activation Requirements of Costimulation Blockade-Resistant CD4 T Cells

J. Espinosa, B. Adams, J. Kearns, F. Shaw, R. Osborne, T. Woody, M. Ellis, J. Cheeseman, A. Kirk.
Acute Antibody Mediated Rejection Treatment Impact on Class I and Class II Anti-HLA Antibodies in Pediatric Kidney Transplant Recipients

E. Kincaide,^1,2,3 K. Hitchman,^1,3 R. Hall,^1,2,3 I. Yamaguchi,³ B. Crowther.^1,2,3
Adjunctive Corticosteroid Immunosuppression Improves Hyperbilirubinemia Following Liver Transplantation (OLT)

G. Malat, D. Reich, G. Xiao, M. Harhay, K. Ranganna, D. Lee, S. Guy, S. Munoz.
Adjusted Body Weight Dosing of Rabbit Antithymocyte Globulin in Obese Renal Transplant Recipients Preserves Excellent Clinical Outcomes at 3 Years and Improves the Value of Care

J. Dann, A. Agarwal, M. Bradley, W. Ally.
Adult-Sized Kidneys Transplanted into Infants and Small Children: Outcomes after Implementing Aggressive Fluid Regimen and Medications to Support Post-Transplant Perfusion

V. Sigurjonsdottir, P. Grimm, A. Chaudhuri.
Advanced Liver Care and Salvage Transplantation Improves Outcomes for Patients with Cirrhosis Requiring Abdominal General Surgical Procedures

D. Milgrom,¹ N. Valsangkar,¹ J. Kays,¹ T. Liang,¹ J. Butler,¹ C. Kubal,¹ M. Maluccio,¹ A. Tector,² L. Koniaris.¹
Advancement in Perioperative Outcomes of Living Donors in Pure Laparoscopic Right Hepatectomy

Y. Choi, H. Han, Y. Yoon, J. Cho, B. Lee.
Age Difference between Donor and Recipient Predisposes to Early Interstitial Fibrosis and Tubular Atrophy in Pediatric Kidney Transplantation

S. Panombualert, M. Pearl, P. Weng, R. Ettenger.
Age Stratified Efficacy and Safety Outcomes of Induction Immunosuppression in Renal Transplantation

D. McKimmy,¹ H. Kuzaro,² S. Sakya,³ K. Belfield,¹ E. Cohen.¹
Age-Specific Effects of Tacrolimus Are Associated to Specific Changes of T Cell Metabolism

Y. Nian, T. Heinbokel, K. Minami, R. Abdi, A. Elkhal, S. Tullius.
Aggressive Pursuit of Donation after Cardiac Death Kidney Donors with High Kidney Donor Profile Index: Good Use of Resources?

J. Rogge, C. Hostetler, B. Nicely, S. Rudich.
Air Pollution Can Support the Development of Cardiac Allograft Vasculopathy

C. Bara,¹ M. Barten,² D. Boethig,¹ Y. Scheibner,¹ J. Tauber,² H. Reichenspurner,² A. Haverich.¹
Alemtuzumab Induction as a Mediator of Nonadherence in Renal Transplantation

G. Mitro, O. Ekwenna, M. Rees, J. Ortiz.
Alemtuzumab Induction is Effective and Safe in Elderly Kidney Transplant Recipients

A. Toledo, K. Szempruch, P. Serrano, K. Andreoni, T. Kozlowski.
Allogeneic Mesenchymal Stem Cells as Induction Therapy Are Safe and Feasible in Renal Allografts: Pilot Results of a Multicenter Randomized Controlled Trial

Q. Sun,¹ F. Han,¹ M. Zhao,² R. Cao,³ D. Zhao,¹ Z. Huang,¹ L. Hong,¹ Y. Peng,¹ Q. Sun.¹
Amiodarone Use Increases Morbidity Not Mortality in Pediatric Heart Transplant Recipients

S. Amdani, A. Dalal, K. Simpson, J. Scheel, A. Abarbanell, P. Eghtesady, C. Canter, C. Castleberry.
An Economic Analysis of the UK Pancreas Allocation Scheme

K. Burke,¹ S. Birch,^2,3 T. Augustine.¹
An Enhanced Educational Program for Kidney Transplant Candidates and Their Supports: Knowledge Gained but Room for Improvement

E. Clifton, A. Eshelman, D. Kim, A. Patel, P. Williams, D. Nicholson, K. Hogan, E. Rubinstein, D. Ramirez, N. Sadik, M. Jesse.
An In Vitro Model of Human Antibody-Mediated Rejection Depicts Key Role for NK Cells

L. Hidalgo,¹ M. Racape,² A. Loupy,² C. Lefaucheur.²
An Initial Experience with the Endowrist Robotic Endostapling Device for Renal Donor Nephrectomy

M. Tan, H. Pollinger.
An Open-Label Proof-of-Principle Phase 2a Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

A. Chruscinski,¹ H. Atkins,² M. Macarthur,¹ C. Anne Marie,² D. Grant,¹ C. Bredsen,² E. Renner,¹ L. Lilly,¹ N. Selzner,¹ O. Adeyi,¹ R. Smith,¹ S. Moshkelgosha,¹ A. Humar,¹ S. Juvet,¹ G. Levy.¹
Analysis of Circulating CD38+/CD138+ Plasma Cells during Development of De Novo Donor Specific Antibody Responses

N-.N. Chai, G. Wu, I. Kim, S. Jordan, A. Klein.
Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection

C. McDermott, K. Carsky, P. Ferrin, A. Gaines, D. Chernobylsky, M. Killackey, A. Paramesh, R. Zhang, J. Buell.
Analysis of Human Islet Damage during In Vitro Culture Using miRNA 375

Y. Shindo,¹ M. Levy,^1,2 M. Kanak.¹
Analysis of NIH Research Funding in Transplantation: The Important Impact of Physician-Scientists in Abdominal Transplant Research

A. Narahari, J. Mehaffey, A. Chandrabhatla, P. Baderdinni, L. Kron, K. Brayman.
Analysis of Patient Reported Outcomes for Patients That Received Living Donor Kidney Transplants

E. Venniro,^1,2 J. Taylor.^1,2
Analysis of Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction in Pediatric Liver Transplant Recipients

D. Newland,¹ M. Royston,¹ D. McDonald,¹ K. Wallace-Boughter,² T. Németh,¹ K. Carlin,³ S. Horslen.²
Analyzing Transplant Medication Myths

R. Krislock, J. Brandenberger, P. Stracener, A. Weiss, K. Wipperling, C. Kuhr.
Angiotensin II Type 1 Receptor Antibodies as Markers of Post Transplant Focal Segmental Glomerulosclerosis and Proteinuria

A. Aala, M. Philogene, N. Alachkar.
Anti-Thymocyte Globulin vs. Alemtuzumab: A Comparison of Long-Term Outcomes among Renal Transplant Recipients

E. Loncharic, A. Dodson, K. Gutierrez.
Antiproteinuric Effect of Spironolactone in Renal Transplantation: Effectiveness and Clinical Outcomes

M. Sousa, C. Do Valle, G. Rivelli, L. Camargo, R. Zollner, M. Mazzali.
Application of RNA-Seq Derived Diagnostic Algorithms of T-Cell Mediated Kidney Rejection (TCMR) to DNA Microarray-Based Gene Expression Datasets

Z. Wang,¹ L. Pan,² Z. Lyu,² P. Liu,³ G. Tseng,³ P. Randhawa.¹
Aquaporin 4 Blockade Alters T Cell Trafficking through a Novel Mechanism of S1PR1 Regulation

M. Nicosia,¹ R. Fan,¹ S. Miyairi,¹ A. Beavers,¹ G. Farr,² P. McGuirk,² M. Pelletier,² A. Valujskikh.¹
Artificial Graft Extension of Renal Vein in Living Kidney Transplantation

S. Cho,¹ W. Cho,¹ M-.J. Cho,¹ C. Choi,¹ S. Ahn,¹ S-.I. Min,¹ S-.K. Min,¹ S. Kim,² J. Ha.¹
Assesment of a Novel Chronic Kidney Disease Educational and Goal Setting Tool among Liver Transplant Recipients

R. Leek,¹ J. Park,¹ C. Koerschner,² J. Mawby,³ J. Wright Nunes,⁴ C. Sonnenday,³ P. Sharma.²
Assessing Fibrosis Burden in Renal Allograft with Chronic Damage Using Functional Magnetic Resonance Imaging

J. Wen,¹ W. Wang,² X. Ni,¹ Y. Yu,³ J. Chen,¹ L. Zhang,³ Z. Liu.¹
Assessing Necroptosis in Brain Dead Kidney Donors: Implications for Predicting Recipient Outcomes

A. Zmijewska, J. Murphy, J. Chen, J. Zmijewski, R. Mannon.
Assessing Renal Transplant Candidate Survival at Listing Using a Risk-Adjusted Multi-State Semi-Markov Model

S. Mehrotra,¹ V. Kilambi.²
Assessing Response to Desensitization: What Makes Sense?

E. Kransdorf, J. Patel, M. Kittleson, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Assessing the Impact of Flow in Hypothermic Machine Perfusion on Human Venous Endothelium Using a Novel Ex Vivo Model

Y. Marie,¹ W. Ries,² K. Patel,¹ C. Turnbull,² N. Jamil,⁴ H. Caldwell,³ R. Telfer,² D. Neil,⁵ J. Nath,¹ N. Inston.¹
Assessment of Anti-CMV Immunity by Monitoring Anti-CMV Antibody (CMV-Ab) and CMV-Specific Cytotoxic T Cells (CMV-Tc) in Pediatric Kidney Transplant Recipients (Ped KTx Pts)

B. Shin,¹ H. Pizzo,² S. Jordan,² D. Lovato,¹ A. Petrosyan,¹ D. Puliyanda,² M. Toyoda.¹
Assessment of Anxiety, Fatigue and Depression in Pediatric Liver Transplant Recipients Using PROMIS Measures: A Pilot Study

S. Mohammad, M. Riordan, K. Neighbors, E. Alonso.
Assessment of Bile Production and Quality during Normothermic Ex Vivo Liver Perfusion to Predict Biliary Injury

D. Kollmann,¹ I. Linares,¹ S. Ganesh,¹ R. Rosales,¹ M. Hamar,¹ P. Urbanellis,¹ A. Wiebe,¹ P. Yip,² O. Adeyi,² M. Selzner,¹ N. Selzner.¹
Assessment of Donor Specific Anti-HLA Antibodies throughout SLK Transplantation

P. Jindra, M. Kueht, S. Gray, D. Giang, M. Cusick, A. Rana, B. Murthy, W. Etheridge, J. Goss, R. Kerman.
Assessment of Methenamine Hippurate for the Prevention of Recurrent Urinary Tract Infections in Adult Renal Transplant Recipients: A Single Center, Retrospective Study

I. Hollyer,¹ F. Varias,³ B. Ho,¹ M. Ison.¹
Assessment of Peak Levels and Metabolism Rates in African American (AA) and Non-AA Kidney Transplant Recipients (KTR) on Immediate-Release Tacrolimus (IR-tac)

T. Horwedel,¹ R. Sodhi,² D. Tsapapas,³ M. Mills,⁴ S. Patel,⁴ G. Towns.⁵
Association between Donor/Recipient BK Viral Serostatus and Risk of BK Viraemia Post-Transplantation

S. Chong,¹ C. Atkinson,² N. Banga,¹ M. Harber,¹ M. Reeves,² C. Magee.¹
Association between Genetic Polymorphisms of Fc Gamma Receptor Genes (FcgR) and the Development of Donor Specific Antibodies (DSA) after Kidney Transplant

D. Min,¹ Y. Chang,² T. Shah.³
Association of Immunosuppressive Therapy Regimen with Sepsis Outcomes among Kidney Transplant Recipients

J. Donnelly,¹ P. MacLennan,¹ R. Mannon,¹ R. Saran,² J. Baddley,¹ H. Wang,³ G. McGwin, Jr.,¹ P. Muntner.¹
Association of Physical Function and Survival in Elderly Renal Transplant Recipients

A. Brar,¹ F. Tedla,¹ M. Salifu,¹ R. Gruessner,² D. John,² N. Sumrani,² A. Gruessner.¹
Associations among Physical Fitness/function, Pain and Depression in Kidney Transplant Patients

A. Kastelz,^1,2 I. Tzvetanov,¹ B. Fernhall,² A. Shetty,³ L. Gallon,³ G. Hachaj,⁴ E. Benedetti.¹
Attitudes of African Canadian Patients with End Stage Kidney Disease toward Living Donor Kidney Transplantation

V. Gupta, C. Richardson, D. Belenko, N. Singh, A. Xu, P. Thiagalingam, D. Wong, H. Ford, M. Novak, I. Mucsi.
Autologous Adipose-Derived Stem Cells with In Vivo Immunomodulatory Properties Can Be Generated in Allograft Recipients under Immunosuppression

A. Sicard,¹ J. Rodriguez,² P. Petruzzo,³ J. Kanitakis,⁴ O. Damour,² L. Badet,⁵ A. Gazarian,⁶ F. Buron,¹ O. Thaunat,¹ K. Tarte,⁷ C. Mesnard,⁷ C. Auxenfans,² E. Morelon.¹
Automated Systems to Identify and Address Adherence Barriers Result in Sustained Reduction of Late Allograft Rejection

D. Hooper, C. Varnell, Jr., K. Rich, J. Huber, D. Dahale, A. Carle, A. Pai, A. Modi.
Autophagy Impacts Specificity and Characteristics of Innate Alloimmune Responses in Aging

T. Heinbokel, K. Minami, Y. Nian, A. Elkhal, S. Tullius.
BK Nephropathy in Non-Kidney Transplant Patients, a Case Series and Systematic Review of the Literature

A. Shah,¹ V. Kumar,² B. Laskin,^2,3 D. Sawinski,^1,2 J. Hogan.^1,2
BLyS^-/- Rats to Prevent Alloantibody Production

N. Bath,¹ B. Verhoven,¹ N. Wilson,¹ S. Reese,² L. Coons,¹ S. Panzer,² A. Djamali,² R. Redfield.¹
Bacterial Complications in Liver Transplant Recipients Undergoing Biliary Tract Manipulation: Effect of an Antibiotic Prophylaxis Protocol

C. Clifford, N. Theodoropoulos, J. Daly, L. Gibson, S. Mehta, H. Malik, A. Bozorgzadeh.
Barriers and Disparities in Listing for Pediatric Solid Organ Transplant

E. A. Steinberg,¹ C. Buchanan,¹ M. Wachs,¹ S. Schmiege.²
Basiliximab Induction in HIV-Positive Renal Transplant Recipients Compared to an HIV-Negative Cohort

J. Schulte,¹ C. Richardson,¹ V. Stosor,² K. Cunningham,¹ C. D'Agostino,¹ C. Kane.¹
Basiliximab Induction in Simultaneous Liver-Kidney Transplant

C. Song, X. Luo, L. Pote, S. Strout, D. Segev, N. Desai, A. Gurakar, F. Navqi, J. Garonzik Wang.
Belatacept and Tacrolimus Corticosteroid-Free Regimens Lead to Elevated Mycophenolic Acid Exposure at 1 and 3 Months after Kidney Transplantation

A. Dao, S. Tremblay, A. Shields, A. Loethen, B. Abu Jawdeh, T. Diwan, A. Govil, E. Woodle, R. Alloway.
Belatacept-Refractory CD8⁺CD28^–CD38^hi Effector/Memory T Cells Are Targeted by mTOR Inhibition Leading to a Preferential Loss of CD40L

C. Castro Rojas,¹ A. Godarova,¹ A. Rike Shields,² R. Alloway,² M. Jordan,³ E. Woodle,² D. Hildeman.¹
Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function

J. Lee,¹ D. Kim,¹ J. Lee,² S. Kim,³ H. Lee,⁴ S. Song,⁵ J. Lee,¹ M. Ju,¹ G. Choi,¹ D. Joo,¹ J. Choi,¹ S. Kim,¹ Y. Jung.¹
Benefit of Patient Portal Usage in Non-High Risk Kidney Transplant Recipients

A. Osband, J. Machan, P. Morrissey.
Biliary pH, Bicarbonate and Glucose Are Suitable Biomarkers of Bile Duct Viability during Normothermic Machine Perfusion of Human Donor Livers

A. Matton,^1,2 Y. de Vries,^1,2 L. Burlage,^1,2 R. van Rijn,^1,2 A. Gouw,³ V. de Meijer,¹ T. Lisman,² R. Porte.¹
Biochemistry Profiles Following Pig-to-Nonhuman Primate Liver Xenotransplantation

N. Louras, M. Patel, J. Shah, D. Sachs, P. Vagefi.
Blood Transfusion is a Critical Determinant of Resource Utilization and Total Hospital Cost in Liver Transplantation

C. Garcia, A. Dugan, D. Davenport, R. Gedaly.
Bloodstream Infection Caused by Enteric Organisms during the First 6 Months after Intestinal Transplant

J. Simkins,¹ J. Morillas-Rodriguez,¹ M. Morris,¹ L. Abbo,¹ J. Camargo,¹ R. Vianna.²
Bone Marrow Derived Myeloid Suppressor Cell (BM-MDSCs) Prolongs the Graft Survival in Murine Heart Transplantation

K. Uchida, K. Fujimoto, K. Takeda, H. Bashuda, E. Yin, K. Okumura.
Building a Third-Party VST Bank from Scratch- The Cincinnati Experience

A. S. Nelson,¹ D. Heyenbruch,² X. Zhu,³ S. M. Davies,¹ C. Lutzko,³ C. Bollard,⁴ P. Hanley,⁴ T. Leemhuis,² L. Danziger-Isakov,⁵ M. S. Grimley.¹
Burden of Infectious Complications after Upper Extremity Allotransplantation: A Matched Cohort Study

A. Conrad,^1,2,3 P. Petruzzo,^4,5 J. Kanitakis,⁶ A. Gazarian,⁷ L. Badet,^3,8 P. Vanhems,^3,9 O. Thaunat,^1,3,10 E. Morelon,^1,3,10 A. Sicard.^1,3
C4d Staining and Graft Survival in Renal Transplant Recipients

N. Mohiuddin, S. Agarwal, A. Patel, R. Prashar.
CD8-Expressing Transitional B Cells Dominate B Cell Reconstitution in Transplanted Monkeys Receiving Mixed Chimerism Conditioning

K. Pruner, J. Paster, S. Wiebke, O. Jane, H. Isabel, D. Abbas, B. Gilles, M. Joren.
CMV Viremia and Development of CMV-Specific Cytotoxic T-Cells (CMV-Tc) in Pediatric Renal Transplant Recipients

H. Pizzo, B. Shin, M. Toyoda, S. Jordan, D. Puliyanda.
CMV and BKV Infections after Kidney Transplantation: Combined Tacrolimus/everolimus Strategy Using Antithymocyte Globulin Induction

T. Jouve,^1,4 R. Germi,^2,4 B. Janbon,¹ G. Fiard,^3,4 P. Malvezzi,¹ L. Rostaing.^1,4
CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation

A. Meesing,¹ R. Abraham,² R. Razonable.¹
CT Based Anthropometric Visceral Fat Measures Predict Complexity, Complications and Low Clearance in Living Donor Nephrectomy

Z. Ahmed,¹ D. Bordom,¹ J. Brown,¹ B. Ridley,¹ R. Uwechue,¹ P. Chandak,¹ N. Kessaris,¹ N. Kurunanithy,² N. Mamode.¹
Calcineurin Inhibitors, Macrolides, and the Risk of Adverse Drug Events in Kidney Transplant Recipients

R. Jeong,¹ R. Quinn,² P. Ravani,² K. Lentine,³ A. Lloyd,¹ B. Hemmelgarn,² K. Wen,¹ B. Braam,¹ S. Gourishankar,¹ A. Wong,¹ N. Lam.¹
Can We Optimise Immunosuppression Strategies in Our Older Renal Transplant Recipients?

M. Morton,¹ K. Parker,¹ C. Morecroft.²
Cancer Incidence after Kidney Transplantation in Saudi Arabia, Comparing Different Induction Agents

H. AlEid, S. Raza, T. Ali, I. Alahmadi, S. Aleid, D. Broering.
Cannabis Use in Liver Transplant Recipients: A Single Center Experience

J. Lee, M. Valadez, E. Moreno, D. Markovic, V. Agopian, J. DiNorcia, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Cardiac MRI May Help to Determine When to Refer Heart Transplant Patients for Redo Heart Transplant

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cardiovascular Risk and Subclinical Vascular Damage in Patients after Pediatric Liver Transplantation

H. Wilke,¹ N. Memaran,¹ I. Goldschmidt,¹ B. Borchert-Mörlins,¹ A. von Wick,¹ E. Bauer,¹ R. Blöte,¹ B. Schmidt,² A. Melk.¹
Change in Estimated Glomerular Filtration Rate Pre and Post Development of Donor-Specific Antibodies after Kidney Transplantation

B. Ho,¹ S. Montag,^1,2 H. Bhagat,³ K. Atiemo,¹ A. Daud,¹ R. Kang,¹ L. Zhao,^1,2 J. Schwartz,³ D. Ladner.¹
Change of Bone and Mineral Metabolism in Kidney Donors after Uninephrectomy; Prospective Observational Study

E. Ko,^1,2 H. Cho,^1,3 B. Choi,^1,2 C. Park,^1,2 Y. Kim,^1,2 C. Yang,^1,2 B. Chung.^1,2
Changes in Gene Expression of Selected Genes in Patient with Type 1 Diabetes in Peripheral Blood

M. Klak, J. Cichoń, F. Ambrożkiewicz, A. Berman, M. Serwańska-Świętek, M. Wszoła.
Characteristics and Outcomes among Patients with Failed Extubation after Lung Transplantation

L. Smith, R. Kanade, L. Mahan, S. Bollineni, J. Mullins, V. Kaza, M. Mohanka, M. Wait, F. Torres, A. Banga.
Characteristics and Outcomes of Kidney Transplant Recipients with More Than 25 Years of a Functioning Graft

S. Parajuli, D. Mandelbrot, F. Aziz, N. Garg, M. Mohamed, B. Muth, B. Astor, A. Djamali.
Characteristics of Polyomavirus Nephropathy in Renal Transplant Recipient in China: 10 Year Experience

G. Huang, X. Chen, L. Chen.
Characterization of Mycobacterium Tuberculosis Memory T Cell Subsets in Solid Organ Transplant Recipients with Previously Treated Active Tuberculosis

S. Nellimarla, Y. Natori, V. Ferreira, S. Husain, A. Humar, D. Kumar.
Characterization of Mesenchymal Stem Cell Phenotype and Its Immunomodulatory Effects during Allo-Specific T Cell Immune-Responses

Q. Gao, A. Kirk, H. Xu.
Chronic Antibody Mediated Rejection in Renal Allografts Shows RNA Transcript Patterns That Evolve with Stage

A. Rosales,¹ B. Adam,² M. Mengel,² T. Oura,¹ M. Matsunami,¹ T. Kawai,¹ A. Cosimi,¹ R. Smith,¹ R. Colvin.¹
Chronic Changes on Time Zero Living Donor Allograft Biopsy Portraits Worse Donor Renal Function

A. Nishio-Lucar,¹ J. Murphy,² A. Sites,³ H. Cathro,² A. Doyle,¹ K. Warburton,¹ A. Agarwal.⁴
Chronic Narcotic Use Increases Mortality Rates in Heart Transplantation

G. St. John, T. Chamogeorgakis, H. Nemeh, C. Tita, Y. Selektor, D. Lanfear, C. Williams.
Chronic Rejection: Risk Factors, Clinical Presentation and Outcome in Pediatric Liver Transplant Recipients: A Single Center Experience

T. Miloh, A. Cheng, D. Schady, R. Himes, K. Mysore, K. Hosek, J. Goss.
Circulating Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V, and Immunoregulatory Molecules Are Present in Bronchiolitis Obliterans Syndrome Following Pediatric Lung Transplantation

M. Sharma,¹ L. Danziger-Isakov,² P. Heeger,³ S. Sweet,⁴ T. Mohanakumar.¹
Circulating T Follicular Helper Cells Expand Following Transplantation and Exhibit a CD44^hi Phenotype That Correlates with Peak Germinal Center Alloreactivity

G. La Muraglia II, M. Wagener, M. Ford, R. Badell.
Clinical Analysis of Impact of Intraoperative Hepatic Blood Inflow on Acute Kidney Injury Following Allogeneic Liver Transplantation

J. Zhang, Q. Liu, X. Li, Y. Meng, L. Yang, C. Zhang, N. Sun, A. Jiao, J. Lin.
Clinical Impact of Antecedent Bariatric Surgery on Liver Transplant Outcomes: A Retrospective Matched Case-Control Study

O. Serrano,¹ K. Peterson,¹ D. Vock,² D. Berglund,¹ R. Kandaswamy,¹ J. Lake,³ T. Pruett,¹ S. Chinnakotla.¹
Clinical Impacts of Deceased Donor Oxygenation Status in Liver Transplant

T. Okamoto,² K. Sasaki,³ H. Niikawa,² M. Fujiki,³ C. Quintini,³ K. Hashimoto,³ C. Miller,³ K. Abu-Elmagd,¹ K. McCurry,² J. Fung.⁴
Clinical Outcomes of HIV-Infected Kidney Transplant Recipients Managed with an Early Corticosteroid Withdrawal Protocol

A. Al Jurdi, E. Liu, M. Aull, M. Lubetsky, D. Serur, S. Kapur, T. Muthukumar.
Clinical Outcomes of Late Conversion to Once-Daily Tacrolimus after Liver Transplant

D. Kim,¹ Y. Jung,¹ J. Lee,¹ J. Lee,¹ S. Kim,² M. Ju,¹ M. Kim,¹ S. Kim,¹ D. Joo.¹
Clinical Outcomes, Care Needs and Adherence in Long Term Intestine Transplant Survivors ≥10 yrs

B. Kosmach-Park,¹ G. Mazariegos.²
Clinical Significance of Isolated v-Lesions in Kidney Transplantation

A. Georgalis,¹ C. Wehmeier,¹ P. Hirt-Minkowski,¹ G. Hönger,¹ H. Hopfer,² J. Steiger,¹ S. Schaub,¹ P. Amico.¹
Clinical Significance of Tacrolimus Trough Level at the Early Period after Kidney Transplantation

W. Park,^1,2 S. Yeo,¹ S. Kang,^1,2 H. Park,¹ K. Jin,^1,2 S. Park,^1,2 S. Han.^1,2
Clinical Trials and Electronic Health Records

J. Chen, S. Bhattachrya, M. Sirota, M. Sarwal, A. Butte.
Clinical Utility and Interpretation of CKD Stages in Living Kidney Donors

A. Massie,¹ M. Henderson,¹ F. Al Ammary,¹ J. Snyder,² D. Segev.¹
Clinical Utility of CMV-Specific CD8+ T-Cell Immune Competence Score in Lung and Heart-Lung Transplant Recipients at Risk of Cytomegalovirus Infection

A. Meesing,¹ R. Abraham,² R. Razonable.¹
Clinically Relevant Variation of Donor-Derived Cell-Free DNA during Longitudinal Surveillance of Renal Allografts

M. Narayanan,¹ T. Alhamad,² D. Hiller,³ J. Yee,³ R. Woodward,³ J. Bromberg.⁴
Closing Pandora's Box: An Evidence Based Approach to Opioid-Tolerant Patients Following Transplantation. The Case for IV Methadone

A. Aljassem, L. Hall, S. Cohn, D. Bedi, M. Alsibae, K. Putchakayala, S. Tasleem, D. Samarapungavan, C. Carpenter, A. Koffron.
Clostridium Difficile Infection after Liver Transplant is Associated with Poor Long-Term Survival

A. Ahearn, P. Mahboub, N. Theodoropoulos, B. Movahedi, P. Martins, M. Campion, R. Nathan, A. Bozorgzadeh.
Cognition after Belatacept Conversion

C. Ogbejesi, E. Cohen, K. Belfield, W. Asch.
Cognitive Function and Health Literacy Assessment Outcomes in the First Months after Renal Transplant in a Diverse Single Center Population

J. Trofe-Clark,^1,2 W. Gbemudu,¹ S. Hamel,¹ J. Shults,¹ R. Neubauer,² S. Ryan,¹ M. Kaminski,¹ D. Sawinski,² S. Goral,² M. Bleicher,² M. Lim,² R. Bloom,² P. Reese.²
Cognitive Impairment Influences Transplant Eligibility

A. Gupta, J. Klein, J. Mahnken, R. Montgomery, A. Ilahe, P. Budhiraja, T. Thomas, T. Schmitt, J. Burns, D. Cibrik.
Cognitive Impairment and Graft Loss in Kidney Transplant Recipients

A. Thomas,¹ J. Ruck,¹ A. Shaffer,¹ C. Haugen,¹ H. Ying,¹ F. Warsame,¹ N. Chu,¹ M. Carlson,¹ A. Gross,¹ S. Norman,² D. Segev,¹ M. McAdams-DeMarco.¹
Colistin (COL) in Solid Organ Transplant Recipients (SOTR): Friend or Foe?

K. Neyra, C. Huauya Leuyacc, C. Kovacs, V. Athans, E. Cober.
Combined Heart–Kidney Compared to Isolated Heart Transplant in Patients with Chronic Kidney Disease – A Single Center Experience

D. Gauvin, A. Bhalla, W. McCallum, A. Vest, N. Goyal.
Comparative Analysis of Alloantigen-Stimulated Gene Expression in HIV(+) Liver Transplant Rejectors versus Non-Rejectors

S. Chu, K. Lee, C. Ward, P. Stock, Q. Tang.
Comparative Analysis of Bone Marrow versus Blood Monocyte-Derived Regulatory Dendritic Cells for Evaluation in a Miniature Swine Vascular Composite Allotransplantation Model

T. Elgendy,¹ D. Kim,² A. Zahorchak,¹ M. Ezzelarab,¹ M. Solari,² A. Thomson.¹
Comparative Cost Analysis of ABO-Incompatible Living Kidney Transplantation

Y. Kakuta,¹ M. Okumi,¹ K. Unagami,² M. Furusawa,¹ H. Ishida,¹ K. Tanabe.¹
Comparing Outcomes between Induction Immunosuppressive Therapies in Simultaneous Liver/Kidney Transplantation

U. Gautam, T. Reichman, J. Yu, S. Koppu, D. Bandyopadhyay, M. Levy, G. Gupta, L. Kamal.
Comparison of Continuous Normothermic Ex Vivo Kidney Perfusion to Hypothermic Preservation Methods in Pig Kidneys Donated after Cardiac Death

M. Hamar,^1,2 P. Urbanellis,¹ D. Kollmann,¹ I. Linares,¹ M. Kaths,¹ D. Bagli,³ A. Konvalinka,⁴ I. Mucsi,¹ A. Ghanekar,¹ L. Robinson,² M. Selzner.¹
Comparison of De Novo Rapamune versus Everolimus Maintenance Immunosuppression; an Interim Analysis

R. Pelletier, A. Rajab, M. Henry, G. Bumgardner.
Comparison of Low Dose and Very Low Dose Extended-Release Tacrolimus / MMF in De Novo Kidney Transplant Recipients- 3 Years Follow-Up

S. Narumi,¹ Y. Watarai,¹ N. Goto,² T. Hiramitsu,¹ M. Tsujita,² M. Okada,¹ K. Futamura,² T. Kobayashi.³
Comparison of No Kasai Portoenterstomy to Failed Kasai: Analysis of UNOS Database

T. Miloh, K. Hosek, S. Harpavath.
Comparison of Outcome in Liver Transplant Patients with Renal Insufficiency and Intraoperative CVVH

J. Gosnell, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Comparison of Outcomes in African-American and White Primary Kidney Transplant Recipients: A Matched-Pair Analysis

F. Tedla, A. Brar, D. John, N. Sumrani, R. Gruessner, A. Gruessner, M. Salifu.
Comparison of Pure Laparoscopic vs Open Living Donor Right Hepatectomy

B. Lee, Y. Choi, H. Han, Y. Yoon, J. Cho.
Comparison of Temperatures for Optimal Preservation of Donor Kidneys during Oxygenated Pulsatile Perfusion

R. Bhattacharjee,¹ M. Richard-Mohamed,² A. Ruthirakanthan,³ R. Mayer,² S. Luke,³ H. Sharma,² M. TunAbraham,² B. Alharbi,² A. Haig,² P. Luke.^1,2,3
Comparison of Tobacco Consumption versus Marijuana Consumption in Liver Transplant Recipients

P. Serrano Rodriguez, R. Watkins, L. Jurgevich, D. Gerber, A. Nayyar, J. Jadi, C. Moses, C. Desai.
Competing Risk Analysis in Renal Allograft Survival: A New Perspective to an Old Problem

M. El ters,¹ B. Smith,² F. Cosio,¹ W. Kremers.²
Complement Activating HLA Class 2 Antibodies Are Associated with Poor Renal Allograft Survival; Multicentre Study

A. Babu,^1,2 O. Shaw,⁵ N. Khovanova,² S. Griffin,⁴ D. Briggs,⁶ N. Krishnan,¹ S. Fletcher,¹ C. Imray,¹ A. Seitz,³ R. Baker,³ M. Wellberry-Smith,³ B. Clarke,³ K. Cullen,³ F. Edwards,⁴ T. Rees,⁴ E. Burrows,⁴ L. Howe,⁵ R. Vaughan,⁵ N. Kessaris,⁷ N. Mamode,⁷ A. Dorling,⁷ D. Zehnder,¹ R. Higgins,^1,2 D. Mitchell,² S. Daga.^2,3
Complement Fixing Donor-Specific Antibodies Are Associated with Increased Risk of Chronic Lung Allograft Dysfunction after Lung Transplantation

C. Ensor,¹ C. Iasella,¹ M. Mangiola,¹ M. Marrari,¹ M. Morrell,¹ N. Shigemura,² J. DCunha,¹ J. McDyer,¹ A. Zeevi.¹
Complications and QoL after Living Donor Hepatectomy: Analysis of 176 Cases at a Single Center

S. Chinnakotla, V. Kirchner, S. Mongin, D. Berglund, O. Serrano, T. Pruett.
Components of Microvascular Inflammation (MVI) in Kidney Transplant Biopsies (KTxBX) Impacting Late Death Censored Graft Failure (DCGF)

J. Grande,¹ L. Hunsicker,² R. LeDuc,³ A. Matas,³ The DeKAF Consortium.
Comprehensive Assessment of NSAID Use and Potential Nephrotoxicity Risk in Adult Veteran Kidney Transplant Recipients

J. Chiasson, C. Fominaya, M. Gebregziabher, D. Taber.
Comprehensive Validation of Different Clinical Prediction Models on Short- and Long-Term Outcome Following Orthotopic Liver Transplantation

J. Boecker,¹ Z. Czigany,¹ J. Bednarsch,¹ I. Amygdalos,¹ F. Meister,¹ D. Morales Santana,¹ W. Schoening,¹ T. Ulmer,¹ M. Krebbers,¹ G. Koek,¹ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
Congestive Hepatic Fibrosis: Correlation with Cardiac Hemodynamics and Changes after VAD or Cardiac Transplant

S. Dhingra,¹ A. Segura,³ N. Cortes-Santiago,¹ M. Schwartz,⁵ S. Mittal,⁴ P. Jalal,² G. Sood.²
Consistency of DCD Procurement Procedures across Organ Procurement Organizations – Preliminary Findings

G. Mitro,¹ A. Ortiz,² R. Warnock,³ P. Wiederhold,³ K. Jiles,³ J. Ortiz.¹
Continuous and Single-Shot Transverse Abdominis Plane (TAP) Block vs. Conventional Analgesia after Kidney Transplant Surgery

J. Sageshima, C. Troppmann, C. Santhanakrishnan, J. McVicar, R. Perez.
Contribution of mTOR Signaling to the β-Catenin Pathway in Regulatory T Cells

F. Marti, L. Turcios, A. Mohamed, M. Mitov, D. Butterfield, R. Gedaly.
Conversion from Twice Daily Immediate Release Tacrolimus to Once Daily Extended Release Tacrolimus (LCP-Tacro) in High Risk Kidney Transplant Recipients

M. Benincasa,¹ V. Colomy,¹ N. Sifontis,¹ S. Rao,² K. Lau,³ S. Karhadkar,³ A. Di Carlo,³ A. Diamond.⁴
Conversion to Mizoribine with Mycophenolate Eliminates or Reduces the BK Virus Load in Kidney Transplant Recipients: A Prospective Study

X-.P. Yuan, C-.B. Chen, Y. Zheng, J. Zhou, C. Wang, X. He.
Corner-Saving Renal Artery Anastomosis for Renal Transplantation

A. Akdur,¹ M. Kus,² G. Moray,¹ S. Yildirim,¹ F. Yarbug Karakayali,³ K. Caliskan,² M. Haberal.¹
Correlation of Kidney Transplant Human Leukocyte Antigen Eplet Mismatching to De Novo Donor Specific Antibody Production and Post-Transplant Outcomes

R. Samudralwar,¹ K. Szempruch,¹ C. Reuter,³ B. Franz,⁴ R. Lee,¹ E. Weimer,⁴ R. Detwiler,² T. Kozlowski,² J. Schmitz.⁴
Cost Analysis of Biliary Strictures Following Orthotopic Liver Transplantation in the United States

J. Jones,¹ N. Bhutiani,¹ D. Wei,² L. Goldstein,³ R. Martin,¹ C. Jones,¹ R. Cannon.¹
Cost Analysis of Loco-Regional Bridging Therapy for Hepatocellular Carcinoma: A National Study

M. Nazzal,¹ R. Ouseph,¹ X. Huiling,¹ M. Schnitzler,¹ C. Varma,¹ H. Randall,¹ J. Tuttle-Newhall,² D. Axelrod,³ K. Lentine.¹
Creatinine Monitoring by Remote Blood Spot Testing in Pediatric Kidney Transplant Recipients

J. Dickerson,¹ K. Jacot,² M. Sinkey,² J. Smith.³
Critical Care Management of Organ Donors with Uncertain Consent Status

M. Varma, J. LaRosa.
Cumulative Sum Analysis of the Learning Curve for Video-Assisted Minilaparotomy Donor Nephrectomy in Healthy Kidney Donors

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Cytokine Profiles in Children after Pediatric Kidney Transplantation with Acute and Chronic Rejection

T. Ahlenstiel-Grunow, N. Borsum, L. Pape.
Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients and Role of Prophylaxis

G. Nance,¹ A. Serluco,¹ S. Deshpande,^2,1 R. Garro,^3,1 R. George,^3,1 M. Kelleman,³ R. Liverman.¹
Cytomegalovirus Prophylaxis Following Alemtuzumab Induction in High Risk Renal Transplant Recipients Experiencing Delayed Graft Function

S. Freedman, B. Ravichandran, B. Masters, E. Heil, K. Saharia, J. Bromberg, A. Haririan, T. Sparkes.
DCD Kidneys with Remuzzi Scores of 4-5 Can Be Accepted for Solitary Kidney Transplantation

X-.P. Yuan, C-.B. Chen, Y. Zheng, J. Zhou, C. Wang, X. He.
DSA Plus TCMR Leads to Poor Outcomes in Renal Allograft Recipients and This is Markedly Exacerbated by Non-Adherence

D. Chittka, A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
Daptomycin Minimum Inhibitory Concentration (MIC) of Vancomycin Resistant Enterococcal (VRE) Blood Isolates Correlates with Allograft Failure in Orthotopic Liver Transplant (OLT) Recipients

R. Lee,¹ G. Haidar,² J. Lewis,³ S. Arif,⁴ J. Hand,⁵ E. Holaday,⁶ H. Clauss,⁶ J. Goldman,⁷ A. Nellore.¹
De Novo Belatacept in Clinical Vascularized Composite Allotransplantation

L. C. Cendales,¹ D. S. Ruch,² A. R. Cardones,³ G. Potter,⁴ J. Dooley,⁵ D. Dore,⁶ J. Orr,¹ G. Ruskin,⁶ M. Song,¹ D. Chen,⁷ A. Selim,⁷ A. D. Kirk.¹
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation

N. Garg, T. Ellis, R. Redfield, S. Parajuli, B. Astor, A. Djamali, D. Mandelbrot.
De Novo Donor Specific Antibodies in Pediatric Kidney Transplant Recipients Are Highly Responsive to Therapy

V. Sigurjonsdottir, P. Grimm.
De Novo Use of Extended Released Tacrolimus (Meltdose, Envasus^R)) after OLT – Does the Colonic Resorption Influences the Outcome?

T. Soliman, G. Györi, M. Hofmann, A. Salat, S. Rockenschaub, G. Berlakovich.
De Novo or Early Conversion to Everolimus and the Risk of Skin Cancers in Kidney Transplant Recipients: A Trial-Based Linkage Study

T. Ying,^1,2 G. Wong, W. Lim, G. Russ, H. Pilmore, J. Kanellis, D. Goodman, P. Trevillian, S. Campbell, M. Suranyi, M. Mathew, R. Faull, R. Masterson, R. Walker, P. O'Connell, S. Chadban.^1,2
Death-Censored Graft Failure (DCGF) Post Kidney Transplant (KTx) is Usually the Result of Rapid Loss of Function after Periods of Stability

R. Gaston,¹ L. Hunsicker,² A. Fieberg,³ A. Matas,³ The DeKaf Consortium.
Decision-Making, Informed Consent, and the Experiences of Recipients of Experimental HCV Positive-to-Negative Renal Transplants

S. Rasmussen, S. Seaman, D. Brown, N. Desai, M. Sulkowski, D. Segev, J. Sugarman, C. Durand.
Decreased Expression of Pro-Carcinogenic Genes Following Tacrolimus to Sirolimus Conversion in Liver Transplant Recipients

M. Bhat,¹ E. Pasini,¹ C. Baciu,¹ S. Kurian,² J. Levitsky.³
Decreased Post Heart Transplant Survival with Epstein-Barr Virus Mismatch in the Current Era

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, S. Mersola, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Deep Vein Thrombosis in Heart Transplant Patients

G. Bhat, T. Setia, C. Nguyen, I. Balanlayos, A-.G. Roska, A. Andrade, W. Cotts, G. Macaluso, S. Pauwaa, M. Bresticker, A. Tatooles, P. Pappas.
Defective Innate Immune Response to Opportunistic Pathogens in Cytomegalovirus-Infected Monocytes

P. Sen, A. R. Wilkie, R. Fernandes, R. J. Lane, S. E. Hickman, T. K. Means, E. R. Rosenberg, D. M. Coen, J. A. Fishman, J. El Khoury.
Defining T Cell Subsets Involved in Rejection of Vascularized Composite Allografts

G. Furtmueller,¹ V. Malek,¹ B. Oh,¹ S. Reddy,¹ M. Iglesias,¹ G. Raimondi,¹ G. Brandacher, D. Cooney.
Dehydropeptidase-Iinhibitor Reduces Tacrolimus-Induced Kidney Injury by Anti-Oxidative and Anti-Apoptotic Effect

K. Luo,¹ S. Lim,¹ J. Il,¹ Y. Shin,¹ E. Ko,^1,2 B. Chung,^1,2 H. Hwang,^1,2 C. Yang.^1,2
Delayed Achievement of Therapeutic Tacrolimus Levels after Renal Transplantation is Not Associated with Increased Incidence of Early Acute Rejection: Single-Center Results

R. Marshall, J. Brandenberger, A. Cantafio, J. Halldorson, R. Bakthavatsalam, A. Dick, S. Rayhill, J. Reyes, J. Perkins.
Delayed Recovery of Renal Function after Donor Nephrectomy

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Delivery of Culturally-Competent Transplant Care among Hmong Kidney Transplant Recipients: Outcomes from a Single Institution

M. Odegard,¹ O. Serrano,¹ K. Peterson,¹ S. Mongin,² D. Berglund,³ D. Vock,⁴ S. Chinnakotla,¹ T. Dunn,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas.¹
Demand for Uterine Transplantation in the United States: Initial Recruitment Results of a Trial of Uterine Transplantation in the Northeast U.S.

P. Porrett,¹ N. Latif,² E. Wang,² L. Sortor,³ S. Levin,⁴ A. Shaked,¹ K. Olthoff,¹ C. Coutifaris,² D. Driscoll,² K. O'Neill.²
Depressive Symptoms, Medication Nonadherence, and Clinical Outcomes Following Lung Transplantation

M. C. Chu,¹ P. J. Smith,² G. L. Stonerock,² J. A. Blumenthal.²
Derivation and Prospective External Validation of Prediction Models for Acute Kidney Injury in Adult Liver Transplant Recipients

Q. Zhao,¹ Z. Guo,¹ M. Chen,¹ S. Ma,¹ J. Lin,⁴ C. Zhang,² M. Han,³ X. He.¹
Determining the Utility of Protocol Biopsies in Kidney Transplant Recipients

J. Patel,¹ K. Heshmati,² A. Rogers,¹ R. Wali,² J. Jonsson,² C. Liu,² E. Emery,² D. Collins,² S. Karzai,² J. Piper.²
Developing a Rationale for an Appropriate Immunosuppressive Regimen in Lung vs Kidney Transplant Recipients: Effects of Induction Therapy

P. Martin-Moreno,^1,2 H. Shin,^1,3 H. Goldberg,⁴ A. Chandraker.¹
Development of Optimal Simplified Equation for Estimation of Mycophenolic Acid Exposure Following Enteric-Coated Mycophenolate Sodium Administration in Chinese Renal Transplant Recipients

W. Peng, C. Tian, Z. Chen, W. Xue, G. Wang, Q. Ye, X. Zhang, M. Gu, M. Zhao, C. Wang, C. Huang, J. Yan, W. Zhang, C. Ding, Y. Fu, S. Ye, X. Hu, R. Tan, M. Li, R. Deng, Y. Ke, W. Wu, M. Fan, J. Chen.
Development of a Classification of Immunosuppressant Medication Nonadherence Tool to Enable the Objective Measurement of Immunosuppressant Medication Nonadherence in Kidney Transplant Patients

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Development of a Screening Tool to Predict Chronic Kidney Disease Risk in Post-Nephrectomy Living Kidney Donors

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Development of an Expert Consensus Guideline for Skin Cancer Screening in Solid Organ Transplant Recipients

L. Crow,¹ S. Arron,¹ C. Chung,² A. Jambusaria-Pahlajani,³ S. Lowenstein,¹ On behalf of the Transplant Skin Cancer Network.
Diagnosis and Prevalence of Strongyloidiasis in Solid Organ Transplant Patients

H. Pritchard,¹ V. Hemmige,¹ R. Mejia,² A. Restrepo.¹
Diagnosis of Acute Renal Rejection Using Saliva Metabolome Analysis

H. Iwamoto,¹ M. Sugimoto,² O. Konnno,¹ Y. Kihara,¹ T. Yokoyama,¹ Y. Nakamura,¹ M. Sunamura,¹ T. Ueno.¹
Diagnostic Performance of Blood Pressure Measurement Modality in Prospective Living Kidney Donors

S. Armanyous, M. Lioudis, G. Thomas, E. Poggio, J. Augustine.
Differences in Pediatric and Adult Lost to Follow-Up Events for Heart, Kidney, and Liver Recipients

A. Robinson,¹ G. Mazariegos,² S. Bartosh,³ W. Mahle.⁴
Differences in Preservation Solution Formulas and Its Effects on Early Graft Function

J. Brooks, P. Wiederhold, K. Jiles, A. Chiodo Ortiz, M. Dewey, M. Bailey, N. Koizumi, E. Rady, J. Ortiz.
Differences in Rejection and Clinical Outcomes in Obese versus Non-Obese Renal Transplant Recipients Receiving Basiliximab Induction Immunosuppression

J. Benken,¹ C. Kane,² A. Lichvar,¹ E. Benedetti.¹
Digital Health Education for the Pediatric Solid Organ Transplant Population

T. Nemeth,¹ J. Smith,² A. Pollack,² W. Swanson,³ E. Hsu.⁴
Discriminative Accuracy of Physician Assessments of Kidney Transplant Candidate Function by Candidate Age, Sex, and Race

M. Harhay,¹ K. Ranganna,¹ L. Levin Mizrahi,¹ G. Xiao,¹ G. Malat,¹ D. Reich,¹ S. Guy,¹ P. Reese.²
Disparate Risk Factors for Early and Late Death Impact Survival after Lung Transplant

C. Lehr, E. Blackstone, K. McCurry, L. Thuita, W. Tsuang, M. Valapour.
Disparities in Re-Transplantation among Pediatric Renal Transplant Recipients with Graft Failure

M. Basu,¹ R. Patzer,¹ R. George.^1,2
Distribution of Biopsy Proven Acute Rejection in a Large Pediatric Kidney Transplant Program: A Four Year Experience

C. Varnell, Jr.,¹ A. Carle,^2,3 D. Hooper.^1,2,3
Does DGF Result in Worse Outcomes in a Second Transplant?

B. Muth,¹ B. Astor,^1,2 J. Blazel,¹ J. Turk,¹ D. Mandelbrot,¹ A. Djamali,¹ S. Parajuli.¹
Does One Size Fit All? Implementing a Protocolized Ambulatory Tacrolimus Dosing Strategy in a Predominantly African American Renal Transplant Population

L. Gylten, C. Mardis, D. Taber, H. Meadows, C. Perez, Z. Elmaasarani, J. Fleming, N. Patel, P. Baliga, V. Rao, V. Rohan, N. Pilch.
Does Pre-Operative Angiographic Kidney Embolization Decrease Complications in Allograft Nephrectomy?

D. Harriman, V. Mujumdar, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, R. Stratta.
Does Prolonged Cold Ischemia Affect Outcomes in Donation after Cardiac Death Kidney Transplants?

D. Harriman, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Does the End Justify the Means? An Analysis of Outcomes in Recipients of Combined Kidney/Hematopoietic Stem Cell (HSC) Transplants and Comparison to Standard of Care (SOC) Patients

J. Leventhal,¹ A. Shetty,¹ L. Gallon,¹ K. Kurtenbach,¹ D. Stare,¹ S. Ildstad.²
Donor Acute Kidney Injury Does Not Affect Fibrosis on 1 Year Post-Transplant Kidney Biopsy

D. van der Windt, X. Chen, K. Lemon, C. Wu, N. Shah, R. Mehta, C. Puttarajappa, P. Sood, S. Hariharan, A. Ganoza, M. Wijkstrom, A. Humar, A. Tevar.
Donor Bacteremia Does Not Impact Survival Following Heart Transplantation: A UNOS Registry Review

S. Hirji, A. Woolley, M. Pelletier, P. Shekar, F. Yazdchi, H. Mallidi, S. Singh.
Donor Plasma Mitochondrial DNA Predicts Post-Transplant Renal Allograft Outcomes

F. Han,¹ S. Wan,² N. Chen,² L. Zheng,³ N. Zhang,⁴ Q. Sun,¹ H. Li,¹ Z. Huang,¹ L. Hong,¹ Q. Sun.¹
Donor Specific Antibodies Increase the Risk of Preeclampsia in Pregnant Kidney Transplant Recipients

M. Lubetzky, T. Muthukumar, J. Lee, J. Lee, C. Hartono, L. Mahla, D. Serur, D. Dadhania.
Donor Specific Antibodies and Clinical Outcomes in Kidney Transplant Recipients

S. Wan,^1,2 S. Chadban,^1,2 K. Wyburn.^1,2
Donor Transmitted Nut Allergy Following Solid Organ Transplantation: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

R. Bag, S. Tlusty, G. Vece, T. Peterson, J. Schaenman, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, P. Wood, N. Theodoropoulos, M. Michaels, C. Wolfe.
Donor-Derived Hepatitis B Virus (HBV) Infection: Analysis of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC)

N. Theodoropoulos, S. Tlusty, G. Vece, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, R. Wood, M. Michaels, C. Wolfe.
Donor-to-Recipient Weight Ratio is Significantly Associated with Hepatic Artery Thrombosis Following Pediatric Whole Liver Transplantation

S. Kim, G. Ramos-Gonzalez, Z. Labib, H. Kim, K. Vakili.
DonorNet and Biases in Decision-Making: An Organ Offer Simulation Study

D. Stewart,¹ J. Lindemans,² J. Schold,³ H. McGehee,¹ J. Kessler,⁴ C. Sullivan,⁴ M. Turner,² K. Mekeel,⁵ C. Berg,² R. Stratta,⁶ R. Formica,⁷ L. Ratner,⁸ D. Klassen,¹ B. Shepard.¹
Dual Function of IRF1/IRF4 on Dendritic Cells in Mouse Liver Transplantation Model

G. Gu, T. Lu, N. Xu, Q. Xia.
Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants

J. Leventhal,¹ L. Gallon,¹ J. Mathew,¹ J. Miller,¹ D. Stare,¹ S. Ildstad.²
Early Adjunctive Treatment with Human Cytomegaly Virus (CMV) Immunoglobulin Increased CMV-Free Survival after Heart Transplantation

M. Barten,¹ C. Neumaier,¹ A. Bernhardt,¹ M. Rybczynski,² R. Plaetke,³ H. Reichenspurner.¹
Early Allograft Biopsy in Kidney Transplant Recipients with DGF – Call for an Individualized Approach

A. Vijay, L. Barrison, M. Cooper, S. Ghasemian.
Early Association of Low Doses of Tacrolimus and a mTOR Inhibitor in BK Polyomavirus Infection in Kidney Transplant Recipients

V. Lopez,¹ T. Vazquez,¹ C. Jironda,¹ M. Cabello,¹ E. Sola,¹ M. Leon,² E. Marques,¹ D. Hernandez.¹
Early Conversion to a CNI-Free Immunosuppression with SRL after Renal Tx – 10 yr Follow-Up Analysis of a Prospective Multicenter Trial

J. Andrassy,¹ M. Guba,¹ A. Habicht,² M. Fischereder,³ A. Pascher,⁴ K. Heller,⁵ B. Banas,⁶ O. Hakenberg,⁷ T. Vogel,⁸ T. Kauke.¹
Early Graft Function Correlates with Survival Benefit in Kidney Transplant Recipients with Peripheral Vascular Disease

E. Min, V. Tatapudi, N. Ali, B. Gelb, N. Dagher, J. Benstein, R. Montgomery, B. Lonze.
Early Life Stress Exposure and Cardio-Renal Outcomes in Pediatric Kidney Transplantation

M. Seifert, P. Perry, R. Romp, R. Mannon, J. Pollock.
Early Outcomes and Risk Factors after Five Years of a Nationwide Strategy for Kidney Transplantation with Controlled Circulatory Death Donor (cDCD)

J. Portoles,^1,2 M. Perez Saez,² D. Hernandez,² J. Juega,² F. Moreso,² N. Maruri,² P. Lopez,^1,2 E. Melilli,² D. Navarro,² E. de Souza,² J. Ruiz,² M. Mazuecos,² A. Gutierrez,² I. Perez-Flores,² D. Janeiro,^1,2 J. Pascual.²
Early Postoperative Acute Kidney Injury among Pediatric Liver Transplant Recipients

H. Sahinturk,¹ A. Kundakci,¹ P. Zeyneloglu,¹ E. Gedik,¹ A. Pirat,¹ M. Haberal.²
Early Steroid Withdrawal or Tacrolimus Minimization versus Standard Immunosuppression in Renal Transplant Recipients: The Allegro Trial

J. Sanders,¹ A. Gomes-Neto,¹ M. v Dijk,¹ M. v Sandwijk,² H. de Fijter,³ J. Homan vd Heide,² A. de Vries,³ F. Bemelman.²
Early Sub-Clinical and Clinical TCMR Are Associated with Progressive Renal Allograft Dysfunction

A. Cherukuri, D. Chittka, R. Mehta, P. Sood, S. Hariharan.
Early Utilization of Telehealth in Kidney Transplantation

T. Young, D. Hricik, E. Sanchez, N. Sarabu.
Early versus Late Cytomegalovirus Prophylaxis after Kidney Transplant

M. Harris, J. Byrns, J. Gommer, M. Laub, M. Ellis.
Effect and Reasons of Rescue Switch to Belatacept among 73 Calcineurin-Inhibitors Treated Kidney Allograft Recipients – A Three Years Retrospective Cohort, Single Center Study

M. Matignon,¹ C. Dudreuilh,¹ P. Rémy,¹ D. Desvaux,² P. Grimbert.¹
Effect of De Novo Use of Everolimus with Reduced Calcineurin Inhibitor versus Standard Mycophenolic Acid-Based Regimen on Wound Healing Events in Kidney Transplant Recipients from TRANSFORM Study

M. Henry, F. Citterio, M. Kim, D. Kim, P. Bernhardt, A. Gupta, Y. Watarai.
Effect of Belatacept on Late Acute Rejection Episodes and Graft Loss in Young Adults between the Ages of 18-24 Years: Post-Hoc Analysis of BENEFIT Study

A. Moudgil.
Effect of Conversion to CTLA4Ig Treatment on Tacrolimus-Induced Diabetic Rats

J. Il,¹ L. Jin,¹ K. Luo,¹ S. Lim,¹ Y. Shin,¹ E. Ko,^1,2 B. Chung,^1,2 C. Yang.^1,2
Effect of Direct-Acting Hepatitis C Treatment Regimens on Calcineurin Inhibitors in Liver and Kidney Transplant Patients

M. Laub, J. Byrns, M. Harris, C. Berg, S. Sanoff.
Effect of Functional and Cognitive Impairment on Readmissions in Geriatric Renal Transplant Recipients

T. Uemura,¹ V. Rodriguez,¹ G. Rosen,² S. Lerner,² O. Apoeso.¹
Effect of Kidney Allocation System on a Solitary, Isolated, Rural Transplant Program

K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² J. Africa.¹
Effect of rATG on Monocytic Myeloid-Derived Suppressor Cells and Its Associated Mechanisms in Kidney Transplantation Recipients

Y. Jiang, X. Zhang.
Effects of Health Literacy and Numeracy Literacy on Adherence, Quality of Life and Readiness to Transition in Pediatric Renal Transplant Recipients

M. Kamel,¹ C. McCracken,¹ A. Wilkerson,¹ N. Alexander,¹ J. Gazmararian,² R. George.¹
Effects of Medication Education Pilot Program in Living versus Deceased Donor Kidney Transplant Recipients.

N. Sulejmani, H. Albanna, B. Summers, A. Jantz, R. Prashar, A. Patel.
Effects of Preformed Antibody on Survival Following Pig-to-Primate Liver Xenotransplantation

N. Louras, M. Patel, J. Shah, A. Andrews, Z. Wang, D. Sachs, P. Vagefi.
Effects of the Addition of Mycophenolate Mofetil on Renal Outcomes in Liver Transplant Recipients: A Single Center Review

M. Henry, M. Vacha.
Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients

E. Kincaide,^1,2,3 K. Hitchman,^1,3 R. Hall,^1,2,3 I. Yamaguchi,³ B. Crowther.^1,2,3
Efficacy and Safety of Immediate- and Prolonged-Release Tacrolimus in De Novo Pediatric Transplantation: Randomized Study

K. Vondrak,¹ F. Parisi,² A. Dhawan,³ R. Grenda,⁴ N. Webb,⁵ S. Marks,⁶ D. Debray,⁷ R. Holt,⁸ A. Lachaux,⁹ D. Kelly,¹⁰ G. Kazeem,¹¹ N. Undre.¹¹
Efficacy and Safety of a Single-Dose Rituximab for Prevention of Focal Segmental Glomerulosclerosis Recurrence after Kidney Transplant

Y. Lu,¹ J. Lyons,² S. Tischer,² K. Woodside,³ J. Park.²
Efficacy of Bronchoscopically-Administered Surfactant in the Setting of Primary Graft Dysfunction after Lung Transplantation

S. Ahmed,¹ M. Soto-Arenall,¹ D. Jackson,¹ D. Erasmus.²
Efficacy of Current Educational Interventions in Improving Living Donor Kidney Transplantation Rates

S. Sandal, N. Dendukuri, S. Wang, E. Guadagno, T. Ekmekjian, A. Alam.
Efficacy of Generic Sofosbuvir and Branded Daclatasvir Compared to Sofosbuvir and Ledipasvir Combination in the Treatment of Genotype 4 Hepatitis C Virus

H. Joharji, A. Al-Jedai, D. Alkortas, A. Ajlan, E. Devol, M. Ahmed, F. Aba Al-Khail, H. El-Siesy, M. Al-Sebayel, H. Al-Ashgar, M. Al-Quaiz, W. Alhomodi, A. Aloubal, A. Almohishir.
Efficacy of Two Valganciclovir Dosing Strategies in Intermediate and High-Risk Liver Transplant Recipients

K. Belfield,¹ M. Malinis,² E. Cohen.¹
Elbasvir-Grazoprevir (Zepatier) is Effective and Safe for the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Virus in the Post Kidney Transplant Patient

P. Brown, D. Venkat.
Elevated Donor Terminal Creatinine Does Not Appear to Be Associated with Worse Outcomes in Kidney Transplantation

S. Rayhill, J. Haldorson.
End Stage Kidney Disease Risk Profile in Living Kidney Donors for Pediatric versus Adult Kidney Transplant Recipients in Australia and New Zealand

D. Lee,^1,2 J. Whitlam,² N. Cook,² A. Walker,³ F. Ierino,⁴ M. Roberts,¹ J. Kausman.³
Endothelin A Receptor (ETaR) siRNA Ameliorates Renal Ischemia Reperfusion Injury through Upregulating Expression of eNOS in Rats

Y. Jia, L. Li, T. Zhu.
Enhanced Recovery after Kidney Transplantation Regardless of Donor Organ Source

O. Ojogho,¹ S. BaniHani,¹ S. Nemr,¹ B. Dieter,² A. Joyce,¹ J. Mejia.¹
Enhanced Recovery after Renal Transplant Surgery Using a Transversus Abdominis Plane Block is Associated with Decreased Hospital Length of Stay

D. Peramunage, D. Auyong, C. Kuhr, J. Brandenberger, N. Cowan, N. Hanson.
Enhancement of Endogenous omega-3 Protect against Ischemia-Reperfusion Renal Injury in Fat-1 Mice

D. Choi,¹ Y. Ham,¹ K. Na,¹ K. Lee,¹ J-.J. Kim,^1,2 J. Jeong.^1,3
Enhancement of Muscle Regeneration and Function via Transplantation of Human Dystrophin Expressing Chimeric Cells as a Novel Myoblast Stem-Cell Based Therapy

M. Siemionow,¹ J. Cwykiel,¹ E. Marchese,¹ G. Rafidi,¹ K. Futoma,¹ A. Heydemann,² J. Garcia-Martinez,² E. Szilagyi.¹
Equivalent Clinical Outcomes and Stable Post-Operative Anti-A IgG Titers in A2 to B Renal Transplant Recipients Compared to Matched B to B Cohort

C. Barnhill,¹ P. Warner,² A. Weiss,¹ C. Kuhr,¹ N. Cowan,¹ J. Brandenberger.¹
Equivalent Post-Donation eGFR after Robotic Assisted versus Laparoscopic Living Donor Nephrectomy

R. Cross, H. Pollinger, M. Tan, M. Mulloy, T. Ommert, A. Ray, C. Klein.
Estimated GFR for Living Kidney Donor Evaluation before and after Donor Nephrectomy

Y. Kakuta,¹ M. Okumi,¹ R. Imamura,² N. Ichimaru,² S. Takahara,² H. Ishida,¹ K. Tanabe.¹
Ethnic Disparities in Elderly Patients Receiving Kidney Transplantation

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Ethnic and Age Disparities in Outcomes among Liver Transplant Waitlist Candidates

M. Mustian,¹ S. Gray,¹ B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ J. White,¹ D. Eckhoff,¹ R. Allman,² J. Locke.¹
Etiologies and Long-Term Outcomes of Acute Kidney Injury in Older Kidney Transplant Recipients

R. Rodriguez, P. Amechi, V. Rao, D. Taber, M. Posadas Salas.
Evaluating Displays of Program Waitlist Mortality on Public Search Results

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^7,4 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2,4
Evaluating PROMIS-57 Domains to Screen for Anxiety and Depression Using Legacy Instruments among Kidney Transplant Recipients

A. Bansal,¹ O. Ekundayo,¹ E. Tang,¹ F. Khalafi,¹ H. Ford,¹ M. Li,³ M. Novak,² I. Mucsi.¹
Evaluating the Impact of Pre-Transplant Malignancy on Outcomes after Kidney Transplantation: A National Database Analysis over a Twenty-Two Year Period

D. Livingston-Rosanoff, L. Wilke, G. Leverson, D. Foley.
Evaluation and Cost Burden of Inappropriately Drawn Immunosuppression Trough Levels in the Acute Care Setting at an Academic Medical Center

A. Brown, J. Geyston, A. Agarwal, B. Jones, W. Ally.
Evaluation of Accepting Kidneys of Varying Quality for Transplantation or Expedited Placement with Decision Trees

S. Mehrotra,¹ H. Gordon,¹ K. Bui,¹ J. Friedewald,² D. Ladner,² B. Kaplan,⁴ V. Kilambi.³
Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients

A. Lichvar,¹ S. Tremblay,² D. Naik,² E. King,⁴ A. Vinks,⁴ U. Christians,³ J. Lipscomb,⁴ R. Alloway.²
Evaluation of Culture/Preservation Conditions on Human Islet Survival and Function

Y. Shindo,¹ M. Levy,^1,2 M. Kanak.¹
Evaluation of Drug Action on IgM Memory B Cell Survival and Growth In Vitro; -Application for Individualized Immunosuppression after Kidney Transplants-

Y. Matsuda,¹ K. Takahashi,¹ R. Imamura,² N. Nonomura,² Y. Yuzawa.¹
Evaluation of Financial Well-Being of Living Kidney Donor Candidates

S. Singh,^1,2 G. Bannerman,² A. Yantsis,² M. Liu,² F. Gumabay,² O. Famure.²
Evaluation of Hepatitis B Vaccination in Transplant Candidates

M. Bosaeed, Y. AlJishi, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Evaluation of Immunosuppression and Infection after Desensitization in Lung Transplantation

S. Hammad, B. Ravichandran, J. Kim, D. KuKuruga, S. Cipriano, Z. Kon.
Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients

C. Staatz,¹ E. Brooks,¹ N. Isbel,² B. McWhinney,³ S. Tett.¹
Evaluation of Risk Factors for Progression of Low Level CMV Viremia in Solid Organ Transplant Recipients

Y. Natori, A. Humar, A. Alghamdi, D. Kumar.
Evaluation of Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection in Adult Liver Transplant Recipients

E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, L. Fehrenbacher, D. Kramer.
Evaluation of Survival and Maintenance Immunosuppression in Elderly Lung Transplant Recipients

P. Nguyen,¹ R. Girgis,^1,2 E. Murphy,^1,2 R. Hadley,^1,2 M. Leacche,^1,2 A. Kumar,^1,2 G. Sathiyamoorthy,^1,2 J. McDermott.^1,2
Evaluation of Tacrolimus Extended-Release in African American Renal Transplant Recipients

T. Sparkes, B. Ravichandran, C. Williams, B. Thomas, B. Masters.
Evaluation of Transplant Kidneys Using a Novel Point of Care 3D Ultrasound System

J. Salinaro,¹ J. Broder,¹ E. Jaffa,¹ M. Morgan,¹ D. Vikraman-Sushama,¹ J. Dahl,² C. Herickhoff,² A. Limkakeng,¹ E. Peethumnongsin,¹ J. Borawski.¹
Evaluation of a Change in CMV Prevention Strategy Following Pediatric SOT

S. Pangonis, A. Miethke, F. Flores, M. Schecter, S. Kocoshis, D. Lazear, T. Hemmelgam, B. Taylor, G. Paulsen, L. Danziger-Isakov.
Evaluation of a Marine OXYgen Carrier (Hemo2Life®) for Organ Preservation: First Use in Kidney Transplantation in Humans

Y. Le Meur,¹ E. Morellon,² M. Essig,³ A. Thierry,⁴ M. Buchler,⁵ S. Drouin,⁶ C. Deruelle,¹ L. Badet,² F. Pesteil,³ P-.O. Delpech,⁴ J-.M. Boutin,⁵ B. Barrou.⁶
Evaluation of the Use of Oral Valganciclovir for the Treatment of Cytomegalovirus Infections in Pediatric Intestinal Transplant Recipients: A Single Center Review

M. Henry, M. Vacha, M. Keck, D. Florescu.
Evanescent Antibodies: A Report on the Natural History of Anti-Blood Group A₂ Antibodies and Their Rapid Resolution in Patients Awaiting A₂ to B Transplantation

S. Radomski, S. Rosen-Bronson, D. Li, M. Awwad, G. Vranic, B. Javaid, P. Abrams, S. Yi, M. Cooper, A. Gilbert.
Everolimus and the Risk of Graft Loss or Death in Kidney Transplant Recipients: A Trial-Based Linkage Study

T. Ying,^1,2 G. Wong, W. Lim, G. Russ, H. Pilmore, J. Kanellis, D. Goodman, P. Trevillian, S. Campbell, M. Suranyi, M. Mathew, R. Faull, R. Masterson, R. Walker, P. O'Connell, S. Chadban.^1,2
Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report

A. Leino,¹ C. Emoto,² T. Fukuda,² M. Privitera,¹ A. Vinks,^1,2 R. Alloway.¹
Evolution of Very Old Donor Grafts

S. Jiménez Alvaro,¹ A. Fernández Rodriguez,¹ C. Galeano Alvarez,¹ S. Elías Treviño,¹ J. Burgos,² F. Liaño García.¹
Ex-Situ Normothermic Human Upper Extremity Perfusion: Preliminary Report

V. Fahradyan, E. Dalla Pozza, M. Madajka, K. Cho, N. Dawlagala, E. Duraes, H. Shah, S. Al-deen Said, C. Ordenana, F. Papay, A. Rampazzo, B. Bassiri Gharb.
Ex-Vivo Pretreatment of Islets with Mitomycin-C Have a Potential to Induce Specific Immune Response for Peripheral Tolerance

N. Sato, A. Kenjo, T. Kimura, R. Okada, T. Ishigame, Y. Kofunato, J. Watanabe, M. Muto, S. Suzushino, T. Shimura, S. Marubashi.
Ex-Vivo Subnormothermic Oxygenated Machine Perfusion of Rodent Hindlimb: Feasibility Study to Elongate Preservation Time of Vascularized Composite Allograft

L. Burlage,^1,2 A. Lellouch,^3,4 S. Tessier,¹ C. Pendexter,¹ S. Cronin,¹ M. Schol,³ M. Randolph,³ R. Porte,² L. Lantieri,⁴ C. Cetrulo,³ K. Uygun.¹
Excellent Long Term Outcomes Transplanting Single Pediatric Kidneys from Donors Five Years and Younger into Adult Recipients

R. Shah,¹ M. Aull,² A. Watkins,² S. Kapur.²
Excellent Long-Term Outcomes with Kidney Transplants from Deceased Donors with Acute Kidney Injury

G. Dube, S. Husain, D. Cohen, S. Mohan.
Excellent Outcomes for HCV-Viremic Recipients of Simultaneous Liver-Kidney Transplant in the Direct Anti-Viral Era

A. Ray, C. Klein, T. Ommert, R. Cross, R. Rubin.
Exenatide Reduces Ischemia/Reperfusion Injury in Donation after Cardiac Death Rat Kidney Transplantation

H. Yang,¹ Y. Shi,² X. Li,¹ C. Long,¹ Z. Xu,¹ L. Luo,¹ W. Luo,¹ Y. Zhang,¹ T. Zeng,³ M. Chen,⁴ H. Li,⁵ Z. Wang.⁵
Exosomes from Umbilical Cord-Derived Mesenchymal Stem Cells on Hepatocytes Proliferation after Small-for-Size Liver Transplantation via RHO/ROCK Pathway

L. Chen, J. Zheng, J. Cai, J. Yao, K. Zeng, Y. Zhang, Y. Yang.
Experience and Safety of Hand-Assisted Laparoscopic Nephrectomy for Living Kidney Donors at Mexico´s General Hospital "Dr. Eduardo Liceaga"

P. Prieto-Olivares, L. Garcia-Covarrubias, A. Bahena-Portillo, A. Cicero-Lebrija, V. Visag-Castillo, H. Hinojosa-Heredia, D. Fernandez-Angel, Y. Carrión, A. Rosas, E. Pedraza, I. Castro, A. García-Covarrubias, H. Diliz-Perez.
Experience in the Development of a Life-Supporting Large Animal Orthotopic Cardiac Xenotransplant Model

L. DiChiacchio,¹ A. Singh,¹ B. Lewis,¹ E. Strauss,¹ P. Odonkor,¹ B. Williams,¹ D. Ayares,² K. Deatrick,¹ Z. Kon,¹ M. Mohiuddin.¹
Experience with Immunosuppressive Strategies in Vascularized Composite Allotransplantation of Face

R. Klasek,¹ B. Kollar,² S. Tasigiorgos,² B. Pomahac.²
Experiences, Perceptions, and Concerns about Successful Aging among KT Candidates and Recipients

F. Warsame, S. Rasmussen, A. Eno, A. Mountford, C. Haugen, M. McAdams-DeMarco, D. Segev.
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Recipients

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Exploring the Impact of Recipient Age with Kidney Donor Risk Index and Estimated Glomerular Filtration Rate at One Year Following Kidney Transplant

S. Chan,^1,2,3 M. Chatfield,⁴ K. Baboolal.^2,3
Exploring the Viability of Kidneys Discarded in the US: A Comparison of Kidney Utilization Patterns and Outcomes in the US and France

O. Aubert, P. Reese, M. Raynaud, D. Viglietti, C. Loheac, N. Kamar, M. Delahousse, C. Legendre, D. Glotz, C. Lefaucheur, A. Loupy.
External Validation of Hennepin Transplant Risk Score for Prediction of Short-Term Mortality and Morbidity after Deceased Kidney Transplantation

A. Velioglu,^1,2 M. Vijayan,¹ H. Shin,^1,3 J. Perry,¹ A. Chandraker.¹
Extracellular Matrix from Pancreas Improves Human Islet Function In Vitro

Y. Shindo,¹ R. Pouillot,² B. Young,² P. Link,² R. Heise,² M. Levy,^1,3 M. Kanak.¹
Extracellular Vesicles Derived from Huc-MSCs Alleviate Rat Hepatic Ischemia-Reperfusion Injury by Suppressing Oxidative Stress and Neutrophil Inflammatory Response

J. Yao,^1,2 J. Cai,^1,2 J. Zheng,^1,2 L. Chen,^1,2 Y. Zhang,^1,2 Y. Yang.^1,2
Extracorporeal Membrane Oxygenation Experience for Graft Failure after Heart Transplantation

S. Lehmann, K. Jawad, S. Feder, A. Meyer, M. Dieterlen, J. Fischer, J. Garbade, M. Borger.
FSGS Pattern with Podocyte Proliferation and Heavy Proteinuria Combined Late Antibody Mediated Rejection of Renal Allograft: Collapsing Glomerulopathy or Transplant Podocytopathy?

J. Wen, M. Zhang, F. Xu, J. Chen, D. Cheng, X. Ni, X. Li.
FSGS Recurrence and Graft Survival in Pediatric Renal Transplants: A NAPRTCS Registry Analysis

L. Koh,¹ K. Martz,² T. Blydt-Hansen.³
Facial Allotransplantation: An Early Look at OPTN Data

J. Wainright,¹ L. Levin,² L. Cendales,³ C. Wholley,¹ W. Cherikh,¹ D. Klassen,¹ B. Pomahac.⁴
Facilitators and Barriers to Patient Portal Use among Pre- and Post-Kidney Transplant Patients at an Urban Center in the United States

M. Lockwood,¹ K. Dunn-Lopez,¹ H. Pauls,¹ L. Burke,¹ Y. Becker,² M. Saunders.²
Factors Associated with Listing for Liver Transplantation in an OPO Other Than the Resident OPO

S. Zhou, A. Massie, S. Gentry, D. Segev.
Factors Impacting Return to Employment after Liver Transplantation

M. Hassan, M. Abouljoud, N. Sadik, A. Mazur, A. Elbanna, A. Yoshida, M. Jesse.
Factors Predicting Viability Achievement on Discarded Donor Livers Submitted to Extra-Corporeal Machine Perfusion

Y. Boteon,^1,2 R. Laing,^1,2 A. Schlegel,² J. Attard,^1,2 L. Wallace,¹ A. Smith,² T. Perera,² J. Isaac,² D. Mirza,² S. Afford,¹ H. Mergental.²
Failure to Remove De Novo Donor-Specific HLA Antibodies is Influenced by Antibody Properties and Identifies Kidney Recipients with Late Antibody-Mediated Rejection Destined to Graft Loss

A. Nocera,¹ M. Cioni,¹ A. Tagliamacco,² S. Basso,³ A. Innocente,⁴ I. Fontana,⁵ A. Magnasco,¹ A. Trivelli,¹ A. Gurrado,³ M. Ramondetta,⁴ S. Boghen,³ L. Catenacci,³ E. Verrina,¹ G. Garibotto,² G. Ghiggeri,¹ M. Cardillo,⁴ F. Ginevri,¹ P. Comoli.³
Failure to Thrive after Pediatric Kidney Transplantation

K. Sgambat,¹ Y. Cheng,¹ O. Charnaya,² A. Moudgil.¹
First-Time Simultaneous vs. Sequential Liver-Kidney Transplantation in Polycystic Kidney Disease: A Review of the UNOS Database

P. Nguyen,¹ A. Rana,¹ T. Miloh.²
Flow DSA-XM: Better Crossmatch or Just Different Problems?

P. Kimball, F. McDougan.
Follow-Up Care of Living Kidney Donors

N. Lam,¹ K. Lentine,² B. Hemmelgarn,³ S. Klarenbach,¹ R. Quinn,³ A. Lloyd,¹ S. Gourishankar,¹ A. Garg.⁴
Follow-Up and Outcomes of Epstein-Barr Virus Negative Recipients after a Kidney Transplant from an Epstein-Barr Virus Positive Donor

C. Dudreuilh, E. Asgari, R. Hilton.
Frailty and Kidney Transplantation: AST-KPCOP Survey of Center Practices

M. McAdams DeMarco, S. Rasmussen, R. Parsons, T. Alhamad, K. Johansen, S. Tullius, R. Lynch, M. Harhay, M. Rao, J. Berger, J. Lappin, J. Tan, X. Cheng, K. Woodside, S. Parajuli, K. Lentine, B. Kaplan, D. Segev, J. Kobashigawa, D. Dadhania.
Frailty and Liver Transplantation

C. Haugen, H. Ying, C. Holscher, J. Lai, J. Garonzik-Wang, M. McAdams-DeMarco, D. Segev.
Frailty, Inflammation, and Waitlist Mortality among Patients with End-Stage Renal Disease

M. McAdams DeMarco,¹ H. Ying,¹ A. Thomas,¹ F. Warsame,¹ A. Shaffer,¹ C. Haugen,¹ J. Garonzik Wang,¹ N. Desai,¹ S. Norman,² D. Segev.¹
Functional Fc Gamma Receptor Gene Polymorphisms and Donor-Specific Antibody-Triggered Transplant Injury

M-.L. Arnold,¹ A. Kainz,² F. Eskandary,² N. Kozakowski,³ M. Wahrmann,² H. Haslacher,⁴ R. Oberbauer,² A. Heilos,⁵ B. Spriewald,⁶ L. Hidalgo,⁷ P. Halloran,⁸ G. Bohmig.²
Functional Reconstruction of Urogenital Tissue Defects Using VCA: A Novel Microsurgical Penis Transplant Model and Clinical & Histological Rejection Classification

S. Fidder,^1,4 G. Furtmüller,¹ B. Simons,² B. Kern,¹ D. Lough,¹ B. Oh,¹ M. Chicco,¹ C. Brayton,³ W. Lee,¹ D. Cooney,¹ R. Redett,¹ G. Brandacher.¹
Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation

S. Udomkarnjananun,¹ N. Townamchai,¹ K. Iampenkhae,² Y. Avihingsanon,¹ S. Eiam-Ong,¹ K. Praditpornsilpa.¹
Further In Vivo and In Vitro Evidence That Anti-CD40 MABS Do Not Induce Thromboembolism

T. Rubic-Schneider, B. Christen, N. Runser Loll, D. Garcia, E. Erard, T. Flandre, B. Cochin de Billy, S. Nock, S. Côté, J. Rush, P. Ulrich.
GDF15 Preventing Renal Ischemia Reperfusion Injury

C. Zhu,^1,2 A. Patel,¹ Y. Su,^1,2 J. Jiang,¹ D. Lian,¹ A. Sener,¹ W. Min,¹ P. Luke,¹ D. Quan,¹ K. Liu,² X. Zheng.¹
Gastrointestinal Autologous Reconstruction for Management of Chronic Gut Failure in the New Era of Visceral Transplantation

K. M. Abu-Elmagd, S. R. Armanyous, N. R. Parekh, D. McMichael, M. Fujiki, K. Hashimoto, A. Khanna, A. Shatnawei, G. Costa.
Gastroparesis after Lung Transplantation: A Single-Center Experience

S. Biswas Roy,¹ M. Davis,² F. Rodriguez,³ R. Serrone,⁴ P. Kang,⁵ T. Ipsen,⁶ M. Smith,⁷ R. Bremner,⁷ J. Huang,⁷ J. Huang.⁷
Generation of Calculated Panel-Reactive Antibody Values Using a Reference Panel of Bone Marrow Donors

E. Kransdorf,¹ L. Gragert,^2,4 M. Pando,³ N. Kaur,² J. Patel,¹ I. Kim,¹ X. Zhang,¹ M. Maiers,⁴ J. Kobashigawa.¹
Genes with Housekeeping Function (GHF) in Renal Allograft Tissue: An RNA-Seq Analysis

Z. Wang,¹ L. Pan,² Z. Lyu,² G. Zeng,¹ P. Randhawa.¹
Genetic Risk Factors of Post-Transplant Thrombocytopenia in Kidney Allograft Recipients

D. Min,¹ Y. Chang,² T. Shah.³
Genomic Diversity of Epstein Barr Virus in Post-Transplant Lymphoproliferative Disorder

E. Maloney,¹ V. Busque,² S. Hui,² S. Krams,^1,2 C. Esquivel,^1,2 O. Martinez.^1,2
Genomic Modifications Associated with Epstein Barr Virus+ Post-Transplant Lymphoproliferative Disorder

M. McPherson,¹ Y. Balachandran,¹ S. Boyd,² H. Zimmermann,³ R. Trappe,³ C. Esquivel,¹ S. Krams,¹ O. Martinez.¹
Geographic Variation in Drug Overdose as Donor Cause of Death

M. Skeans, D. Zaun, B. Kasiske.
Geographic Variation in the Treatment of Adult Heart Transplant Candidates in the US

W. Parker,¹ M. Churperk,¹ D. Hedeker,¹ E. Huang,¹ E. Garrity,¹ M. Siegler,¹ A. Anderson.²
Graft CEACAM1 is Essential to Autophagy Induction and T-Cell Regulation in Liver Transplantation: From Mouse-to-Human

K. Nakamura,¹ S. Kageyama,¹ M. Kujawski,² T. Ito,¹ A. Aziz,¹ D. Oncel,¹ B. Ke,¹ R. Sossa,³ E. Reed,³ F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Graft Failure in Recurrent IgA Nephropathy Following Living Kidney Transplantation: Predictive Factors Analysis of 102 Biopsies

J. Zhang, J. Qiu, G. Chen, C. Wang, L. Chen.
Graft Immunocomplex Capture Fluorescence Analysis Can Detect Intra-Graft Anti-Blood Group A/B Antibodies

T. Nakamura,¹ H. Ushigome,¹ Y. Imanishi,² S. Kawai,³ T. Shirouzu,³ M. Osaka,¹ K. Masuda,¹ T. Matsuyama,¹ S. Harada,¹ S. Nobori,¹ N. Yoshimura.¹
Graft Perfusion with Alvespimycin, an HSP90 Inhibitor, Suppresses Acute Allograft Rejection and Prolongs Graft Survival in Murine Heart Transplantation

T. Tanaka, T. Maehana, N. Masumori.
Greater Access to Kidney Transplantation in Competitive DSAs: Due to Improved Referral?

J. Adler,¹ D. Chang,² H. Yeh.²
Greater Susceptibility for Metabolic Syndrome in Pediatric Transplant Recipients – A Case-Control Study

R. Bloete,¹ N. Memaran,¹ B. Borchert-Mörlins,¹ D. Thurn,¹ E. Bauer,¹ R. Büscher,² J. Oh,³ B. Schmidt,⁴ A. Melk.¹
HIV-Positive Donors to HIV-Positive Transplant Recipients: The Italian Experience

P. Grossi,¹ D. Dalla Gasperina,¹ A. Petrolo,¹ D. Lombardi,¹ M. Balsamo,¹ M. Moioli,² G. Travi,² M. Merli,² F. Ferla,² M. Tozzi,¹ L. De Carlis,² G. Carcano,¹ M. Puoti,² A. Nanni Costa.³
HLA Mismatching and cPRA Do Not Affect BK Viremia and Nephropathy Risk in Kidney Transplantation: A Retrospective Analysis

B. Suleiman, S. Saleh, W. Hassan, K. Wang, A. Maibam, A. Karim, A. Hines, X. Mei, A. El-Husseini, M. Yaseen, V. Cornea, A. Castellanos, R. Gedaly, T. Waid.
HLA Typing, Panel Reactive Antibody and Donor Specific Antigen Tests Are Not Necessary for Successful Parathyroid Allotransplantation

E. Kanimdan,¹ B. Goncu,² Y. Gelmez,³ O. Idiz,⁴ C. Toka,⁵ B. Ozdemir,² H. Basoglu,⁶ N. Ozten Kandas,⁷ E. Yucesan,⁸ Y. Ersoy,⁵ R. Kazancioglu,⁹ E. Aysen.⁵
HOPE Act Deceased Organ Donors: True and False Positive Donors

C. Durand,¹ S. Seaman,¹ M. Bowring,¹ B. Doby,¹ D. Ostrander,¹ A. Redd,¹ M. Waldram,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² N. Turgeon,³ R. Friedman-Moraco,³ A. Massie,¹ D. Segev.¹
Hard-To-Place Kidney Offers: Granular Examination of Donor Risk Factors for Discard

R. Narvaez, J. Nie, K. Noyes, M. Leeman, L. Kayler.
Having Your Cake and Eating It Too: An Aggressive Protocol for DSA Treatment Does Not Doom Patients to High Infectious Risk

A. Murthy, A. Karaballa, G. Vranic, B. Javaid, J. Moore, S. Yi, J. Verbesey, P. Abrams, S. Ghasemian, M. Cooper, A. Gilbert.
Heart Transplant across Low or Moderate Level Donor-Specific Antibodies Have Acceptable Outcome

M. Olymbios, J. Patel, R. Levine, S. Dimbil, M. Kittleson, M. Rafiei, X. Zhang, J. Kobashigawa.
Heart Transplantation in Patients with Complex Congenital Heart Disease

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa, R. Garg, E. Zahn.
Heart and Lung Offer Acceptance Practices Are Associated with Organ Yield and Local Placement

A. Wey, M. Skeans, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
Hemodialysis Catheter-Related Right Atrial Thrombus Detected Prior to Kidney Transplantation

S. Jeung, H. Kim, C. Baek, S-.K. Park.
Hemodynamic and Functional Analysis of Human DCD Hearts Undergoing Normothermic Ex Vivo Perfusion

W. Sommer, N. Roy, S. Kilmarx, J. O., J. Titus, M. Villavicencio, J. Stone, J. Madsen, D. D'Alessandro.
Hepatitis C Recurrence after Liver Transplant: A Comparison of Antibody Induction versus No Antibody Induction

S. Patel, J. Jin, E. Benedetti, P. West-Thielke.
High Body Mass Index in Organ Donor is Significantly Correlated to Low PaO₂/FiO₂ Ratio in SRTR Database

T. Okamoto,¹ L. Thuita,¹ H. Niikawa,¹ K. Ayyat,¹ Y. Itoda,¹ M. Valpour,² E. Blackstone,¹ K. McCurry.¹
High Calcineurin Inhibitor Intra Patient Variability is Associated with Early Renal Allograft Inflammation, Chronicity and Loss

A. Sharma,¹ A. Cherukuri,² R. Mehta,¹ P. Sood,¹ S. Hariharan.¹
High Dose Tissue Plasminogen Activator Flush during Donation-after-Cardiac-Death (DCD) Liver Procurements Offers Optimal Outcomes

J. Torabi,² J. Graham,^1,2 S. Bellmare,^1,2 M. Kinkhabwala,^1,2 J. Rocca.^1,2
High GFR in Kidney Donors is Associated with Increased Risk of Proteinuria and Diabetes

D. Keys, S. Riad, V. Vakil, S. Jackson, D. Berglund, A. Matas.
High Grade Cytomegalovirus Viremia Events in Solid Organ Transplant Recipients: Description and Quality Improvement

M. Spinner,¹ V. Athans,¹ C. Koval.²
High Kidney Donor Profile Index (KDPI) Donor Kidneys: Use Them, Don't Lose Them!

D. Harriman, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
High Prevalence of Hypertension and Alterations in Rhythmicity in Recipients of Pediatric Transplants

N. Memaran,¹ M. Kirchner,² R. Blöte,¹ B. Maecker-Kolhoff,³ I. Goldschmidt,¹ C. Müller,⁴ J. Epping,⁵ R. Sugianto,¹ B. Borchert,¹ B. Schmidt,⁶ E. Wühl,⁷ A. Melk.¹
High Prevalence of Kidney Transplant-Associated Thrombotic Microangiopathy after ABO-Incompatible Kidney Transplantation: Risk Factors, Rapid Clinical Diagnosis, and Prompt Successful Treatment

K. Tanabe,¹ M. Okumi,¹ K. Unagami,² Y. Kakuta,¹ M. Inui,¹ H. Ishida.¹
High Tacrolimus Variability is Associated with Worse Outcomes in Pediatric Renal Transplant Recipients

S. Solomon, M. Del Rio, A. Colovai, N. Hayde.
Higher Concordance in the Incidence of DGF and Post-Transplant BKV Infection among Recipients Receiving Mate Kidneys from the Same Deceased Donor: A Paired Deceased Donor Kidney Transplant Analysis

K. Venkatesh,¹ C. Wu,¹ C. Puttarajappa,¹ R. Mehta,¹ P. Sood,¹ A. Tevar,² S. Hariharan.¹
Higher Rates of Rejection in HIV-Infected Kidney Transplant Recipients on Ritonavir-Boosted Protease Inhibitors–Three-Year Follow Up

B. Rollins, S. Farouk, G. DeBoccardo, S. Lerner, M. Rana, S. Huprikar, L. Miko, V. Delaney, S. Florman, R. Shapiro.
Highly Correlative Whole-Tissue Gene/protein Signatures to Score FFPE Transplant Biopsies with Inflammation and Acute Rejection

T. Sigdel, M. Nguyen, D. Dobi, S-.C. Hsieh, J. Liberto, F. Vincenti, Z. Laszik, M. Sarwal.
Hispanics' Perceptions of Shared Decision Making in the Transplant Context: A Mixed Methods Study

N. Alhalel,¹ J. Caicedo,¹ R. Ruiz,² A. Salazar,² S. Primeaux,² E. Gordon.¹
Histogenomics: Molecular Profiling of Kidney Biopsies Predict Delayed Graft Function

P. Rao,¹ D. Deo,¹ B. Fyfe-Kirschner,² R. Siderits.²
Hospital Readmission Patterns in the First Year after Kidney Transplantation: A Twelve-Year, Single-Center Experience

M. Nguyen, C. Avila, J. Benedict, A. El-Hinnawi, A. Rajab, R. Pelletier, M. Henry, G. Bumgardner.
Hospitalization and Life Support before Liver Transplantation – Easily Available Predictors for Post-Transplant Patient Survival

L. Wiering, P. Ritschl, M. Hippler-Benscheidt, F. Aigner, M. Biebl, D. Eurich, M. Schmelzle, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
Host Factors and Clinical Spectrum of Adenovirus Infection in Pediatric Solid Organ Transplantation: A Closer Look at the Infant, the Toddler and the Child

C. Del Valle Mojica, S. Chen, H. Gans.
How Early is Too Early for a Preemptive Kidney Transplant? A Markov Decision Process-Based Retrospective Analysis

M. Kurt,¹ A. Khojandi,² M. Barah,² B. Tanriover.³
How Evaluation for Living Kidney Donation Saved My Life

M. Guthoff,¹ T. Mühlbacher,¹ S. Nadalin,² N. Heyne.¹
How Old is Too Old? Expanding Living Kidney Organ Transplantation from Donors above 60 Years of Age with Associated Comorbidity.

A. Ghazanfar, L. Salih.
How Safe is Immunosuppression Maintenance 1 Year after Renal Allograft Failure?

A. Mena-Gutierrez, K. Alquadan, A. Santos, K. Womer, M. Casey.
How the Spouses (Husbands) of Living Kidney Donors View Kidney Donation: A Grounded Theory Study

J. Kieffer.
Human Atrial Natriuretic Peptide (hANP) in Cold Storage of Donation after Cardiac Death Livers: A New Tool for Protecting Vascular Endothelia?

Y. Nigmet,¹ K. Hata,¹ Y. Okamura,¹ I. Tamaki,¹ T. Tsuruyama,² H. Hirao,¹ T. Kubota,¹ J. Kusakabe,¹ J. Yoshikawa,¹ T. Goto,¹ T. Tajima,¹ H. Tanaka,¹ S. Uemoto.¹
Human Endothelial-Like Cells Transdifferentiated from Peripheral CD14⁺ Monocytes Inhibit T Cells in Response to Allo-Stimulation

Y. Tanaka, H. Ohdan.
Human Urine-Derived Stem Cells Protect Renal Function by Releasing miR-129-5p Which Targets High-Mobility Group Box-1 (HMGB1) in Rat Ischemia Reperfusion Injury Model

L. Liu, X. Li, Q. Su, Z. Bi, H. Huang, C. Wang.
Humoral Immunity to CMV Remains Intact after Dual Targeting Desensitization in Allosensitized Nonhuman Primates

P. Schroder, B. Ezekian, F. Saccoccio, J. Yoon, M. Dennis, K. Freischlag, J. Kwun, S. Permar, S. Knechtle.
Hypothermic Machine Perfusion Protects DCD Liver Graft through Metabolism of Xenobiotics by Cytochrome P450 Pathway

Q. Ye,^1,2 W. Liang,¹ Z. Zhong,¹ S. Ye,¹ B. Tang,¹ Q. Hu,¹ J. Liang,¹ Y. Wang.¹
Hypothermic Machine Perfusion Protects Rabbit Kidney Graft through Down Regulation SPP1-MMP7 Signaling Axis

Q. Hu,¹ Z. Zhong,¹ S. Xue,¹ W. Liang,¹ J. Lan,¹ J. Liang,¹ Y. Xiong,¹ Y. Wang,¹ Q. Ye.^1,2
Hypothermic Oxygenated Machine Perfusion in Liver and Kidney Transplantation of Extended Criteria Donors: A Phase-1 of Clinical Trial

M. Ravaioli,¹ V. De Pace,¹ M. Cescon,¹ M. Del Gaudio,¹ V. R. Bertuzzo,¹ A. Siniscalchi,¹ A. D'Errico,² G. Comai,² G. La Manna,² A. D. Pinna.¹
IVIG Induction May Be Helpful in Highly Sensitized Patients after Heart Transplantation

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Identification of Novel Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients Using Next Generation Sequencing

C. Dorr,^1,2,3 B. Wu,² R. Remmel,² A. Muthusamy,¹ D. Schladt,¹ J. Abrahante,² W. Guan,² R. Mannon,⁴ A. Matas,² W. Oetting,² P. Jacobson,² A. Israni.^1,2,3
Identification of T Cells as Target of Intervention to Decrease Anti-LG3 Autoantibody Levels Prior to Transplantation

M. Dieudé, L. Padet, A. Karakeussian-Rimbaud, B. Yang, J. Turgeon, H. Cardinal, M-.J. Hébert.
Identifying Differences in Antimicrobial Resistance with a Liver Transplant Antibiogram

J. Rago, M. Crotty, E. Milas, E. Dominguez.
Identifying Patients with CPRA>99.95% Likely to Be Offered Deceased Donor Kidneys

R. Parsons, S. Bumb, H. Decker, R. Bray, H. Gebel.
Identifying Specificity Groups in the CMV IE-1 T Cell Receptor Repertoire

M. Lucia,¹ F. Rubelt,² S. Luque,³ S. Krams,¹ C. Esquivel,¹ O. Bestard,³ O. Martinez.¹
IgG De Novo HLA Antibody Subclass Analysis in Patients Undergoing Allograft Nephrectomy after Transplant Failure

G. Lucisano,¹ A. Gueret-Wardle,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ M. Willicombe,¹ D. Taube.¹
Immune Modulatory Effect of Thalidomide and Dexamethasone Co-Treatment on Murine Splenocytes

E. Kim,^1,2 J. Kim,¹ K. Huh,^1,3 Y. Cho,¹ M. Kim,^1,3 Y. Kim,^1,3 B. Kim.^1,4
Immune Profiling in Highly Sensitized Kidney Transplant Recipients

S. Negi, A. Rutman, S. Paraskevas, J. Tchervenkov.
Immunogenic HLA Mismatches and Evidence That Belatacept May Be the First Therapy Able to Prevent DQ De Novo DSA: An Analysis of the BENEFIT and BENEFIT-EXT Trial Cohorts

M. Everly,¹ V. Jucaud,¹ M. Roberts,² H. Gebel,³ R. Bray.³
Immunoglobulin Replacement Therapy in Pediatric Renal Transplant Patients

A. Lewis, M. Fasano, D. Zepeda-Orozco.
Immunomonitoring of Operational Tolerance in Intestinal Transplantation

O. Aguirre, B. Houlihan, T. Fishbein, A. Kroemer.
Immunosuppression Does Not Affect Adverse Pathological Outcomes in Men Who Underwent Radical Prostatectomy

M. Eltemamy, A. Elshafei, Y. Nyame, A. Crane, A. Wee, V. Krishnamurthi, E. Klein, S. Jones.
Immunosuppression and the Risk of Dementia among Older Kidney Transplant Recipients

M. McAdams DeMarco,¹ C. Haugen,¹ S. Bae,¹ K. Lentine,² D. Segev.¹
Impact of AB0-Incompatible Kidney Transplantation on Lymphocele Formation

C. Salabe,¹ S. Zschiedrich,² P. Pisarski,¹ B. Jänigen.¹
Impact of Aberrant Post-Transplant Laboratory and Blood Pressure Values on Graft Survival and Racial Disparities in Kidney Transplant

D. Taber, Z. Su, J. Fleming, N. Pilch, A. Posadas, V. Rao, P. Mauldin, D. Dubay.
Impact of Age and Race on BK Viremia among Kidney Transplant Recipients

S. Mehta,^1,3 N. Ali,^1,3 B. Lonze,^2,3 A. Stachel.³
Impact of Antecedent Malignancy on Kidney Transplant Outcomes: Patient, Graft, and Cancer-Free Survival

O. Serrano,¹ S. Mongin,² D. Berglund,¹ D. Vock,³ S. Chinnakotla,¹ T. Dunn,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas.¹
Impact of Aortic Abdominal Calcification among Living Donor Liver Transplant Recipients; a Retrospective Study

Y. Imaoka, M. Ohira, S. Simizu, H. Tahara, K. Ide, Y. Tanaka, H. Ohdan.
Impact of Cigarette Smoking on Living Kidney Donor

Y. Yoon,¹ H. Lee,² J. Na,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.³
Impact of De Novo DSA Development and Management on Kidney Transplant Outcomes

M. Cote,¹ M. Pavlakis,² F. Cardarelli,² J. Pena,³ A. Dinh,³ K. Richards,¹ K. Joyal,¹ C. Rogers.¹
Impact of Direct Antiviral Therapy for Hepatitis C on Acute Rejection and DSA Formation in Kidney Transplant Recipients

Z. Zaky, S. Armanyous, L. Herlitz, E. Poggio, J. Augustine.
Impact of Donor Age on Outcomes after Living Donor Liver Transplantation

K. Hayashi,¹ K. Gotoh,¹ H. Eguchi,¹ Y. Iwagami,¹ D. Yamada,¹ T. Asaoka,¹ T. Noda,¹ K. Kawamoto,¹ S. Kobayashi,¹ K. Umeshita,² Y. Doki,¹ M. Mori.¹
Impact of Early Corticosteroid Treatment in Patients with Indeterminate Acute Severe Hepatitis

E. Mohr,¹ R. Sucher,² T. Müller,³ T. Kaiser,⁴ T. Berg.¹
Impact of Elderly Donor Obesity on Long-Term Outcomes in Renal Transplant Recipients

M. Yamada,¹ R. Jandarov,² T. Kaur,¹ S. Shah.¹
Impact of Fluconazole Prophylaxis on Fungal Infections in Liver Transplant Recipients

K. Roach,¹ S. Todd,² M. Lyon,² R. Subramanian.²
Impact of Glomerular Filtration Rate Normalization to Body Surface Area on Donor Selection and Outcome in over 4000 Living Kidney Donors

S. Riad,¹ D. Keys,¹ D. Vock,¹ S. Jackson,¹ D. Berglund,¹ V. Vakil,¹ A. Matas,¹ H. Ibrahim.³
Impact of High Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients

J. Fose, M. Jorgenson, M. Siodlak, G. Leverson, J. Smith, R. Redfield.
Impact of Immediate Graft Function in Kidney Transplant Outcomes

C. Arias-Cabrales, M-.J. Pérez-Sáez, D. Redondo-Pachón, M. Crespo, M. Mir, J. Pascual.
Impact of Immunogenicity on Kidney Allograft Survival in Patients Treated with Induction Therapy

D. Bekbolsynov, B. Mierzejewska, M. Rees, J. Ortiz, O. Ekwenna, S. Stepkowski.
Impact of Influenza Vaccine Implementation by Transplant Pharmacy in Solid Organ Transplant Recipients

S. Gattis,¹ I. Yildirim,^1,2 S. Serluco,¹ C. McCracken,² R. Liverman.¹
Impact of Lymphoceles after Kidney Transplantation on Long-Term Outcomes

L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, D. Khadzhynov, K. Budde, O. Staeck.
Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence after Liver Transplant

N. Hendon,¹ D. Salerno,¹ C. Sammons,¹ K. Halazun.²
Impact of Once-Daily Tacrolimus on Adherence in Stable Adolescent and Young Adult Renal Transplant Recipients

M. Moss,¹ J. Goebel,² M. Bock.²
Impact of Overseas Organ Transplantation on Outcome of Kidney Transplant Patients

M. Mammadli,¹ H. Ismayilov,¹ A. Asgarli,² F. Babayev,⁴ I. Hemidov,⁴ R. Shahbazov.³
Impact of Positive Donor Blood Cultures in Liver Transplant Recipients

D. Bley, D. Lo, G. Lyon III, R. Subramanian, S. Todd.
Impact of Pre-Transplant Non-Dialysis Renal Dysfunction in Heart Transplant Recipients on Post-Transplant ESRD: A UNOS Database Analysis

S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.
Impact of Preserved Collateral Veins on Small-for-Size Grafts in Living Donor Liver Transplantation

B-.G. Na, E. Lee, S. Kim, S. Park.
Impact of Providing Care Locally Compared to at a Transplant Center for Pre-And Posttransplant Liver Patients

R. Shahbazov,¹ K. Knapp,² S. Tsutsui,² A. Nickkholgh,¹ P. Northup,³ J. Oberholzer,¹ D. Maluf,¹ M. Shiffman,⁴ S. Pelletier.¹
Impact of Psychosocial Variables on Renal Allograft Rejection Risk: A Multivariate Analysis

D. Chernobylsky, K. Carsky, C. McDermott, P. Ferrin, R. Fernandez, I. Gaines, M. Killackey, R. Zhang, A. Paramesh, J. Buell.
Impact of Pulsatile Perfusion Machine on Postoperative Outcomes in Standard Criteria Donor Kidney Transplants

S. Costa,^1,2 T. Sandes-Freitas,^1,2 P. Fernandes,² R. Esmeraldo.¹
Impact of Renal Parenchymal Calcifications in a Cohort of Renal Transplanted Patients and Their Correlations with Long Term Graft Outcome

C. Alfieri,¹ G. Moroni,¹ D. Cresseri,¹ A. Regalia,¹ F. Zanoni,¹ V. Binda,¹ M. Gandolfo,¹ M. Campise,¹ M. Meneghini,¹ M. Ikehata,¹ P. Messa.^1,2
Impact of Sever Hypoxemia after Liver Tansplantation in Hepatopulmonary Syndrome

M. Pitchaimuthu, M. Fujiki, K. Sasaki, K. Hashimoto, B. Eghtesad, C. Miller, C. Quintini.
Impact of Single Nucleotide Polymorphisms on P450 Oxidoreductase and Peroxisome Proliferator-Activated Receptor alpha on Tacrolimus Pharmacokinetics in Renal Transplant Recipients

Z. Wang, Z. Han, J. Tao, H. Chen, S. Li, R. Tan, M. Gu.
Impact of Sleep Apnea Syndrome on Late Graft Dysfunction

A. Afzal,¹ K. Tecson,² A. Jamil,³ A. Wazir,¹ J. Felius,³ H. Qin,³ P. Garcha,¹ S. Carey,¹ S. Hall.¹
Impact of Steroid Maintenance on the Outcomes of HLA-DR Mismatch Kidney Transplantation

B. Chopra, K. Sureshkumar.
Impact of an Anastomosis Time on Transplant Outcomes in Deceased Donor Kidney Transplantation

K. Jeong, H. Jung, J. Choi, J-.H. Lim, J. Choi, J-.H. Cho, S-.H. Park, Y-.L. Kim, C-.D. Kim.
Implementation of Intensive Standardized Follow-Up in Kidney Transplant Recipients

A. Crane, M. Eltemamy, T. Coy, P. Babbar, A. Sun, D. Jacobsen, M. Ponziano, E. Poggio, A. Wee, R. Fatica, V. Krishnamurthi.
Implementation of the Lung Allocation Score is Associated with Decreased Mortality in Combined Liver-Lung Allograft Recipients

K. Freischlag,¹ P. Shroder,² B. Ezekian,² M. Mulvihill,² S. Knechtle.²
Improved Mouse Renal Transplantation Model Mimicking Clinical Antibody Mediated Rejection

D. Zhao,¹ T. Liao,¹ S. Li,¹ J. Zhou,² F. Han,¹ Y. Dong,³ Q. Sun.¹
Improved Value with Individualized Antithymocyte Globulin Dosing Protocol in Renal Transplant

J. Dann, W. Ally, M. Bradley, J. Geyston, A. Agarwal.
Improvement in Intermediate Graft Survival among Deceased Donor Recipients in the Last Decade Due to Improvements in Outcomes of Higher KDPI Kidney Recipients

D. Keith.
Improving Participation in Non-A1/Non-A1B to B Deceased Donor Program Post Kidney Allocation System (KAS)- A Single Center Experience

H. Khamash, J. Adamski, R. Heilman, A. Mathur, A. Moss, A. Kumar, Q. Lu, K. Reddy.
Incidence of Atrial Arrhythmia after Lung Transplantation with a Universal Prophylaxis Strategy

M. Sullivan,¹ J. Lin,² R. Bag,² L. Potter.¹
Incidence of BK Viraemia and BK Virus Associated Nephropathy with Standard vs. Augmented Immunosuppression

R. Rathore, S. Anastassiadou, A. Kaur, J. Timms, N. Krishnan.
Incidence of Epstein Barr Virus (EBV) DNAemia in EBV-Seronegative Solid Organ Transplant (SOT) Recipients with EBV-Seropositive Donors

C. Burton,¹ C. Mabilangan,² J. Preiksaitis.²
Incidence of Pneumonitis in Heart Transplant Patients Started on a Proliferation Signal Inhibitor

R. Levine, J. Patel, M. Levine, M. Kittleson, E. Kransdorf, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Incidence of Rejection and Antibody Formation after Immunosuppression Reduction in Patients with Biopsy Proven Polyomavirus Nephropathy

M. Kleman, R. Detwiler, H. Singh, V. Nickeleit.
Incisional Hernia after Orthotropic Liver Transplantation: A Systematic Review and Meta-Analysis

J. Butler, D. O'Brien, J. Kays, C. Kubal, B. Ekser, J. Fridell, R. Mangus, J. Powelson.
Increase on Regulatory Cells in Kidney Transplanted Patients Presenting Donor-Specific Antibodies

G. Maciel,¹ M. Fernandes,^1,2 E. Barbosa,² H. Rodrigues,¹ N. Panajotopolus,¹ F. Agena,² E. David-Neto,² V. Coelho,¹ M. Castro.²
Increased Expression of CEACAM1 is Cytoprotective during Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation

R. Sosa,¹ J. Nevarez-Mejia,¹ M. Rossetti,¹ A. Zarrinpar,² F. Kaldas,² C. Lassman,¹ B. Naini,¹ N. Datta,² R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,² E. Reed.¹
Increased Expression of HLA-DPB1 in Pre-Implantation Kidney Biopsies is Associated with Poor Late Graft Function

K. Mine,¹ T. Mourão,¹ C. Felipe,² G. Rampim,¹ J. Medina-Pestana,² H. Tedesco-Silva,² M. Gerbase-DeLima.¹
Increased Gene Expression of TGF-b in Renal Transplant Patients with Polyomavirus BK Viremia

W. Yin.
Increased Length of Stay of the Donor Decreases Heart Transplant Recipient Survival

H. Copeland,¹ R. Talluri,² A. Panos,¹ R. Cochran,¹ L. Creswell,¹ D. Baran.³
Increasing Obesity Prevalence in the United States Pediatric End-Stage Renal Disease Population

B. Shelton,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. McWilliams,¹ D. Sawinski,² J. Locke.¹
Increasing Obesity and Diabetes Prevalence in the United States End-Stage Renal Disease Population

B. Shelton,¹ D. McWilliams,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. Sawinski,² J. Locke.
Individualized Immunosuppression through Risk-Stratification in Renal Transplantation Preserves Excellent Outcomes at Three Years

J. Dann, A. Agarwal, M. Bradley, J. Geyston, W. Ally.
Induction Agents and Post-Transplant Malignancies in Kidney Transplants: An Examination of Outcomes at a Large Volume Center over 20 Years

D. Livingston-Rosanoff, X. Wang, G. Leverson, D. Kaufman, D. Foley.
Induction Therapy with Low-Dose Rituximab Could Be a Risk Factor of BKV Associated Nephropathy in Kidney Transplant Recipients

R. Murakami,¹ D. Nagawa,¹ M. Nakata,¹ I. Narita,¹ T. Fujita,¹ M. Shimada,¹ N. Nakamura,¹ H. Tomita,¹ S. Hatakeyama,² T. Yoneyama,² Y. Hashimoto,² T. Koie,² C. Ohyama.²
Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation

K. Sureshkumar, S. Hussain, B. Chopra.
Infection Outcomes in Solid Organ Transplant Recipients Receiving Trimethoprim-Sulfamethoxazole as Opposed to Atovaquone for Prophylaxis

A. Drelick,¹ W. Mowrey,² G. Minamoto.³
Infectious Complications Associated with Eculizumab Used for ABO-Incompatible Renal Transplantation

M. Campara, P. West-Thielke, K. Progar, N. Jasiak, A. Lichvar, I. Tang, E. Benedetti.
Influence of 6 Months Protocol Biopsies with and without Intervention on Course of GFR after Pediatric Renal Transplantation

L. Pape, C. Lerch, T. Ahlenstiel-Grunow, J. Bräsen, N. Kanzelmeyer.
Influence of Dendritic Cell Subsets on Enhancing Oral Tolerance in Cardiac Transplantation Model

G. Gu, T. Lu, N. Xu, Q. Xia.
Influence of Trough Level in Tacrolimus on the Appearance Rate of De Novo Donor Specific Antibody (dnDSA) under Low Dose-Based Tacrolimus Protocol during 7 Years Follow-Up after Renal Transplantation

H. Ishida,¹ K. Tanabe,² T. Shimizu,¹ M. Furusawa.²
Informatics Tools for Mapping Molecular HLA Typing Data to UNOS Antigen Equivalencies

N. Kaur,¹ E. Kransdorf,² M. Pando,³ M. Maiers,⁴ L. Gragert.^1,4
Informed Clustering of Donor Service Areas for Better Benchmarking

S. Noreen, R. Carrico, J. Rosendale.
Inhibition of IL-1R1 Signaling Delays Costimulation Blockade–Resistant Allograft Rejection by Preventing CD8 TEM Expansion

Y. Liu, Y. Dong, D. Mathews, A. Ghosh, A. Adams.
Institution-Based, Pharmacist-Managed Anticoagulation in Patients with a Left Ventricular Assist Device

T. Bibb,¹ L. Halder,¹ D. McDanel,¹ A. Briasoulis,² P. Alvarez,² K. Horner,¹ J. Bhama,³ S. Larson.³
Intensified Immunosuppression Improves Early Renal Allograft Function after Transplantation in a Porcine Model with Extended Asystolic Warm Ischemic Time

M. Xu,¹ X. Wang,¹ S. Garcia-Aroz,¹ B. Banan,¹ B. Rabe,¹ Z. Zhang,¹ J. Jia,¹ G. Upadhya,¹ P. Manning,² J. Gaut,³ Y. Lin,¹ W. Chapman.¹
Intention to Treat Outcomes of Patients with Hepatocellular Carcinoma Downstaged to within Milan

P. Tabrizian,¹ M. Holzner,¹ J. Emond,² S. Florman,¹ R. Brown,² M. Schwartz,¹ K. Halazun.²
Intervention for Splenorenal Shunt May Decrease the Incidence of Post-Liver Transplant Acute Kidney Injury

J. Wang, A. Nickkholgh, R. Shahbazov, S. Pelletier, D. Maluf.
Intra- versus Extra-Peritoneal Approaches in Renal Transplantation of Adult-Sized Kidneys for Children Weighting under 15kg – A Single Center Study

T. Mizutani,¹ M. Muramatsu,¹ Y. Hamasaki,² Y. Takahashi,² Y. Itabashi,¹ J. Hashimoto,² Y. Hyodo,¹ K. Sakurabayashi,¹ T. Kawamura,¹ S. Shihido.^1,2
Intraoperative Blood Loss during Pediatric Liver Transplantation: A Single Center Experience

J. Kohler,¹ D. Yoeli,¹ R. Sigireddi,¹ R. Ackah,¹ M. Kueht,² T. Galvan,² R. Cotton,² A. Rana,² C. O'Mahony,² J. Goss.²
Intravenous Immunoglobulins and Methylprednisolone Stabilizes Renal Allograft Function in the Majority of Patients with C-aABMR

K. Sablik, M. Clahsen-van Groningen, C. Looman, J. Damman, M. van Agteren, M. Betjes.
Investigating the Variability of Fluid Resuscitation during Laparoscopic Donor Nephrectomy

A. Williams,¹ S. Kumar,² R. Sung,¹ K. Woodside,¹ M. Englesbe,¹ M. Alameddine,¹ S. Waits.¹
Involvement of Additional Surgeons in Robot Assisted Kidney Transplantation Does Not Affect Surgical Outcomes, in the Context of a Structured Robotic Surgery Program. Results from a CUSUM Analysis

F. Gheza,¹ C. Di Bella,¹ P. Giulianotti,¹ J. Oberholzer,² E. Benedetti,¹ I. Tzvetanov.¹
Involvement of PD-L1 Upregulation in Anti-A/B Antibody-Induced Graft Accommodation: Reduction of CD4 T Cell Allo-Response against Graft HLA Class II DR

K. Iwasaki,¹ Y. Miwa,¹ H. Hamana,³ H. Kishi,³ A. Muraguchi,³ K. Uchida,¹ T. Kobayashi.²
Is BMI > 35 a Barrier to Kidney Transplantation?

D. Walczak, E. Benedetti, C. Ryan.
Is It Better Choice to Perform Kidney Transplantation for Elderly CKD Patients?

R. Imamura,¹ K. Tsutahara,² K. Yamanaka,³ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ T. Abe,¹ H. Kishikawa,³ N. Ichimaru,⁴ K. Nishimura,³ S. Yamaguchi,² N. Nonomura.¹
Is Kidney Transplantation Safe in Patients over 71 Years Old?

G. Andani, P. Tulissi, M. Gropuzzo, S. Crestani, C. Vallone, U. Baccarani, D. Montanaro, A. Risaliti.
Is Renal Function after Heart Transplantation an Issue for Patients with Cardiac Amyloidosis?

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Isavuconazole – The Real-World Use Experience

H. Hassouna, V. Athans, K. Brizendine.
Ischemia-Free Liver Transplantation for Fatty Liver Grafts in Human

W. Ju, S. Huang, Z. Guo, G. Chen, X. He.
Ischemia-Free Liver Transplantation in Pigs: Ischemia Reperfusion Injury is Avoidable?

Z. Guo, X. He, Y. Tang, F. Ji, Z. Zhang, Q. Zhao, S. Huang, Z. Zhu, W. Ju, G. Chen.
Itraconazole Prophylaxis, Trough Concentration, and Identification of Fungal Pathogens in Lung Transplant

H. Hassouna, V. Athans, K. Brizendine.
JC Virus-Associated Nephropathy in Renal Transplant Recipient

G. Huang,¹ M. Wang,² X. Chen,¹ S-.C. Yang,³ L. Chen.¹
Kidney Graft Outcomes in Combined Heart-Kidney Transplantation: A UNOS Database Analysis 2000-2015

A. Riaz, O. Adebiyi, D. Mishler, M. Yaqub, T. Taber, A. Sharfuddin.
Kidney Related Issues Leads the Medical Reasons to Exclude Potential Living Kidney Donors from Donation ; Prospective Study

H. Al-Eid, N. Sadaqah, I. Ibrahim, S. Aleid, A. Abdulbaki, S. Raza, I. Alahmadi, T. Ali, J. Brockman, D. Broring.
Kidney Transplant Outcome in the Patients with Lupus Nephritis

Y. Kim,¹ H. Lee,¹ H. Chin,² Y. Kim,^3,4 S. Han.¹
Kidney Transplant Outcomes in Patients with CPRA Values > 98% after Implementation of the New OPTN/UNOS Kidney Allocation System (KAS): A Single Center Study Update

N. Kaur,¹ M. Kamoun,² J. Kearns,² J. Trofe-Clark,¹ P. Abt,³ M. Levine,³ S. Goral.¹
Kidney Transplantation (KTx) Using Kidneys from Deceased Donors (DD) with AKIN Stage 2 and 3 Are Associated with Excellent Graft Outcomes

A. Kumar, K. Reddy, A. Srinivasan, J. Huskey, H. Khamash, M. Smith, A. Moss, R. Heilman.
Kidney Transplantation (KTx) Using Kidneys from Deceased Donors (DD) with Severe AKI Does Not Negatively Impact 1 Year Biopsy Chronic Changes

A. Kumar, A. Srinivasan, A. Mathur, J. Huskey, H. Khamash, M. Smith, A. Moss, K. Reddy, R. Heilman.
Kidney Transplantation (KTx) Using Kidneys from Deceased Donors (DD) with Severe Acute Kidney Injury (AKI) Requiring Renal Replacement Therapy (RRT)

A. Srinivasan, R. Heilman, A. Kumar, H. Khamash, M. Smith, K. Reddy, A. Moss.
Kidney Transplantation Alone in End-Stage Renal Disease Patients with Hepatitis B Liver Cirrhosis

M. Jang,¹ M. Lee,² S. Kim.¹
Kidney Transplantation from Uncontrolled Donation after Circulatory Death, Good Outcomes after Very Long Time

M. Molina,¹ J. Cabrera,² E. Gonzalez,¹ A. Hernandez,¹ P. Natalia,¹ A. Andres.¹
Kidney Transplantation in Older Recipients: Preemptive High KDPI Kidney vs. Lower KDPI Kidney after Varying Dialysis Vintage

B. Chopra, S. Hussain, K. Sureshkumar.
Kidney after Liver Transplant: A Matched Pair Analysis

M. Eerhart, J. Reyes, J. Danobeitia, L. Zitur, P. Chlebeck, L. Fernandez.
Kidney and Liver DCD Outcomes – A Five Year Review

J. Buggs,¹ J. Boone,² M. Adesunkanmi,² R. Mehta,² E. Rogers,³ A. Kumar,⁴ A. Alsina,¹ V. Bowers.¹
Klotho Enhances FoxO3-Mediated Manganese Superoxide Dismutase Expression by Negatively Regulating PI3K/AKT Pathway during Tacrolimus-Induced Oxidative Stress

S. Lim,¹ K. Luo,¹ J. Il,¹ Y. Shin,¹ E. Ko,^1,2 B. Chung,^1,2 C. Yang.^1,2
Klotho, HMGB-1 and Kynurenine as Marker for Injury and Function in Renal Transplantation

M. Stangl,¹ D. Abendroth.²
Krüppel-Like Factor 15 is a Key Suppressor of the Glomerular Epithelial Cell Fibrosis under Centrifugal Force Driven Pressure

M. Yu,¹ Y. Kim,¹ H. Lee,¹ J. Lee,² R. Cha,³ C. Lee,⁴ Y. Kim,¹ S. Yang.⁵
Lack of Efficacy of Eculizumab for Prevention of Delayed Graft Function (DGF) in Deceased Donor Kidney Transplant Recipients

P. Heeger,¹ E. Akalin,² M. Baweja,¹ R. Bloom,³ S. Florman,¹ B. Haydel,¹ D. Hricik,⁴ S. Kulkarni,⁵ A. Mehrotra,¹ A. Patel,⁶ E. Poggio,⁷ L. Ratner,⁸ S. Schröppel,¹ R. Shapiro.¹
Laparoscopic Donor Nephrectomy – The BMI Effect

V. Chia,¹ F. Khan,² M. Newell,² L. J. Chen.³
Laparoscopic Donor Nephrectomy Safety: Experience of 500 Cases in Hispanic Population at a Single Institution

Y. Baez Suarez, F. Giron Luque, J. Amaya Nieto.
Large Volume Intraoperative Fluid Use in Small (<20kg) Renal Recipients is Safe

N. Liow,¹ N. Mudalige,² N. Melhem,¹ S. Boyle,¹ N. Kessaris,¹ H. Hume-Smith,¹ S. Marks,¹ N. Mamode,¹ J. Stojanovic.¹
Late Conversion from Calcineurin Inhibitors to Belatacept is Associated with a Sustained Improvement in Kidney Allograft Function

S. Sethi, J. Choi, A. Vo, R. Najjar, A. Peng, S. Jordan, E. Huang.
Late Donor-Specific Antibody (Especially Class II) Development is Associated with an Increased Risk for Cardiac Allograft Vasculopathy

E. Kransdorf, J. Patel, M. Kittleson, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Latent Tuberculosis Diagnosis Prior to Kidney Transplantation in a High Burden Country: Improvement with Serological Tests

V. Garcia, G. Meinerz, C. da Silva, E. Keitel.
Left Ventricular Assist Devices Complicated by Gastrointestinal Bleeding and Outcomes on Transplant

L. Aurora, O. Sadiq, H. Nemeh, C. Williams.
Less Induction Therapy Means Fewer Early Readmissions with No Change in Rejection or Infection

S. Kush, K. Boyle, J. Gray, S. Rega, I. Feurer, A. Shah, J. Lindenfeld.
Liposomal Bupivacaine: Friend or Foe in Kidney Donation?

Y. Yang, A. Jantz, B. Summers, A. Patel, L. Malinzak, N. Sulejmani.
Liver Biopsy Fibrosis Not Liver Imaging Predicts Survival after Heart Transplant

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Liver Preservation with Machine Perfusion and a New Human-Derived Hemoglobin-Based Oxygen Carrier Solution (HDHBOC)

W. R. Light,¹ A. Malavalli,¹ K. Vandegriff,¹ P. Fontes.²
Liver Transplant Recipients with End-Stage Renal Disease Largely Benefit from Kidney Transplantation

W. Ju, Y. Tang, Q. Zhao, L. Jing, S. Huang, Z. Zhu, F. Ji, Z. Zhang, X. He, G. Chen, Z. Guo, D. Wang.
Liver Transplantation Post Gastric Bypass: Surgical Complications and Outcomes

A. Vijay, A. Nigam, R. Girlanda, A. Kroemer, J. Hawksworth, C. Matsumoto, T. Fishbein.
Liver Transplantation as a Life Saving Procedure after Post Resection Liver Failure and Iatrogenic Liver Injuries

T. Thorsen,¹ J. Solheim,¹ R. Horneland,¹ P-.D. Line,¹ K. Labori,² E. Aandahl.¹
Liver Transplantation for Hepatocellular Carcinoma Outperform Other Populations in the New Hepatitis C Era

A. Alsina,¹ A. Athienitis,² J. Buggs,¹ E. Fallon,³ E. Parkinson,³ C. Albers,³ N. Kemmer.³
Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma Treated with Neoadjuvant Therapy: A Pilot Cohort Study

K. Lunsford,¹ M. Javle,² K. Heyne,¹ R. Shroff,² R. Hassan Ali,² C. Mobley,¹ D. Victor,¹ A. Kaseb,² T. Aloia,² C. Conrad,² X. Li,¹ H. Monsour,¹ A. Gaber,¹ J-.N. Vauthey,² R. Ghobrial.¹
Liver Transplantation for Severe Alcoholic Hepatitis: Is Early Always Necessary?

T. Wu,¹ N. Nissen,² C. Galloway,² A. Klein,² T. Tran,¹ W. Ayoub,¹ M. Noureddin,¹ I. Kim,² T. Todo,² V. Sundaram.¹
Liver Transplantation in Foreign Nationals: Lower Rates of Waitlist Mortality and Higher Rates of Lost to Follow-Up Post-Transplant

N. Ferrante, D. Goldberg.
Liver Transplantation with or without Left Renal Vein Ligation: Comparative Study of 105 Cases

M. Perosa,¹ H. Noujaim,¹ J. Branez,¹ L. Mota,¹ B. Zeballos,¹ R. Santos,¹ A. Watanabe,² G. Ferreira,² A. Moraes,² A. Silvestre,³ G. Martinho,⁴ N. Siqueira,⁵ T. Genzini.¹
Liver Transplants from Older Donors Have Worse Outcomes in Elderly Recipients with Renal Dysfunction

R. Schilke,¹ M. Safwan,¹ S. Nagai,¹ M. Abouljoud,² A. Patel.¹
Livers from Diabetic Donors Can Safely Be Used in Donation after Circulatory Death Liver Transplantation

I. Brüggenwirth,¹ I. Vasiliauskaire,² A. Westerkamp,¹ W. Polak,² A. Braat,³ R. Porte.¹
Living Donor Liver Transplant (LDLT) at a Single Center- Intraoperative Technical Modifications and Optimization of Flow Dynamics to Improve Outcomes

A. Humar, S. Ganesh, A. Tevar, M. Molinari, C. Hughes.
Living Donor Liver Transplantation for Hepatocellular Carcinoma beyond UCSF Criteria: Can We Achieve a Modest Long-Term Survival? A Single Center Retrospective Analysis of Using Extended Criteria

A. Thorat, L.-B. Jeng, S.-C. Hsu, C.-C. Yeh, T.-H. Chen, H.-R. Yang, K.-S. Poon, P.-C. Li.
Living Donor Nephrectomy: Is It as Safe as It Can Be? Analysis of Living Donor Deaths in the United States

D. Keith,¹ J. Brown,² K. Andreoni.³
Living Liver Donation is Safe in Donors Heterozygous for an alpha-1 Antitrypsin Gene Mutation

T. Bittermann,¹ L. Wood,² P. Abt,² A. Shaked,² K. Olthoff,² D. Goldberg.^1,3
Living Liver Donation: The Role of Facebook in Directed Donation

A. Lai, J. Steel, S. Ganesh, O. Ola, S. Shen, N. Zharichenko, S. Nawaz, A. Tevar, A. Humar.
Living Liver Donors Face Substantial Out-of-Pocket Donation-Related Costs

J. Ruck, A. Massie, J. Garonzik-Wang, S. Ottman, A. Cameron, B. Philosophe, D. Segev.
Living-Donor Preemptive Kidney Transplant Timing Calculator: An Online Decision Support Tool

M. Barah,¹ M. Kurt,² A. Khojandi,¹ B. Tanriover.³
Locoregional Treatments before Liver Transplantation for Hepatocellular Carcinoma: A Cohort Study from the European Liver Transplant Registry

H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, P. De Simone, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.
Long Term Culture of Functional Bone Marrow-Derived Human Plasma Cells

N. Moore, K. Bonner, M. D'Costa, M. Stegall.
Long Term IVIG Infusions for Treatment of Chronic Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients

A. Al-Uzri,¹ C. Shaut,² S. Iragorri,¹ R. Jenkins,¹ K. Richardson,¹ D. Rozansky,¹ M. Wright,¹ K. Roayaie.²
Long Term Outcomes of Renal Allografts with De Novo DSA in the Setting of Stable Graft Function versus Acute Rejection

R. Knight,¹ D. Nguyen,² E. Graviss,² T. Eagar,² S. Kuten,³ S. Patel,³ L. Moore,¹ A. Gaber.¹
Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant

Y. Kassis,¹ S. Park,¹ A. Shetty,¹ J. Leventhal,¹ V. Mas,² L. Gallon.¹
Long-Term Effect of BMI on Renal Function in Asian Living Kidney Donors

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Long-Term Effects of Ketoconazole in Rapid Tacrolimus Metabolizers Post-Renal Transplantation

J. Ching,¹ S. Anders,¹ M. Janusek,¹ L. Hutchinson,¹ A. Freeman,¹ U. Patel,¹ A. Mohammed,⁴ H. Bohorquez.^2,3
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 9 Years Follow-Up

S. Narumi,¹ Y. Watarai,¹ N. Goto,² T. Hiramitsu,¹ M. Okada,¹ M. Tsujita,² K. Futamura,² M. Nishihira,³ T. Kobayashi.⁴
Long-Term Efficacy and Safety of Prolonged-Release Tacrolimus in Stable Pediatric Allograft Recipients Converted from Immediate-Release Tacrolimus

N. Undre,¹ J. Rubik,² D. Debray,³ D. Kelly,⁴ F. Iserin,⁵ N. Webb,⁶ P. Czubkowski,² K. Vondrak,⁷ A-.L. Sellier-Leclerc,⁸ S. Riva,⁹ B. Tönshoff,¹⁰ L. D'Antiga,¹¹ S. Marks,¹² R. Reding,¹³ G. Kazeem.¹
Long-Term Follow Up of Living Kidney Donors with CKD at 1 Year after Nephrectomy

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Long-Term Follow-Up of Pediatric Kidney Recipients Who Received Alemtuzumab Induction

D. Harriman, A. Chen, J. Rogers, R. Stratta, G. Orlando, A. South, J-.J. Lin, A. Farney.
Long-Term Outcome of Pediatric Kidney Transplantation: A Single-Center Experience over the past Three Decades in Japan

Y. Aoki,¹ H. Satoh,¹ Z. Matsui,¹ R. Hamada,² Y. Hamasaki,³ S. Shishido.³
Long-Term Outcomes after Living Liver Donation: Analysis of National Data Base

S. Hong, N-.J. Yi, K. Yoon, J-.H. Cho, J-.M. Lee, H. Kim, K. Lee, K. Suh.
Long-Term Outcomes of Graft Function in Elderly Kidney Transplant Recipients

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Long-Term Outcomes of Liver Transplantation in Patients with Pre-Transplant Renal Dysfunction Treated with Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus

M. Gastaca,¹ J. Bustamante,² A. Ventoso,¹ J. Fernandez,² P. Ruiz,¹ M. Testillano,² M. Prieto,¹ P. Salvador,² I. Palomares,¹ M. Senosiain,² M. Suarez,² A. Valdivieso.¹
Long-Term Outcomes of Primary Kidney Transplant from Expanded Criteria Maastricht Category 3 DCD Donors: A Single-Centre Observational Study

E. Favi,¹ C. Puliatti,² S. Iesari,³ M. Ferraresso,¹ R. Cacciola.²
Long-Term Outcomes of a Steroid-Free, Belatacept-Based Immunosuppressive Regimen Plus Sirolimus Using Alentuzumab Induction in Renal Transplantation

A. Guasch,¹ A. Ghali,¹ S. Mead,¹ A. Mehta,¹ H. Xu,² A. Kirk.²
Long-Term Prognosis of BK Virus Associated Nephropathy in Kidney Transplant Recipients

W. Park,^1,3 S. Yeo,¹ S. Kang,^1,3 H. Park,¹ K. Jin,^1,3 S. Park,^1,3 M. Choe,^2,3 S. Han.^1,3
Long-Term Renal Function in Living Kidney Donors with Renal Cysts

M. Waldram, A. Thomas, A. Muzaale, C. Holscher, A. Nguyen, S. Halpern, S. Anjum, J. Alejo, B. Boyarsky, S. Ottman, J. Garonzik-Wang, D. Segev, A. Massie.
Long-Term Social Outcome after Pediatric Kidney Transplantation

Y. Hamasaki,¹ T. Matsuda,¹ M. Kubota,¹ J. Hashimoto,¹ Y. Takahashi,¹ M. Muramatsu,² T. Kawamura,³ K. Sakai,² S. Shishido.^1,2
Long-Term Success of Treatment for Cardiac Transplant AMR May Depend Upon Suppressing Class II Donor Specific Antibodies

J. Hofmann,¹ D. Weisshaar,² D. Kiprov.³
Lower Incidence of De Novo Donor-Specific Antibodies against HLA-DR in ABO-Incompatible Renal Transplantation

M. Okada,¹ K. Futamura,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ Y. Watarai,¹ K. Iwasaki,² T. Kobayashi.²
Lymph Node Stromal Laminins Modulate the Dynamic Balance of the Treg/Th17 Axis

L. Li, T. Simon, W. Piao, Y. Xiong, V. Saxena, T. Zhang, C. Wagner, J. Bromberg.
Lymphocyte Proportions Post Thymectomy Are Associated with Allergic Disorders in Heart Transplanted Children

T. Kim,¹ L. Ionescu,^1,2,3 N. Avdimiretz,⁴ M. Larsen,^1,2,3 F. Murdoch,^1,2 B. Motyka,^1,2,3 S. Gilmour,^1,2 L. West,^1,2,3 S. Urschel.^1,2,3
MCS and Desensitization

J. Kobashigawa, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, E. Passano, L. Czer, J. Moriguchi, F. Arabia.
MICA/B Polymorphisms and the Relationship of the Matching Degree between MICA/B and HLA of Related Donor-Recipient Pairs in Allo-HSCT

Y. Sun, Y. Hao, J. Jin, L. Ding, F. Liang, N. Liu, J. Long, X. Zhao, Y. Xi.
Machine Learning to Assess Kidney Donor Risk

A. Shah, M. Li, Z. Chen.
Maintenance Immunosuppression Trends in Hand and Facial VCA Transplantation

A. Manjunath,¹ M. Cammarata,¹ R. Kantar,¹ W. Rifkin,¹ A. Jacoby,¹ B. Gelb,² R. Diaz-Siso,¹ E. Rodriguez.¹
Making Right Donor Nephrectomy Great Again: Evaluating Right Hand Assisted Retroperitoneal Donor Nephrectomy

H. Alahdal,¹ F. Alghamdi,¹ M. Shoukri,² J. Brockmann,¹ D. Broering.¹
Malignancies in Kidney Transplant Recipients: A Long-Term Observational Study

D. Khadzhynov, F. Halleck, F. Froehlich, L. Lehner, E. Schrezenmeyer, K. Budde, O. Staeck.
Many Highly Sensitized Candidates Still Waiting for Transplant Despite the Kidney Allocation System Change: Making the Case for Incompatible Transplantation

C. Schinstock, B. Smith, A. Bentall, M. Stegall.
Maternal and Fetal Outcomes in Living Kidney Donors in Korea

H. Lee,¹ K. Yoo,² M. Yu,¹ Y. Kim.¹
Maximizing Utilization in Pancreas Transplantation: Phenotypic CharacteristicsDifferentiating Aggressive from Nonaggressive Transplant Centers

O. K. Serrano,¹ D. M. Vock,² T. B. Dunn,¹ R. Kandaswamy,¹ E. B. Finger.¹
Mayo Clinic's First Face Transplant: 17 Months On

H. Amer, S. Jowsey-Gregoire, C. Rosen, R. Razonable, K. Reid, M. Gandhi, L. Ewoldt, B. Edwards, S. Mardini.
Measles and Varicella Vaccination Status and Evidence of Immunity during Solid Organ Pre-Transplantation Evaluation

H. Daniels, C. Saracusa, S. Worley, B. Gonzalez.
Medical Contraindications to Solid Organ Transplant Listing: A Survey of Heart, Liver, Lung and Kidney Programs

A. Wall, G. Lee, J. Maldonado, D. Magnus.
Medical and Psychosocial Outcomes of Directed and Non Directed Living Liver Donors

J. Steel, S. Ganesh, A. Lai, S. Shen, N. Zharichenko, S. Nawaz, K. Kingsley, M. Dulovich, A. Tevar, C. Hughes, A. Humar.
Medicare Part D Plans Deny Coverage for Off-Label and Off-Compendia Immunosuppressant Use: A Case Series

L. Potter, E. Garrity.
Melatonin Prolongs Heart Allograft Survival by Induction of Foxp3+ Regulatory T Cells

L. Liu, Q. Su, Y. Xiong, Z. Bi, H. Huang, Y. Peng, C. Wang.
MeltDose Prolonged-Release Once-Daily Tacrolimus (LCPT) vs. Conventional Tacrolimus Formulations in the Initial Maintenance of De Novo Kideny Transplant Recipients across Europe: STEADY Study

K. Budde,¹ G. Piotti,² C. Procaccianti,³ G. Nicolini,³ S. Geraci,³ D. Surace.³
Memory T Cell Dysfunction after Pregnancy Alloimmunization Prolongs Transplant Survival

P. Porrett,¹ J. Cohen,² R. Xu,¹ E. Lewis,³ M. Elovitz,³ E. Wherry,⁴ D. Sawinski.²
Metabolic Acidosis after Kidney Transplantation: Prevalence, Risk Factors and Graft Outcome in a French Cohort

F. Garo, I. Szwarc, G. Mourad, M. Le Quintrec, J-.E. Serre.
Metabolic Regulation of Neuropeptides Induces Weight Loss and is Linked to Prolongation of Allograft Survival

M. Quante,^1,2 T. Heinbokel,¹ K. Minami,¹ Y. Nian,¹ A. Elkhal,¹ S. Tullius.¹
Micafungin Prophylaxis in Liver Transplant Recipients at High Risk for Invasive Fungal Infections

A. Nolan, N. Harriott, K. Startsman.
Microbiology and Outcomes of Febrile Neutropenia Episodes after Kidney Transplant

G. Dube, S. Husain, H. Morris, D. Cohen, S. Mohan.
Midodrine Associated with Increased Mortality on Liver Transplant Waitlist

J. Kalil, M. Hertl, E. Schadde, J. Poirier, N. Alvey, E. Chan.
Minimal Invasive Surgery is Feasible and Safe in Patients with Liver and Kidney Transplant Patients

W. Yin.
Mitigating Risk: Post-Exposure Prophylaxis in Liver Transplant Recipients from Donors with Potential Infectious Exposure

A. Nolan, D. Yarosh, S. Shaikh.
Mitochondrial Quality Control through PGC-1α in Syngenic Mouse Heart Transplant

A. Cherry,¹ K. Porter,¹ H. Suliman,¹ J. Wang,² M. Mulvihill,² A. Kirk.²
Modification of Macrophage Phenotype by the Magnetic Field

M. Kloc,¹ W. Chen,¹ J. Kubiak,^2,3 X. Li,¹ R. Ghobrial,¹ J. Wosik.⁴
Modified Protocol for ABO-Incompatible Living Donor Liver Transplantation with Rituximab and Intravenous Immunoglobulin without Plasma Exchange

B-.G. Na, E. Lee, S. Kim, S. Park.
Molecular Assessment of Post-Transplant Glomerular Disease Comparing to Transplant Glomerulopathy

E. Akalin,¹ M. e Silva,² Y. Bao,¹ V. Bontha,³ M. Ajaimy,¹ V. Mas,³ P. [Oacute] Broin.²
Molecular Injury and Repair Assessment in Ex Vivo Perfused Swine Heart Transplants

N. Herbers, S. Hatami, P. Dromparis, J. Nagendran, M. Mengel, D. Freed, B. Adam.
Monitoring of Small Bowel Allografts with Kynurenine Serum Levels

M. Stangl,¹ D. Koliogiannis,¹ J. Bucher,¹ M. Guba,¹ D. Abendroth.²
Mortality of Live Kidney Donors in the UK: 15 Year Comparative Cohort Study

N. Krishnan,¹ L. Mumford,³ G. Lipkin,⁴ S. Fletcher,¹ I. Gupta,⁵ P. Gill,⁶ R. Ryan,⁷ N. Raymond.⁸
Multi-Center Examination of the Reliability and Validity of the Live Donor Assessment Tool (LDAT) as an Enhancement to the Psychosocial Evaluation of Living Donors

D. LaPointe Rudow,¹ S. Jowsey-Gregoire,² F. Desrosiers,³ J. Trompeta,⁴ LDAT Study Group.¹
Multi-Drug Resistant Urinary Tract Infections Following Renal Transplant: Risk Factors and Patient Outcomes

D. Hooker,¹ K. Gutierrez,² K. Foster,¹ A. Dodson.²
Multi-Targeting Desensitization Therapy Alters Peripheral B-Cell Homeostasis and Suppresses Recall Alloantibody Responses

I. Kim, G. Wu, N-.N. Chai, A. Klein, S. Jordan.
Multi-Visceral Transplant in an HIV Positive Recipient – One Year Survival

S. Nagaraju, R. Mangus, J. Fridell.
Multiparametric MRI for Assessment of Renal Transplant Fibrosis: A Pilot

M. Menon, O. Bane, S. Lewis, R. Khaim, S. Florman, P. Kennedy, S. Hectors, V. Delaney, F. Salem, B. Taouli.
Multiplexed Immunofluorescence to Investigate the Immune Response to BK Virus in Pediatric Kidney Transplant Recipients

C. Fajardo,¹ P. Grimm,¹ N. Kambham,² G. Nolan,³ N. Samusik,³ J. Maltzman.³
Multivariate Cox Proportional Hazards Model for Estimating Long-Term Risk of Aging Kidney Transplant Recipients

A. Yaldo, I. Bajjoka, X. Han, C. Crombez, M. Abouljoud.
Mycophenolate Monotherapy is Safe and Effective in HLA-Matched Kidney Transplant Recipients

A. Hennes, K. Holdener, W. Burlingham, B. Astor, A. Djamali.
Mycophenolic Acid Reduces BK Polyomavirus Replication in an In Vitro Model of Renal Tubular Epithelial Cells Infection

E. Favi,¹ S. Delbue,² C. Colico,¹ P. Ferrante,² S. Villani,² I. Perna,² N. Mondoni,² A. Giussani,¹ M. Ferraresso.¹
NKG2C+CD57+ NK (G2C+57+) Cells Expanded by CMV Infection Are Highly Responsive to Allo-Antibody (Ab)-Mediated NK Cell Stimulation

B. Shin,¹ D. Puliyanda,² H. Pizzo,² S. Jordan,² M. Toyoda.¹
National Landscape of HIV+ Liver Transplant Candidates

A. Shaffer,¹ A. Thomas,¹ A. Massie,¹ S. Gustafson,² J. Snyder,² B. Shelton,³ R. Reed,³ J. Locke,³ D. Segev,¹ C. Durand.¹
National Outcomes of Donor and Recipient Sex Mismatch in Kidney Transplantation

J. Buggs,¹ L. Wang,³ R. Liu,³ E. Rogers,² V. Bowers.¹
National Survey of Living Donor Coordinators to Identify Barriers to Living Donation

D. Moore,¹ M. Dietrich,¹ P. Buerhaus,² J. Rodrigue,³ A. Minnick.¹
National Survey of Living Donor Program Educational Components and Resources

D. Moore,¹ M. Dietrich,¹ P. Buerhaus,² J. Rodrigue,³ A. Minnick.¹
Native Kidney Volume Decreases after Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Less Patients Need Nephrectomy?

R. Murakami,¹ D. Nagawa,¹ M. Nakata,¹ I. Narita,¹ T. Fujita,¹ M. Shimada,¹ N. Nakamura,¹ H. Tomita,¹ S. Hatakeyama,² T. Yoneyama,² Y. Hashimoto,² T. Koie,² C. Ohyama.²
Neutrophil to Lymphocyte Ratio (NLR) Does Not Predict Outcomes after Liver Transplant (LT) for Hepatocellular Carcinoma (HCC)

E. Harding-Theobald, N. Mehta, F. Yao.
New Factors Predicting Delayed Graft Function: A Multi-Center Cohort Study Based on Kidney Donation after Brain Death Followed by Circulatory Death

Q. Sun,¹ H. Zhou,² M. Lin,³ X. Hua,¹ L. Hong,¹ Z. Huang,¹ N. Na,¹ R. Cai,³ G. Wang,² Q. Sun.¹
New SLK Allocation Policy May Impact Transplant Outcomes in Women

G. Cullaro,¹ R. Hirose,² J. Lai.¹
New Sensitive Markers for Early Diagnosis of Transplant Glomerulopathy in Kidney Recipients

Y-.C. Xu-Dubois, K. Louis, C. Jouanneau, D. Buob, N. Ouali, A. Hertig, E. Rondeau.
No Deleterious Effect from the Presence of Donor Specific Antibodies (DSA) or Positive Flow Cytometry Crossmatch (FCXM) on the Outcomes of Simultaneous Liver-Kidney (SLK) Transplant Recipients

H. Khamash, A. Kumar, B. Aqel, R. Heilman, A. Jaramillo, K. Reddy, A. Moss.
Non-Immunologic Pairing of Kidney Transplant Donors and Recipients: How Important is HLA Match Status?

A. Miller, B. Kiberd, K. Tennankore.
Non-Medical Factors Predict Receipt and Type of Kidney Transplant

H. Wesselman,¹ X. Li,¹ J. Chang,¹ K. Kendall,¹ J. Pleis,¹ E. Croswell,¹ M. Dew,¹ R. Shapiro,² L. Myaskovsky.³
Noninvasive Quantization of Intra-Renal Allograft C4d Deposition with Targeted Ultrasound Imaging

T. Liao,¹ Y. Zhang,¹ J. Ren,² H. Zheng,¹ H. Zhang,² X. Liu,¹ T. Yin,² Q. Sun.¹
Nontuberculous Mycobacteria in Lung Transplant Recipients: Prevalence, Risk Factors and Impact on Survival and Graft Function

D. Friedman, C. Cervera, K. Halloran, G. Tyrrell, K. Doucette.
Normothermic Ex Vivo Liver Perfusion Prior to Liver Transplantation Can Prevent Platelet Aggregation and Platelet Induced Sinusoidal Cell Injury

D. Kollmann,¹ I. Linares,¹ S. Ganesh,¹ R. Rosales,¹ N. Tessandier,² E. Boilard,² M. Hamar,¹ P. Urbanellis,¹ P. Yip,³ O. Adeyi,³ M. Selzner,¹ N. Selzner.¹
Normothermic Ex-Vivo Kidney Perfusion Restores the Genetic Profile of Marginal Kidney Grafts Subjected to Warm Ischemia

P. Urbanellis,¹ M. Hamar,¹ I. Linares,¹ D. Kollmann,¹ S. Ganesh,¹ R. John,¹ P. Yip,¹ I. Mucsi,¹ A. Ghanekar,¹ D. Bagli,² A. Konvalinka,¹ D. Grant,¹ L. Robinson,² M. Selzner.¹
Novel Approach to Molecular Testing Using Routine Diagnostic Tissue

P. Herzyk,¹ F. McMonagle,¹ P. Shiels,¹ S. Coley.²
Novel Low Dosing of Rabbit Antithymocyte Globulin Preserves Excellent Outcomes and Improves the Value of Care in Low Risk Renal Transplantation

J. Dann, W. Ally, M. Bradley, J. Geyston, A. Agarwal.
OPTN VCA Waiting List Trends

J. Wainright, C. Wholley, W. Cherikh, J. Musick, D. Klassen.
Obesity is Associated with Increased Risk of Mortality among Living Kidney Donors

R. Reed,¹ A. Massie,² D. Sawinski,³ P. MacLennan,¹ B. Shelton,¹ M. Mustian,¹ D. McWilliams,¹ V. Kumar,¹ R. Mannon,¹ R. Gaston,¹ D. Segev,² C. Lewis,¹ J. Locke.¹
Objective Markers of Frailty Predict Successful Listing and Survival for Renal Transplant

A. Tevar, K. Lemon, C. Wu, N. Shah, R. Mehta, C. Puttarajappa, P. Sood, S. Hariharan, A. Ganoza, M. Wijkstrom, M. Molinari, A. Humar, Y. Wang, J. Steel.
Occupational and Financial Outcomes of Directed and Non-Directed Living Liver Donors

J. Steel, M. Dulovich, K. Kingsley, S. Ganesh, O. Ola, A. Lai, S. Shen, N. Zharichenko, S. Nawaz, A. Tevar, C. Hughes, A. Humar.
Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection

Y. Matsuoka,¹ K. Iwasaki,² Y. Miwa,² K. Horimi,¹ K. Uchida,² T. Kobayashi.¹
Once-Daily MeltDose Tacrolimus Formulation and Renal Function in Caucasian Fast Tacrolimus Metabolizers: Does Early Identification Have an Impact in PK Sensitive Patients?

K. Budde,⁶ B. Suwelack,¹ D. Stevens,³ W. Du,⁴ C. Procaccianti,⁵ C. Maas,⁵ S. Bunnapradist.²
Once-Daily Prolonged-Release Tacrolimus versus Twice-Daily Tacrolimus in Liver Transplantation: A Meta-Analysis

R. Deng, B. Huang, Y. Shi, Y. Ma.
Once-Daily versus Twice-Daily Tacrolimus in De Novo Living Kidney Transplantation Patients: A Multicenter, Parallel Group, Open-Label, 5-Year Randomized Noninferiority Trial

Y. Kakuta,¹ M. Okumi,¹ K. Unagami,² M. Furusawa,¹ H. Ishida,¹ K. Tanabe.¹
One-Year Graft Survival for Longevity Matched Kidneys in the Post-KAS Era

A. Wilk,¹ M. Aeder,² V. Casingal,³ N. Turgeon.⁴
One-Year Outcomes in Patients with Advanced Liver Fibrosis or Compensated Cirrhosis from Chronic Hepatitis C Receiving Kidney Transplant Alone

P. Brown, F. Kumssa, D. Venkat.
Opioid Use Following Ultrasound-Guided Transverse Abdominis Plane Blocks in Living Donor Nephrectomy Patients

E. Henricksen,¹ D. Quan,¹ C. Freise.²
Optimal Anti-Thymocyte Globulin Dose for Induction Immunosuppression in Kidney Transplantation

A. Mitrokhin, J. Goldman, B. Trivedi, V. Vidyasagar, N. Vadivel, M. Hart.
Optimal Protocol for ABO Incompatible Kidney Transplantations: Analysis of 400 Cases in a Single Center Experience

H. Kwon, Y. Kim, J. Choi, S. Shin, J. Jung, M. Cho, J. Kim, D. Han.
Opting out and Offers of 'Alibis' for Potential Living Kidney Donors in the US

R. Iskander,¹ S. Kulkarni,² C. Thiessen.²
Oral Health Related Quality of Life for Children with Kidney Disease

P. Verghese,¹ J. Sotillo,² J. Diaz,¹ E. Sarwas.²
Oral Vancomycin Monotherapy versus Combination Therapy in Solid Organ Transplant Recipients with Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study

G. Korayem,^1,2,4 K. Eljaaly,^2,3 K. Matthias,^2,4 T. Zangeneh.^4,5
Organ Donation and Transplantation in US States and Europe – Is There a Benefit to Opting Out?

R. J. Vela,¹ J. Pruszynski,¹ T. Mone,³ P. Niles,² M. Peltz.¹
Organ Procurement Organization Run Department of Motor Vehicle Office Leads to Increased Organ Donor Registry Enrollments

L. Dageforde,¹ W. Muren,² S-.H. Chang,¹ N. Vachharajani,¹ D. Brockmeier,² B. Anderson,¹ A. Khan,¹ J. Wellen,¹ S. Shenoy,¹ Y. Lin,¹ W. Chapman,¹ M. Doyle.¹
Organ Transplant Abuse in China (1): Scale

G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
Organ Transplant Abuse in China (2): Continued Growth after Gaining International Attention

G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
Organ Transplant Abuse in China (3): Transplants Conducted on Demand

G. Yin,¹ D. Li,¹ M. Fu,² Y. Xia.³
Organ Transplant Abuse in China (4): Organ Sources

D. Li, G. Yin.
Organ Transplant Abuse in China (5): Role of the Chinese State

D. Li,¹ Y. Xia,² M. Li,¹ G. Yin.¹
Outcome Analysis of Renal Re-Transplantation Compared to a Matched Control Group of First Transplantation

A. Schwarz,¹ F. Schaefer,¹ T. Framke,² S. Linnenweber,¹ H. Haller.¹
Outcomes Associated with Rabbit Anti-Thymocyte Globulin Induction According to Mg/Kg of Total Body Weight in Kidney Transplant Recipients

A. Brueckner, A. Logan, L. Bowman.
Outcomes after Cardiac Transplantation for Adult Congenital Heart Disease in the Modern Era

X. Zeng,¹ R. Vela,² J. Pruszynski,² J. Martinez,² S. Ring,² M. Peltz.²
Outcomes after Kidney Transplant (KTx) from Deceased Donors (DD) Aged ≥ 70

A. Srinivasan, R. Heilman, H. Khamash, K. Reddy, A. Moss.
Outcomes after Kidney Transplantation in Patients with AL Amyloid Following Autologous Stem Cell Transplantation

V. Gutgarts,^1,2 I. Jaffer Sathick,² C. Rosenbaum,³ T. Muthukumar,¹ H. Hassoun,⁴ C. Flombaum,² H. Landau.⁴
Outcomes and Risk Factors of Kidney Transplantation from Pediatric Donors to Adult Recipients

G. Chen, X. Liu, C. Wang, Z. Wu, C. Wang, L. Chen.
Outcomes from 194 Consecutive Split Left Liver Transplants: Comparison of Living versus Deceased Donors

D. Adamson, P. Tabrizian, M. Parides, K. Iyer, J. Moon, J. Chu, R. Arnon, S. Florman.
Outcomes in Liver Transplant Patients on Renal Sparing Protocol

A. Polyak,¹ D. Ganger,² A. Shetty.²
Outcomes in Living Kidney Transplant Donor and Recipient Operations with Same vs. Different Surgeons

J. Sokolich,¹ J. Buggs,¹ D. Mahon,² E. Rogers,³ V. Bowers.¹
Outcomes in Renal Transplant Recipients with Bipolar Disorder: A Large Retrospective Cohort

S. Hamel,¹ D. Sawinski,² R. Weinrieb,³ S. Dave,³ J. Trofe-Clark.^1,2
Outcomes of Antiviral Treatment (AVT) in Hepatitis C Virus (HCV) Liver Transplant (LT) Patients off Immunosuppression (IS) in Direct Acting Antivirals (DAA) Era

E. Agudelo,^1,2 I. Campos-Varela,³ N. Terrault.^1,2
Outcomes of Donation after Cardiac Death Liver Grafts from Donors ≥ 50 Years of Age: A Multi-Center Analysis

K. P. Croome,¹ A. K. Mathur,³ D. D. Lee,¹ A. A. Moss,³ C. B. Rosen,² J. K. Heimbach,² C. B. Taner.¹
Outcomes of Donor and Recipient Obesity in Kidney Transplantation

J. Buggs,¹ R. Mehta,² M. Adesunkanmi,² J. Boone,² E. Rogers,³ A. Kumar,⁴ V. Bowers.¹
Outcomes of Early Steroid Withdrawal in 6-Antigen Human Leukocyte Antigen (HLA)-Matched Kidney Transplant Recipients

H. Champion, K. Holdener, B. Astor, F. Aziz, D. Mandelbrot.
Outcomes of Hispanic Kidney Transplant Recipients under a Cyclosporine versus Tacrolimus Based Immunosuppression Protocol

P. West-Thielke, M. Campara, I. Tang, E. Benedetti.
Outcomes of Kidney Transplant Recipients with Early Allograft Inflammation: A Prospective Study

R. Mehta, S. Tandukar, P. Sood, C. Puttarajappa, C. Wu, N. Shah, A. Tevar, S. Hariharan.
Outcomes of Liver Transplant in Sequential Eras in Patients with Polycystic Liver Disease at Various Stages of Disease

C. Desai,¹ J. Shurney,¹ P. Serrano Rodriguez,¹ A. Barritt,¹ D. Gerber,¹ A. Gruessner.²
Outcomes of Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma in the U.S. (2002-2015)

T. Bittermann,¹ S. Prenner,¹ P. Abt,² D. Goldberg.^1,3
Outcomes of Renal Transplantation in Pediatric Patients with VACTERL Association

J. Diaz,¹ B. Chavers,² S. Chinnakotla,³ P. Verghese.²
Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures

L. Chen,¹ D. Kamiyama,² L. Francalacci,¹ E. Zhu,² M. Donnelley,² N. Clayton,² K. Alman,¹ A. De Mattos,¹ J. Brown.³
Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 1100 Cases at a Single Center

K. Omoto,^1,2 M. Okumi,¹ Y. Kakuta,¹ H. Noguchi,¹ K. Unagami,¹ M. Inui,¹ H. Ishida,¹ K. Tanabe.¹
Outcomes of Subsequent Pregnancies in Female Heart Transplant Recipients

S. Rao,^1,2 D. Armenti,¹ L. Coscia,¹ S. Constantinescu,^1,2 M. Moritz.^1,3,4
Outcomes of Very Old Kidney Recipients of Grafts from Very Old Donors

H. Trujillo, A. García, T. Cavero, B. Redondo, C. Moliz, T. Bada, E. González, M. Praga, A. Andrés.
Overcoming Barriers to Transplant: An A2 to B Program Need Not Be Difficult, Expensive, or Time Consuming Even for Large Centers

S. Radomski, B. Diedrich, D. Li, M. Awwad, S. Rosen-Bronson, A. Langeberg, A-.A. Hamby, M. Cooper, A. Gilbert.
Pancreas Decellularization Protocol – Comparison of Methods

A. Berman, K. Karzynski, M. Serwanska-Swientek, N. Pilka, M. Klak, K. Kosowska, J. Cichon, F. Ambrozkiewicz, M. Wszola.
Parathyroid Cell Xenotransplantation with Ultrapure Alginate Based Microencapsulation Technique

B. Goncu,¹ E. Yucesan,² H. Basoglu,³ M. Celikten,¹ O. Huseyinbas,¹ B. Ozdemir,¹ N. Ozten Kandas,⁴ F. Akbas,⁵ Y. Ersoy,⁶ E. Aysan.⁶
Participation in Paid Work across the Transplant Trajectory from the Perspective of End-Stage-Kidney-Disease Patients

K. Gaudet, M. Achille.
Patient Experience after Kidney Transplant: Factors That Lessen the Burden of Treatment after Kidney Transplant

E. Lorenz,¹ J. Egginton,¹ M. Stegall,¹ R. Heilman,² S. Nair,² M. Mai,³ D. Eton.¹
Patient and Graft Survival in Pediatric Renal Transplant Recipients Compared to Adult Multi-Organ (Kidney-Pancreas, Simultaneous Liver-Kidney, or Heart-Kidney) Transplant Recipients: An Analysis of OPTN Data

P. Almond,¹ S. Al-Akash,¹ D. Stewart,² A. Robinson.²
Patient and Transplant Outcome in Infants Starting Renal Replacement Therapy before Two Years of Age

J. Hogan,^1,2,3 J. Harambat,⁴ E. Berard,⁵ C. Couchoud,³ M-.A. Macher.^2,3
Patient-Centered Outcomes after Liver Transplantation: A Qualitative Study

G. Lee, J. Obayemi, E. Rubin.
Patient-Researcher Partnership Platform within the Canadian National Transplant Research Program: The First Year Experience

M-.C. Fortin,^2,3,6 S. Bédard,^1,2 J. Allard,^2,3 F. Ballesteros,^2,3 S. Anthony,^2,4,5 A. Boivin,^1,3 A. Lespérance,^1,3 D. Hartell.²
Patients Prioritize Waitlist Factors over Outcomes When Evaluating Kidney Transplant Centers

A. Michelson, C. Brennan, A. Mattoo, B. Kil, D. Tsapepas, S. Husain, S. Mohan.
Patients with C-aABMR and V-Lesions in Their Renal Transplant Biopsy Have a Superior Response to Treatment

K. Sablik, M. Clahsen-van Groningen, C. Looman, M. Betjes.
Pattern of Respiratory Virus Infection (RVI) and Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant Recipients (LTR)

L. Somerville, S. Drews, K. Halloran, N. Lee, D. Kabbani, H. Hirji, K. Doucette, C. Cervera.
Pediatric Kidney Allograft Outcomes Following Identification of Transplant Glomerulopathy by Electron Microscopy

J. Grodsky, R. Craver, I. Ashoor.
Pediatric Kidney Transplant in Norway – Results after Switching from Midline to Retroperitoneal Approach in Recipients below 25 kg

R. Horneland, A. Khan, G. Steinar, T. Thorsen, M. Hagness.
Pediatric Transplantation within the ASTS: A Member Survey

W. Andrews, S. Chinnakotla, J. Nathan, A. Gallo, P. Healey, J. Dominique, C. Esquivel.
Perceptions, Motivations, and Concerns about Living Organ Donation among People Living with HIV

S. Rasmussen, M. Henderson, J. Bollinger, S. Seaman, C. Durand, D. Segev, J. Sugarman.
Performance of Molecular Diagnostic Algorithms of T-Cell Mediated Kidney Rejection (TCMR) in Non-Transplant Biopsies with Interstitial Nephritis

Z. Wang,¹ P. Liu,² G. Tseng,² G. Zeng,¹ P. Randhawa.¹
Peri-Operative Hemoglobin, Blood Transfusion and Delayed Graft Function in Kidney Transplant Recipients

S. MacIsaac, A. Ramankumar, C. Saw, V. Naessens, M. Cantarovich, D. Baran, S. Paraskevas, J. Tchervenkov, P. Chaudhury, S. Sandal.
Peripheral but Not Follicular T Helper Cells Are Activated by Allogeneic Human Endothelial Cells under IRI-Like Conditions and Promote Donor Specific Antibody

W. Fu,¹ P. Yoo,² J. Pober,³ D. Jane-wit.¹
Persistence and Homing of Autologous Donor-Reactive Ex-Vivo Expanded Regulatory T Cells to Heart Allografts in Lymphodepleted Recipient Monkeys

M. Ezzelarab, Z. Hong, A. Zahorchak, L. Lien, T. Nakao, H. Dai, D. van der Windt, A. Perez-Gutierrez, J. Bhama, A. Thomson.
Persistent Progressive Acute Kidney Injury and Graft Failure Post Liver Transplantation

T. Hussaini,^1,4 N. Partovi,^1,4 E. Yoshida,^2,4 S. Erb,^2,4 C. Scudammore,^3,4 S. Chung,^3,4 V. Marquez.^2,4
Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients

Z. Wang, Z. Han, J. Tao, H. Chen, L. Sun, R. Tan, M. Gu.
Pharmacokinetics of Mycophenolic Acid Following Enteric-Coated Mycophenolate Sodium Administration in Chinese Renal Transplant Recipients

W. Peng, C. Tian, Z. Chen, W. Xue, G. Wang, Q. Ye, X. Zhang, M. Gu, M. Zhao, C. Wang, C. Huang, J. Yan, W. Zhang, C. Ding, Y. Fu, S. Ye, X. Hu, R. Tan, M. Li, R. Deng, Y. Ke, W. Wu, M. Fan, J. Chen.
Pharmacologic Donor Management Influences Liver Transplant Graft Survival and Transplant Admission Length of Stay: An Update

J. Brandenberger,¹ J. Perkins,² A. Cantafio,³ A. Dick,² J. Halldorson,⁴ J. Reyes.²
Phosphoproteomic Analysis of Mouse Hepatic Ischemia/Reperfusion Injury

A. Zarrinpar,² S. Duarte,¹ Y. Lai.²
Pilot Study of Health IT Feasibility and Impact on Quality of Life for Young Adult Kidney Transplant Recipients

C. Blosser, R. Katz, J. Himmelfarb, N. Bansal.
Pinching an Inch in Kidney Transplantation: Subcutaneous Depth as a Risk Factor for Wound Complications

R. Ruiz, T. Cox, K. Wicklund, N. Jennings, N. Onaca, G. Testa, T. Anthony, H. Fernandez, J. Bayer, G. McKenna.
Polyclonal Cellular Immune Function is Dose-Dependently Inhibited by Immunosuppressive Drugs but Has Limited Value in Predicting Infection or Rejection Episodes

S. Marx,¹ C. Adam,² S. Leyking,² U. Sester,² M. Sester.
Polymorphisms of Nucleotide Factor of Activated T Cells Cytoplasmic 2 and 4 and the Risk of Acute Rejection Following Kidney Transplantation

Z. Wang, Z. Han, J. Tao, H. Chen, L. Sun, R. Tan, M. Gu.
Portal Vein Flow as an Indicator of Liver Transplantation for Acute Liver Failure

C-.H. Cheng,¹ C. Lee,² Y-.C. Wang,¹ T-.H. Wu,¹ C-.F. Lee,¹ T-.J. Wu,¹ H. Chou,¹ K-.M. Chan,¹ W-.C. Lee.¹
Positive Implications of an Enhanced Recovery after Surgery Protocol Using Liposomal Bupivacaine for Transverse Abdominis Plane Block in the Perioperative Phase of Robotic Assisted Laparoscopic Living Donor Nephrectomy

A. Nickkholgh,¹ A. Agarwal,¹ B. Sarosiek,² A. Sites,³ A. Nishio Lucar,⁴ J. Oberholzer,¹ P. Amato.⁵
Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation: A Single Institute Experience with Focus on Epstein-Barr Virus Status

P. Zhang,¹ R. King,¹ K. Ristow,² L. Cornell,¹ F. Cosio,³ T. Habermann,² M. Alexander.¹
Postoperative Immunological Profiles of Adult ABO-Incompatible Living Donor Liver Transplant Recipients

T-.J. Wu, Y-.C. Wang, C-.H. Cheng, T-.H. Wu, C-.F. Lee, H. Chou, K-.M. Chan, W-.C. Lee.
Postoperative Renal Function Predicts Length of Stay for Incisional Hernia Repair after Liver Transplantation

J. Butler, D. O'Brien, J. Kays, C. Kubal, B. Ekser, J. Fridell, R. Mangus, J. Powelson.
Potential Barriers to Renal Patient Care: Perspectives of Dialysis and Transplant Social Workers

D. Lim,¹ A. Patel,² N. Khoury,² R. Prashar.²
Potential Impact of DCD Donor Recoveries on Heart Transplantation: Retrospective Analysis of a Limited UNOS Dataset

J. Lindower,² M. Farr,¹ S. Taylor,² U. Jorde,³ L. Chen,⁴ A. Gass,⁵ L. Truby,¹ S. Delair,² S. Pinney.⁶
Poverty, End Stage Liver Disease, and Transplantation in Georgia

R. Lynch,¹ K. Ross,¹ J. Magliocca,¹ D. Goldberg,² R. Patzer.¹
Pragmatic Surgical Risk Assessment Criteria in Critically Ill Patients Prior to Liver Transplantation

C. Bonham, Z. Tulu, M. Melcher, P. Kwo, W. Concepcion, A. Ahmed, C. Esquivel.
Pre Liver Transplant (LT) Prediction of Surgical Complexity by Recipient Risk Grading and Optimizing Outcomes: The Ochsner Experience

H. Sharma,¹ H. Bohorquez,^1,2 D. Bruce,¹ J. Seal,¹ A. Cohen,^1,2 E. Bugeaud,¹ I. Carmody,^1,2 D. Sonnier,¹ A. Mathur,¹ D. Marroquin,¹ M. Voltz,¹ L. DeGregorio,¹ G. Loss.^1,2
Pre-Existing Allograft Diabetic Nephropathy from Diabetic Donor is Reversible after Kidney Transplantation in Non-Diabetic Recipient

K. Hotta,¹ D. Iwami,¹ H. Harada,² Y. Fukasawa,² H. Okada,¹ H. Higuchi,¹ T. Hirose,² N. Fukuzawa,² N. Shinohara.¹
Pre-Existing Renal Cell Carcinomas in Patients with Polycystic Kidney Disease Undergoing Simultaneous Native Nephrectomy and Living Donor Kidney Transplantation

M. Aull,¹ J. Del Pizzo,² A. Watkins,¹ S. Kapur.¹
Pre-Kidney Transplant Inflammation and Post-Transplant Outcomes.

H. Ying, M. McAdams DeMarco, D. Segev.
Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Pre-Transplant versus De Novo Donor Specific Antibodies: Differences in Clinical Outcomes and Antibody Mediated Rejection

M. Ajaimy, N. Hayde, A. Colovai, E. Akalin.
Precision (re)Phenotyping of Histologically Stable Kidney Transplants

D. Rychkov,¹ T. Sigdel,² M. Sirota,¹ M. Sarwal.²
Predicting Acute Kidney Injury after Orthotopic Liver Transplantation Using a Recurrent Neural Network

A. Bishara, R. Kothari, M. Bokoch, C. Niemann, D. Adelmann.
Predicting Early and Late eGFR Variability in Kidney Transplant Recipients

K. Soliman, D. Taber, S. Zemin, V. Rao.
Predicting Outcomes of Rat Vascularized Composite Allotransplants through Quantitative Measurement of Chimerism with PCR-Amplified Short Tandem Repeat

H. Cheng,¹ X. Huang,² C-.F. Lin,¹ N. AL Deek,² L. Shih,² C-.H. Lin,^1,2 F-.C. Wei.^1,2,3
Predicting Pediatric Liver Transplant Rejection with Peripheral Blood Leukocyte (PBL) Transcripts-Considerations and Design Limitations

M. Ningappa, C. Ashokkumar, Q. Sun, B. Higgs, K. Soltys, G. Bond, G. Mazariegos, R. Sindhi.
Prediction of 90 Days Readmission after Kidney Transplantation Including Natural Language Processing

X. Zhang,¹ M. Arenson,⁴ J. Kim,⁴ G. Karadkhele,¹ J. Hogan,^1,5 Y. Zhang,⁶ A. Adams,¹ R. Patzer.^1,2,3
Prediction of BK Viremia by Urine BK Viral Load in Renal Transplant Patients: BK Viral Load Results in Paired Urine and Plasma Samples

K. Madden,¹ C. Janitell,² S. Yang.²
Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis

A. Humar,¹ P. Liu,² J. Luo,³ M. Nalesnik,³ A. Singhi,³ G. Tseng,² G. Michalopoulos.³
Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast EnhancedUltrasonography

C. Yang,¹ S. Wu,³ T. Zhu,¹ W. He.²
Predictive Value of mRECIST in HCC Response to the Neoadjuvant Locoregional Therapies and Prognosis Affected by the Peak AFP Level before Liver Transplantation

M. Xu,¹ T. Fraum,² S. Garcia-Aroz,¹ N. Vachharajani,¹ N. Saad,³ K. Fowler,² Y. Lin,¹ W. Chapman.¹
Predictors of Kidney Transplant Recipient Readmissions

A. Crane, M. Eltemamy, D. Jacobsen, T. Coy, A. Sun, P. Babbar, M. Ponziano, E. Poggio, A. Wee, R. Fatica, V. Krishnamurthi.
Preemptive B Cell Depletion Modulates Pathogenic Alloimmunity Associated with Selective Non-Activating CD28 Blockade

N. O'Neill,¹ T. Zhang,¹ W. Sun,¹ G. Braileanu,¹ X. Cheng,¹ I. Tatarov,¹ W. Hassanein,¹ Z. Habibabady,¹ B. Cerel,¹ K. Reimann,² A. Azimzadeh,¹ R. Pierson.¹
Preemptive Plasma Therapy and Eculizumab (ECU) Rescue for Atypical Hemolytic Uremic Syndrome (aHUS) Relapse Following Kidney Transplantation (KTX)

C. Aigner,^1,2 G. Böhmig,¹ F. Eskandary,¹ M. Gaggl,¹ R. Kain,² R. Sunder-Plassmann,³ Z. Prohaszka,⁴ A. Schmidt,¹ G. Sunder-Plassmann.¹
Preemptive Rituximab in Focal and Segmental Glomerulosclerosis Patients at Risk for Recurrence after Transplantation

P. Auñon,¹ N. Polanco,¹ M. Perez,² E. Rodrigo,³ A. Sancho,⁴ J. Pascual,² A. Andres,¹ M. Praga.¹
Pregnancy Outcomes after Living Liver Donation

G. Lee, E. Sonnenberg, K. Olthoff, D. Goldberg, P. Abt.
Pregnancy Outcomes in Kidney Recipients with Lupus Nephritis

S. Rao,^1,2 L. Coscia,¹ D. Armenti,¹ M. Moritz,^1,3,4 S. Constantinescu.^1,2
Preoperative Anemia in Transfusion Free Patients Undergoing Kidney Transplant May Be Associated with Poor Outcome

N. Kaur, A. Pita, C. Lane, M. Bhatnagar, L. Matsuoka, R. Selby, K. Dhanireddy.
Preoperative Antibiotics Treatment Decreases Endoplasmic Reticulum Stress and Protects Liver Transplant from Ischemia-Reperfusion Injury

T. Ito, F. Kaldas, K. Nakamura, S. Kageyama, A. Aziz, R. Busuttil, J. Kupiec-Weglinski.
Preparation for Transfer to Adult Kidney Transplant Care: Impacts of Providing Written Guidance

H. Stephens,¹ M. Clementi,¹ A. Al-Uzri, M. Wright,⁴ S. Iragorri,² D. Rozansky,² R. Jenkins,² J. Wade,³ K. Richardson,⁵ K. Freeman.¹
Presence of Chronic Vascular Lesions on Allograft Biopsy is Associated with Greater Improvement in Renal Function after Conversion from Tacrolimus to Belatacept

M. Perez-Saez,^1,2 B. Yu,¹ A. Uffing,¹ N. Murakami,¹ J. Azzi,¹ S. El Haji,³ S. Gabardi,³ L. Riella.¹
Presentation and Outcomes of Post-Transplant Proliferative Disorder at a Single Institution Pediatric Transplant Center

G. Ramos-Gonzalez,¹ A. Allain,¹ T. Agur,¹ L. O'Melia,¹ S. Staffa,² S. Burchett,¹ B. Siegele,³ O. Weinberg,³ N. Rodig,¹ R. Fawaz,¹ T. Singh,¹ D. Freiberger,¹ K. Heung Bae.¹
Pretransplant Use of Rituximab is Associated with Posttransplant Malignancies Events and Death by Neoplasia in Incompatibility Living Donor Kidney Transplants

I. Revuelta,^1,2,3,4 V. Tubita,² D. Cucchiari,^1,2 E. De Sousa,¹ P. Piselli,⁵ M. Lozano,⁶ J. Cid,⁶ E. Palou,⁷ J. Martorell,⁷ F. Oppenheimer,^1,2,3,4 F. Diekmann,^1,2,3,4 J. Campistol.^1,2,3,4
Prevalence and Infection-Related Outcomes Associated with Transplant Tourism

J. Slomovic, S. Humar, D. Kumar, A. Humar.
Prevalence and Persistence of Cardiovascular Risk Factors and Subclinical Vascular Damage in Patients after Pediatric Lung Transplantation

M. Onnen,¹ N. Memaran,¹ B. Borchert,¹ R. Blöte,¹ R. Sugianto,¹ C. Müller,² A. Melk.¹
Prevalence of Abnormal Hemoglobin A1C in Pediatric Kidney Transplant Recipients

A. Serluco,¹ R. Liverman,¹ R. George,^1,2 R. Garro.^1,2
Prevalence of Metabolic Syndrome (MetS) and Insulin Resistance in Living Kidney Donors

I. Agboli, L. Moore, D. Nguyen, E. Graviss, H. Ibrahim, A. Gaber, A. Sadhu.
Prevalence, Risk Factors and Impact of BK Viremia on Kidney Transplantation: Single Center Experience

W. Hassan, A. El-Husseini, B. Suleiman, K. Wang, M. Yaseen, A. Maibam, A. Karim, A. Hines, A. Castellanos, V. Cornea, X. Mei, R. Gedaly, T. Waid.
Preventing Recurrence of Incisional Hernia after Liver Transplantation

J. Butler, D. O'Brien, J. Kays, C. Kubal, B. Ekser, J. Fridell, R. Mangus, J. Powelson.
Preventing of Rejection of Vascularized Composite Allografts by Targeting T Cell Metabolism

B. Oh,¹ C. Cheng,² G. Furtmüller,¹ K. Donovan,¹ W. Lee,¹ J. Powell,² G. Brandacher.¹
Primary Insult to the Native Lungs Are Needed for Antibodies to Lung Self-Antigens, Kα1Tubulin and Collagen V, to Be Pathogenic for the Development of Obliterate Airway Disease

M. Sharma, W. Liu, T. Mohanakumar.
Primary Oral Vancomycin Prophylaxis Reduces the Incidence of Clostridium difficile Infection among Lung Transplant Recipients

V. Bajrovic, K. Brizendine.
Procurement Travel Safety: Current Practices, Accident Frequency, Perceptions of Safety and Means to Reduce Risk

A. Schenk, A. Adams, R. Lynch.
Prognostic Value and Biological Significances of Five Long Non-Coding RNAs in Hepatocellular Carcinoma

Y. Hou,¹ Z. Yu,² N. Tam,¹ S. Huang,¹ J. Yang,¹ L. Wu,¹ Y. Ma,¹ X. He.¹
Program-Specific Transplant Rate Ratios: Association with Allocation Priority at Listing and Posttransplant Outcomes

A. Wey, S. Gustafson, N. Salkowski, J. Pyke, B. Kasiske, A. Israni, J. Snyder.
Prolonged-Release Tacrolimus Dosing in De Novo Kidney Transplantation: Randomized, Open-Label, Pilot Study

Y. Kim,¹ Y. Chiang,² S. Kim,³ M. Kim,⁴ S. Park,⁵ S. Wu,⁶ K. Horita,⁷ Y. Nakashima,⁷ H. Jiang,⁸ D. Han.¹
Promoting Medication Adherence from the Perspectives of Teen and Young Adult Kidney Recipients, Parents and Health Care Professionals

C. Nguyen,¹ M. Dew,¹ A. DeVito Dabbs,¹ T. Irizarry,¹ M. McNulty,¹ B. Foster.²
Prophylaxis of Wound Infections- Antibiotics in Renal Donation (POWAR): A Multicentre UK Double Blinded Placebo Controlled Randomised Controlled Trial

Z. Ahmed, R. Uwechue, N. Kessaris, N. Mamode.
Prospective Study of Switching from Tacrolimus to Low-Dose Cyclosporine A Preserving Allograft Function in BK Virus-Associated Nephropathy

G. Huang, X. Chen, S. Yang, C. Wang.
Prospective Validation of Prediction Models for Kidney Discard

S. Zhou, A. Massie, C. Holscher, M. Waldram, D. Segev.
Prostate Cancer Characteristics in Men on Immunosuppressive Medications

M. Eltemamy, A. Elshafei, A. Salah, Y. Nyame, H. Arora, A. Wee, V. Krishnamurthi, S. Jones.
Protective Effect of Ceria-Nanoparticle on Renal Ischemia Reperfusion Injury in Rats

S-.I. Min,¹ S. Kim,² S. Kim,³ J. Ha.¹
Protein S Deficiency as an Independent Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients Awaiting Liver Transplantation

H-.C. Hung,¹ J-.C. Lee,¹ C-.H. Cheng,² Y-.C. Wang,² T-.H. Wu,² C-.F. Lee,² T-.J. Wu,² H. Chou,² K-.M. Chan,² W-.C. Lee.²
Protocol Biopsies after Paediatric Kidney Transplantation: A Single Centres' 17 Year Experience

T. Alsulaimi,¹ M. Aloufi,² S. Grisaru,¹ S. Samuel,¹ L. Hamiwka.¹
Proton Pump Inhibitor Use among Kidney Transplant Recipients

N. Wilson, S. Bala, B. Concepcion.
Providing Transplant Candidates with Guidance about Differences in Acceptance Criteria across Programs

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^4,7 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2
Providing Transplant Candidates with Patient-Specific Public Reports about Programs That Transplant Patients Like Them

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^7,4 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2
Psychiatric Disorders and Disturbances in Transplant Listing Decisions

G. Lee, A. Wall, D. Magnus, J. Maldonado.
Psychosocial Assessment of Candidates for Transplantation (PACT) Identifies Non-Adherence in Pediatric Kidney Transplantation

K. Freischlag,¹ V. Chen,² S. Nagaraj,² A. Chua,² E. Chambers.²
Psychosocial Factors Affecting Recipients of Vascular Composite Allotransplantation

S. Rasmussen, M. Henderson, C. Cooney, J. Shores, W. Lee, D. Segev, G. Brandacher.
Psychotic Disorders and Outcomes after Kidney Transplantation

M. Molnar,^1,2 J. Eason,^1,2 A. Gaipov,³ M. Talwar,^1,2 P. Potukuchi,³ K. Kalantar-Zadeh,⁴ C. Kovesdy.^3,5
Pump Resistive Index Values and Not Preimplantation Kidney Biopsy Predict Kidney Allograft Survival

J. Liu,¹ A. Blumfield,¹ M. Trivedi,¹ N. Mishra,¹ O. Mohammed,^1,2 J. Lin,³ M. Ajaimy,^1,2 J. Graham,^1,2 J. Rocca,^1,2 E. Akalin,^1,2 S. Greenstein.^1,2
Pumping Donor Kidneys Reduces DGF and Improves Allograft Survival without Affecting Rejection Rates

M. Samoylova, A. Nash, T. Brennan.
Quality of Life after Kidney Transplant in Andalucia (Spain)

J. de Teresa Alguacil, C. de Gracia Guindo, C. Ruiz Fuentes, R. Castellano Carrasco, M. Torres Sánchez, P. Galindo Sacristán, A. Osuna Ortega.
Quantification of the Indirect Effect of Recipient Characteristics on Kidney Graft Function

S. Rao,¹ A. Gillespie,¹ J. Lee,¹ K. Lau,² S. Karhadkar,² A. Di Carlo,² S. Constantinescu.¹
RNA Expression Profiling of Renal Allografts in a Non-Human Primate Identifies Inflammation as a Risk Factor in Chronic Antibody Mediated Rejection

R. Smith,¹ B. Adam,² A. Rosales,¹ M. Matsunami,³ T. Oura,³ B. Cosimi,³ T. Kawai,³ M. Mengel,² R. Colviin.¹
Race and Socioeconomic Disparities in Organ Type, Recovery and Readmission in Kidney Transplant Recipients

A. Crane, T. Coy, N. Yerram, M. Eltemamy, E. Poggio, R. Fatica, A. Wee, C. Modlin, V. Krishnamurthi.
Racial and Ethnic Disparities in Preemptive Transplantation before and after the Introduction of Kidney Allocation System, in Pediatric and Young Adult End Stage Renal Disease Patients

R. George,¹ M. Basu,² R. Garro,¹ J. Hogan,¹ R. Patzer.²
Racial/Ethnic Disparities in Living Donor Kidney Transplantation before and after the New National Kidney Allocation System

X. Zhang,¹ T. Melanson,² L. Plantinga,^3,6 M. Basu,¹ S. Pastan,^1,7 S. Mohan,^4,5 M. Garber,⁶ R. Patzer.^1,6,7
Radiation Exposure to the Transplant Surgeon: A Case Study of Recent Yttrium-90 Treatment in an Explanted Liver

M. Decoteau,¹ P. Lewis,¹ S. Steuterman,² R. Schaffer,¹ J. Fisher,¹ J. Case,¹ C. Marsh.¹
Radioisotopic Evaluation of Glomerular Filtration Rate (GFR) before and 1 Year after Kindey Donation for Transplantation: The Concept of Estimated Renal Functional Reserve (eRFR)

V. Cantaluppi,¹ G. Guglielmetti,¹ M. Mora,¹ A. Airoldi,¹ F. Orsini,² M. Quaglia,¹ G. Sacchetti,² C. Ronco.³
Rapamycin Therapy Impairs Treg Expression of CXCR3 and Limits Treg-Dependent Survival of Vascularized Composite Allotransplants

H. Xu,¹ Z. Chen,² W. Hancock,^3,4 S. Levin,⁵ Y. Zhang.¹
Re-Endothelialization of Liver Xenografts Utilizing Human Endothelial Cells

W. Hassanein,¹ P. Patel,¹ A. Werdsheim,¹ J. Brilliant,¹ E. Buckingham,¹ N. Shockcor,¹ C. Drachenberg,² R. Barth,¹ J. LaMattina.¹
Re-Hospitalization after Pediatric Kidney Transplantation in Steroid Avoidance Protocols

P. Verghese, S. Chinnakotla, D. Berglund, A. Matas, B. Chavers.
Reassessment of Virtual Crossmatch: The Clinical Meaning of Cell-Based Actual Crossmatch for Kidney Transplantation

B. Peng,^1,2 M. Yu,^1,2 Q. Zhuang,^1,2 H. Liu,^1,2 L. Zhu,^1,2 Y. Liu,^1,2 K. Cheng,^1,2 Y. Ming.^1,2
Receiving Hypertensive Donor Has an Inferior Prognosis in Simultaneous Liver Kidney Transplantation Recipient

Z. Guo, Z. Zhu, S. Huang, Y. Tang, Z. Zhang, X. He, G. Chen.
Recipient ABO Blood-Type is Associated with Their Survival after Adult-to-Adult Living-Donor Liver Transplantation: Blood-Type O is Disadvantage?

T. Goto,¹ K. Hata,¹ M. Nagao,² J. Kusakabe,¹ Y. Okamura,¹ T. Tajima,¹ I. Tamaki,¹ Y. Nigmet,¹ T. Tajima,¹ J. Yoshikawa,¹ H. Tanaka,¹ S. Ichiyama,² S. Uemoto.¹
Recipient Outcomes in Age Mismatched Living Kidney Transplants from Donors > 60 Years: A UNOS Database Analysis

O. Adebiyi, A. Riaz, M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin.
Recurrence of Focal Segmental Glomerulosclerosis (FSGS) and Response to Prolonged Plasmapheresis Therapy: A Single Center Pediatric Experience

A. Bobrowski, D. Matossian.
Reduced Ratio of FoxP3/ RORγt Gene Expression, in Peripheral Blood, is Associated with Acute Allograft Rejection in Recipients with Kidney Transplantation

R. Dhital,^1,2 R. Minz,³ M. Minz,^1,4 A. Sharma,¹ R. Nada,⁵ S. Singh,¹ D. Kenwar,¹ S. Anand.³
Reducing Discards for Deceased Kidney Donors over Age 50 by Restricting Biopsy Criteria

C. Hostetler, J. Rogge, B. Nicely, S. Rudich.
Regulation of Indoleamine 2,3-Dioxygenase in Porcine Kidney Transplants

Y. Wang,¹ X. Fang,¹ D. Kleven,¹ C. Ho,² S. Nahman,^1,3 T. Merchen.¹
Regulation of NK Cell Cytotoxicity by TEC Expression of Clr Proteins in Kidney Ischemia Reperfusion Injury (IRI)

B. Fuhrmann,^1,5 D. Lian,⁵ Z. Yin,⁵ S. Ma,^4,5 J. Arp,⁵ Z. Zhang,^2,3,4,5 A. Jevnikar.^1,3,4,5
Regulatory Dendritic Cell (DCreg) Cell Infusion in Living Donor Liver Transplantation

A. Thomson, A. Humar, F. Lakkis, S. Styn, A. Zahorchak, C. Macedo, D. Metes.
Reliability of Bronchiolitis Obliterans Syndrome Reporting to the OPTN

R. Carrico,¹ R. Lehman,¹ K. Uccellini,¹ K. Chan,² T. Whelan.³
Reliability of Deceased Donor Procurement Biopsy Images at the Time of Kidney Allocation

S. Mansour,¹ E. Hall,² P. Reese,³ Y. Jia,¹ H. Thiessen-Philbrook,¹ G. Moeckel,¹ F. Weng,⁴ P. Revelo,² M. Khalighi,² A. Trivedi,⁵ M. Doshi,⁶ B. Schroppel,⁷ C. Parikh.¹
Renal Allograft Cortical Perfusion Quantification by 3D-Arterial Spin Labeling Could Be Used to Identify Subclinical Antibody-Mediated Rejection

W. Wang,¹ J. Wen,² F. Xu,² Y. Yu,³ L. Zhang,³ Z. Liu.²
Renal Allograft Transplantation among Middle Eastern Population with Alemtuzumab Induction

G. Mitro, O. Ekwenna, M. Rees, J. Ortiz.
Renal Transplant Outcomes in Recipients Weighing 8-10 Kilograms

P. Singer, Y. Tseng, C. Sethna, L. Castellanos-Reyes, E. Molmenti, A. Fahmy, E. Grodstein, L. Teperman.
Renal and Bone Safety in Post Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide for HBV Prophylaxis

E. Gane,¹ B. George,¹ S. Munn,¹ H. Wang,² V. Suri,² A. Gaggar.²
Renal-Sparing Protocol May Be Harmful If Performed Early Post-Heart Transplant

J. Patel, M. Johl, E. Kransdorf, M. Kittleson, S. Dimbil, R. Levine, D. Chang, L. Czer, J. Kobashigawa.
Reported Effects of the SRTR 5-Tier Rating System on US Transplant Centers

S. Rasmussen,¹ A. Thomas,¹ J. Garonzik-Wang,¹ M. Henderson,¹ S. Stith,² D. Segev,¹ L. Hersch Nicholas.¹
Results of UNOS Survey on Diagnosis, Treatment and Follow-Up Evaluation of Clinical and Sub-Clinical TCMR and ABMR in Kidney Transplant Recipients

P. Sood,¹ W. Cherikh,² A. Toll,² R. Mehta,¹ C. Puttarajappa,¹ S. Hariharan.¹
Rhesus Monkey Have natural Antibody toward Swine That is Not Influenced by Allosensitization nor by Carfilzomib/tocilizumab

J. Yoon, B. Ezekian, M. Manook, J. Kwun, S. Knechtle.
Rhesus-Specific Anti-Thymocyte Globulin as an Adjuvant to Costimulatory-Blockade-Based Immunotherapy

M. Mulvihill,¹ B. Ezekian,¹ Q. Gao,¹ K. Samy,¹ R. Davis,¹ F. Leopardi,¹ A. Belli,² W. Flores,² A. Buzby,² K. Reimann,² B. Collins,¹ A. Kirk.¹
Risk Factors and Outcomes with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections among Solid Organ Transplant Recipients

J. Anesi,¹ E. Blumberg,¹ E. Lautenbach,¹ J. Omorogbe,¹ P. Tolomeo,¹ P. Tamma,² K. Thom,³ K. Alby,¹ W. Bilker,¹ A. Werzen,³ K. Nemati,² J. Han.¹
Risk Factors and Sequelae of Post-KT Delirium

M. McAdams DeMarco, A. Mountford, F. Warsame, R. Berkowitz, H. Ying, C. Haugen, D. Brennan, D. Segev.
Risk Factors for Failure to Complete Post-Donation Follow-Up among Obese Living Kidney Donors

R. Reed,¹ P. MacLennan,¹ B. Shelton,¹ M. Mustian,¹ D. McWilliams,¹ D. Sawinski,² J. Locke.¹
Risk Factors for Postoperative Bleeding after Lung Transplantation

D. Adelmann,^1,2 S. Koch,¹ J. Menger,¹ P. Jaksch,³ M. Kurz,¹ M. Mouhieddine,¹ W. Klepetko,³ B. Steinlechner.¹
Risk Factors of De Novo Malignancies after Liver Transplantation

M. Altieri,¹ O. Seree,² J. Dumortier,³ GREF2 Groupe de Recherche Français en Greffe de Foie.
Risk of Bacteremia According to Transplant Induction Immunosuppression Regimen

E. Misch, S. Kelley, G. Leverson, B. Astor, D. Kaufman.
Risk of Infection in Treatment of Acute Cellular Rejection in Heart Transplant Recipients

T. Fallah, A. Logan, A. Rumore, C. Doligalski.
Rituximab Induction to Prevent the Recurrence of PSC after Liver Transplantation-The Lessons Learned from ABO-Incompatible Living Donor Liver Transplantation-

Y. Yamada,¹ K. Hoshino,¹ M. Shinoda,¹ H. Obara,¹ S. Uemoto,³ T. Kaido,³ H. Okajima,³ T. Yagi,⁴ T. Yoshizumi,⁵ Y. Inomata,⁶ T. Hibi,⁶ K. Kubota,⁷ T. Suzuki,⁸ Y. Kitagawa,¹ H. Egawa,² T. Kuroda.¹
Role of BK Virus-Specific T Cell Immune Monitoring for BK Virus-Associated Nephropathy in Kidney Transplant Recipients

J. Bruminhent,¹ S. Srisala,² C. Klinmalai,³ S. Pinsai,¹ S. Watcharananan,¹ S. Kantachuvessiri,⁵ S. Hongeng,⁴ N. Apiwattanakul.³
Role of Calcium/Calmodulin Kinase IV on Podocyte Function in Transplant Glomerulopathy

R. Bhargava, K. Maeda, A. Ferreti, M. Pavlakis, G. Tsokos.
Role of Obesity in Pediatric Liver Transplantation

K. Covarrubias, M. Denhard, X. Luo, J. Garonzik-Wang, A. Cameron, D. Segev, D. Mogul.
Safety and Efficacy of Rabbit Anti-Thymocyte Globulin Induction in Pediatric Patients Undergoing Cardiac Transplantation

M. Sell,¹ A. Haney,¹ K. Sprott,¹ A. Burnette,² H. Henderson,² A. Savage.²
Safety and Efficacy of Real-World Use of Everolimus for Kidney Transplant Patients: Post-Marketing Surveillance in Japan

H. Harada,¹ Y. Watarai,² J. Uchida,³ O. Kamisawa.⁴
Safety and Efficacy of Sofosbuvir-Based Direct-Acting Antiviral Agents in Kidney Transplant Recipients with HCV: A Systematic Review and Meta-Analysis

X. Wang,¹ P. Tan,¹ T. Xiang,² Y. Qiu,¹ T. Song,¹ T. Lin.¹
Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review

Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Scoring Transplant Glomerulopathy Using Morphometry: Correlation with Banff Criteria

M. Morales, A. Denic, W. Park, B. Smith, M. Alexander, M. Stegall.
Screening Coccidioides Serology in Kidney Transplant Recipients: A 10-Year Cross-Sectional Analysis

K. Phonphok,¹ T. Duong,¹ N. Datta,¹ O. Beaird,² J. Shaenman,² S. Bunnapradist.¹
Searching for Recipient-HLA Class II and Donor-HLA-Derived Peptide Complexes Inducing Protective Effect against De Novo Donor-Specific HLA Antibodies Formation in Kidney Transplantation

T. Tomosugi,¹ K. Iwasaki,¹ M. Okumura,¹ Y. Matsuoka,¹ K. Horimi,¹ M. Okada,² Y. Watarai,² T. Kobayashi.¹
Self-Reported Post-Surgical Pain Following Living Kidney Donation

A. Fleishman,¹ J. Schold,² P. Morrissey,³ J. Whiting,⁴ J. Vella,⁴ L. Kayler,⁵ D. Katz,⁶ J. Jones,⁶ B. Kaplan,⁷ M. Pavlakis,¹ D. Mandelbrot,⁸ J. Rodrigue.¹
Sequential Percutaneous Insertion of Two Plastic Biliary Stents through One Percutaneous Access for Biliary Anastomotic Strictures after Liver Transplantation

F. Boyvat,¹ A. Harman,¹ A. Akdur,² C. Aytekin,¹ M. Kirnap,² G. Moray,² M. Haberal.²
Serum Beta-(1,3)-D-Glucan as a Case-Finding Tool during an Outbreak of Pneumocystitis jirovecii Pneumonia in Abdominal Transplant Patients

J. Mittal, J. Mogollon, K. Cowman, P. Nori, V. Muggia, G. Minamoto, Y. Puius.
Shared Genetic Ancestry as a Predictor of Medium Term Renal Transplant Outcome in Deceased Donor Transplants

C. Stapleton,¹ On behalf of the UK and Ireland Renal Transplant Consortium, P. Conlon,² G. Cavalleri.¹
Sharing Works; Avoiding Kidney Transplantation to an Unintended Recipient by Precision Virtual Cross Match with Excellent Outcomes

G. Roll,¹ A. Webber,¹ M. Travakol,¹ D. Gae,¹ L. Mayen,² V. Corpuz,¹ J. Roberts,¹ N. Ascher,¹ P. Stock,¹ R. Rajalingam.¹
Shikonin Inhibits Th17 Development through Repressing STAT3 Activation

H. Fang,¹ R. Zhang,¹ F. Liang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
Short-Term Outcome Prediction Model in Deceased Donor Kidney Transplant Recipients

K. Archer,¹ Y. Zhang,¹ S. Bontha,² E. Akalin,³ L. Gallon,⁴ D. Maluf,² V. Mas.²
Shortened Cold Ischemia Time and Reduced Incidence of Delayed Graft Function for Kidney Transplants through Enhanced Tissue Compatibility Testing

I. Helanterä,¹ T. Saarinen,² J. Peräsaari,² M. Lempinen,¹ J. Lauronen.²
Shortening Length of Post-Operative In-Patient Stay for Living Kidney Donors

M. Loiselle, H. Bruschwein, J. Jacobs, S. Gulin, T. Rose, H. Arora, R. Nash, A. Toledo, T. Kozlowski.
Should Kidneys from Donation after Cardiac Death Expanded Criteria Donors Be Transplanted?

D. Harriman, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Side Effect Profile of Everolimus in Liver Transplant Patients

F. Kumssa, O. Sadiq, M. Alimirah, R. Kaur, A. Patel, S-.M. Jafri.
Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients

S. Lee,¹ K. Huh,² J. Jeon,³ S-.J. Kim,⁴ Y. Kim,² C-.K. Oh.¹
Simultaneous Persistence and Development of Donor and Recipient Tissue Resident Memory T Cells in Lung Transplantation

M. Snyder,¹ T. Connors,² C. Marboe,³ L. Benvenuto,¹ L. Shah,¹ H. Robbins,¹ J. Hook,¹ F. D'Ovidio,⁴ M. Bacchetta,⁴ J. Sonnett,⁴ S. Arcasoy,¹ D. Farber.^4,5
Single Center Experience of HLA-Related Donor Specific Antibody in Living Donor Liver Transplantation

H. Egawa,¹ Y. Kotera,¹ A. Ohmori,¹ S. Yamashita,¹ T. Kato,¹ S. Nemoto,¹ T. Ishizuka,² M. Yamamoto.¹
Single Reduced Dose Thymoglobuline as Induction in Kidney Retransplant

K. Linhares-Silva, M. Cristelli, L. Viana, C. Felipe, H. Proença, R. de Marco, J. Medina-Pestana, H. Tedesco Silva J�nior.
Single versus Bilateral Simultaneous Nephrectomy during Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease

C. Choi,¹ S. Cho,¹ M-.J. Cho,¹ W. Cho,¹ S. Ahn,¹ S-.I. Min,¹ S-.K. Min,¹ S. Kim,² J. Ha.¹
Single vs. Multi-Drug Antibiotic Prophylaxis for Continuous-Flow Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis

S. Patel,¹ J. Choi,¹ E. Moncho Escrivà,² S. Rizvi,¹ L. Samuels,¹ J. Luc,³ R. Morris,¹ H. Massey,¹ V. Tchantchaleishvili,¹ N. Aburjania.⁴
Single-Center Experience of Biliary Reconstruction for Multiple Bile Duct in Right Lobe Living Donor Liver Transplantation

J-.D. Kim, D-.L. Choi, T. Kim.
Single-Dose Basiliximab Induction in Liver Transplant Recipients with Delayed CNI Initiation

D. Salerno,¹ N. Lange,¹ R. Rosenblatt,² C. Sammons,³ B. Fortune.²
Single-Dose Pharmacokinetics and Pharmacodynamics of Belatacept in Adolescent Kidney Transplant Recipients

A. Moudgil,¹ V. Dharnidharka,² D. Feig,³ B. Warshaw,⁴ V. Perera,⁵ B. Murthy,⁵ M. Roberts,⁵ M. Polinsky,⁵ R. Ettenger.⁶
Sirolimus Use Improves Cancer-Free Survival Following Transplantation: A Single Center 10-Year Analysis

P. Chen,² L. Nair,² A. Ata,² D. Conti,¹ R. Lopez-Soler.¹
Sirolimus-Based, Prednisone-Free Regimen in Kidney Transplantation: Long Term Results of an Open-Label, Randomized Controlled Trial

A. Shetty,¹ B. Ho,¹ V. Mas,² Y. Kassis,¹ S. Park,¹ J. Leventhal,¹ D. Chhabra,³ L. Gallon.¹
Small-for-Size Grafts Increase Recurrence of Hepatocellular Carcinoma in Liver Transplantation beyond Milan Criteria

E. Lee, S. Kim, J. Shim, J. Park, B. Na, S-.J. Park.
Solid Organ Transplantation and Data Mining: Risk Factors for Invasive Fungal Disease in Heart Transplant Recipients

N. Barros, D. Xie, C. Yek, T. Liu, X. Li, B. Adams-Huet, J. Martinez, S. Garg, J. Grodin, R. Morelend, A. Amin, F. Aras, J. Thibodeau, P. Mammen, M. Peltz, M. Drazner, W. Ring, R. Haley, R. La Hoz.
South Asian and Muslim Canadian Patients Are Less Likely to Receive Living Donor Kidney Transplant Offers Compared to Caucasian, Non-Muslim Patients

A. Ali,¹ A. Ayub,¹ C. Richardson,¹ N. Edwards,¹ T. Ahmed,¹ M. Novak,^2,3 I. Mucsi.¹
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients

M. Selim,¹ M. Zimmerman,¹ J. Kim,¹ T. Pearson,¹ C. Eriksen,¹ M. Wong,¹ B. Boettcher,² K. Regner,³ K. Saeian,⁴ H. Woehlk,² J. Hong.¹
Spigelius' Line Incision as a Successful Route to Extract the Kidney during Retroperitoneal Laparoscopic Live-Donor Nephrectomy

J. Qiu, G. Chen, Z. Wu, C. Wang, L. Chen.
State of the Union: Outcomes of a Single Center's A₂-to-B Transplants Two Years after the Implementation of KAS

S. Radomski, S. Rosen-Bronson, D. Li, M. Awwad, G. Vranic, B. Javid, P. Abrams, S. Yi, M. Cooper, A. Gilbert.
Steroid Avoidance in Renal Transplant Patients Treated with Everolimus and Low-Exposure Tacrolimus

T. Sandes-Freitas,^1,2 M. Sales,¹ J. Oliveira,¹ M. Oliveira,¹ G. Dantas,² C. Girão,¹ R. Esmeraldo.¹
Strongyloides Pre-Transplant Screening in Solid Organ Transplantation (SOT): Single Center Analysis

M. Al-Obaidi,¹ K. Vigil,¹ R. Hasbun,¹ A. De Golovine,² V. Machicao,³ L. Ostrosky,¹ S. Bynon,⁴ M. Nigo.¹
Sub-Clinical Acute Rejection (subAR) Detected by Both Surveillance Biopsy (SBx) and a Peripheral Blood Molecular Biomarker Correlates with De Novo Donor Specific Antibody (dnDSA) Following Kidney Transplant (KT)

R. Heilman,¹ J. Friedewald,² K. Kurian,⁵ T. Whisemant,⁵ E. Poggio,³ C. Marsh,⁵ P. Baliga,⁷ N. Bridges,⁴ J. Odim,⁴ M. Brown,⁴ D. Ikle,³ B. Armstrong,³ L. Zhao,² D. Salomon,⁵ M. Abecassis.²
Subclinical Borderline Rejection: More Than Meets the Eye?

M. Bernard, G. Agarwal, H. Fatima, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, A. Patel, G. Towns, M. Seifert, R. Mannon.
Subnormothermic Machine Perfusion (SNMP) with Human Hemoglobin(Hb)-Based Oxygen Carriers (HBOCs)perfusate Decreased Hepatocellular Reperfusion Injury of Donation after Cardiac Death (DCD) Donor in Pig Model

T. Shonaka,¹ N. Matsuno,¹ H. Obara,² R. Yoshikawa,² Y. Nishikawa,³ M. Gochi,¹ M. Otani,¹ H. Takahashi,¹ H. Azuma,³ H. Sakai,⁴ H. Furukawa.¹
Successful Desensitization with Carfilzomib-Based Regimen to Facilitate Lung Transplantation: Initial Experience

C. Ensor,¹ A. Zeevi,¹ M. Mangiola,¹ C. Iasella,¹ M. Marrari,¹ M. Morrell,¹ E. Lendermon,¹ S. Kilaru,¹ N. Shigemura,² J. DCunha,¹ J. McDyer.¹
Successful Management of Simultaneous Liver-Kidney Transplant Recipient with Primary Hyperoxaluria Using Intensive Continuous Dialysis

A. Abdelaziz, A. Nishio-Lucar, A. Doyle, S. Pelletier, S. Rasmussen, P. Lobo, K. Warburton.
Successful Patency in Blood Conduits for an Artificial Kidney Membrane with Biocompatible Coatings

R. Forbes,¹ E. Marsh,¹ S. Karp,¹ A. Buck,¹ D. Colvin,¹ P. Williams,¹ B. Chaudhuri,² S. Roy,² W. Fissell.¹
Successful Transplantation in a Sensitized Patient Allergic to Commercially Available Antibody Induction Agents

K. Venkatachalam, A. Malone.
Successful Transplantation of Black Kidneys from Rhabdomyolysis Donors

X-.P. Yuan,¹ C-.B. CHen,¹ Y. Zheng,¹ X. Gu,² Q. Zu,³ C. Wang,¹ X. He.¹
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85 in Older Recipients

A. Nickkholgh,¹ A. Agarwal,¹ A. Nishio Lucar,² K. Brayman,¹ A. Doyle,² J. Oberholzer.¹
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85: The Organ is Not Wholly to Blame

A. Agarwal,¹ A. Nishio Lucar,² A. Nickkholgh,¹ K. Brayman,¹ A. Doyle,² J. Oberholzer.¹
Supercooling of Human Livers to Extend the Preservation Time for Transplantation

R. de Vries,^1,2 S. Tessier,^1,2 P. Banik,^1,2 S. Ozer,^1,2 S. Napgal,^1,2 S. Cronin,^1,2 J. Markmann,^1,2 H. Yeh,^1,2 K. Uygun.^1,2
Surgical Categorization Improve Outcomes and Organ Utilization in Liver Transplant

H. Bohorquez,^1,2 H. Sharma,¹ D. Bruce,¹ A. Cohen,^1,2 C. Carmody,^1,2 J. Seal,¹ E. Bugeaud,¹ D. Sonnier,¹ A. Mathur,¹ D. Marroquin,¹ M. Voltz,¹ D. Lucia,¹ G. Loss.^1,2
Surgical Technique and Outcomes of Portal Vein Reconstruction of Adult-to-Adult Living Donor Liver Transplantation Recipients with Portal Vein Thrombosis

N. Kuriyama, A. Hayasaki, T. Fujii, Y. Iizawa, H. Kato, Y. Murata, A. Tanemura, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Surveillance for Mycoplasma/Ureaplasma Infection in Lung Transplant Recipients (LTRs)

L. Somerville, W. Sligl, N. Zelyas, D. Lien, J. Preiksaitis.
Survey of Rabbit Anti-Thymocyte Globulin Usage for Kidney Transplant Induction Therapy in the United States

K. Foster,¹ A. Dodson,² K. Gutierrez.²
Survival in Deceased Donor Kidney Transplant by Kidney Donor Profile Index versus Intensive Home Hemodialysis

A. Nishio-Lucar,¹ G. Lyons,² S. Bose,³ J. Ma,² K. Awuah,³ R. Lockridge.³
Survival, Cancer and PTLD Diagnosis after Late EBV Infection in Adult Kidney Transplantation

M. Morton,¹ G. Scullin,² K. Daga,² P. Klapper,² P. Vallely,² M. Picton.¹
Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life

S. Elwir,¹ A. Warren,¹ G. Saracino,¹ S. Asrani,¹ T. Elliott,² G. Klintmalm.¹
T Cell Lineage Imbalance and Regulatory Immune Populations in HCC Patients Undergoing Downstaging While Waitlisted for Liver Transplantation

P. Thevenot,¹ K. Nunez,¹ T. Sandow,² J. Gimenez,² J. Gonzalez-Rosario,¹ M. Patel,¹ A. Alfadhli,¹ D. Wyczechowska,³ A. Cohen.¹
T-bet and STAT6 Double Deficiency Favors IL-17 Immunity after Lung Transplantation

F. Liang,¹ R. Chen,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
T2Candida for Diagnosis of Candidemia in Solid Organ Transplant Recipients

T. McCarty, J. Baddley, J. Locke, R. Mannon, D. Eckhoff, V. Rusanov, S. Moser, P. Pappas.
TACI Polymorphisms Associated with Allograft Rejection in Mice and in Man

M. Barbosa,¹ E. Farkash,² J. Platt,³ M. Cascalho.³
TACI-Ig as a Desensitization Agent in a Rat Model of Antibody Mediated Rejection

N. Wilson,¹ B. Verhoven,² B. Boldt,² N. Bath,² X. Ding,¹ R. Redfield III.²
TLR-Activated Bregs Promote Islet Allograft Tolerance in an IL-10-Independent and TGF-β-Dependent Manner

L. Kojima, K. Lee, K. Deng, H. Tector, C. Dai, S. Kimura, C. Rickert, H. Yeh, J. Markmann.
TLR2 with TCR Signaling Mobilizes Treg Lymphatic Migration

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
TP53 Mutations Lead to Increased Transcription of Circular RNAs in Exosomes Enhancing Tumor Invasiveness in Hepatocellular Carcinoma Bases on Bioinformatics Analysis

Z. Yu, Y. Hou, R. Wang, X. Huang.
Tacrolimus and Isavuconazole Therapy: What about the Drug Interaction?

C. Gill,¹ N. Mercuro,¹ R. Kenney,¹ A. Jantz,¹ B. Summers,¹ N. Sulejmani,¹ S. Davis.^1,2
Tacrolimus-Based Maintenance Immunosuppression Decreases the Number of Peripheral Blood Transitional B Cells in Nonhuman Primates

J. Paster, K. Pruner, M. Hanekamp, J. O., W. Sommer, K. Robins, A. Bean, G. Benichou, J. Madsen.
Taking Specific Steps to Pursue Living Donor Kidney Transplant is Associated with Greater Odds of Having a Potential Living Donor Identified

A. Ali,¹ D. Toews,¹ N. Singh,¹ A. Ayub,¹ C. Richardson,¹ S. Dano,¹ D. Wong,¹ J. Peipert,² A. Waterman,² M. Novak,¹ I. Mucsi.¹
Target Tacrolimus Troughs and CYP3A5 Polymorphisms Do Not Predict Therapeutic Drug Exposure in African American and Caucasian Renal Transplant Recipients

K. Tornatore,^1,4 K. Attwood,² D. Brazeau,³ S. Chang,⁴ R. Venuto.⁴
Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation

J. Kwun,¹ B. Ezekian,¹ M. Manook,¹ J. Park,¹ J. Yoon,¹ J. Sloan-Lancaster,² C. Fortier,³ P. Rao,⁴ S. Knechtle.¹
Targeting Histone Deacetylase in Renal Tubular Epithelial Cells Inhibits Amplification of TH1 Cell-Mediated Inflammation

S. Kang, Y. Kim, S. Seo.
Targeting LTβR Classical NFκB Signaling Facilitates Inflammation Resolution

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
Targeting Lymphotoxin Signaling in Lymphatics Regulates Immune Sensitization, Elicitation, and Resolution

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
Targeting Plasma Cells with Anti-CD38mAb (Daratumumab) and CXCR4 Antagonist (Plerixafor) for Desensitization

J. Kwun,¹ E. Brian,¹ M. Manook,¹ J. Park,¹ K. Freischlag,¹ J. Yoon,¹ J. Yi,¹ M. Stegall,² S. Knechtle.¹
Technical Aspects of Orthotopic Liver Transplantation – A Survey-Based Study within the Eurotransplant, Swisstransplant, Scandiatransplant and British Transplantation Society Networks

Z. Czigany,¹ J. Bednarsch,¹ J. Böcker,¹ F. Meister,¹ I. Amygdalos,¹ W. Schöning,¹ T. Ulmer,¹ X. Rogiers,² P. Dutkowski,³ P-.D. Line,⁴ M. Malagó,⁵ U. Neumann,¹ G. Lurje.¹
Technical Challenges in Living Donor Kidney Transplantation – Diagnosis and Solutions

R. Öllinger,¹ K. Alqasim,¹ F. Klein,¹ N. Raschzok,¹ P. Ritschl,¹ S. Chopra,¹ N. Otto,² T. Denecke,³ U. Gerlach,¹ M. Schmelzle,¹ P. Reinke,² J. Pratschke.¹
Temporal Changes in Impact of HLA Mismatch among Pediatric Kidney Transplant Recipients

J. Ruck, A. Massie, N. Desai, D. Segev, J. Garonzik-Wang.
Temporal Trends in Living Kidney Donor Candidates

S. Singh,^1,2 V. DiCecco,² M. Luo,² Y. Li,² O. Famure.²
Temporary Contraindication of Obese Recipients in Kidney Transplantation: A New Morphometric Tool for Decision Support

U. Pinar,¹ Y. Renard,² D. Bedretdinova,³ C. Lebacle,¹ B. Parier,¹ Y. Hamoudi,¹ J. Irani,¹ T. Bessede.¹
Ten Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients

S. El Hajj, J. Azzi, M. Kim, S. Gabardi.
The AKI-Predict-Score: A New Prediction Model for Acute Kidney Injury after Liver Transplantation

M. Kalisvaart,¹ A. Schlegel,¹ I. Umbro,² K. Roberts,¹ D. Mirza,¹ T. Perera,¹ J. Isaac,¹ A. P. Mitterhofer,² J. de Jonge,³ P. Muiesan.¹
The Aggressive Phenotype: Center-Level Characteristics in the Use of Suboptimal Lungs

M. Kosztowski, E. Bush, X. Luo, A. Thomas, M. Bowring, D. Segev, J. Garonzik Wang.
The Anterior Rectus Sheath Approach Resulted in No Difference in Wound Complication Rates in Obese versus Non-Obese Renal Transplant Recipients

S. King,² S. Hill,² L. Lipscomb,² A. Jones,² R. Jeffries,² J. Africa.¹
The Association between Transplant Glomerulopathy and Graft Outcomes among Patients Undergoing Kidney Transplantation: Results of a Meta-Analysis

G. Kovács,¹ G. Devercelli,² Z. Vokó,^1,3 T. Zelei,¹ I. Hirji,² P. Keown.^4,5
The Brazilian Epitope Virtual Crossmatch Protocol: A Reliable Tool for Increasing Kidney Allocation among Highly Sensitized Patients

L. Sousa,¹ A. Silva,¹ M. Marroquim,¹ A. Coelho,¹ A. Lima,¹ F. Silva,¹ C. Carracosa,² G. Willcox,³ T. Leão,³ B. Correa,³ E. Guimarães,³ G. Maciel,³ J. Andrade,⁴ A. Andrade,⁴ R. Neto,⁴ S. Cavalcante,⁴ C. Leão,⁴ F. Cavalcante,⁵ A. Holanda,⁵ N. Gomes,⁶ A. Rego,⁶ S. Monte.¹
The Chauvet Workgroup: From Inception to the Future

H. Amer,¹ S. Jowsey-Gregoire,¹ M. Kumnig,² E. Moreno,³ W. Dean,⁴ C. Brown,⁵ S. Jarvholm,⁶ K. Coffman,⁷ P. Petruzzo,⁸ E. Morelon.⁸
The Clinical Efficacy of Seasonal Influenza Vaccination – Characteristics of Two Outbreaks of Influenza A(H1N1) in Immunocompromised Patients

I. Helanterä,¹ R. Janes,² V-.J. Anttila.³
The Combination of Area under Curve of Estimated Glomerular Filtration Rate for 2 Years and Annual Rate Change of Estimated Glomerular Filtration Rate Predicts Long-Term Graft Survival in Kidney Transplants

E. Lee,¹ J. Jeon,¹ S. Kim,¹ M. Kim,¹ K. Lee,¹ H. Jang,¹ J. Lee,¹ J. Hwang,² D. Kim,¹ Y-.G. Kim,¹ H. Oh,¹ W. Huh,¹ J. Kim.³
The Combination of pAMR and Circulating Donor-Specific Antibodies is Even More Associated with Cardiac Allograft Vasculopathy after Heart Transplant

J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Continuous Debate of Older Donors into Older Recipients: Another Angle

J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Effect of Donor Nephrectomy in the Older Living Kidney Donor: Single Centre Experience

K. Koutroutsos, A. Kousios, R. Charif, J. Galliford, N. Stubbs, H. Dulku, H. Orr, M. Loucaidou.
The Effect of Donor-Recipient Gender Matches on Living Donor Liver Transplantation

J. Han, Y. You, H. Choi, B. Kwak, D. Kim.
The Effect of Intravenous Immunoglobulin on In Vitro Human Antibody Binding to Genetically-Engineered Pig Cells – Relevance to Clinical Xenotransplantation –

T. Yamamoto,¹ Q. Li,¹ H. Iwase,¹ D. Ayares,² D. Cooper,¹ H. Hara.¹
The Effect of Pre-Transplant Insomnia and Post-Transplant Insomnia on Survival among Solid Organ Recipients

K-.F. Lee,² Y. Tsai,¹ C. Lin,¹ C-.B. Hsieh,^3,5 S. Wu,⁴ T. Chen,⁵ Y-.C. Lin,¹ W-.H. Lee,^6,7 F. Lin,⁸ C. Tsai.^1,9,10
The Effect of Tacrolimus Trough Level and Intrapatient Variability on the Transplant Outcomes in Kidney Transplantation

J. Lee,¹ J. Lee,¹ Y. Jung,¹ D. Kim,¹ S. Song,² J. Lee,³ J. Lee,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ B. Kim,⁴ K. Huh.¹
The Effect of an Organ Procurement Experience on Preclinical Medical Student Perceptions of Transplant Surgery

M. Feinstein, S. Marcus, D. Amara, B. Durcanova, G. Roll, B. Orandi.
The Effects of Age-Adjusted Marriage Duration on Graft Outcomes in Spousal Donor Kidney Transplantation

M. Yu,¹ J. Park,² H. Cho,¹ J. Ha,¹ C. Ahn,¹ Y. Kim,¹ H. Lee.¹
The Efficacy and Safety of Rituximab as Induction Therapy in Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials

X. Wang,¹ J. Chen,² X. Tu,² Y. Qiu,¹ T. Song,¹ T. Lin.¹
The Efficacy of Laser Speckle Flowgraphy Device for Intraoperative Evaluation of Renal Blood Flow after Reperfusion

M. Muramatsu,¹ Y. Itabashi,¹ Y. Takahashi,² K. Sakurabayashi,¹ T. Mizutani,¹ Y. Hyodo,¹ Y. Hamasaki,² T. Kawamura,¹ K. Sakai,¹ S. Shishido.^1,2
The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial

J. Yang, X. He, L. Wu, Z. Guo.
The Grade of Pre-Transplant Portal Vein Thrombosis in Liver Transplant Recipients Impacts Graft and Patient Survival

M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud, M. Rizzari.
The Impact of ABO Blood Type and Geography on Access to Lung Transplant

W. Tsuang, D. McMichael, X. Wang, M. Budev.
The Impact of Conversion from Immediate Release Twice-Daily Tacrolimus (Prograf®) to Once-Daily Extended Release Tacrolimus (Envarsus®) in Liver Transplant Recipients

M. Del Gaudio,¹ M. Cescon,¹ M. Ravaioli,¹ V. Bertuzzo,¹ C. Zanfi,¹ M. Serenari,¹ L. Maroni,¹ C. Morelli,² A. Pinna.¹
The Impact of Duration on Dialysis on the Pre-Transplant Allosensitization According to Panel Reactive Antibody Levels

Y. Jung,¹ D. Kim,¹ J. Lee,¹ S. Song,² J. Lee,³ B. Kim,⁴ J. Lee,¹ S. Kim,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
The Impact of Induction Agent on Development of Febrile Neutropenia Following Kidney Transplant

G. Dube, S. Husain, D. Cohen, S. Mohan.
The Impact of Lymphocele Formation after Kidney Transplantation on De Novo Donor Specific Antibody Formation

L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, K. Budde, O. Staeck, D. Khadzhynov.
The Impact of Marginal Factors on Postoperative Kidney Function of Complex Living Donors for Kidney Transplantation

T. Hiramitsu, K. Futamura, M. Okada, M. Tsujita, T. Ichimori, N. Goto, S. Narumi, Y. Watarai.
The Impact of Pre-Operative Opioid Use on Delayed Graft Function in Adult Kidney Transplant Recipients

N. Patel, B. O'Brien, D. Taber, N. Pilch, P. Baliga, Z. Elmaasarani, S. Ball, P. Mauldin, L. Wilson, R. Gilbert, J. Fleming.
The Impact of Rapamycin Conversion in Pediatric Liver Transplantation on Anti-HLA Antibody Formation and Allograft Fibrosis

R. Fischer,² L. Fromm,¹ J. Daniel,² A. Kats,² R. Hendrickson,² W. Andrews.²
The Impact of Spontaneous Bacterial Peritonitis on Patient Outcomes after Liver Transplantation Using the Scientific Registry of Transplant Recipient (SRTR) Database

D. Moonka,¹ G. Divine,² S. Nagai.³
The Impact of a Tobacco Prohibition Policy Compared to a Restrictive Policy on Liver Transplant Candidate Outcomes

A. Likhitsup,¹ A. Hassan,¹ J. Mellinger,¹ F. Askari,¹ G. Winder,² P. Sharma,¹ N. Saeed,³ C. Sonnenday,⁴ R. Fontana.¹
The Impact of the Influenza Vaccine on Pediatric Kidney Transplant Outcomes

M. Camerino,¹ S. Jackson,² S. Chinnakotla,³ P. Verghese.¹
The Importance of Transplant Program Measures: Surveys of 3 National Patient Advocacy Groups

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ J. Snyder,^2,5 B. Kasiske,^1,4 A. Israni.^1,2,4
The Incidence and Risk Factors for Non – Adherence to Medical Treatment among Patients after Kidney Transplantation

T. Mashraki,^1,2,3 B. Rozen-Zvi,^1,4 E. Mor,^2,4 A. Yussim,^1,2 C. Avry,^1,4 R. Rahamimov.^1,2,3
The Influence Factors of DCD Donors' Family Members' Willingness in Chinese Current Status (Hunan Province Experience)

B. Tu, C. Li, C. Li, S. Liu, Y. Zhao, X. She, Y. Ming.
The Influence of Rabbit Antithymocyte Globulin (rATG) Dose on the Incidence of CMV Infection in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis. A Propensity Score Matched Cohort Analysis

M. Ivani de Paula,^1,2 S. Bae,¹ J. Garonzik-Wang,¹ C. Felipe,² M. Cristelli,² A. Massie,^1,3 J. Medina-Pestana,² D. Segev,^1,3 H. Tedesco Silva J�nior.²
The Influence of a Conversion to Sirolimus-Based Immunosuppression on Non-Melanomatous Skin Cancer Incidence in Kidney Transplant Recipients over Long Term Follow Up

F. Daly,¹ P. O'Kelly,¹ F. Moloney,² D. Sexton,¹ P. Conlon.¹
The Infusion with a Difference: Patient Experiences with Belatacept

H. Murad, D. Malhotra, E. Cohen, W. Asch.
The Internet as a Source of Transplant-Related Information for New Kidney Transplant Candidates

W. Fu, N. Chai, P. Yoo.
The Kidney Allocation System from the Perspective of a Small Program in a Donor Service Area

K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² S. Hanna,² J. Africa.¹
The Learning Curve in 100 Consecutive Live Liver Donors Undergoing Pure Laparoscopic Right Hepatectomy

K. Suh, S. Hong, K. Yoon, J-.M. Lee, J-.H. Cho, N-.J. Yi, K. Lee.
The MicroRNA Landscape of EBV+ and EBV- PTLD

Y. Balachandran,¹ H. Zimmermann,² C. Esquivel,¹ S. Krams,¹ R. Trappe,² O. Martinez.¹
The Net State of Immunosuppression in Septuagenarian Liver Transplant Recipients: Balancing Rejection and Infection Risks

J. Casale,¹ J. Clark,¹ B. Ravichandran,¹ J. LaMattina.²
The New Crescentic Incision: A Good Option for Donor Nephrectomy

M. Haberal,¹ M. Kirnap,¹ A. Akdur,¹ E. Ayvazoglu Soy,¹ S. Yildirim,¹ G. Moray,¹ Z. Kayhan,² A. Torgay.²
The Novel Polymer Pro-Drug APP-103 Reduces I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model

K. Minami,^1,3 H. Uehara,^1,3 A. Elkhal,^1,3 A. Weins,³ S. Bae,^2,3 J. Reder,⁴ B. Houser,⁴ P. Kang,^2,3 S. Tullius.^1,3
The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis

R. Deng, B. Huang, Y. Shi, Y. Ma.
The Overriding Importance of HLA-DR Donor-Specific Antibody That is Correlated to CAV after Heart Transplant

E. Kransdorf, J. Patel, M. Kittleson, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Preclinical Application of the Tactile Discrimination Task in Rat Models

S-.H. Wu,^1,2 C-.J. Wen,^1,2 J-.J. Huang,^1,2,3 Y-.C. Pei,^1,2,3 C-.H. Lin,^1,2,4,5 H. Cheng,¹ Z-.L. Peng,^1,4,5 H-.I. Yang,⁶ F-.C. Wei.^1,2,5
The Prognostic Implications of Renal Function Recovery and Delayed Graft Function in Kidney Transplantation

S. Sandal, M. Cantarovich, A. Ramankumar, N. Saberi, C. Saw, D. Baran, P. Chaudhury, S. Paraskevas, J. Tchervenkov.
The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients

A. Khalil,¹ A. Chhabra,¹ A. Merchak,¹ L. Kahn,¹ J. Leventhal,² S. Ildstad.¹
The Renal Sparing Protocol after Heart Transplant That Keeps Giving

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, R. Sharoff, J. Kobashigawa.
The Role of Ex Vivo Normothermic Preservation in Minimizing Postreperfusion Syndrome in Liver Transplantation

A. Hassan, J. Cywinski, Q. Liu, D. Pezzati, D. Yang, L. Liu, G. Iuppa, K. Hashimoto, F. Aucejo, M. Fujiki, B. Eghtesad, S. Irefin, J. Fung, K. Abu-Elmagd, C. Miller, C. Quintini.
The Role of Pre-Emptive Antibiotic Therapy in Kidney Recipients of Donors with Urine-Only Positive Cultures

P. Cabrera,¹ A. Centeno,¹ J. Revollo,¹ J. Camargo.²
The Role of Resilience in Healthcare Transitions among Adolescent and Young Adult Kidney Transplant Recipients

S. Quinn,¹ H. Fernandez,² T. McCorkle,¹ F. Barg,³ K. Ginsburg, R. Rogers,¹ S. Amaral.
The Safety and Efficacy of Splenic Artery Ligation in Living Donor Liver Transplant Recipients

Y. Gunay, S. Ganesh, M. Molinari, A. Tevar, C. Hughes, A. Humar.
The Secret is Selection of Muscular Dystrophy for Success after Heart Transplant

M. Kittleson, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
The Study of the Influence on hIAPP Deposition and Dysfunction in INS-1 Cell by Calcineurin Inhibitors

J. Zhang, W. Lv, C. Zhang, N. Sun, X. Li, Y. Shi, A. Jiao, J. Lin, Y. Lv.
The Superiority of Plasma Enriched Perfusate for Assessment of Donor Kidneys in an Ex-Vivo Normothermic Perfusion (EVNP) Setting

J. Palma, I. Palma, Y. Smolin, A. Perry, J. Sageshima, R. Perez.
The Technique of Ileobladder and Kidney Transplantation in Rats and Pigs

M. Haberal,¹ M. Kirnap,¹ D. Ersoz,¹ D. Bacanli,² Z. Ersoy,³ M. Bayzakov,¹ A. Torgay,³ H. Ozdemir.⁴
The Value of Serum Dilution on DSA Outcome Analysis in Renal Transplantation

W. Huang,¹ L. Rebellato,² K. Briley,² P. Bolin,² S. Kendrick,³ A. Maldonado,⁴ D. Leeser,² C. Haisch,² M. Everly.¹
Therapeutic Drug Monitoring (TDM) of Suspension (SUS), Extended-Release (ER), and Intravenous (IV) Posaconazole (POS) at a Large Transplant Center

G. Haidar, R. Shields, C. Clancy, M. Nguyen.
Thymic Irradiation as a Maneuver for Repertoire Exchange in Costimulatory-Blockade-Based Immunotherapy

M. Mulvihill,¹ B. Ezekian,¹ Q. Gao,¹ K. Samy,¹ R. Davis,¹ F. Leopardi,¹ W. Giles,² F-.F. Yin,² C. Willett,² B. Collins,¹ A. Kirk.¹
Thymoglobulin Dose and Effect on Short-Term Kidney Transplant Outcomes

P. Sood, W. Christine, R. Mehta, A. Tevar, C. Puttarajappa, K. Schonder, K. Shimko, S. Hariharan.
Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations in Renal Transplant Recipients

K. Khalil, P. West-Thielke, A. Lichvar, E. Benedetti, S. Patel.
Time-Effect of Donor and Recipient Characteristics on Graft Survival after Kidney Transplantation

E. Molmenti,¹ J. Yang,³ C. Molmenti,² E. Grodstein,¹ H. Rilo,¹ L. Teperman.¹
Timeline and Histopathological Characteristics of Graft Failure after Kidney Transplantation: What is Preventable and What is Not?

S. Parajuli, F. Aziz, N. Garg, B. Muth, M. Mohamed, W. Zhong, B. Astor, D. Mandelbrot, A. Djamali.
Timing of Infections after Total Artificial Heart Implantation. What Did We Learn?

H. Chambers, A. Kalil, D. Florescu.
Timing of Treatment for Chronic Hepatitis C Infection in Patients with End-Stage Renal Disease Awaiting Transplantation

M. Eckman,¹ E. Woodle,² C. Thakar,¹ F. Paterno,² K. Sherman.¹
Torsion and Inversion of Intraperitoneal Kidneys Manifesting as Acute Allograft Dysfunction – A Case Series

P. Kandula, A. Patel, S. Bains, H. Sun.
Transmission of Rabies through Solid Organ Transplant: A Big Issue in China

J. Zhang, J. Lin, Y. Tian, L. Ma, W. Sun, L. Zhang, Y. Zhu, W. Qiu, L. Zhang.
Transplant Benefit to Patients with Long Dialysis Vintage

A. Massie, D. Crews, T. Purnell, J. Garonzik-Wang, D. Segev.
Transplant Cost Reduction in a Developing Country: “The Case of Guatemala”

S. Méndez,¹ B. Remey,² E. Reyes,¹ A. Aguilar-González,¹ R. Lou-Meda.¹
Transplant Psychiatry- A Growing Subspecialty. Introducing the Transplant Psychiatry Special Interest Group from the Academy of Psychosomatic Medicine

P. Zimbrean,¹ A. DiMartini,² C. Crone.³
Transplant Trends in Young Adults: Silent Alcohol Epidemic

N. Kemmer,² N. Bozanich,¹ S. Agrawal,² C. Albers,² R. Syed,² A. Alsina.²
Transplantation Tourism and Recipients Perspectives and Experience

F. Al Rahbi, I. Al Salmi.
Transplantation of DCD Livers vs. NDD and LDLT: Is There a Difference in Post-Transplant Kidney Dysfunction?

D. Kollmann,¹ S. Neong,¹ R. Rosales,¹ G. Sapisochin,¹ M. Bhat,¹ M. Cattral,¹ P. Greig,¹ L. Lilly,¹ D. McGilvray,¹ A. Ghanekar,¹ D. Grant,¹ M. Selzner,¹ F. Wong,² N. Selzner.¹
Transplantation of Restored Kidneys from Living Related Donors after Small Renal Tumor Resection: Report of 5 Cases

Y. Ogawa,¹ S. Shiroma,² K. Kojima,² R. Mannami,² M. Mannami,² N. Mitsuhata,² M. Nishi,⁴ H. Afuso.³
Transplantation of Very Small Pediatric En Bloc Renal Allografts from Donors Less Than 8 Months of Age Have Similar Outcomes to Donors More Than 8 Months

S. Aquil,^1,2,3 N. Mitrou,^1,3 V. McAlister,^1,2,3 A. Sener,^1,2,3 P. Luke.^1,2,3
Treatment Outcomes of FSGS Recurrence

J. Mansur,¹ D. Chang,² G. Medeiros,¹ M. Cristelli,¹ L. Viana,¹ S. Stopa,¹ C. Felipe,¹ G. Kirsztajn,¹ H. Tedesco-Silva.¹
Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis

X. Huang,² N. Joshi,¹ L. Luo,¹ G. Mitri,³ B. Lovelace,² A. Pham,³ X. Gao.¹
Treatment and Outcomes of Orthotopic Liver Transplant Patients Secondary to Hepatitis C Virus: A Single Center Experience

T. Chen,¹ M. Moaddab,¹ B. Pierce,¹ R. Ghobrial.²
Treatment of BK Viremia: Single-Center Experience

A. Karim, A. Hines, K. Wang, S. Saleh, B. Suleiman, W. Hassan, A. Maibam, M. Yaseen, A. Castellanos, V. Cornea, X. Mei, R. Gedaly, T. Waid, A. El-Husseini.
Treatment of HCV Infection in Renal Transplant Recipients

M. Rial, L. Tana, C. Alonso, H. Curcio, E. Chulluyan, D. Casadei.
Treatment of Multi-Drug Resistant Gram Negative Infections after Solid Organ Transplant

M. Heldman, B. Nelson, T. Babu, M. Ison.
Treg Regulate Distinct Lymphatic NFκB Signaling Pathways to Alter Migration and Immunity

W. Piao, Y. Xiong, L. Li, V. Saxena, J. Bromberg.
Tregs Expression Predicts Prognosis in Patients with Hepatocellular Carcinoma

A. Baquerizo,¹ V. Vavinskaya,² C. Frenette,¹ M. Nelson,¹ R. Schaffer,¹ J. Fisher,¹ L. Sher,³ B. Madani,¹ P. Pockros,¹ C. Marsh.¹
Trends of Racial and Education Disparity in Post-Kidney-Transplant Graft Survival and Patient Survival: Do Different Metrics Lead to Different Conclusions?

M. Garber, K. Ross, R. Hamoda, L. Plantinga, R. Patzer.
Triptolide Reduces the Required Dose of Tacrolimus by Attenuating Inflammation, Enhancing Immunosuppression, and Increasing Donor Chimerism in a Heterotopic Hindlimb Transplantation Model

C. Gu, F. Liu, J. Yang.
Tumor Recurrence in Kidney Transplant Recipients with a History of Pretransplant Malignancy

F. Becker,¹ K. Schütte Nütgen,² S. Reuter,² L. Kebschull,¹ T. Vowinkel,¹ N. Senninger,¹ D. Palmes,¹ T. Vogel,¹ R. Bahde.¹
Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life after Kidney Transplantation

T. Schachtner,^1,2,3 N. Otto,¹ P. Reinke.^1,2
Two Similar Risk Models Identify Different Patients for Graft Loss: Implications for Clinical Trials in DSA+ Kidney Transplant Recipients

A. Bentall, B. Smith, W. Park, C. Schinstock, M. Stegall.
UPMC Living Donor Champion Program

C. Caruso, C. Zell, G. Swaytha, B. Angela, S. Sarah, L. Elaine, P. Susan, W. Travis, H. Abhinav.
Ultrastructural Changes in Lung Allografts: Endothelial Changes Correlate with Donor Specific Antibody & Antibody Mediated Rejection

M. Alexander, A. Bentall, P. Abell Aleff, J. Scott, A. Roden.
Unilateral vs. Bilateral Dual Kidney Transplantation: University of Bologna Experience

M. Del Gaudio,¹ M. Ravaioli,¹ C. Zanfi,¹ V. Bertuzzo,¹ L. Maroni,¹ G. La Manna,² G. Liviano,² A. Siniscalchi,³ A. D'Errico,⁴ A. Pinna.¹
Upper Limb Early Cannulation Arteriovenous Grafts (ecAVG) for Complex Vascular Access – A Healthy Alternative to Central Venous Catheters (CVC)

M. Khurram,¹ I. Mosca,² F. Calder.³
Upper Limb Transplantation in the US: An Early Look at OPTN Data

J. Wainright,¹ L. Levin,² C. Wholley,¹ W. Cherikh,¹ D. Klassen,¹ L. Cendales.³
Upper Limb and Craniofacial VCA Donors in the US

J. Wainright, C. Wholley, W. Cherikh, J. Rosendale, D. Klassen.
Urinary CXCL9 Monitoring to Accompany a Safe CNI-to-Belatacept Conversion in Kidney Transplant Patients

P. Malvezzi,¹ C. Fischman,² T. Jouve,¹ B. Janbon,¹ P. Heeger,² L. Rostaing,¹ P. Cravedi.²
Urinary Cell Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

S. Joseph, H. Medel-Martinez, T. Bottiglieri, B. Wasek, S. Yeramaneni, J. Felius, C. Bonilla, O. Sido, C. Gottlich, B. Lima, S. Hall.
Urinary Microbiome Associated with Chronic Allograft Dysfunction in Kidney Transplants

A. Israni,^1,2 A. Muthusamy,² B. Wu,³ B. Guo,³ D. Knights,⁴ G. Al-Ghalith,⁴ J. Wu,¹ W. Oetting,⁵ D. Schladt,² R. Remmel,⁵ P. Jacobson,⁵ For DeKAF Genomics & GEN03 Investigators.¹
Urinary Proteomic Biomarkers for Prediction of Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients

H. Jung,¹ K. Jeong,¹ J-.H. Lim,¹ J. Choi,¹ J-.H. Cho,¹ S-.H. Park,¹ Y-.L. Kim,¹ C-.H. Lee,² M-.C. Baek,² B. Chung,³ S-.H. Lee,⁴ C-.D. Kim.¹
Urinary Proteomics as a Dignostic Mean for Chronic Humoral Rejection after Pediatric Kidney Transplantation

L. Pape, A. Melk, P. Zürbig, N. Kanzelmeyer.
Urinary Sulfate Excretion and Late Graft Failure in Renal Transplant Recipients

M. Said,¹ A. Post,¹ I. Minovic,¹ M. van Londen,¹ H. van Goor,² D. Postmus,³ M. Heiner-Fokkema,⁴ E. van den Berg,¹ A. Pasch,⁵ G. Navis,¹ S. Bakker.¹
Urinary Tract Infections May Be Associated with De Novo Donor-Specific Anti-Human Leucocyte Antigen Antibodies: Single-Center Study

M. Everly,¹ A. Babu,¹ K. Briley,² P. Bolin,² S. Kendrick,³ H. Jones,³ K. McLawhorn,³ A. Maldonado,⁴ C. Haisch,² D. Leeser,² L. Rebellato.²
Urine Pellet Podocyte mRNAs Correlate Closely with Late Kidney Allograft Loss-of-Function

A. Naik,¹ J. Aqeel,¹ D. Cibrik,² M. Samaniego,¹ M. Chowdhury,¹ S. Wang,¹ F. Afshinnia,¹ R. Wiggins.¹
Urine Podocin mRNA to Nephrin mRNA Ratio as a Marker of "Podocyte Stress" among Kidney Allografts Losing Function

A. Naik,¹ J. Aqeel,¹ D. Cibrik,² M. Samaniego,¹ S. Wang,¹ M. Chowdhury,¹ F. Afshinnia,¹ R. Wiggins.¹
Urological Complications of Prophylactic Ureteral Stent vs. No Stent in Kidney Transplant Recipients at Erie County Medical Center (ECMC)

M. Hamid,¹ J. Kumar,¹ S. Anjum,¹ S. Patel,² G. Gudleski,⁴ S. Mietz,³ M. Ott,³ S. Chang.¹
Use of Cyclin-Dependent Kinase Inhibitors to Reduce Gammaherpesvirus Reactivation

J. Hazleton,¹ L. van Dyk.²
Use of Granulocyte Colony-Stimulating Factor for Leukopenia Post-Renal Transplant

S. Hamel,¹ V. Kuo,² D. Johnson,¹ R. Bloom,³ D. Sawinski,³ J. Trofe-Clark.^1,3
Use of Perfusion Machine after Long Cold Ischemia Time: 3 Years Results

A. Matos,¹ L. Requião-Moura,¹ E. Tonato,¹ M. Souza-Durão,^1,2 M. Borrelli,¹ M. Nogueira,¹ P. Rubio,¹ A. Pacheco-Silva.^1,2
Use of Public Health Service Increased Risk Kidneys in Pediatric Renal Transplant Recipients: Recipient Characteristics

M. Meyers,¹ J. Shults,¹ B. Laskin,¹ P. Porrett,² M. Levine,² P. Abt,² S. Amaral,^1,2 D. Goldberg.¹
Use of Right or Left Kidneys in Living-Donor Kidney Transplantation. Comparative Study of 320 Cases

M. Perosa,¹ J. Branez,¹ H. Noujaim,¹ L. Mota,¹ B. Zeballos,¹ M. Castro,¹ G. Marchini,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ A. Saldanha,² H. Abensur,² W. Luconi,¹ T. Genzini-Miranda,³ R. Haddad,⁴ T. Genzini.¹
Using Distal Abdominal Aorta as an Outflow Tract for En Bloc Kidney Transplantation from Infant Donors with Extremely Low Body Weight

H. Dai,^1,2 L. Peng,¹ F. Peng,¹ G. Lan,¹ Y. Wang,¹ J. Chen,¹ L. Liu,¹ C. Gao,¹ Y. Guo,¹ C. Fang,¹ M. Nie,¹ W. Long,¹ S. Yu.¹
Using Visual Icons to Present Program Transplant Rate Information to the Public: Results of a Randomized Trial

C. Schaffhausen,^1,5 S. Chu,⁴ M. Bruin,⁴ J. Hibbard,³ J. Snyder,^2,5 B. Kasiske,^1,5 A. Israni.^1,2,5
Using a Data Analytics Platform to Improve Patient Care in Pediatric Lung Transplantation

B. Scully,¹ K. Hosek,² D. Dash,² K. Carberry,^1,2 E. Melicoff,³ M. Gazzaneo,³ G. Mallory,³ J. Heinle.¹
Using the Remuzzi Score to Guide Single vs. Dual Transplantation Mitigates the Risk of Early Graft Failure

J. Ayorinde, G. Pettigrew.
Utility of Combining Stereotactic Body Radiation Therapy (SBRT) to Transarterial Chemoembolization as Destination Therapy for Hepatocellular Cancer (HCC) within Milan Criteria

A. Murali, K. Soota, M. Karwal, T. Tanaka, J. Dunkelberg, M. Voigt.
Utilization of Public Health Service Increased Risk Kidneys in Pediatric Renal Transplant Recipients by Era

M. Meyers,¹ J. Shults,¹ B. Laskin,¹ P. Porrett,² M. Levine,² P. Abt,² S. Amaral,^1,2 D. Goldberg.²
Val-Ganciclovir Prophylaxis Delays Onset of EBV Viremia in the First Year Post-Solid Organ Transplantation in High-Risk Patients

S. Albatati,¹ A. Sharma,² S. Gantt,¹ K. Haubrich,¹ A. Wright,¹ T. Blydt-Hansen.¹
Validating MORAL in Living Donor Liver Transplantation for Hepatocellular Carcinoma

A. Bhatti, A. Qureshi, N. Khan, M. Butt, A. Waheed, A. Rana, F. Dar.
Validation of Edmonton Symptom Assessment Survey in Kidney Transplant Recipients (KTR)

M. Pokarowski, S. Dano, A. Albdalla, M. Khalid, O. Ekundayo, Y. Liao, N. Edwards, I. Mucsi.
Validation of Genetic Variants Identified in GWAS for Tacrolimus Troughs

P. Jacobson,¹ D. Schladt,² W. Guan,³ J. van Setten,⁶ R. Remmel,⁴ B. Wu,³ C. Dorr,⁵ B. Keating,⁷ D. Ikle,⁹ R. Mannon,¹⁰ A. Matas,⁸ A. Israni,⁵ W. Oetting.¹
Validation of the PROMIS-57 and PROMIS-29 Questionnaires in Kidney Transplant Recipients

E. Tang, A. Bansal, S. Cao, M. Li, M. Novak, I. Mucsi.
Validation of the alpha-Fetoprotein Model for Hepatocellular Carcinoma Recurrence after Transplantation in an Asian Population

J. Rhu, J. Kim, G. Choi, C. Kwon, J. Joh, S. Kim.
Variation in Hypothermic Machine Perfusion Utilization and Clinical Outcomes for Deceased-Donor Kidneys

V. Krishnamoorthy,¹ S. Wunsch,² K. O'Connor,² M. Souter.³
Variation in Living Donor Kidney Transplantation among U.S. Transplant Centers

T. Melanson,¹ M. Basu,¹ L. Plantiga,¹ S. Pastan,¹ S. Mohan,² R. Patzer.¹
Vascular Allografts in Renal Transplantation

D. Reino, G. Schnickel, E. Ale, S. Ebaid, N. Agrawal, S. Rhazouani, S. Gebreselassie, A. Tzakis.
Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry

H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, F. Filipponi, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.
Viability Outcomes for Donor Livers Discarded Due to Steatosis Following Extra-Corporeal Machine Perfusion of the Liver

Y. Boteon,^1,2 R. Laing,^1,2 D. Neil,² A. Schlegel,² J. Attard,^1,2 G. Reynold,¹ P. Muiesan,² D. Mirza,² S. Afford,¹ H. Mergental.²
Wait Times for Pediatric Liver Transplantation and the Impact of PELD/MELD Exception

K. Khan,¹ C. Desai,² F. Thomas,¹ K. Alexander.¹
Water-Jet Dissection for Donor Hepatectomy during Living Donor Liver Transplantation

K. Gotoh,¹ H. Eguchi,¹ Y. Iwagami,¹ D. Yamada,¹ T. Asaoka,¹ T. Noda,¹ K. Kawamoto,¹ S. Kobayashi,¹ K. Umeshita,² Y. Doki,¹ M. Mori.¹
Weight Changes before and after Kidney Donation

A. Bugeja,¹ S. Harris,² J. Ernst,¹ K. D. Burns,¹ G. Knoll,¹ E. G. Clark.¹
What Happened When the 'Soft Opt-Out' to Organ Donation Was Implemented in Wales? Family and Professional Views and Experiences, and Consent Rates for the First 18 Months

L. Mc Laughlin, J. Noyes, K. Morgan, P. Walton, A. Roberts, M. Stephens.
What Threshold MFI is the Luminex 1:8 Dilution the Poor Man's C1q for Patients Awaiting Heart Transplant?

M. Kittleson, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis

K. Yoon, K. Lee, S. Hong, J-.H. Cho, J-.M. Lee, N-.J. Yi, K. Suh.
Why the Low Usage of HIV Positive Donors? A Survey of the Transplant Community

S. Nazarian,¹ C. Watts,² D. Sawinski,² P. Reese,² D. Goldberg,² P. Abt,¹ S. Halpern,² J. Shea,² E. Blumberg.²
Willingness to Accept HIV-Positive and Increased Infectious Risk Donor Organs among HIV-Positive Transplant Candidates

M. Waldram, A. Eno, E. Lee, S. Seaman, A. Nguyen, S. Halpern, S. Anjum, J. Sugarman, M. Henderson, A. Tobian, D. Segev, C. Durand.
Willingness to Consider Increased Risk Donors: A Single Center Experience

V. Richards,¹ C. Johnson,¹ J. Perkins,² A. Limaye,³ L. Sibulesky.²
Y-Adapter Mediated Next Gen Sequencing of BKPyV from Archived FFPE Tissue

E. Harake,¹ W. Wu,² J. Opp,² E. Farkash.¹
You've Gotta Have HOPE: Seeking HIV Donors in a Large US OPO

A. Friedman,¹ S. Huprikar,² K. Delli Carpini.¹
mRNA Transcript Profiling of 3 Genes in Renal Allograft Biopsies (Bx) Improves Accuracy of Antibody-Mediated Rejection (ABMR) Diagnosis in Transplant Recipients Desensitized with IVIG+Rituximab+Immunoglobulin G-Degrading Enzyme of Streptococcus Pyogenes (IdeS)

H. Zhang,¹ C. Nast,² J. Doldron,² M. Cheung,² A. Vo,³ S. Jordan,³ M. Toyoda.¹
mTOR Inhibitor Based Immunosuppression Regimens Are Not Associated with Lower Risk for BK Infection

R. Daloul,¹ R. Pelletier,² A. Rajab,² G. Bumgardner,² M. Alebrahim,² C. Akateh,³ K. Washburn,² A. El-Hinnawi.²
p40 Homodimer Induced Proliferation of Endogenous Donor-Reactive Memory CD8 T Cells within High Risk Allografts Requires Memory CD8 T Cell Expression of CD122

H. Tsuda, A. Valujskikh, R. Fairchild.
Activity Nanosensors for Early and Noninvasive Detection of Acute Organ Transplant Rejection

Q. Mac,¹ D. Mathews,² J. Kahla,¹ C. Stoffers,¹ O. Delmas,¹ B. Holt,¹ A. Adams,² G. Kwong.¹
Carfilzomib and Belatacept Reduces DSA and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation

B. Ezekian, J. Kwun, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Cochran, K. Kroning, J. Yi, S. Knechtle.
Elevated Skin Specific Non-HLA Antibodies Correlate with Acute Rejection Episodes in Clinical VCA

B. Kollar,¹ A. Uffing,² T. Win,¹ S. Tasigiorgos,¹ B. Pomahac,¹ F. Quintana,³ L. Riella.²
Specific Monocyte Memory to Allogeneic MHC Mediated by Paired Immunoglobulin Receptors (PIR)

H. Dai,¹ P. Lan,² A. Friday,¹ A. Williams,¹ M. Oberbarnscheidt,¹ X. Li,² F. Lakkis.¹
CFZ533, a New Anti-CD40 mAB Demonstrates Comparable Efficacy and Better Renal Function versus Tacrolimus in De-Novo CNI-Free Kidney Transplantation

B. Nashan,¹ H. Tedesco,¹ M. van den Hoogen,¹ S. Berger,¹ D. Cibrik,¹ S. Mulgaonkar,¹ D. Leeser,¹ R. Alloway,¹ A. Patel,¹ J. Pratschke,¹ C. Sommerer,¹ A. Wiseman,¹ A. van Zuilen,¹ U. Laessing,² J. Rush,² B. Haraldsson,² O. Witzke.¹
Designing Novel Selective Immunoproteasome Inhibitors Reveals a Critical Role of the Immunoproteasome in Protecting Antibody Secreting B Cells from Apoptosis

J. Assaker,¹ N. Murakami,¹ S. Eskandari,¹ M. Uehara,¹ C. Nathan,² H. Li,³ G. Lin,² J. Azzi.¹
Donor Bone Marrow CXCR4+ Foxp3+ Treg Cells Are Essential for Costimulation Blockade-Induced Long-Term Survival of Murine Limb Transplants

L. Wang,¹ Z. Wang,¹ R. Han,¹ G. Ge,¹ L. Levin,² M. Levine,² W. Hancock.^1,2
Identification of Macrophage Innate Receptors in Recognition and Rejection of Allogeneic Non-Self in Transplantation

P. Lan,¹ H. Dai,² W. Liu,¹ S. Chen,¹ L. Minze,¹ Y. Dou,¹ Y. Zhao,¹ W. Chen,¹ X. Xiao,¹ P. Pan,¹ H-.H. Chen,¹ F. Lakkis,² X. Li.¹
Depletion Resistant Effector Memory T Cells Mediate Thymoglobulin Refractory Allograft Rejection in Human Intestinal Transplant Recipients

O. Aguirre, B. Houlihan, A. Karabala, C. Cosentino, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.
Outcomes after HIV+ Kidney Transplant: A HOPE in Action Study

C. Durand,¹ M. Bowring,¹ A. Tobian,¹ D. Brown,¹ N. Desai,¹ S. Bagnasco,¹ D. Ostrander,¹ A. Redd,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² S. Chandran,³ A. Chao,³ J. Locke,⁴ S. Mehta,⁴ R. Freidman,⁵ N. Turgeon,⁵ A. Massie,¹ D. Segev.¹
Role of B Cell Intrinsic NLRP3 in the Development of Chronic Rejection

J. Nie,¹ B. Ramaswami,² X. Guo,³ R. Hoffman,² G. Chalasani.³
Superior Outcomes Using Normothermic Regional Perfusion in CDCD Liver Transplantation

A. Hessheimer, E. Coll, A. Valdivieso, M. Gómez, J. Santoyo, P. Ramírez, M. Gómez-Bravo, R. López-Andujar, J. Villar, C. Jiménez, F. Lluís, L. Lladó, D. Casanova, M. Barrera, R. Charco, J. López-Baena, J. Briceño, F. Pardo, G. Blanco, D. Pacheco, B. Domínguez-Gil, V. Sánchez-Turrión, C. Fondevila.
An Early Look at the OPTN's New SLK Allocation Policy

A. Kucheryavaya,¹ R. Formica,² N. Turgeon,³ D. Stewart,¹ A. Wilk.¹
Risk of ESRD in Prior Living Kidney Donors

J. Wainright, A. Robinson, A. Wilk, D. Klassen, W. Cherikh, D. Stewart.
Superiority of Early Everolimus-Based Quadruple Immunosuppression versus Standard Triple Therapy after Lung Transplantation: 12 Months Results from Prospective 4EVERLUNG Study in Germany

J. Gottlieb, C. Neurohr, J. Müller-Quernheim, H. Wirtz, B. Sill, H. Wilkens, V. Besa, C. Knosalla, M. Junge, C. Capusan, M. Strüber.
Despite the Growing Impact of the American Opioid Epidemic on Organ Donation, a Small Percentage of Drug Intoxication Deaths Result in Organ Donation

L. Hickman,¹ J. Killian,¹ S. Windham.^1,2
Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study

S. Mulgaonkar,¹ J. Pascual,¹ S. Chadban,¹ H. Tedesco,¹ S. Berger,¹ Y. Qazi,¹ C. Legendre,¹ N. Basic-Jukic,¹ P. Bernhardt,² F. Vincenti.¹

« View all sessions from the 2018 American Transplant Congress